Conditions > Cancer of Colon
Page last updated: 2024-09-28

Cancer of Colon

Synonyms(6)

Synonym
Neoplasms, Colonic
Colon Neoplasms
Cancer of Colon
Colonic Cancer
Cancer of the Colon
Colon Cancer

Research Excerpts

Overview

ExcerptReference
"Cancer of the colon is subject to somewhat different controlling elements than cancer of the breast because of the nature of the cell kinetics governing these tissues."( Weisburger, JH, 1979)
"Incidence rate of colon cancer is low in India compared to the Western countries."( Gangadharan, P; Jussawalla, DJ, 1977)
"Screening for colon cancer is discussed with a selective diagnostic approach and with emphasis on this approach in early diagnosis of asymptomatic high risk patients."( Copeland, MM, 1976)
"Human colon cancer is resistant to a variety of alkylating agents including the nitrosoureas."( Arce, C; Berger, NA; Gerson, SL; Petzold, SJ; Willson, JK, 1992)
"Colon cancer is the second most common type of cancer in the United States."( Bernstein, H; Cheah, PY, 1990)
"Colon cancer is one of the tumors most refractory to treatment by chemotherapy, and this may be due to inherent phenotypic instability of such tumor cells with respect to the biochemical determinants of drug sensitivity."( Cheng, YC; Ferguson, PJ, 1989)
"Preclinical colon cancer is associated with a further decrease in serum cholesterol levels."( Broitman, SA, 1986)
"The incidence of colon cancer is increasing in Sweden."( Mellström, D; Rundgren, A, 1983)
"Rat colon neoplasms are distributed 60% in the distal colon (DC) and 40% in the proximal colon (PC), similar to distribution of colon cancers in the industrialized world."( Holt, PR; Liu, T; Mokuolu, AO; Rao, CV; Reddy, BS, 1995)
"Colon cancer is associated with elevated levels of PGE2, while aspirin, the prototypical inhibitor of PG synthesis, appears to reduce the incidence of colon cancer by 50%."( Arvind, P; Duceman, B; Lovelace, CI; Papavassiliou, ED; Qiao, L; Rigas, B; Tsioulias, GJ, 1995)
"Human colon cancer is associated with antigenic and structural changes in mucin-type carbohydrate chains (O-glycans)."( Brockhausen, I; Byrd, JC; Chung, YS; Kim, YS; Matta, KL; Okuno, M; Siddiki, BB; Sowa, M; Yang, JM, 1994)
"Colon cancer is one of the major health problems in industrialized countries, and its incidence appears to be increasing."( Aquino, A; Armenio, S; Civitelli, S; Francini, G; Lorenzini, L; Mancini, S; Marsili, S; Marzocca, G; Petrioli, R; Tanzini, G, 1994)
"Human colonic cancer is associated with multiple genetic deletions, mutations, and alterations in gene expression; in contrast, gene amplification has not been recognized as a prominent characteristic of human colonic tumors."( Augenlicht, LH; Benson, A; Corner, G; Haller, D; Heerdt, BG; Multani, AS; Pathak, S; Richards, C; Ryan, L; Wadler, S, 1997)
"Colon cancer is the second most common cause of cancer mortality."( Bohdiewicz, PJ, 1998)
"Human colon cancer is a multistage disease which has been shown to have a number of well-defined histological and genetic events."( Davies, MJ; Rumsby, PC, 1998)
"Colon cancer is one of the commonest cancers in the Western world."( Holt, PR, 1999)
"Colon cancer is the third most common newly diagnosed cancer in the United States and the third most common cause of cancer-related deaths."( Davis, CD; Feng, Y; Finley, JW, 2000)
"Colon cancer is the third leading class of cancer causing increased mortality in developed countries."( Argov, S; Goldstein, J; Guterman, H; Mordechai, S; Ramesh, J; Salman, A; Sinelnikov, I, 2002)
"The risk of colon cancer is decreased among current and recent users of postmenopausal HRT but the molecular mechanisms involved remain unclear."( al-Azzawi, F; Wahab, M, 2002)
"Colon cancer is one of the most common forms of malignant tumors in humans, and its incidence is increasing."( Manju, V; Menon, VP; Nalini, N, 2004)
"The incidence of colon cancer is high in many developed nations, especially New Zealand."( Ferguson, LR; Karunasinghe, N; Philpott, M, 2004)
"Metastatic colon cancer is frequent and often simulates ovarian endometrioid adenocarcinoma."( Prat, J, 2005)
"Colon cancer is one of the highest incidence rates throughout the world and some evidences have indicated carotenoids as possible agents that decrease the risk of colorectal cancer."( Agner, AR; Bazo, AP; Ribeiro, LR; Salvadori, DM, 2005)
"The development of colon cancer is characterised by alterations in multiple genetic and epigenetic pathways in colon tissue leading ultimately to deregulation of colon epithelial cells."( Arthur, JR; Drew, JE; Duncan, G; Duthie, GG; Farquharson, AJ; Lufty, A; Morrice, PC; Reid, MD; Rucklidge, GJ; Russell, WR, 2005)
"Colon cancer is the second leading cause of cancer death in the United States, whereas cancer of the small intestine is relatively rare."( Chapkin, RS; Donnelly, KC; Lupton, JR; Popovic, N; Turner, ND; Zhou, GD, 2005)
"Colon cancer is the third most common cancer and second leading cause of cancer-related death in the United States."( Balasubramaniyan, V; Manju, V; Nalini, N, 2005)
"Colon cancer is one of the most common malignancies in many regions of the world and is thought to arise from the accumulation of mutations in a single epithelial cell of the colon and rectum."( Deeptha, K; Kamaleeswari, M; Nalini, N; Sengottuvelan, M, 2006)
"Colon cancer is a leading cause of cancer and cancer deaths in Western countries."( Cilley, J; Mulcahy, MF, 2006)
"Mortality from colon cancer is significant with an expected 30,350 colon cancer deaths in 2005 with current treatment(s)."( Alli, AA; Gower, WR; Vesely, BA; Vesely, DL, 2005)
"Colon cancer is the second most common cancer among men and women worldwide."( Manju, V; Menon, VP; Nalini, N, 2006)
"Colon cancer is a leading cause of cancer death and its prevention is of great interest throughout the world."( Kamaleeswari, M; Nalini, N, 2006)
"Colon cancer is becoming increasingly common in Asian countries and still remains the second leading cause of cancer death in the United States."( Manju, V; Nalini, N, 2006)
"Colon cancer is c-kit positive and responsive to the specific tyrosine kinase inhibitor imatinib."( Chalkiadakis, G; Kanakis, I; Karamanos, NK; Kletsas, D; Mavroudis, D; Roussidis, AE; Stahtea, XN; Tzanakakis, GN, 2007)
"Colon cancer is the third most malignant neoplasm in the world and it remains today an important cause of death, especially in western countries."( Namasivayam, N; Sreedharan, V; Venkatachalam, KK, 2009)
"Colon cancer is a major cause of morbidity and mortality in developed and developing countries."( Nalini, N; Sengottuvelan, M; Srihari, T, 2008)
"Colon cancer is a public health problem worldwide."( Duhoux, F; Mano, MS, 2008)
"Colon cancer is still one of the leading causes of death in USA and is increasing at an alarming rate in Asia."( Aranganathan, S; Nalini, N; Panneer Selvam, J, 2009)
"Colon cancer is also associated with the expression of pyruvate kinase M2, a splice variant with low catalytic activity."( Carswell, KN; Ganapathy, V; Prasad, PD; Thangaraju, M, 2009)
"Colon cancer is one of the leading causes of cancer death in men and women in Western countries."( Rimando, AM; Suh, N, 2008)
"Colon cancer is a major cause of morbidity and mortality in developed and developing countries and its etiology is known to be a combination of hereditary, environmental, dietary factors and lack of physical activity."( Giftson, JS; Jayanthi, S; Nalini, N, 2010)
"Colon cancer is a serious health problem in most of the countries and is the leading cause of cancer mortality throughout the world."( Aranganathan, S; Gopalan, R; Nalini, N; Selvam, JP, 2009)
"Colon cancer is the third most common cancer and third most common cause of cancer-related death in the USA according to 2008 American Cancer Society statistics."( Chen, J; Huang, XF, 2009)
"Colon cancer is one of the major causes of cancer mortality worldwide."( Ashokkumar, P; Prabhu, PN; Sudhandiran, G, 2009)
"Colon cancer is the second leading cause of cancer death worldwide."( Babaei, MH; Ghannadi Maragheh, M; Mesbah-Namin, SA; Taghikhani, M; Yavari, K, 2010)
"Progression of colon cancer is associated with the up-regulation of cyclooxygenase-2 (COX-2) and hydroxymethyl glutaryl CoA reductase (HMG-R)."( Guruswamy, S; Rao, CV, 2009)
"Colon cancer is the third most malignant neoplasm in the world and it remains an important cause of mortality in Asian and Western countries."( Nagendraprabhu, P; Sudhandiran, G, 2011)
"Colon cancer is a major cause of cancer deaths."( Aluri, L; Badal, S; Bissonnette, M; Cerasi, D; Cerda, S; Delgado, J; Dougherty, U; Fichera, A; Hart, J; Joseph, L; Kocherginsky, M; Mustafi, R; Sehdev, A; Taylor, I; Tekin, U; Threadgill, D; Zhu, H, 2009)
"Colon cancer is one of the most common malignant tumors, and its pathogenesis is not fully understood."( Huo, JR; Ren, JZ, 2010)
"Colon cancer is the third and fourth most prevalent cancer among Iranian men and women, respectively."( Amanzadeh, A; Azadmanesh, K; Teimoori-Toolabi, L; Zeinali, S, 2010)
"Colon cancer is the leading cause of cancer death in both men and women worldwide."( Ramana, KV; Srivastava, SK; Tammali, R, 2010)
"Since colon cancer is highly sensitive to dietary intervention adults who may have preneoplastic lesions in their colon may be benefited by silibinin."( Aranganathan, S; Nalini, N; Panneerselvam, J; Rama, G; Sangeetha, N; Shanthi, P, 2010)
"Colon cancer is the third leading cause of cancer-related deaths worldwide."( Graham, B; Rogers, C; Stevens, JJ; Tchounwou, PB; Walker, AM, 2010)
"Colon cancer is a common malignant tumor that is associated with increased morbidity and mortality."( Guo, Q; Lian, P; Liao, M; Shen, S; Wang, X, 2010)
"Colon cancer is the fourth most common cancer globally with 639,000 deaths reported annually."( Colombo, G; Sonvico, F; Wong, TW, 2011)
"Colon cancer is a public health problem worldwide."( Aravantinos, G; Bafaloukos, D; Bamias, A; Basdanis, G; Dimopoulos, MA; Economopoulos, T; Efstratiou, I; Fountzilas, G; Kafiri, G; Kalofonos, HP; Karanikiotis, C; Karina, M; Klouvas, G; Korantzis, I; Makatsoris, T; Malettou, L; Matsiakou, F; Miliaras, D; Papadimitriou, CA; Papakostas, P; Papaspirou, I; Pectasides, D; Pentheroudakis, G; Pisanidis, N; Samantas, E; Xiros, N, 2011)
"Colon cancer is the third most malignant neoplasm in the world and chemoprevention through dietary intervention is an emerging option to reduce its mortality."( Sudhandiran, G; Umesalma, S, 2011)
"Colon cancer is the third leading cause of cancer deaths in men and women."( Das, UN; Radhakrishnan, S; Reddivari, L; Sclafani, R; Vanamala, J, 2011)
"Colon cancer is the third most common cause of cancer and is the second leading cause of cancer deaths in the USA."( Awasthi, S; Evers, BM; Qiu, S; Ramana, KV; Reddy, AB; Rychahou, PG; Saxena, A; Srivastava, SK; Tammali, R, 2011)
"Colon cancer is a leading cause of cancer deaths in Western countries and is associated with diets high in red meat."( de Wit, N; Dekker, J; IJssennagger, N; Jonker-Termont, D; Müller, M; Rijnierse, A; van der Meer, R, 2012)
"Colon cancer is one of the most common human cancers worldwide."( Chang, JL; Chen, TC; Ho, JY; Wang, TH; Wu, HC, 2012)
"Colon cancer is one of the serious health problems in most developed countries and its incidence rate is increasing in India."( Akbarsha, MA; Bernini, R; Menon, VP; Nalini, N; Preethy, CP; Riyasdeen, A; Sivagami, G; Vinothkumar, R, 2012)
"Colon cancer is one of the most common malignancies, mainly initiated by the abnormal activation of Wnt/β-catenin signaling."( He, B; Liu, Y; Mu, Y; Wu, K; Yang, Q; Zhou, L; Zhou, Q, 2012)
"Colon cancer is the second most common cause of cancer death in Iceland and accounts for 8% of malignancies."( Alexiusdottir, KK; Björnsson, ES; Jonasson, JG; Jonasson, L; Möller, PH; Olafsdottir, EJ; Snaebjornsson, P; Tryggvadottir, L, 2012)
"The model of distal colon cancer is feasible."( Abrantes, AM; Batista, JN; Botelho, MF; Cardinalli, IA; Neves, S; Priolli, DG, 2012)
"Colon cancer is one of the most common malignances."( Ding, M; Du, JL; Pan, JY; Wen, G; Weng, XL; Yu, ML; Zhao, F; Zhao, J, 2012)
"Colon cancer is the third most common cancer and one of the leading causes of cancer-related death in the world."( Li, J; Xiong, Y; Xu, W; Yan, Z; Zheng, G, 2012)
"Colon cancer is associated with a poor prognosis, motivating strategies to prevent its development."( Ha, J; Kim, EJ; Ko, YG; Lee, M; Lee, YJ; Park, JJ; Seo, SM, 2012)
"Colon cancer is the third most common malignancy around the world."( Cha, EY; Kim, JY; Lee, JS; Lee, MS; Park, JB; Song, IS; Sul, JY, 2012)
"Colon cancer is the third most common malignant neoplasm in the world and it remains an important cause of death, especially in western countries."( Ali, F; Hamiza, OO; Khan, AQ; Khan, R; Lateef, A; Rehman, MU; Sultana, S; Tahir, M, 2012)
"Colon cancer is a common malignant neoplasm causing huge morbidity and mortality worldwide."( Chitra, P; Manikandan, R; Saiprasad, G; Sudhandiran, G, 2013)
"Colon cancer is one of the most commonly diagnosed cancers in the United States."( Debnath, B; Garofalo, A; Grande, F; Imada, T; Masuda, M; Neamati, N; Oshima, T; Xu, S, 2013)
"Colon cancer is among the most common cancers in the United States, and the median age of patients at diagnosis is 70."( Goldberg, RM; Wu, C, 2013)
"Colon cancer is one of the major malignancies worldwide and it still remains resistant to much of the currently available chemotherapy."( Feng, Y; Gao, SH; Liu, C; Wei, J, 2013)
"Colon cancer is the leading cause of morbidity and mortality worldwide."( Dharmalingam, P; Ganapasam, S; Munusamy, A; Pandurangan, AK; Ramar, M; Sadagopan, SK, 2013)
"Colon cancer is a disease of the elderly and accordingly, there is a large subgroup of patients for which guidelines for adjuvant treatment remain less clear."( Ågesen, TH; Guren, MG; Lothe, RA; Nesbakken, A; Skotheim, RI; Sveen, A; Tveit, KM, 2013)
"Colon cancer is a malignancy that develops in colon and rectal tissues."( Haniu, H; Matsuda, Y; Tsukahara, T, 2013)
"Colon cancer is still the second leading cause of cancer deaths in the United States."( Knackstedt, RW; Morris, J; Moseley, VR; Wargovich, MJ, 2013)
"Colon cancer is a major public health problem."( Borrelli, F; Cascio, MG; Izzo, AA; Pagano, E; Pertwee, RG; Romano, B, 2014)
"Colon cancer is the third most global oncologic problem faced by medical fraternity."( Balasubramanian, T; Nalini, N; Sudha, M; Vinoth Kumar, R; Vinothkumar, R; Viswanathan, P, 2014)
"Colon cancer is one of the third most common cancer in man, the second most common cancer in women worldwide, and the second leading cause of mortality in the USA."( Ramamoorthi, G; Sivalingam, N, 2014)
"Colon cancer is one of the most common malignancies and the treatments for colon cancer have been developed substantially in the last decades, but there is still a great clinical need to explore new treatment regimens due to the undesirable prognosis."( Chen, L; Deng, ZL; He, BC; Huang, J; Liu, Y; Liu, YZ; Luo, JY; Meng, ZJ; Sun, WJ; Wang, DX; Wang, X; Wu, K; Yang, JQ; Yin, LJ; Yuan, SX; Zuo, GW, 2014)
"Colon cancer is the third most leading causes of death due to cancer worldwide and the chemo drug 5-fluorouracil's (5-FU) applicability is limited due to its non-specificity, low bioavailability and overdose."( Anitha, A; Chennazhi, KP; Jayakumar, R; Lakshmanan, VK; Sreeranganathan, M, 2014)
"Colon cancer is the third most common cancer and the third largest cause of cancer-related death."( Chen, J; Gu, W; Li, L; Shao, R; Xu, ZP, 2014)
"Colon cancer is one of the most common cancers in both men and women."( Karthikkumar, V; Nalini, N; Sivagami, G; Viswanathan, P, 2015)
"Colon cancer is one of the major causes of death in the Western world."( Corem-Salkmon, E; Grinberg, I; Kolitz-Domb, M; Margel, S, 2014)
"Colon cancer is among the most dangerous tumors affecting humankind."( de Paula Garcia, W; Fernandes, CR; Frajacomo, FT; Garcia, SB; Kannen, V, 2015)
"Colon cancer is associated with a high incidence and a poor prognosis."( Dong, L; Gao, Y; Huo, X; Sai, H; Sun, X; Wei, G; Wu, J; Xu, Y; Zhang, Y, 2015)
"Colon cancer is a world concerning disease; it shows a high mortality rate and may be related to eating habits."( Aguirre-Riverab, JR; Andrade-Zaldívar, H; Dávila-Céspedes, A; Juárez-Flores, BI; Loyola-Martínez, ED; Oros-Ovalled, AC; Pinos-Rodríguezc, JM, 2014)
"Colon cancer is one of the most common malignancies, causes considerable morbidity and mortality."( He, BC; Huang, J; Jin, JL; Sun, WJ; Wan, LH; Wang, DX; Wu, K; Wu, QX; Yang, JQ; Yuan, SX; Zhou, M, 2015)
"Colon cancer is the second most lethal cancer."( Biddick, L; Dai, W; Lightfoot, S; Rao, CV; Reddy, A; Sanghera, S; Yamada, HY; Zhang, Y, 2016)
"Colon cancer is one of the leading causes of cancer-associated death worldwide."( Dehghan Esmatabadi, MJ; Farhangi, B; Kazerooni, H; Sadeghizadeh, M; Safari, Z; Shirzad, H; Zolghadr, F, 2015)
"Colon cancer is the third most common cancer in humans which has a high mortality rate, and 5-Fluorouracil (5-FU) is one of the most widely used drugs in colon cancer therapy."( Jin, Y; Lin, D; Pei, S; Wang, H; Yang, X; Zhang, D; Zhang, H; Zhang, L; Zhang, Y; Zhou, B, 2015)
"Colon cancer is one of the most common tumors in the human population."( Alho, EJ; Friedrich, M; Garcia, SB; Gasser, M; Heinsen, H; Heinze, KG; Kannen, V; Mönch, R; Scholz, CJ; Silva, WA; Stopper, H; Waaga-Gasser, AM, 2015)
"Stage III colon cancer is currently treated as an entity with a unified therapeutic principle."( Deng, G; He, J; Ma, J; Pei, H; Shen, H; Wu, X; Zeng, S; Zhang, S; Zhang, Y, 2015)
"Colon cancer is one of the most common malignancies worldwide and has a high mortality rate."( Cao, Y; Fan, K; Li, L; Li, X; Qi, H; Sun, H; Zhang, Q, 2015)
"Colon cancer is the third most common cause of death in the United States."( Alam, S; Ansari, KM; Kumar, R; Mir, SS; Pal, A, 2016)
"Colon cancer is one of the most commonly diagnosed cancers, and is a major cause of cancer morbidity and mortality worldwide."( Arivalagan, S; Chandrasekaran, B; Kuppsamy, T; Mani, V; Namasivayam, N; Siddique, AI; Thomas, NS, 2015)
"In this protocol, colon cancer is induced in mice through a series of injections with 1,2-dimethylhydrazine."( Gurley, KE; Kemp, CJ; Moser, RD, 2015)
"Colon cancer is one of the most common cancers worldwide with high mortality."( Chen, J; Gu, W; Li, F; Liu, JP; Monteiro, M; Shao, R; Xu, ZP, 2015)
"Colon cancer is one of the leading causes of cancer-related death worldwide, and the therapeutic application of 5-fluorouracil (5-FU) is limited due to its nonspecificity, low bioavailability, and overdose."( Huo, ZJ; Li, XC; Liu, K; Liu, P; Ma, Y; Qin, YH; Wang, SJ; Wang, ZQ, 2015)
"Colon cancer is one of the most common malignancies."( Chen, QZ; Chen, ZH; He, BC; Huang, J; Li, Y; Ren, CM; Shao, Y; Sun, WJ; Wang, DX; Wu, K; Wu, QX; Yu, Y; Yuan, SX; Zeng, YH, 2015)
"Colon cancer is the third most commonly diagnosed cancer and the second leading cause of cancer mortality worldwide."( Chen, M; Chen, W; Hu, S; Hui, J; Ji, J; Liang, G; Wang, Y; Xu, S; Zhou, J, 2015)
"Colon cancer is one of the most common malignancies of the digestive system."( Bai, Y; Chen, QZ; He, BC; Li, Y; Ren, CM; Shao, Y; Sun, WJ; Wang, DX; Wu, K; Wu, QX; Yang, JQ; Yu, Y; Yuan, SX; Zeng, YH; Zhang, P, 2016)
"Colon cancer is a frequently occurring primary malignant tumor."( Cai, S; Hu, J; Xu, Y, 2015)
"Colon cancer is a common type of cancer with high mortality."( Chen, J; Han, M; Saif, MW, 2016)
"The invasion of colon cancer is associated with the tumor angiogenesis."( Hu, TY; Lv, JY; Wang, G; Wang, RY; Zhu, JM, 2016)
"Colon cancer is one of the leading causes of cancer death worldwide."( Adachi, N; Aoyama, H; Fujibayashi, Y; Furukawa, T; Saga, T; Wakizaka, H; Yoshii, Y; Zhang, MR, 2016)
"Colon cancer is the third most common malignancy worldwide."( Chen, BC; Lien, GS; Lin, CH; Wu, MS; Yang, YL, 2016)
"Colon cancer is one of the most common internal malignancies, and conventional chemotherapy is not effective in its treatment."( Divsalar, A; Izadi, Z; Saboury, AA; Sawyer, L, 2016)
"Colon cancer is invariably accompanied by altered coagulation activity; however, the precise role of phosphatidylserine (PS) in the hypercoagulable state of colon cancer patients remains unclear."( Bi, Y; Kou, J; Piao, D; Shi, J; Zhao, L, 2016)
"Colon cancer is the third most incident type of cancer worldwide."( Alcaide, A; Ávila-Román, J; de Carvalho, JE; Garcia-Mauriño, S; Motilva, V; Pelizzaro-Rocha, KJ; Pilli, RA; Talero, E; Vendramini-Costa, DB, 2016)
"Colon cancer is the third most common cancer in the world, with drug resistance and metastasis being the major challenges to effective treatments."( Garcia Carcedo, I; Gu, W; Li, L; Monteiro, M; Xu, ZP; Zou, H, 2016)
"Colon cancer is one of the leading causes of cancer mortality, worldwide."( Anandasadagopan, SK; Ganapasam, S; Sekar, V, 2016)
"Colon cancer is one of the most incident cancers in the Western World."( Abrantes, AM; Botelho, MF; Carvalho, RA; Encarnação, JC; Fernandes, E; Freitas, M; Pires, AS; Proença, C; Roleira, FM; Tavares-da-Silva, EJ; Varela, CL, 2016)
"Colon cancer is the third leading cause of cancer mortality worldwide, which results from interactions of different factors."( Mohamed, MI; Tawfik, MK, 2016)
"BACKGROUND Colon cancer is one of the most prevalent and deadly cancers worldwide."( Hu, JC; Jiang, LX; Qu, Z; Sui, MH; Sun, HQ; Yu, X; Zhai, HY; Zheng, HT; Zhou, K, 2016)
"Colon cancer is one of the leading causes of cancer-related death worldwide and the therapy with 5-fluorouracil (5-FU) is mainly limited due to resistance."( Budillon, A; Leone, A; Maiolino, S; Pagliara, V; Quaglia, F; Russo, A; Russo, G; Scalia, G; Tatangelo, F; Ungaro, F, 2016)
"Colon cancer is a leading cause of cancer-related death in humans."( Spencer, NJ, 2016)
"Colon cancer is still the third most common cancer which has a high mortality but low five-year survival rate."( Huang, X; Li, W; Tan, Z; Wang, H; Wang, J; Yu, R; Zhang, L; Zhang, Y; Zhong, J, 2017)
"The risk of colon cancer is increased in patients with Crohn's disease and ulcerative colitis."( Bakthavatchalu, V; Bryant, EM; Conaway, EA; Fox, JG; Gong, G; Holcombe, H; Horwitz, BH; Muthupalani, S; Parry, NAP; Puglisi, DA; Sheh, A; Short, SP; Tannenbaum, SR; Wang, C; Williams, CS; Wogan, GN, 2017)
"Colon cancer is one of the most widespread disease, the mortality rate is high due to cancer metastasis and the development of drug resistance."( Ghosh, B; Keshari, AK; Kumar, D; Kumar, U; Rai, A; Raj, V; Saha, S; Singh, AK; Trivedi, P, 2018)
"Metastatic colon cancer is a major cause of deaths among colorectal cancer (CRC) patients."( Chen, H; Cui, H; Ignatenko, NA; Pandey, R; Sells, E; Skovan, BA, 2017)
"Colon cancer is one of the most lethal varieties of cancer."( Gao, S; Li, C; Li, X; Ma, L, 2018)
"Colon cancer is common worldwide and accounts for the significant cancer related morbidity and mortality in patients."( Chen, QZ; He, BC; He, F; Huang, M; Li, Y; Liao, YP; Ren, WY; Shao, Y; Wang, H; Wang, J; Wu, K; Zeng, YH; Zhou, LY; Zhu, JH, 2017)
"Colon cancer is thought to develop in a stepwise fashion."( Clichici, S; Djerdjouri, B; Moulahoum, H; Nagy, AL, 2018)
"Colon cancer is one of the leading causes of cancer-related deaths."( Bao, M; Chen, R; Dai, X; Dong, X; Liang, G; Shen, X; Sun, X; Vladimir, K; Zhuge, W; Zia, K, 2018)
"Colon cancer is the third most common cancer, and yet there is a lack of effective therapeutic method with low side effects."( Wang, J; Yang, X; Yuan, S; Zhai, X; Zou, P, 2018)
"Colon cancer is the most common type of gastrointestinal cancer."( Hanušová, V; Králová, V; Matoušková, P; Skálová, L, 2018)
"Colon cancer is one of the most common digestive tumors."( Dai, GH; Mao, H; Wang, ZK; Wu, LL; Yang, L; Zhang, PF; Zhou, YH, 2017)
"Colon cancer is a world-wide health problem and one of the most dangerous type of cancer, affecting both men and women."( Ahmad Ganaie, M; Ahmad, B; Ali, R; Bilal Ahmad, S; Farooq, A; Hussain, I; Madkhali, H; Masoodi, M; Muzamil, S; Rahman Mir, MU; Rashid, SM; Rehman, MU, 2018)
"Colon cancer is the third most frequently diagnosed malignancy and has high morbidity worldwide."( Cheng, H; Fan, H; Li, L; Miao, Y; Shen, W; Sun, D; Tan, J; Xu, C; Yang, Y; Zhang, F; Zhang, H, 2018)
"Colon cancer is a commonly diagnosed cancer that often has a poor prognosis."( Guo, J; Jiang, H; Jin, D; Li, K; Liu, C; Qin, C; Wu, Y, 2018)
"Colon cancer is characterized by invasion and migration."( Ren, J; Tang, L; Zhu, J, 2018)
"Colon cancer is the main cause of cancer mortality worldwide."( Jiang, Z; Kang, YJ; Wang, C; Wang, S; Xu, Y; Yang, H; Zhang, Y, 2018)
"Colon cancer is the third most common malignancy in both sexes of Korea."( Kang, YR; Kawk, SH; Kim, YH, 2018)
"Colon cancer is among the most widely occurring cancer types, leading to considerably high mortality rate."( Chen, Q; Han, MK; Kang, Y; Merlin, D; Viennois, E; Wan, Y; Wang, L; Xiao, B; Zhang, Y; Zhang, Z, 2018)
"Colon cancer is common in the elderly, but owing to under representation in clinical trials, the benefit of standard therapies is uncertain in this age group."( Aghmesheh, M; Brungs, D; Carolan, M; Clingan, P; de Souza, P; Ranson, M; Rose, J, 2018)
"Colon cancer is the most aggressive form of cancers, that causes 0."( Al-Buloshi, M; Bakshi, HA; Hakkim, FL; Hasson, SSAA; Javid, F; Krishnan, M; Kumar, NR; Nagarajan, K; Rashan, L; Revathi, S, 2018)
"Colon cancer is a prevalent malignancy affecting the gastrointestinal tract."( He, BC; Hu, XL; Liao, YP; Liu, RX; Ma, Y; Ren, WY; Sun, WJ; Wang, H; Wu, K; Zhu, JH, 2018)
"Colon cancer is a devastating illness that is associated with gut inflammation."( Balboa, MA; Balsinde, J; Cubero, Á; García-Rostán, G; Győrffy, B; Lordén, G; Meana, C; Orduña, A; Peña, L, 2018)
"Colon cancer is the major health disease related with high mortality."( Khan, AQ; Khan, R; Rehman, MU; Sultana, S; Tahir, M, 2018)
"Colon cancer is one of the most lethal and common malignancies worldwide."( Bak, Y; Hong, J; Jang, HJ; Kim, BY; Kwon, SB; Pham, TH; Yoon, DY, 2018)
"BACKGROUND Colon cancer is one of the most common cancers and it is the fourth leading cause of cancer-related deaths worldwide."( Huang, Y; Tian, X; Wang, C; Xiong, P; Zhang, J; Zhao, B; Zhu, J, 2018)
"Colon cancer is a common type of cancer worldwide and accounts for a significant number of cancer‑related deaths."( Bie, L; Chen, B; Chen, X; Deng, W; Guo, Y; Guo, Z; Jin, G; Li, D; Li, N; Liu, Y; Luo, S; Wang, G; Yao, K; Zhao, Z, 2019)
"Colon cancer is one of the most common cancers in the developed countries."( Chang, WC; Cho, EC; Hung, WH; Yu, CY; Zheng, JH, 2018)
"Colon cancer is one of the fatal forms of cancer all round the world with a equal frequency of occurrence in both male and female population."( Iqbal, Z; Mishra, H; Mishra, PK; Siddiqui, L; Talegaonkar, S, 2018)
"Colon cancer is a common cause of cancer-related death worldwide."( Liu, JM; Lv, HZ; Wang, CC; Ye, XY; Zhang, F, 2018)
"Diabetes and colon cancer are the leading cause of mortality worldwide."( Ambasta, RK; Bhattacharya, S; Gupta, R; Kumar, D; Kumar, P; Sarkar, A, 2018)
"Colon cancer is one of the most frequently occurring types of cancers in the world."( Akimov, V; Badiola, I; Clerigué, AS; Ibarretxe, G; Kratchmarova, I; Marquez, J; Osinalde, N; Unda, F, 2019)
"Human colon cancer is one of the higher aggressive solid tumors, whose high mortality, much like many other solid tumors, results from metastasis formation."( Cassata, G; Cavallaro, G; Cicero, L; Giammona, G; Licciardi, M; Puleio, R; Scialabba, C, 2019)
"Colon cancer is one of the most common malignant tumors worldwide."( Li, X; Liu, KX; Wang, XM; Zhang, R; Zheng, XF, 2019)
"Colon cancer is a major health problem worldwide."( Bai, R; Feng, T; Lv, W; Shi, Z; Yu, X; Yuan, M; Zhong, H, 2019)
"Although colon cancer is one of the most important triggers of cancer related mortality, a few therapeutic options exist for this disease, including combination chemotherapy, anti-EGFR and anti-angiogenic agents."( Azizi, G; Ghalamfarsa, G; Hojjat-Farsangi, M; Jadidi-Niaragh, F; Karpisheh, V; Namdar, A; Nikkhoo, A; Sabz, G; Yousefi, B; Yousefi, M, 2019)
"Colon cancer is one of the most common cancer around the world."( Aktas, B; Aslim, B; Tukenmez, U; Yavuz, S, 2019)
"Colon cancer is one of the leading causes of cancer-related deaths."( Shao, R; Shen, H; Shen, X; Wang, B; Xia, Y; Zhang, J; Zhang, T; Zheng, P; Zou, P, 2019)
"Colon cancer is one of the most lethal cancers worldwide even with the significant progress made in screening techniques and therapeutic agents."( Cho, EC; Hsieh, YC; Lin, MH; Wang, JS; Zheng, JH, 2019)
"Colon cancer is a malignant type of cancer with high prevalence and is one of the primary causes of cancer-related deaths."( Cao, P; Cui, R; He, W; Hong, L; Liang, G; Shen, X; Xia, Y; Zhang, T; Zheng, P; Zou, P, 2019)
"Colon cancer is a major cause of death around the world."( Ali, ANM; Ghasemian, A; Kareem, SM, 2020)
"Colon cancer is the 4th most common cancer causing death in both male and female equally, mainly caused due to the improper diet plans, consumption of the red meat and lack of exercise."( Karthika, C; Sureshkumar, R, 2019)
"Colon cancer is one of the leading cause of cancer deaths that is severely threatening human health."( Hui, T; Xu, C; Ye, K, 2019)
"Globally, colon cancer is a predominant cause of increased morbidity and mortality annually; therefore, in addition to traditional treatments, new protocols are under continuous investigation."( Alnaggar, M; Chen, Y; Xiao, H, 2019)
"Background: Colon cancer is aggressive and it causes 0."( Bakshi, HA; Changez, M; Hakkim, FL; Kayalvizhi, N; Krishnan, M; Ramesh Kumar, N; Revathi, S; Sangilimuthu, AY; Tambuwala, MM, 2019)
"Colon cancer is a member of malignant tumors in the digestive system."( Chen, J; Fan, W; Feng, Y; Feng, Z; Guo, M; Guo, S; Jia, H; Liu, S; Wang, Z; Wu, Q; Zhang, C; Zhang, Y; Zhao, T; Zhou, Q, 2020)
"Colon cancer is one of the most life-threatening cancers with high incidence and mortality rates."( Pham, DT; Saelim, N; Tiyaboonchai, W, 2020)
"Colon cancer is the second most common deadliest malignancy in the world and better understanding of its underlying mechanisms is needed to improve clinical management."( Chandimali, N; Kong, LZ; Kwon, T; Lee, DS; Liu, R; Sun, HN; Zhen, X, 2019)
"Advanced colon cancer is extremely difficult to cure, underscoring the need to develop novel therapeutic agents."( Epifano, F; Fiorito, S; Genovese, S; Majumdar, APN; Nangia-Makker, P; Preziuso, F; Slater, J, 2020)
"Colon cancer is one of the most common malignancies."( Cui, MZ; Deng, Y; He, BC; Hu, Y; Huang, J; Li, FS; Li, L; Li, PP; Shu, DZ; Zeng, JR, 2020)
"Colon cancer is one of the leading causes of cancer-related deaths and its five-year survival rate remains low in locally advanced or metastatic stages of colon cancer."( Chen, CH; Cho, EC; Hsieh, YC; Liu, YR; Yang, PM, 2020)
"Colon cancer is considered to be the third most common cancer worldwide."( Abd El-Hady El-Safti, FE; Abdel-Rahman, SA; Badr El-Kholy, W; Mohey Issa, N, 2021)
"However, colon cancer is difficult to treat due to its resistance to TRAIL."( Kim, B; Lee, KY; Park, B; Seo, JH, 2020)
"Colon cancer is one of the most common and has the highest mortality rate in the world."( Chen, YH; Huang, XL; Huang, ZM; Li, YL; Lin, XR; Wu, XX, 2020)
"Colon cancer is one of the most common malignancies and the fourth leading cause of cancer-related mortality in the world."( Alikhani, MY; Hakimi Alni, R; Kosari, F; Moradi, A; Taheri, M, 2020)
"Colon cancer is a serious malignant type of cancer in the world."( Asemi, Z; Karimian, A; Majidina, M; Mir, SM; Safa, A; Shi, X; Valizadeh, A; Yosefi, B, 2020)
"Colon cancer is characterized by a shift in sphingolipid balance that favors the production and accumulation of oncogenic species such as sphingosine 1-phosphate (S1P)."( Grbčić, P; Sedić, M, 2020)
"Colon cancer is one of the most common cancers with high mortality in humans."( Chen, M; Fang, L; Feng, HT; Lee, MH; Tang, BZ; Xiong, F; Zou, S, 2020)
"Colon cancer is a common and deadly human digestive tract malignant tumor with poor prognosis."( Cao, G; Gao, C; Gao, G; Jiang, X; Wang, W; Zhao, J, 2021)
"Colon cancer is one of the most prevalent diseases, and traditional chemotherapy has not been proven beneficial in its treatment."( Deshmukh, R, 2020)
"Colon cancer is a highly anabolic entity with upregulation of glycolysis, glutaminolysis, and de novo synthesis of fatty acids, which also induces a hypercatabolic state in the patient."( Dueñas-Gonzalez, A; Schcolnik-Cabrera, A, 2021)
"The risk of colon cancer is greater in patients with inflammatory bowel disease (IBD) than in the general population."( Castaño-García, A; de Francisco, R; González-Bernardo, O; Jiménez-Beltrán, V; Pérez-Martínez, I; Riestra, S; Rollé, V; Suárez, A; Suárez, P; Vivas, S, 2021)
"Colon cancer is the commonest cancer worldwide."( Bahr, HI; El-Sherbiny, M; Elbahaie, AM; Elmahdi, HS; Gabr, AM; Ibrahiem, AT; Soliman, N; Youssef, AM; Zaitone, SA, 2021)
"Colon cancer is the third most deadly and one of the most diagnosed diseases in the world."( Muralikrishna, KS; Nelson, VK; Pullaiah, CP; Sahoo, NK; Sahu, M; Sudhan, HH, 2020)
"Colon cancer is one of the most common causes of deaths by cancer worldwide."( Alkhuriji, AF; Alnafjan, AA; Alobaid, H; Alomar, SY; Alsaiari, SG; El-Khadragy, MF, 2021)
"Colon cancer is a common and leading cause of death and malignancy worldwide."( Huang, L; Kong, W; Li, P; Zhu, J; Zhu, S, 2021)
"Colon cancer is one of the most familiar malignancies worldwide, with high morbidity and high mortality."( Gao, D; Guo, W; Qu, Y; Wang, J; Xiong, L; Yang, Y; Zhang, Y, 2021)
"Colon cancer is the fourth leading cause of cancer deaths around the world."( Fuel, M; Martínez, R; Melguizo, C; Mesas, C; Porres, JM; Prados, J, 2022)
"Colon cancer is a life-threatening disease all over the world and is linked to constant oxidative stress and inflammation."( Afzal, SM; Ali, N; Islam, J; Rashid, S; Shree, A; Sultana, S; Vafa, A, 2021)
"Colon cancer is a top lethal cancer in man and women worldwide and drug resistance is the major cause of cancer-related death."( Gu, W; Hu, Y; Ji, X; Jiang, T; Li, F; Li, L; Niu, X; Pang, L; Qi, Y; Wang, C; Xu, Z; Zhang, K; Zhao, W; Zheng, X; Zhu, X; Zou, H, 2021)
"Colon cancer is one of the leading causes of cancer death worldwide."( El-Nezami, H; Lee, JC; Lo, EKK; Turner, PC, 2021)
"Colon cancer is an adenocarcinoma, which subsequently develops into malignant tumors, if not treated properly."( Albalawi, R; Khan, FA; Pottoo, FH, 2022)
"Also, colon cancer is initiated by aberrant Wnt signaling in ISCs known to express high levels of LGR5."( Alharbi, SA; Ovchinnikov, DA; Wolvetang, E, 2021)
"Colon cancer is a malignant condition that affects the lower gastrointestinal tract and has unfavorable prognosis."( Ali, DA; Arab, HH; Ashour, AM; Kabel, AM, 2021)
"Colon cancer is one of the leading causes of cancer-related deaths worldwide."( Abdelaziz, LA; Gertallah, LM; Harb, OA; Taha, HF, 2022)
"Colon cancers are among the top three causes of cancer-related deaths."( Coskun, D; Dik, B; Er, A, 2022)
"Colon cancer is characterised by the persistent change in bowel habits due to the formation of polyps (cancerous) in the inner lining of the colon."( Dua, K; Gowthamarajan, K; Gulati, M; Gupta, G; Kaur, J; Kumar Chellappan, D; Kumar, B; Pandey, NK; Singh, SK; Vishwas, S, 2021)
"Colon cancer is accompanied by a decrease of epithelial barrier properties, which are determined by tight junction (TJ) proteins between adjacent epithelial cells."( Amasheh, S; Bekusova, V; Droessler, L; Markov, AG, 2021)
"Colon cancer is one of the most common malignant tumors in the digestive system."( Dang, C; Guo, J; Jia, H; Li, J; Li, M; Li, R; Li, X; Li, Y; Liu, Z; Wang, S; Zhang, Y; Zhao, T; Zhu, G, 2021)
"Colon cancer is one of the most common cancers, currently treated with traditional chemotherapies or alternative therapies."( Arena, A; Bassetti, E; Benedetti, R; Caiazzo, R; Cirone, M; D'Orazi, G; Gilardini Montani, MS; Maretto, M; Romeo, MA, 2021)
"Colon cancer is one of the most commonly diagnosed malignancies, which begins as a polyp and grows to become cancer."( Fakhri, KU; Imtiyaz, K; Nafees, S; Rizvi, MMA; Uroog, L; Zeya, B, 2022)
"Colon cancer is a most common malignant cancer in digestive system, and it is prone to develop resistance to the commonly used chemotherapy drugs, leading to local recurrence and metastasis."( Bai, S; Cheng, Y; Ji, Q; Jiang, C; Liu, D; Liu, M; Mei, Q; Sun, Y; Ye, W; Zhang, B; Zhou, S, 2021)
"Colon cancer is one of the leading causes of death in the world."( Bronikowska, J; Czuba, ZP; Janeczko, T; Kostrzewa-Susłow, E; Kłósek, M, 2022)
"Colon cancer is one of the most important causes of death in the entire world."( Collin, A; Kohan, R; Picotto, G; Tolosa de Talamoni, N, 2022)
"Colon cancer is one of the most common cancers."( Armağan, I; Bayram, D; Özgöçmen, M; Semerci Sevimli, T; Sevimli, M, 2022)
"Colon cancer is emerging as one of the most prevalent cancers globally."( Chen, L; Duan, H; Gao, Z; Hou, Y; Huang, W; Jin, J; Jin, M; Liu, C, 2022)
"Colon cancer is a gastrointestinal malignancy that is one of the leading causes of tumor-associated deaths."( Liu, ZJ; Lou, J; Lv, JX; Zhang, YP, 2022)
"Colon cancer is a common cause of death in the world, and its main cause of therapy failure is chemoresistance."( Deng, YY; Fu, J; Pan, SL; Qin, XJ; Zhang, YH; Zhang, ZJ, 2022)
"Colon cancer is the fourth leading cause of death in the world."( Abdolazimi, H; Fallah, A; Nazari Robati, F; Talaei, B; Tezerji, S, 2022)
"Colon cancer is one of the most leading death-causing cancers in the world."( Cao, W; Hong, H; Huang, C; Liu, C; Wang, Q, 2022)
"Colon cancer is a gastrointestinal malignancy with high incidence and poor prognosis."( Fu, X; Lin, L; Liu, Z; Sui, H; Wang, Y; Xia, W; Zhang, Y, 2022)
"Colon cancer is the third most predominant cancer caused by genetic, environmental and nutritional factors."( Adhikary, S; Banerjee, A; Dharshnaa, V; Duttaroy, AK; Esmeeta, A; Pathak, S; Swarnamughi, P; Ummul Maqsummiya, Z, 2022)
"Drug resistance in colon cancer is gradually affecting the treatment."( Chen, X; Guo, M; Li, B; Lin, C; Qiu, H, 2022)
"Colon cancer is the second most frequently diagnosed cancer in women in Norway, where incidence rates of colon cancer increased 3-fold between 1955 and 2014, for unknown reasons."( Borch, KB; Laaksonen, MA; Licaj, I; Lukic, M; Rylander, C; Weiderpass, E, 2023)
"Colon cancer is a common malignant tumor of the digestive tract."( Shi, C; Wang, S; Zhang, Z; Zhu, Q, 2023)
"Colon cancer is the third most common cancer worldwide, and the second in mortality rate."( Agarwal, S; Gor, R; Karri, U; Madhavan, T; Pachaiappan, R; Ramalingam, S; Saha, L; Sohani, A, 2022)
"Most deaths from colon cancer are due to metastasis."( Bae, KB; Baik, H; Hur, DY; Kang, MS; Kim, SH; Song, SE, 2022)
"Colon cancer is a widespread life-threatening malignancy with complex and multifactorial etiology."( Cui, Z; Li, P; Li, W; Liu, K; Min, L; Teng, S; Wang, Y; Wu, J; Xu, J; Yang, Y; Zhang, N; Zhang, S; Zhao, M, 2023)
"Colon cancer is a widespread life-threatening malignancy with complex and multifactorial etiology."( Cui, Z; Li, P; Li, W; Liu, K; Min, L; Teng, S; Wang, Y; Wu, J; Xu, J; Yang, Y; Zhang, N; Zhang, S; Zhao, M, 2023)
"Colon cancer is a widespread life-threatening malignancy with complex and multifactorial etiology."( Cui, Z; Li, P; Li, W; Liu, K; Min, L; Teng, S; Wang, Y; Wu, J; Xu, J; Yang, Y; Zhang, N; Zhang, S; Zhao, M, 2023)
"Colon cancer is a major malignant neoplasm with a low survival rate for late-stage patients."( Chang, CH; Cho, EC; Hsieh, YC; Lee, CH; Liu, HH; Liu, YR; Zheng, JH, 2022)
"Colon cancer is a major malignant neoplasm with a low survival rate for late-stage patients."( Chang, CH; Cho, EC; Hsieh, YC; Lee, CH; Liu, HH; Liu, YR; Zheng, JH, 2022)
"Colon cancer is a major malignant neoplasm with a low survival rate for late-stage patients."( Chang, CH; Cho, EC; Hsieh, YC; Lee, CH; Liu, HH; Liu, YR; Zheng, JH, 2022)
"Colon cancer is a relatively common malignant tumor of the digestive tract."( Fu, X; Li, H; Li, M; Li, T; Niu, Y; Xia, W, 2023)
"Colon cancer is a type of cancer that begins in the large intestine."( Chen, H; Li, Y; Tian, M, 2023)
"Colon cancer is the second most common cancer in women and the fourth most common cancer worldwide."( Hafuth, S; Randhawa, S, 2022)
"Colon cancer is a great threat to human health."( Tong, Q; Wu, Z, 2024)
"Colon cancer is a significant global health issue, and its primary treatment, chemotherapy, is limited by toxicity and drug resistance."( Alsadooni, JFK; Barzegar, A; Feizi, MAH; Haghi, M, 2023)
"Accurate staging of colon cancer is imperative in directing treatment and prognostication."( Gao, Y; Gauci, CM; Kim, TJ; Perera, DS, 2023)
"Colon cancer is emerging as one of the most common cancers worldwide, ranking in the top three in morbidity and mortality."( Chen, S; He, JN; Liu, XQ; Nie, ZQ; Yang, CT; Yang, JM; Zhang, J; Zhao, Y; Zhu, FD, 2023)
"Colon cancer is a common and deadly malignancy of the gastrointestinal tract."( Ding, C; Gao, H; Han, F; Lee, IS; Lee, KY; Li, C; Li, W; Liang, Q; Tang, K; Xiao, Y; Xiong, F, 2023)

Context

ExcerptReference
"Human and mouse colon cancers have specific binding sites for gastrin and demonstrate a trophic response to gastrin."( Chicone, L; Narayan, S; Singh, P; Townsend, CM, 1989)
"Detection of colon cancer has improved in Manitoba over the last 20 years with decreases in diagnostic delay and failure."( MacEwan, DW; Semelka, RC, 1987)
"Human colon cancers have a high frequency of p53 mutations, and cancer cells expressing mutant p53 tend to be resistant to current chemo- and radiation therapy."( Huang, L; Pardee, AB, 1999)
"Colon cancer has clearly moved from an exclusive surgeons' stronghold to a disease where a multimodal approach will provide better and more promising results."( Fey, MF, 2000)
"However, colon cancer has only rarely been associated with hypercalcemia of malignancy."( Levine, EA; Paschold, EH; Thompson, JT, 2001)
"The treatment of colon cancer has been aimed by approaches of oral drug administration."( Kawashima, Y; Lamprecht, A; Takeuchi, H; Yamamoto, H, 2003)
"Some patients with colon cancer have a high risk of local recurrence postoperatively."( Benson, AB; Donohue, JH; Fisher, B; Goldberg, RM; Gunderson, LL; Mailliard, JA; Martenson, JA; Myerson, R; Sargent, DJ; Thomas, CR; Willett, CG, 2004)
"Colon cancer has become one of the major causes of cancer mortality."( Deeptha, K; Kamaleeswari, M; Nalini, N; Sengottuvelan, M, 2006)
"The majority of colon cancers have somatic mutations in the APC (adenomatous polyposis coli) tumour-suppressor gene."( Gerner, EW, 2007)
"More than 40% of colon cancers have a mutation in K-RAS or N-RAS, GTPases that operate as central hubs for multiple key signaling pathways within the cell."( Alford, SK; Haigis, KM; Kreeger, PK; Lauffenburger, DA; Mandhana, R, 2009)
"Chemotherapies for colon cancer have recently advanced."( Cho, DH; Hong, YS; Jin, DH; Jung, KA; Kim, JC; Kim, SM; Kim, TW; Lee, JS; Na, YS; Ro, S; Ryu, MH; Yang, SJ, 2010)
"Patients with dMMR colon cancers have reduced rates of tumor recurrence, delayed TTR, and improved survival rates, compared with pMMR colon cancers."( Allegra, C; Foster, NR; Gallinger, S; Kim, GP; Labianca, R; Marsoni, S; Monges, G; Moore, MJ; Sargent, DJ; Sinicrope, FA; Thibodeau, SN; Yothers, G, 2011)
"The incidence of colon cancer has been increasing in recent years with the improvement in living standard, and becomes one of the leading causes of cancer-related death."( Liu, Y; Yang, X, 2014)
"Metastatic colon cancer has a 5-year survival of less than 10% despite the use of aggressive chemotherapeutic regimens."( Hua, X; Jin, J; Katona, BW; Liu, Y; Ma, A, 2014)
"Colon cancer have higher levels of sumoylated MATα2, total MATα2, Ubc9 and Bcl-2 and higher MATα2 binding to the Bcl-2 P2 promoter."( Giordano, P; Lu, SC; Mato, JM; Ramani, K; Ryoo, M; Tomasi, I; Tomasi, ML, 2015)
"Mouse models of colon cancer have been developed and characterized."( Clipson, L; Grimes, IC; Hadac, JN; Halberg, RB; Miller, DD; Newton, MA; Schelman, WR, 2016)
"The progression of colon cancer has a positive correlation with hyperinsulinemia."( Cao, D; Chen, X; Liang, H; Song, Q; Xu, X, 2018)
"Gastric and colon cancers have been the leading causes of cancer mortality in the world with limited therapy."( Chen, S; Kang, T; Tan, Z; Zhang, L; Zhang, X, 2018)
"Studies on colon cancer have demonstrated that the depletion of E2F1 leads to reduced levels of homologous recombination (HR), resulting in interrupted DNA replication and the subsequent accumulation of DNA lesions."( Choi, EH; Kim, KP, 2019)
"More than 90% of colon cancers have variations in the Wnt pathway."( Dong, C; Fan, J; Guo, J; Li, M; Li, Y; Ma, D; Peng, X; Wang, H; Wang, J; Xia, W; Zhang, S, 2019)

Actions

ExcerptReference
"Colon cancer affects millions of individuals in Western countries."( Aviello, G; Borrelli, F; Capasso, R; Di Marzo, V; Gallo, L; Izzo, AA; Piscitelli, F; Romano, B, 2012)
"Colon cancer affects 1."( Kılıç Süloğlu, A; Selmanoğlu, G; Sünnetçioğlu, MM; Yonar, D, 2019)

Treatment

ExcerptReference
"The treatment of rectal and colonic cancer with bony metastases, is disappointing as the disease is always fatal within a relatively short period, usually less than one year after the diagnosis of the bone involvement."( Cayla, J; Forest, M; Heisbourg, A; Meary, R; Rondier, J, 1975)
"Twenty patients with advanced colon cancer were treated with a combination of low-dose weekly cyclophosphamide, vincristine, and methotrexate (COM) after demonstrated progression of disease with 5-fluorouracil (5-FU)."( Desai, SA; DeWys, WD; Taylor, SG, 1978)
"For adjuvant therapy of colon cancer having positive nodes (Dukes C), internal radiation therapy of the liver is best done with Phosphorus-32 Colloid passed through the circulation of the gut to be effectively and homogeneously trapped by the Kupffer cells of the liver."( Grady, ED, 1979)
"The therapy of cancer of the colon still remains unsatisfactory: the rate of remissions could be increased, but survival remains unaltered."( Hartmann, D; Obrecht, JP, 1978)
"CAI pretreatment of HT-29 human colon cancer and 5R ras-transfected rat embryo fibroblast cells inhibits the formation and growth of experimental pulmonary metastases in nude mice."( Kohn, EC; Liotta, LA; Sandeen, MA, 1992)
"Pretreatment of human colon cancer LoVo-H cells and human breast cancer ZR-75 1A cells with low doses of verapamil, a Ca2+ channel blocker, for 48 h has a slight growth stimulatory effect and substantially increases cell sensitivity to lymphokine-activated killer (LAK) mediated cytotoxicity in the standard 51Cr release assay."( Bianco, AR; Celio, L; Correale, P; Genua, G; Montagnani, S; Tagliaferri, P, 1991)
"Because many patients with colon cancer will suffer a relapse we recommend that they be offered the opportunity to participate in clinical trials of adjuvant therapy."( Eisenhauer, E; Erlichman, C; Germond, C; Kerr, I; Levine, M; Lofters, W; Maroun, J; Rayner, HL; Skillings, JR; Yoshida, S, 1991)
"MAWI colonic cancer cells respond to sequential treatment in vitro with carboxypeptidase G2 and trimetrexate by a delay in cell growth as measured by cell numbers, but an increase in incorporation of 75-Se-selenomethionine per cell."( Bagshawe, KD; Bradshaw, T; Mellor, B; Melton, RG; Pedley, RB; Searle, F; Sherwood, RF, 1990)
"Nude mice bearing subcutaneous human colon cancer xenografts (LS174T) were treated with 120 microCi of yttrium 90-labeled anti-carcinoembryonic antigen monoclonal antibodies (specific therapy), 120 microCi of 90Y-labeled anti-melanoma monoclonal antibodies (nonspecific therapy), or phosphate-buffered saline solution (no treatment control)."( Beatty, BG; Beatty, JD; Buras, RR; Harris, JB; Hill, LR; Wanek, PM; Williams, LE, 1990)
"In 14 gastric cancer and 15 colonic cancer cases, to which UFT 400 mg/day and OK-432 2KE 2/W were administered orally and intra-muscularly for 2 weeks preoperatively until surgical treatment, intratumor 5-fluorouracil (5-FU) concentration was measured and compared with that of patients who given UFT 400 mg/day orally for 2 weeks (15 gastric cancer and 15 colonic cancer cases)."( Hosoi, H; Kitagawa, M; Sinmyo, K; Susaki, H; Suwa, H; Yamaguchi, K, 1989)
"Patients (1,256 with colon cancer, 1,221 with rectal cancer) were divided into the treatment group (group A) and the control group (surgical resection only, group B)."( Abe, O; Hattori, T; Inokuchi, K; Kikuchi, K; Kodaira, S; Komi, N; Kondo, T; Ogawa, N; Taguchi, T; Uchino, J, 1989)
"Mucin from xenografts of LS174T human colon cancer cells was treated with anhydrous HF for 1 h at 0 degree C to give a product (HFA) with over 80% of the glucosamine and hexose removed, but retaining some galactosamine, and for 3 h at room temperature to give a product (HFB) devoid of carbohydrate."( Byrd, JC; Erickson, R; Itzkowitz, SH; Kim, YS; Kuan, SF; Lamport, DT; Siddiqui, B, 1989)
"Nude mice bearing xenografts of colon cancer CX1 or X56 were treated for 14-25 days subcutaneously with saline, pentagastrin (0."( Smith, JP; Solomon, TE, 1988)
"Twenty patients with colon cancer metastatic to the liver underwent successful hepatic resection and adjuvant perioperative therapy that included hepatic arterial mitomycin C and floxuridine (FUDR)."( Ames, FC; Boddie, AW; Charnsangavej, C; Claghorn, LJ; Cleary, KR; Mavligit, GM; McBride, CM; Patt, YZ, 1987)
"Twenty-one patients with inoperable colon cancer in the pelvis were treated with intra-arterial 5-fluorouracil (5-FU) and mitomycin C, given bilaterally into the internal iliac arteries."( Chuang, VP; Claghorn, L; Mavligit, G; Patt, YZ; Peters, RE; Wallace, S, 1985)
"Thirty-five patients with metastatic colon cancer received hepatic arterial FUDR administered with implanted infusion pumps."( Hohn, DC; Lewis, BJ; Price, DC; Stagg, RJ, 1985)
"We treated 45 patients with advanced colon cancer with HDFA and 5-FU for 5 consecutive days."( Astone, A; Barone, C; Cassano, A; Cavallaro, A; Garufi, C; Grieco, A; Netri, G; Noviello, MR; Ricevuto, E; Rossi, S, 1987)
"Although previous in vitro reports on colon cancer cell lines have suggested that sodium butyrate might have a role to play as a chemotherapeutic "differentiating agent," the results of this in vivo study indicate that sodium butyrate treatment enhanced the development of colonic neoplasia and was associated with increased fecal butyric acid concentrations."( Freeman, HJ, 1986)
"Twenty patients with metastatic colon cancer without prior chemotherapy received 2 g/m2 of 5-fluorouracil (5-FU) infused over 24 h for 5 days preceded by allopurinol 900 mg orally for 1 week and then continued during, and for 1 week after the infusion was completed."( Ahmann, FR; Garewal, H; Greenberg, BR, 1986)
"An experimental model of colonic cancer can be obtained in rodents by administration of 1-2 Dimethylhydrazine."( Delapierre, F; Halkin, E; Laumonier, R; Roussel, F, 1985)
"Retreatment of patients with colon cancer and liver metastases by hepatic arterial infusion of fluorodeoxyuridine and mitomycin C can result in significant prolongation of survival in patients with response to this treatment."( Chuang, VP; Mavligit, G; Patt, YZ; Peters, RE; Wallace, S, 1983)
"Throughout the experiment, 50 colon cancers developed in 16 DMH-treated mice (mean, 3."( Diekema, KA; King, WW; Kingsnorth, AN; Malt, RA; McCann, PP; Ross, JS, 1983)
"Two cohorts of rats, 240 with colon cancer and 150 controls, were assessed clinically and immunologically for their response to tumour and its management which was either by surgical excision alone or by surgical excision combined with either adjuvant chemotherapy or immunotherapy."( House, AK; Maley, MA, 1983)
"One of the responding patients with colon cancer and two with breast cancer had failed to respond to prior therapy with 5-FU; one of the responding patients with breast cancer had previously received an inadequate trial of a similar regimen."( Ervin, TJ; Kufe, DW; Meshad, MW; Weiss, GR, 1982)
"The radical treatment of colonic cancer results in a gradual normalization of nitrogen-protein metabolism."( Buttaev, RM; Fedotov, IL; Gegenava, AP, 1980)
"At the current time, patients with colon cancer of Dukes stage C should be offered adjuvant chemotherapy with 5-FU/levamisole outside of clinical studies."( Herrmann, R; Rochlitz, CF, 1995)
"Since treatment of colonic cancer remains difficult because of the lack of effective chemotherapeutic agents, it is important to continue to search for cellular functions that can be disrupted by chemotherapeutic drugs and inhibit the development or progression of this disease."( Magnuson, BA; Moyana, TN; Raju, RV; Sharma, RK, 1995)
"Chloride efflux from colon cancer cells is stimulated by cyclic AMP and vaso-active intestinal peptide (VIP), and can be inhibited by pretreatment of the cells with phorbol myristate acetate, which downregulates the cAMP-regulated chloride efflux mechanism."( Pålsgård, E; Roomans, GM; von Euler, A; von Steyern, CV, 1993)
"Recurrence of gastric cancer or colon cancer was observed in some patients who received 5-fluorouracil (5-FU) high-dose continuous Methotrexate (MTX)-Leucovorin (LV) therapy (FML therapy) previously."( Fujihara, T; Inokuchi, T; Kawano, K; Kimoto, K; Mori, F; Tamura, Y; Yoshioka, Y, 1994)
"A 47-year-old man with ascending colon cancer with multiple liver metastases and bone metastasis (VII thoracic vertebra) showed a remarkable response to the combination therapy of tegafur and cisplatin."( Arima, S; Futami, K; Hara, F; Harada, Y; Inada, S; Kotoh, T; Nishida, T; Tateishi, S; Yamasaki, K, 1995)
"A recurrence of colon cancer developed in the left lower lung 16 months after surgery, and 5'-DFUR was administered at a dose of 1,600 mg/body/day."( Fujimoto, T; Iihara, K; Kitada, M; Murotani, M; Okumura, Y; Shibata, T; Takada, T; Takami, M; Tsukahara, Y; Watanabe, T, 1995)
"For Dukes' C colon cancer, postoperative adjuvant chemotherapy with a combination of fluorouracil and levamisole is now recommended as standard therapy."( Ilson, DH; Kelsen, DP, 1994)
"Thirty-nine patients with gastric or colonic cancer were given preoperative chemotherapy with UFT (an admixture of tegafur and uracil)."( Arizono, S; Kajiura, N; Konishi, T; Kubota, K; Makuuchi, M; Nakao, K; Oka, T; Teruya, M; Tsushima, H, 1994)
"Following the diagnosis of colon cancer (Duke's classification D), a chemotherapy regimen of 5-FU and levamisole was started."( Israel, MK; Scarfe, MA, 1994)
"Human colon cancer (HT29) cell survival was decreased by almost 1 log when treated with 500 microM temozolomide prior to 150 microM BCNU."( Dolan, ME; Mitchell, RB, 1993)
"Treatment of human colon cancer cell lines, LS 174T, COLO 205, and SW620, with sodium butyrate and 8-Cl-cAMP or tyrphostins AG-30 and AG-34, significantly attenuated TPK activity concomitantly with an increase in the activity of alkaline phosphatase, an enzymatic marker of intestinal cell differentiation."( Kim, YS; Lamprecht, SA; Niv, Y; Polak-Charcon, S; Schwartz, B, 1995)
"JAK3 mRNA was neither detected in colon cancer cells nor did IL-4 treatment cause phosphorylation of JAK3."( Murata, T; Noguchi, PD; Puri, RK, 1995)
"The intrinsic resistance of human colon cancer to multiple anticancer drugs precludes effective therapy of disseminated disease with available chemotherapeutic regimens."( Gravitt, KR; Gupta, KP; O'Brian, CA; Ward, NE, 1995)
"Projected charges or chemotherapy for colon cancer (5-FU infusion vs."( Anderson, NR; Lokich, JJ; Moore, CL, 1996)
"In another MMR-proficient colon cancer cell line, SW480, cell death occurred five days after MNNG treatment."( Boland, CR; Carethers, JM; Chauhan, DP; Hawn, MT; Koi, M; Luce, MC; Marra, G, 1996)
"Other colon cancer cell lines were examined for the extent of cell death following treatment with TPA/butyrate."( Eastman, A; McBain, JA; Mueller, GC; Pettit, GR; Simmons, DL, 1996)
"In patients with stage III colon cancer, adjuvant chemotherapy with fluorouracil and levamisole has been shown to produce a 40 percent reduction in the recurrence rate at a median follow-up of 6."( Ratkin, GA, 1997)
"The incidence of exophytic or invasive colon cancer and tumor multiplicity were similar in all treatment groups, although the incidence of exophytic neoplasms was higher with 2."( Aliaga, C; Braley, J; Pittman, B; Reinhardt, J; Rivenson, A; Weisburger, JH; Zang, E, 1998)
"Two cases of liver metastasis from colon cancer were treated by percutaneous ethanol (PEI) and acetic acid (PAI) injection for the recurrent lesion after surgery."( Iguchi, Y; Sato, K; Shibata, N; Takesue, M; Tsunoda, T; Yamamoto, S, 1998)
"A group of 205 colon cancer patients (104 in the 5FU arm and 101 in the 5FU + IFNapha-2a arm) were included in the final intention-to-treat analysis."( Bernardo, G; Bruni, G; Colucci, G; Danova, M; Dastoli, G; Della Vittoria Scarpati, M; Di Lauro, L; Filippelli, G; Gebbia, N; Leonardi, V; Lo Russo, V; Meli, M; Palmeri, S; Palmieri, G; Piazzi, M; Rausa, L; Russo, A; Spada, S, 1998)
"SW1116 colon cancer cells were seeded onto Matrigel-coated Boyden chambers and treated with unsupplemented media or media containing 10 mM acetate, propionate, or butyrate."( Basson, MD; Emenaker, NJ, 1998)
"Treatment of two human colon cancer cell lines (HT-29 and WiDr) with 5-FU + gamma-IFN resulted in an increase of CEA expression higher than that obtainable with both agents alone, although no synergistic effects were obtained."( Aquino, A; Bonmassar, E; De Filippi, R; De Vecchis, L; Giuliani, A; Graziani, G; Greiner, JW; Masci, G; Prete, SP; Turriziani, M, 1998)
"Nineteen patients (16 with colon cancer and 3 with breast cancer) who were treated with systemic 5-FU with complaints of tearing were studied retrospectively."( Fezza, JP; Klippenstein, KA; Wesley, RE, 1999)
"Results from experiments performed on colon cancer xenografts also show an association between PARP cleavage and response to treatment with TPT or CPT-11."( Berger, NA; Whitacre, CM; Willson, JK; Zborowska, E, 1999)
"Following treatment of three colon cancer cell lines, HCT116, SW480, and VACO-8, for 48 h with 0."( Belfi, CA; Berger, NA; Berger, SJ; Chatterjee, S; Gosky, DM, 1999)
"The exposure of human colon cancer cells HT-29 to 1,25-dihydroxyvitamin D3 or its analog, 1alpha, 25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-choleca lci ferol (Ro 25-6760), at the 10(-6) M concentration resulted in significant growth inhibition with induction of the apoptotic process after three days of treatment detected by TUNEL assay and agarose gel electrophoresis of DNA."( Bogrash, E; Evans, SR; Shchepotin, EB; Shchepotin, IB; Soldatenkov, V, 1999)
"Patients with Dukes' B colon cancer benefit from adjuvant chemotherapy and should be presented with this treatment option."( Atkins, JN; Bear, HD; Jones, J; Mamounas, E; Rockette, H; Song, K; Wieand, S; Wolmark, N, 1999)
"At present, studies in B2 colon cancer designed with a no-treatment control arm should be considered appropriate."( , 1999)
"We examined whether patients with colon cancer undergoing surgery with or without adjuvant chemotherapy change the internal standards on which they base their quality-of-life (QL) estimation, and, if they do so, whether this reframing alters interpretation of QL findings."( Bernhard, J; Herrmann, R; Hürny, C; Laffer, U; Maibach, R, 1999)
"Patients with colon cancer substantially reframe their perception in estimating QL both under radical resection and under adjuvant chemotherapy or observation."( Bernhard, J; Herrmann, R; Hürny, C; Laffer, U; Maibach, R, 1999)
"The present treatment of colon cancer is based on 5-fluorouracil (5-FU)."( An, Z; Han, Q; Hoffman, RM; Rashidi, B; Sasson, A; Sun, FX; Sun, X; Tan, X; Tan, Y; Wang, X; Xu, M, 1999)
"In both types of colon cancer cells investigated, 10(-8) M 1alpha,25-(OH)2D3 reduced basal cell proliferation by about 50%, and prevented any rise in proliferation when colon cancer cells were treated with 25 ng/ml EGF: this can be explained by a marked inhibitory effect of 1alpha,25-(OH)2D3 on EGFR mRNA and protein expression."( Cross, HS; Ellinger, A; Hofer, H; Peterlik, M; Tong, WM, 1999)
"Mice bearing human colon cancer were treated with a combination of 4."( Aburano, T; Hiramatsu, T; Kinuya, S; Konishi, S; Michigishi, T; Shuke, N; Takayama, T; Tega, H; Tonami, N; Watanabe, N; Yokoyama, K, 1999)
"Caco2 and HCT116 colon cancer cells were treated with 2 microM PYY for 24 hours."( Cole, M; Kim, F; Kling, K; McFadden, D, 1999)
"Sixty-two patients with 73 colon cancers who were radiographically overlooked were eventually confirmed and treated."( Fujisawa, H, 1999)
"Human colon cancers have a high frequency of p53 mutations, and cancer cells expressing mutant p53 tend to be resistant to current chemo- and radiation therapy."( Huang, L; Pardee, AB, 1999)
"GW-39 human colonic cancer xenografts for therapy studies."( Blumenthal, RD; Goldenberg, DM; Lew, W; Osorio, L; Reising, A; Soyne, D; Ying, Z, 2000)
"Thirty-four patients with metastatic colon cancer were treated with 5 fluorouracil and folinic acid."( Giovannini, M; Reggio, H; Sauvan, R; Seigner, C, 1995)
"Five hundred patients with Dukes' C colon cancer were randomly assigned to adjuvant treatment for one year with 5-fluorouracil (450 mg/m2 i."( Bleeker, WA; Hermans, J; Mulder, NH; Otter, R; Plukker, JT, 2000)
"Mice bearing human colon cancer xenografts were administered 2."( Hiramatsu, T; Kawashima, A; Kinuya, S; Konishi, S; Michigishi, T; Shuke, N; Takayama, T; Tonami, N; Watanabe, N; Yokoyama, K, 2000)
"Treatment of four human colon cancer cell lines with iso-effective concentrations of this agent resulted in depletion of c-raf-1 and akt and inhibition of signal transduction."( Banerji, U; Clarke, PA; Hostein, I; Judson, I; Maloney, A; Stefano, FD; Walton, M; Workman, P, 2000)
"We encountered a case of unresectable colon cancer that disappeared following pharmacokinetic modulating chemotherapy (PMC)."( Asahara, T; Nakahara, H; Nakahara, M; Okajima, M; Yano, M, 2000)
"An experimental rat model of induced colon cancer treated for 30 days with bosentan, a mixed antagonist of both ET receptors, confirmed the morphological changes observed during the tumor vascularization."( Bosman, FT; Egidy, G; Jeannin, JF; Juillerat-Jeanneret, L; Korth, P; Pinet, F, 2000)
"A total of 18 patients (13: colon cancer, 5: gastric cancer) with multiple liver metastases (H3) underwent hepatic arterial infusion chemotherapy (HAI) using an implanted arterial port with portable syringe pumps in our outpatient clinic."( Fukunaga, M; Goda, F; Maeba, T; Maeta, H; Mihara, T; Mori, S; Ohkawa, M; Okada, H; Okano, K; Senda, S; Uchida, Y; Usuki, H; Wakabayashi, H, 2000)
"Treatment of HCT116 human colon cancer cells with the specific mitogen-activated protein kinase kinase, U0126 (5-50 microM) resulted in a time- and dose-dependent inhibition of ERK1/2 phosphorylation, and induction of apoptosis."( Ahnen, DJ; Driggers, LJ; Goldberg, RJ; Ray, EC; Rice, PL, 2001)
"Synchronized HCT 116 colon cancer cells treated with 100 microM SeMet for 66 h were found to have a transient delay in G2/M phase of the cell cycle at 18 and 24 h after treatment."( Chigbrow, M; Nelson, M, 2001)
"The adjuvant treatment of colon cancer is now accepted as an effective therapy following surgical resection of the primary tumor in patients at high risk for relapse."( O'Connell, MJ, 2001)
"The mainstay of treatment of colon cancer is 5-Fluoruracil (5-FU), which should be combined with folinic acid in case of bolus (2-4 min."( Mross, K; Semsek, D, 2001)
"Therefore, two human colon cancer cell lines, WiDr and Lovo, with a different clonogenic origin, were treated with equitoxic concentrations of 5-FU, AG337, and MTA to determine the induction of DNA damage, cell cycle arrest, downstream protein expression, and cell death."( Backus, HH; Jansen, G; Kuiper, CM; Peters, GJ; Pinedo, HM; van Groeningen, CJ; Wouters, D, 2000)
"Treatment of colon cancer cells with MNNG causes DNA damage with reduced telomeric signals in a p53-dependent manner, but increased cell cycle arrest in S-G(2)/M by both p53-dependent and independent mechanisms."( Jaiswal, AS; Multani, AS; Narayan, S; Pathak, S, 2001)
"Brief incubation of colon cancer cells with low concentrations of either Taxol or vinblastine increased the efficacy of a subsequent treatment with topotecan."( Bahadori, HR; Catapano, CV; Green, MR, 2001)
"Selected elderly patients with colon cancer can receive the same benefit from fluorouracil-based adjuvant therapy as their younger counterparts, without a significant increase in toxic effects."( Francini, G; Goldberg, RM; Haller, DG; Jacobson, SD; Labianca, R; Macdonald, JS; Sargent, DJ; Seitz, JF; Shepherd, LE, 2001)
"Patients with colonic cancer were divided into two group: abdominal lymphatic chemotherapy group and control group."( Liu, X; Liu, Y; Ruan, C; Sun, Y; Wang, Q; Wang, S; Wang, Y, 2000)
"Human colon cancer cells (Caco-2 and HT-29) were treated with deoxycholate or its two structural isomers, 3-beta-12-alpha-dihydroxy-5-beta-cholan-24-oic acid and 3-alpha-12-beta-dihydroxy-5-beta-cholan-24-oic acid."( Caspary, WF; Faust, D; Milovic, V; Stein, J; Teller, IC, 2002)
"Since 1981, 100 colon cancer patients have been treated with combination therapy including surgical resection, chemotherapy, and external plus intraoperative radiotherapy."( Devine, RM; Donohue, JH; Gunderson, LL; Haddock, MG; Larson, DR; Nagorney, DM; Nelson, H; O'Connell, MJ; Rubin, J; Taylor, WE, 2002)
"Next, human HCT-8 and HCT-116 colon cancer cells retrovirally transduced to express a DHFR-herpes simplex virus 1 thymidine kinase (HSV1 TK) fusion protein and treated with the DHFR inhibitor TMTX exhibited increased levels of the DHFR-HSV1 TK fusion protein and an increase in ganciclovir sensitivity by 250-fold."( Akhurst, T; Balatoni, J; Banerjee, D; Bertino, JR; Blasberg, R; Bornmann, W; Doubrovin, M; Finn, R; Fong, Y; Gelovani Tjuvajev, J; Iwamoto, M; Larson, S; Malhotra, S; Mayer-Kuckuk, P, 2002)
"In patients with stage II colon cancer it is still unclear whether adjuvant chemotherapy is effective."( Boige, V; Ducreux, M, 2002)
"Human colon cancer cell lines were treated with the NO donor GTN."( Bettaieb, A; Hammann, A; Jeannin, JF; Mignotte, B; Millet, A; Prevotat, L; Renaud, F; Solary, E, 2002)
"Six unselected human colon cancer cell lines (HT29, HCT15, HCT116, Caco2, SW480 and SW620) were treated with a single 3-h exposure to cisplatin or oxaliplatin at suprapharmacological concentrations, ranging from 50 to 200 microg/ml."( Chapusot, C; Chauffert, B; Correia, M; Franco, N; Isambert, N; Lizard-Nacol, S; Sergent, C, 2002)
"Treatment of the human colon cancer cells Hct116 with SN-38 (an active metabolite of CPT-11) resulted in G2 cell cycle arrest without induction of apoptosis."( Commes, T; Motwani, M; Schwartz, GK; She, Y; Sirotnak, FM, 2002)
"p53 wild- and mutant-type gastric and colon cancer cell lines were treated by 5FU alone, TRAIL alone, and a combination of 5FU and TRAIL, and cell viability after each treatment was determined by MTT assay."( Kaminishi, M; Kusada, O; Mochizuki, Y; Shimoyama, S, 2002)
"CT-26 colon cancer cells were treated with VES in vitro and in an in vivo model of liver metastases."( Barnett, KT; Fokum, FD; Malafa, MP, 2002)
"This is the first study of colon cancer carcinogenesis demonstrating that DHEA treatment can decrease the number of ACF without apparently modifying their malignant potential."( Matsuhashi, N; Nagase, H; Nakagama, H; Nakajima, A; Ochiai, M; Omura, M; Osawa, E; Sekihara, H; Ueno, N; Wada, K; Yoshida, S, 2002)
"Here, the cultured colon cancer cell line HCT-15 that exhibited VIP receptor expression was treated with the VIP hybrid antagonist neurotensin(6-11)VIP(7-28)."( Dreznik, Z; Fridkin, M; Gal, R; Gozes, I; Granoth, R; Levy, A, 2002)
"Adjuvant chemotherapy for colon cancer has been established during the past decade."( Dencausse, Y; Fritze, D; Hagmüller, E; Hartung, G; Kopp-Schneider, A; Lindemann, H; Queisser, W; Sturm, J; Wojatschek, C, 2002)
"Patients with stage III colon cancer after curative en bloc resection were randomized in 3 treatment groups: arm A (5-FU/LEV, weekly, 12 months), arm B (5-FU/FA, days 1-5, every 4 weeks, 12 months) and arm C (like B, 6 months)."( Dencausse, Y; Fritze, D; Hagmüller, E; Hartung, G; Kopp-Schneider, A; Lindemann, H; Queisser, W; Sturm, J; Wojatschek, C, 2002)
"Human colon cancer LoVo cells were treated in both a dose- and time-dependent manner using clinically relevant concentrations of and exposure to 5-FU and/or SN-38."( Azzariti, A; Church, SW; Colucci, G; Johnston, PG; Lacalamita, R; Paradiso, A; Tommasi, S; Xu, JM, 2002)
"In vivo, human colon cancer xenografts were transplanted into BALB/C nude mice and treated with TNP-470 alone and combination with 5-FU."( Fan, YF; Huang, ZH; Nie, J, 2002)
"After curative resection of a stage III colon cancer, adjuvant treatment with 5-FU plus leucovorin is generally well tolerated."( Arkenau, HT; Bermann, A; Porschen, R; Rettig, K; Strohmeyer, G, 2003)
"CT-26 murine colon cancer cells transfected with HSV-tk, alone or in combination with bcl-xL or bfl-1, were either grown in vitro or injected into syngeneic mice, followed by GCV administration."( Choi, HY; Jeong, J; Kim, CW; Ko, JK; Kwon, GY; Lee, MJ; Shim, YH; Woo, JK, 2003)
"HT-29 colon cancer xenografts in paricalcitol-treated nude mice were smaller (1044 mm(3) and 1752 mm(3), difference = 708 mm(3), 95% confidence interval = 311 to 1104 mm(3); P =."( Koeffler, HP; Kumagai, T; O'Kelly, J; Said, JW, 2003)
"We present a case of colon cancer with idiopathic leukopenia who tolerated chemotherapy without worsening of leukopenia."( Mehdi, SA; Pervez, H; Potti, A, 2003)
"The treatment of colon cancer has been aimed by approaches of oral drug administration."( Kawashima, Y; Lamprecht, A; Takeuchi, H; Yamamoto, H, 2003)
"Treatment of human colon cancer cell lines with apoptotic concentrations of sulindac metabolites (sulindac sulfide, sulindac sulfone) induced a dose- and time-dependent inhibition of beta-catenin protein expression."( Ahnen, DJ; Beard, KS; Driggers, LJ; Kelloff, J; Kuwada, S; Piazza, G; Rice, PL; Sullivan, H, 2003)
"Treatment of colon cancer cells with 15S-HETE inhibited cell proliferation and induced apoptosis, which was preceded by an increase in TGF-beta-inducible early gene (TIEG) and a decrease in Bcl-2."( Chan, UP; Chen, GG; Lee, JF; Leung, KL; Spelsberg, TC; Subramaniam, M; Wang, SH; Xu, H, 2003)
"HCT116, HT29, and SW620 colon cancer cells were treated with 17AAG, and extracts were examined by 31P-MRS."( Banerji, U; Chung, YL; Griffiths, JR; Jackson, LE; Judson, IR; Leach, MO; Ronen, SM; Stubbs, M; Troy, H; Walton, MI; Workman, P, 2003)
"Treatment of certain human colon cancer cell lines with the HER-2 inhibitory antibody mAb 4D5 demonstrated a role for HER-2 in mediating proliferation, apoptosis and tumorigenicity."( Coffey, RJ; Florell, SR; Gray, PD; Kuang, J; Kuwada, SK; Li, X; Scaife, CL; Wong, RF, 2004)
"Patients with high-risk resected colon cancer obtain benefit from FU-based therapy across subsets of age, sex, location, T stage, nodal status, and grade."( Alberts, SR; Benedetti, J; Cha, SS; Chen, W; Francini, G; Francois Seitz, J; Gill, S; Goldberg, RM; Haller, DG; Heldebrant, MP; Labianca, R; Loprinzi, CL; Sargent, DJ; Shepherd, LE; Thomé, SD, 2004)
"We subjected HCT116 colon cancer cells to two different 5-FU treatment protocols in an attempt to generate resistant derivatives: one that simulated the clinical bolus regimens using clinically-achievable 5-FU levels, the other that utilized serial passage in the presence of increasing 5-FU concentrations (continuous exposure)."( De Angelis, PM; Haug, T; Kravik, KL; Reichelt, WH; Tunheim, SH, 2004)
"The standard adjuvant treatment of colon cancer is fluorouracil plus leucovorin (FL)."( André, T; Boni, C; Bridgewater, J; Clingan, P; de Gramont, A; Hickish, T; Mounedji-Boudiaf, L; Navarro, M; Tabah-Fisch, I; Tabernero, J; Topham, C; Zaninelli, M, 2004)
"We report a patient with metastatic colon cancer who developed a hypersensitivity reaction to oxaliplatin during the sixth cycle of combination chemotherapy with oxaliplatin, high-dose 5-fluorouracil and leucovorin."( Chang, MC; Chang, YF; Hsieh, RK; Huang, MJ; Lim, KH; Lin, HC; Lin, J; Su, YW, 2004)
"Future studies in adjuvant therapy for colon cancer will explore oxaliplatin and 5-FU with or without antiangiogenesis or anti-epidermal growth factor agents."( Andre, T; de Gramont, A, 2004)
"We prepared a colon cancer-bearing Yoshida sarcoma rat model to examine the dose-response relationship of antitumor activity of intracolonically or orally administered 5-fluorouracil (5-FU; 45, 30, 20, 13, and 8 mg/kg)."( Fujimura, A; Goto, T; Kobayashi, E; Tomizawa, N, 2004)
"Moreover, EP(3) expression in colon cancer cell lines was analysed with or without 5-aza-2'-deoxycytidine (5-aza-dC) treatment."( Kawamori, T; Kitamura, T; Maruyama, T; Narumiya, S; Negishi, M; Shoji, Y; Sugimoto, Y; Sugimura, T; Takahashi, M; Wakabayashi, K; Watanabe, K, 2004)
"Patients with resected colon cancer with tumor adherence or invasion of surrounding structures, or with T3N1 or T3N2 tumors of the ascending or descending colon were randomly assigned to receive fluorouracil and levamisole therapy with or without radiation therapy."( Benson, AB; Donohue, JH; Fisher, B; Goldberg, RM; Gunderson, LL; Mailliard, JA; Martenson, JA; Myerson, R; Sargent, DJ; Thomas, CR; Willett, CG, 2004)
"The protein and mRNA levels in colon cancer cell lines with and without treatments were determined by Western and Northern blot analysis, respectively."( Jaiswal, AS; Narayan, S, 2004)
"When SW620 colon cancer-derived metastatic cells were exposed to nanomolar concentrations of Taxol, colchicine or (Z)-3,5,4'-trimethoxystilbene (R3), huge aneuploid, polynuclear cells survived the treatment."( Gossé, F; Raul, F; Schleiffer, R; Schneider, Y; Seiler, N, 2004)
"For patients with resectable colon cancer, improved identification of LN disease would significantly advance patient care by identifying patients likely to benefit from adjuvant therapy."( Bem, J; Bertagnolli, M; Compton, C; Dowell, J; Fleshman, J; Mayer, R; Miedema, B; Niedzwiecki, D; Redston, M; Zinner, M, 2004)
"We report a case of recurrent colon cancer resistant to 5-FU, whose QOL and PS has been well maintained with low-dose CPT-11/CDDP administered on an outpatient basis for more than 28 months."( Fukuhara, A; Kikuchi, S; Murayama, M; Nakamura, E; Nishimoto, Y; Nozaki, H; Shouda, S; Watanabe, Y; Yagyu, T, 2004)
"To estimate patterns of colon cancer presentation, diagnosis, and treatment according to history of dementia using National Cancer Institute (NCI) Surveillance, Epidemiology, and End-Result (SEER) Medicare data."( Gupta, SK; Lamont, EB, 2004)
"Three human colon cancer cell lines were treated with BB-pol: HT-29, HCT-116, and Caco-2."( Ji, GE; Oh, DK; You, HJ, 2004)
"In human colonic cancer HCT8 cells, the hydrogen peroxide (H(2)O(2))-induced increase in nuclear condensation, the population of sub-G(1) peak, and the number of TUNEL-positive cells were observed in cells pretreated with edible mushroom lectin, an inhibitor of the nuclear transport of GSTpi."( Goto, S; Ihara, Y; Kamada, K; Kawai, Y; Kondo, T; Matsuo, T; Nagata, I; Okunaga, T; Osawa, T; Tsuji, K; Uchida, K, 2004)
"In vitro, human colon cancer cell lines were treated with anti-CEA MAb IgG1, hMN-14 (labetuzumab), to assess direct effects on proliferation, as well as antibody-dependent cellular cytotoxicity (ADCC), and complement-dependent cytotoxicity (CDC)."( Blumenthal, RD; Goldenberg, DM; Hansen, HJ; Hayes, MK; Horak, ID; Osorio, L, 2005)
"Results showed that pretreating colon cancer cells with cigarette smoke extract (CSE) promoted colon cancer growth in the nude mouse xenograft model."( Bruce, IC; Cho, CH; Shin, VY; Wong, BC; Wu, WK; Ye, YN, 2005)
"Quercetin treatment of the SW480 human colon cancer cells was found to result in the decreased expression of three proteins and the increased expression of one protein."( Grider, A; Hargrove, JL; Kolli, K; Mouat, MF; Orlando, R, 2005)
"Pretreatment of HCT116 and RKO colon cancer cells (wild-type p53) or primary human fibroblasts (1043SK) with nutlins for 24 hours followed by incubation with paclitaxel for additional 48 hours did not increase significantly their mitotic index and protected the cells from the cytotoxicity of paclitaxel."( Carvajal, D; Heimbrook, DC; Tovar, C; Vassilev, LT; Vu, BT; Yang, H, 2005)
"Adjuvant chemotherapy for colon cancer has changed significantly during the past 5 years."( Vega-Stromberg, T, 2005)
"Adjuvant chemotherapy for colon cancer and combined chemotherapy and radiation therapy (RT) for rectal cancer increases the proportion of patients cured of their disease."( Hobday, TJ, 2005)
"Treatment of KM12L4a human colon cancer cells with CHIR-258 resulted in a dose-dependent inhibition of vascular endothelial growth factor receptor 1 and PDGFRbeta phosphorylation and reduction of phosphorylated extracellular signal-regulated kinase (ERK) levels, indicating modulation of target receptors and downstream signaling."( Aukerman, SL; Garrett, E; Gelb, AB; Harris, A; Heise, C; Lee, SH; Lopes de Menezes, D; Nordahl, L; Samara, E; Vora, J; Ye, H, 2005)
"WiDr human colon cancer cells treated with IL-15 and/or TGF-alpha induced reduction of nucleus-localized amphoterin and an increase in cytosolic and membranous amphoterin."( Kuniyasu, H; Sasahira, T; Sasaki, T, 2005)
"Patients with curatively resected colon cancer (stages UICC IIb and III) were stratified according to T, N, and participating center and randomized to receive a 12-month treatment using 5-FU + LEV alone or in combination with FA or IFN-alpha."( Beger, HG; Kornmann, M; Kron, M; Link, KH; Redenbacher, M; Staib, L, 2005)
"A panel of nine colon cancer cell lines were characterised for expression of HER 1/EGFR and then treated with gefitinib alone, or IFN alpha alone, or IFN alpha plus gefitinib, following a pre-treatment using vehicle or IFN alpha."( Goldstein, D; Qu, XJ; Russell, PJ; Yang, JL, 2005)
"A human colon cancer cell line (S1) was treated with various doses of oxaliplatin, 5FU, radiation, and combinations thereof."( Johnsson, A; Kjellén, E; Kjellström, J, 2005)
"Moser, a human colon cancer cell line, was treated with bexarotene and rosiglitazone alone or in combination and the effect on growth and differentiation were examined."( Bissonnette, RP; Cesario, RM; Lamph, WW; Stone, J; Yen, WC, 2006)
"The patient, who had unresectable colon cancer metastases to the liver and lung, was referred to us for chemotherapy from an affiliated hospital; he had no cardiac history."( Hatakeyama, K; Muneoka, K; Shirai, Y; Wakai, T; Yokoyama, N, 2005)
"Treatment of colon cancer cells with beta-cyclodextrin significantly reduced not only matrilysin binding to the cell surface but also matrilysin-dependent proteolysis and cell aggregation."( Higashi, S; Honke, K; Kioi, M; Miyazaki, K; Tsunezumi, J; Yamamoto, K, 2006)
"Four human colon cancer cell lines including HCT116 and RKO (wild type p53), HCT116-p53KO (isogenic control of HCT116 cells with p53 knocked out) and Caco-2 (mutant p53) were treated with 0-100 microM of selenomethionine for 24, 48 and 72 h."( Boland, CR; Fuerst, F; Goel, A; Hotchkiss, E, 2006)
"A 72-year-old Latino male with stage IV colon cancer entered into hospice care and was treated for major depressive disorder with mirtazapine."( Guardiola, VD; Ladino, M; Paniagua, M, 2006)
"A subset of patients with colon cancer staged by conventional methods have occult micrometastases and do not receive adjuvant chemotherapy."( Filipenko, D; Hwang, H; Phang, PT; Smith, J; Wiseman, KW, 2006)
"Mortality from colon cancer is significant with an expected 30,350 colon cancer deaths in 2005 with current treatment(s)."( Alli, AA; Gower, WR; Vesely, BA; Vesely, DL, 2005)
"(1) The standard treatment for colon cancer is surgical excision, but without additional treatment nearly 50% of surgically treated patients die from relapse and metastatic disease progression."( , 2006)
"EGCG treatment to colon cancer cells resulted in a strong activation of AMPK and an inhibition of COX-2 expression."( Baik, HW; Ha, J; Hwang, JT; Kim, YM; Lee, SK; Park, IJ; Park, OJ, 2007)
"In stage II colon cancer, treatment strategies are more debated."( Afchain, P; André, T; de Gramont, A; Segura, C, 2006)
"SLN mapping is feasible for colon cancer and can identify a subset of patients who could benefit from adjuvant chemotherapy."( Geisinger, KR; Lechner, J; Levine, EA; Shen, P; Thomas, KA; Waters, GS, 2006)
"HCT116 colon cancer cells were treated with docetaxel, flavopiridol, and 5-FU in several different administrative schedules in vitro, either sequentially or simultaneously."( Becerra, CR; Frenkel, EP; Fu, YC; Guo, J; Tripathy, D; Verma, UN; Zhou, AW, 2006)
"We present a colon cancer patient with the UGT1A1 polymorphism (UGT1A1 *28) as a known high risk for irinotecan, who was treated with a combination of doxifluridine and irinotecan for peritoneal dissemination resulting in stable disease for 2 years without adverse reactions, although the patient initially developed severe adverse effects to the combination of the protracted venous infusion of 5-FU and irinotecan."( Hiro, J; Inoue, Y; Kusunoki, M; Miki, C; Nakatani, K; Nobori, T; Ojima, E; Toiyama, Y; Watanabe, H, 2006)
"Human colon cancer cell lines were treated with the nitric oxide donor glyceryl trinitrate (GTN) before analyzing beta-catenin expression by immunofluorescence, immunoblotting, and immunoprecipitation methods and its transcriptional activity using a luciferase reporter gene driven by a T-cell factor-responsive promotor."( Bettaieb, A; Filomenko, R; Jeannin, JF; Prévotat, L; Solary, E, 2006)
"Two metastatic colonic cancer patients were successfully treated by the combination therapy of UFT plus oral Leucovorin (UFT/LV)."( Ando, T; Goto, H; Ina, K; Inagaki, J; Ito, A; Kataoka, T; Kato, H; Nagao, S; Niwa, Y; Ohkita, T, 2006)
"Human colon cancer Caco-2 cells were treated with either: placebo, IND (0."( Chai, J; Huang, RH; Tarnawski, AS, 2006)
"Treatment of colon cancer cells SW480 with sodium butyrate (NaB), which induces colon cancer cell differentiation, can induce the upregulation of GCIP expression, suggesting that the protein functions as a negative regulator in cell proliferation."( Li, D; Li, X; Liu, M; Luo, J; Ma, W; Ning, G; Stafford, LJ, 2007)
"Human colon cancer HCT-116 and HCT-15 cells cultured in vitro were treated with troglitazone."( Luo, HS; Meng, XZ; Ming, M; Yu, HG; Yu, JP; Zhou, YH, 2006)
"Human colon cancer cell line HCT-15 was treated with DAC and/or CPT-11 both in vitro and in vivo."( Enomoto, M; Iida, S; Ishiguro, M; Kato, K; Makino, H; Morita, S; Sugihara, K; Takagi, Y; Uetake, H, 2007)
"Human colon cancer cell line SW1116 cells were treated with Rottlerin."( Chen, ZF; Fang, JY; Lu, R; Sun, DF; Wang, X; Weng, YR, 2006)
"The X-ACT (Xeloda in Adjuvant Colon Cancer Therapy) trial compared the efficacy and safety of the oral fluoropyrimidine capecitabine with bolus 5-fluorouracil (5-FU)/leucovorin (LV; Mayo Clinic regimen) as adjuvant therapy for stage III colon cancer."( Twelves, CJ, 2006)
"In the human colon cancer cell line SW1116, treatment with the DNA methyltransferase 1 (DNMT1) inhibitor 5-aza-2'-deoxycytidine (5-aza-dC) or the ERK-MAPK inhibitors PD98059 or rottlerin, or transient transfection with the MAP/ERK kinase (MEK)1/2 small interfering RNA down-regulates DNMT1 and proliferating cell nuclear antigen levels."( Chen, ZF; Fang, JY; Lu, R; Sun, DF; Tian, XQ; Wang, X, 2007)
"Patients aged > or = 70 years with colon cancer benefit from chemotherapy, with no major added toxicities compared with a younger population."( Fakih, MG; Reddy, N; Yu, J, 2007)
"Treatment of the human colon cancer cell line, LS174T, with 1-2 mM sodium butyrate stimulated MUC2 mucin production, as determined by histological PAS staining of carbohydrate chains of mucin, and confirmed at the protein and mRNA levels by immunoblotting with anti-MUC2 antibody and real-time RT-PCR, respectively."( Abe, T; Hatayama, H; Iwashita, J; Kuwajima, A, 2007)
"HT-29 and SNU-C4 human colon cancer cell lines were treated with 5-FU and their relative chemoresistance, and Hsp70 were determined."( Correa, LP; da Rocha, AB; Grivicich, I; Henriques, JA; Jotz, GP; Regner, A; Schwartsmann, G; Zanoni, C, 2007)
"Gene expression of 7 colon cancer cell lines was evaluated before and after treatment with the demethylating agent 5-aza-2'-deoxycytidine (5Aza-dC) by oligonucleotide microarray analysis."( Kang, HJ; Kim, H; Kim, NK; Koh, KH; Rhee, H; Yang, E, 2007)
"Human colon cancer HT-29 cells were cultured in vitro and treated with fluorouracil and/or rosiglitazone."( Cao, JG; Dong, L; Liu, HQ; Qin, Y; Sun, L; Tang, XQ; Xia, H; Zhang, YQ, 2007)
"Two human colon cancer cell lines (HCT-15 and HT-29) were treated with 5-FU and celecoxib, alone and in combination."( Bae, YM; Chun, WJ; Lim, YJ; Rhee, JC, 2007)
"Human colon cancer cells were treated with vehicle or mesalazine (4 mm or 40 mm)."( Ahluwalia, A; Chai, J; Chu, EC; Tarnawski, AS, 2007)
"One of the major problems in treating colon cancer is chemoresistance to cytotoxic chemotherapeutic agents."( Baillie, GS; Brunton, VG; Frame, MC; Houslay, MD; Leslie, NR; McEwan, DG, 2007)
"Treatment of human colon cancer RKO cells with 10 micromol/L 5-FU resulted in significantly increased levels of p53 protein with maximal induction observed at 24 h."( Chu, E; Ju, J; Kudo, K; Schmitz, JC; Song, B, 2007)
"One of the most promising strategies in colon cancer therapy is the sensitization of cancer cells to natural proapoptotic cytokines, such as death ligands and interferons, which are able to eliminate abnormal cells."( Pajak, B, 2007)
"Patients with stage II colon cancer were randomised to either adjuvant chemotherapy with 5-FU/LV (100 mg m(-2) LV+450 mg m(-2) 5-FU weekly, weeks 1-6, in 8 weeks cycles x 7) or surveillance only."( Gnant, M; Greil, R; Herbst, F; Hofbauer, F; Jagoditsch, M; Jakesz, R; Rabl, H; Samonigg, H; Schaberl-Moser, R; Schippinger, W; Steger, GG; Thaler, J; Thödtmann, R; Tschmelitsch, J; Wohlmuth, P, 2007)
"A 57-year-old woman with metastatic colon cancer was receiving oxaliplatin, fluorouracil and leucovorin every 2 weeks and showed a partial response to therapy."( Abad, J; Borrás-Blasco, J; Casterá, E; Galan-Brotons, A; Giner-Marco, V; Rosique-Robles, D; Vicent Verge, JM, 2007)
"Treatment with rifampicin in colon cancer LS180 cells, a cell line known to express endogenous PXR, also inhibited apoptosis."( Liu, M; Xie, W; Zhai, Y; Zhou, J, 2008)
"An 82-year-old female with unresectable colon cancer accompanied by multiple lung metastasis was treated with S-1."( Arita, A; Fujimoto, M; Mochizuki, K; Sakai, Y, 2008)
"A 48-year-old woman, diagnosed as colon cancer with metastases in the liver, lung, bone and left rectus abdominis, developed refractory left abdominal pain in spite of escalating administration of opioids and nerve block therapy, and intrathecal analgesia was applied."( Chigusa, S; Ikegaki, J; Kaetsu, H; Kato, H; Kurihara, Y, 2008)
"Data sets of 855 colon cancer patients treated between 1992 and 1999 within a multicenter adjuvant trial comparing 5-FU modulation with folinic acid or interfereron-alpha were examined."( Baumann, W; Ette, C; Formentini, A; Henne-Bruns, D; Kornmann, M; Kreuser, ED; Kron, M; Link, KH; Sander, S; Staib, L, 2008)
"Human colon cancer cell lines HCT116-XIAP(+/+) cells and HCT116-XIAP(-/-) cells were treated with various concentrations of rosiglitazone."( Chan, KW; Dai, Y; Gu, Q; Lan, HY; Li, Z; Ma, J; Qiao, L; Wang, Y; Wong, BC; Wong, BL; Zou, B, 2008)
"DR5 expression was assessed on human colon cancer cell lines using flow cytometry, and cellular cytotoxicity after TRA-8 treatment, alone and in combination with SN-38, was determined by measuring cellular ATP levels."( Buchsbaum, DJ; Kim, H; LoBuglio, AF; Nan, L; Oliver, PG; Wang, W; Zhou, T; Zinn, KR, 2008)
"The X-ACT trial (Xeloda in Adjuvant Colon Cancer Therapy) compared traditional bolus 5-FU/LV (as per the Mayo Clinic regimen) with capecitabine, in the adjuvant treatment of 1987 stage III colon cancer patients."( Cassidy, J; Glen, H, 2008)
"In the colitis-associated colon cancer (CAC) model, we induced colonic tumors in C57/BL6 mice by azoxymethane and dextran sulfate sodium administration, and evaluated simvastatin's effect on tumor growth."( Cho, SJ; Jung, HC; Kim, JM; Kim, JS; Lee, JY; Song, IS, 2008)
"In the recent X-ACT (Xeloda in Adjuvant Colon cancer Therapy) trial, oral capecitabine (Xeloda) demonstrated superior efficacy and an improved safety profile compared with infused fluorouracil + leucovorin (folinic acid) [FU+LV] in patients with Dukes' C colorectal cancer."( Amadori, D; Antonuzzo, L; Barone, C; Bertetto, O; Carlo Merlano, M; Di Costanzo, F; Gasperoni, S; Labianca, R; Longo, F; Luppi, G; Mansueto, G; Ravasio, R; Sobrero, A; Vinante, O, 2008)
"Human colon cancer cells DLD1-TRAIL/R, with acquired resistance to TRAIL, were firstly transfected with Bcl-XL siRNA for 24 h followed by the treatment of TRAIL protein."( Chen, LL; Chen, W; He, C; Hu, JZ; Huang, XF; Zhou, W; Zhu, HB, 2008)
"The blockade of 5-LOX inhibits colon cancer cell proliferation both in vitro and in vivo and may prove a beneficial chemopreventive therapy in colon cancer."( Adrian, TA; Bell, RH; Bentrem, DJ; Ding, XZ; Kennedy, TJ; Melstrom, LG; Rao, SM; Salabat, MR; Strouch, M; Talamonti, MS; Ternent, CA; Witt, RC, 2008)
"We reported a case of super-elderly colon cancer with peritoneal dissemination effectively treated with modified FOLFOX6 chemotherapy."( Fujita, S; Ishida, H; Kabuto, T; Nakaguchi, K; Wada, A; Watanabe, Y, 2008)
"The incidence of tumors/polyps in the colon cancer of rats and treated with morin showed reduced incidence (40%) of tumors, as compared to DMH (100%) treated rats."( Karthik Kumar, V; Nalini, N; Vennila, S, 2009)
"The data set assembled by the Adjuvant Colon Cancer Endpoints Group, a collection of individual patient data from 18 trials and more than 20,800 patients testing fluorouracil-based adjuvant therapy in patients with stage II or III colon cancer, was analyzed."( Andre, T; Buyse, M; de Gramont, A; Francini, G; Goldberg, R; Green, E; Grothey, A; Haller, D; Labianca, R; O'Callaghan, C; O'Connell, MJ; Sargent, D; Seitz, JF; Sobrero, A; Yothers, G; Zheng, Y, 2009)
"Despite recent progress, colon cancer is often resistant to combination chemotherapy, highlighting the need for development of novel therapeutic approaches."( Gaub, MP; Guenot, D; Guérin, E; Larsen, AK; Lelong-Rebel, I; Nicolet, C; Oudet, P; Pencreach, E; Voegeli, AC, 2009)
"Twenty-five patients diagnosed with colon cancer at an initial, intermediate and late phase submitted to specifically devised therapy were assessed."( Busamia, BE; Campos, ML; Dubersarsky, C; Finkelberg, AB; Jarchum, G; Lavarda, M; Linares, JA; Mazzeo, MA, 2009)
"The treatment of the colon cancer cell lines SW480 and DLD-1 with paclitaxel resulted in increased activation of the MAPK pathway, which was blocked by PD98059, a MEK inhibitor."( Akiyoshi, T; Katano, M; Koga, K; Mibu, R; Nagai, S; Nakamura, M; Sato, N; Wada, J; Xu, R; Yanai, K, 2009)
"Chinese drug ZW3 for the treatment of colonic cancer could improve the main clinical symptoms, improve the QOL, increase body weight and prolong the survival time of patients, showing a favorable integral effect."( Shan, ZZ; You, JL; Zhou, LY, 2009)
"In a further study of compounds in colon cancer, we used half of the IC(50) dose, values in combined treatments of Rg3 (50 microM) with conventional agents - docetaxel (5 nM), paclitaxel (10 nM) cisplatin (10 microM) and doxorubicin (2 microM)."( Choi, SS; Han, SB; Hong, JT; Kim, SM; Kim, Y; Lee, SY; Moon, DC; Oh, KW; Yuk, DY, 2009)
"Our data demonstrate that treatment of colon cancer cells with sorafenib + vorinostat activates CD95 via de novo ceramide synthesis that promotes viability via autophagy or degrades survival via either the extrinsic or intrinsic pathways."( Dent, P; Graf, M; Grant, S; Houghton, PJ; Mitchell, C; Park, MA; Rahmani, M; Voelkel-Johnson, C; Walker, T; Yacoub, A, 2009)
"In spite of improvements in care of colon cancer patients, prevention may enable potential patients to avoid cancer therapy."( Marshall, JR, 2009)
"Treatment of p53 mutant colon cancer cells with 5-FU led to an elongated G1 in a Mirk-dependent manner, as G1 was shortened by ectopic overexpression of cyclin D1 mutated at the Mirk phosphorylation site (T288A), but not by wild-type cyclin D1."( Ewton, DZ; Friedman, E; Hu, J; Jin, K; Park, S, 2009)
"In addition, after human colon cancer cell lines were treated with Survivin siRNA and/or 5-fluorouracil, MTT assay and flow cytometry were used to analyze cell proliferation and apoptosis."( Cai, CX; Cai, M; Tao, KX; Wang, GB, 2009)
"For patients with T3N0M0 colon cancer without known risk factors, the necessity of chemotherapy has no definite consensus."( Cho, YB; Chun, HK; Kim, HC; Lee, WY; Yun, HR; Yun, SH, 2009)
"Human colonic cancer cell line SW620 was treated with EGCG at 40, 60 and 80 micromol/L and cultured in RPMI 1640 medium for 0, 24, 48 and 72 h."( Chen, XQ; Li, MS; Song, YG; Wu, JB; Yang, XQ, 2009)
"After HT-29 colon cancer cells were treated with norcantharidin, cell apoptosis increased remarkably."( Agrez, M; Chen, R; Lin, P; Liu, E; Liu, X; Niu, J; Niu, W; Peng, C; Wang, J; Xu, K; Zhang, Z, 2009)
"In the present study, the human colon cancer cell lines HCT116 and HT29 were used to examine the relationships between Met activation, EGCG treatment, and H(2)O(2) generation."( Dashwood, RH; Larsen, CA, 2009)
"An 82-year-old man with unresectable colon cancer liver metastases was referred to our department for chemotherapy with the FOLFOX protocol."( Hatakeyama, K; Muneoka, K; Sakata, J; Sasaki, M; Shirai, Y; Wakai, T, 2009)
"HCT116 and HT29 colon cancer cells were treated with LBH589 or vorinostat and growth inhibition, acetylation status and apoptosis were analyzed in response to treatment using MTS, Western blotting and flow cytometric analyses."( Fazzone, W; Groshen, S; LaBonte, MJ; Ladner, RD; Lenz, HJ; Wilson, PM, 2009)
"A 79-year-old woman with colon cancer and multiple liver metastases was admitted to our hospital for systemic chemotherapy."( Fujita, J; Hirata, T; Kinjyo, F; Kobashikawa, K; Matayoshi, R; Nakamura, M; Ohshiro, M; Takaki, R; Tamura, J, 2009)
"We report a case of ascending colon cancer successfully treated for synchronous liver metastases with mFOLFOX6 after a resection of the primary tumor."( Hazama, S; Nakatsu, H; Oka, M; Tokuhisa, Y; Tomochika, S; Yoshida, S; Yoshino, S, 2009)
"Azoxymethane-induced colon cancer animals were treated with 400 mg/kg body weight of W."( Amanullah, S; Basha, MI; Dinda, AK; Muralikrishnan, G; Shakeel, F, 2010)
"Furthermore, treatment of colon cancer SW620-bearing nude mice with sunitinib plus TRAIL resulted in more significant tumor growth inhibition (52."( Cai, T; Ding, W; He, Q; Lu, W; Tu, C; Wu, R; Yang, B; Yang, L; Zhu, H, 2010)
"Interestingly, treating pancreatic and colon cancer cells with valproic acid (VPA, 2-propylpentanoic acid), a known histone deacetylase (HDAC) inhibitor, leads to up-regulation of GRP78, an endoplasmic reticulum chaperone immunoglobulin-binding protein."( Bayer, TA; Iffland, L; Rossner, C; Schweyer, S; Tamboli, IY; Venkataramani, V; Walter, J; Wirths, O, 2010)
"We report a resected case of ascending colon cancer with left supraclavicular and paraaortic lymph nodes and liver metastases which completely responded in terms of metastases but not the primary tumor to FOLFOX4 therapy."( Fuji, H; Furumoto, K; Ito, D; Kogire, M; Kojima, H; Mizuno, R; Mori, T; Okuno, M; Takaya, H, 2010)
"Human COLO-205 colon cancer cells were cultured and treated with beta-estradiol for 24 h."( Doucet, K; Duke, V; Johnson, N; Morra, A; Wilkins, HR, 2010)
"Unresectable chemorefractory colon cancer liver metastases treated with (90)Y radioembolization in 28 patients were evaluated at pre- and posttreatment multidetector computed tomographic (CT) and FDG PET scans."( Atassi, B; Berggruen, S; Nikolaidis, P; Rezai, P; Rezvani, M; Salem, R; Tochetto, SM; Yaghmai, V, 2010)
"Changes in attenuation of colon cancer liver metastases treated with (90)Y radioembolization correlate highly with metabolic activity at FDG PET and may be useful as an early surrogate marker for assessing treatment response."( Atassi, B; Berggruen, S; Nikolaidis, P; Rezai, P; Rezvani, M; Salem, R; Tochetto, SM; Yaghmai, V, 2010)
"Forty-eight-hour treatment of colon cancer HCT-116 and HT-29 cells with FOLFOX resulted in 60-70% survival, accompanied by a marked activation of insulin like growth factor-1 receptor (IGF-1R) and minor to moderate increase in epidermal growth factor receptor (EGFR), v-erb-b2 erythroblastic leukemia viral oncogene homolog 2 (HER-2) as well as v-akt murine thymoma viral oncogene homolog 1 (AKT), cyclooxygenase-2 (COX-2) and cyclin-D1."( Elliott, AA; Gupta, D; Majumdar, AP; Patel, BB; Sengupta, V; Yu, Y, 2010)
"IL-6 treatment of colon cancer cells resulted in an increase in DNMT1 expression, independent of de novo gene expression."( Egan, LJ; Foran, E; Garrity-Park, MM; Limburg, PJ; Mureau, C; Newell, J; Smyrk, TC, 2010)
"While many patients with early-stage colon cancer are cured with surgery alone, the standard of care remains a uniform approach to adjuvant chemotherapy based primarily on tumor stage."( Gangadhar, T; Schilsky, RL, 2010)
"Molecular markers in colon cancer are needed for a more accurate classification and personalized treatment."( Creemers, GJ; Fariña-Sarasqueta, A; Lemmens, VEPP; Moerland, E; Rutten, HJT; van den Brule, AJC; van Lijnschoten, G, 2010)
"In this study, we treated human colon cancer HT-29 cells with SAA and SBA, and found a significant exposure time-dependent increase of cytotoxicity in both treatments, with a higher cytotoxicity for 24 h with SAA (IC(50) = 5 mM) than SBA (IC(50) = 10 mM)."( Che, CT; Cheung, FW; Kochi, M; Liu, WK; Sakagami, H, 2010)
"Chemotherapy is the main treatment for colon cancer, while multidrug-resistance is the main reason for chemotherapy failure and tumor relapse."( Bi, F; Lang, N; Liu, M; Liu, Z; Qiu, M; Tang, QL, 2010)
"WiDr human colon cancer cells were treated with 150, 300, 600 or 1200 ppm of soy saponin to determine the effect on cell growth, cell morphology, alkaline phosphatase (AP) and protein kinase C (PKC) activities, and P53 protein, c-Fos and c-Jun gene expression."( Chen, YH; Chien, YW; Huang, WH; Lin, SH; Tsai, CY, 2010)
"In human colon cancer cells (HCT116, HT29) and non-immortalized primary fetal colon cells (FHC), CA- and CE-treatment upregulated cellular protein levels of Nrf2 and established Nrf2 targets involved in the antioxidant response including heme oxygenase 1 (HO-1) and gamma-glutamyl-cysteine synthetase (gamma-GCS, catalytic subunit)."( Bause, AS; Jiang, T; Lamore, SD; Villeneuve, NF; Wondrak, GT; Zhang, DD, 2010)
"In addition, the growth of the colon cancer cell lines Caco-2 and colon-26 was significantly inhibited by treatment with the 3 hanabiratakelides."( Hashimoto, T; Inose, T; Kimura, T; Kokudo, N; Yamamoto, K; Yoshikawa, K, 2010)
"Human colon cancer cells SW480 were divided into two groups: SW480 cells in experimental group were treated with NS398 in different concentrations(25 micromol/L, 50 micromol/L, 100 micromol/L and 200 micromol/L) for 48 h or 72 h."( Ni, SM; Wang, SM; Wu, X; Yang, G; Ye, M, 2010)
"Altogether, our results suggest that colon cancer cells can acquire rhTRAIL resistance by primarily reducing the basal procaspase 8/c-FLIP ratio and by increasing active caspase 8 degradation after rhTRAIL treatment."( De Jong, S; De Vries, EG; Ek, WB; Le, PT; Pennarun, B; Spierings, DC; Van Geelen, CM, 2010)
"Azoxymethane induced colon cancer animals were treated with 400 mg/kg body weight of W."( Dinda, AK; Muralikrishnan, G; Shakeel, F, 2010)
"Pyrvinium treatment of colon cancer cells with mutation of the gene for adenomatous polyposis coli (APC) or β-catenin inhibits both Wnt signaling and proliferation."( Cselenyi, CS; Ghidu, VP; Hang, BI; Hanson, AJ; Jernigan, KK; Kim, K; LaFleur, B; Lee, E; Lee, LA; Melancon, B; Meyers, KC; Miller, DM; Orton, D; Salic, A; Schneider, J; Sulikowski, GA; Tahinci, E; Thorne, CA; Waterson, AG, 2010)
"Stage III colon cancer patients receiving standard adjuvant oxaliplatin/capecitabine chemotherapy were vaccinated at the same time with keyhole limpet haemocyanin (KLH) and carcinoembryonic antigen (CEA)-peptide pulsed DCs."( Aarntzen, EA; Adema, GJ; de Boer, A; de Vries, IJ; Figdor, CG; Lesterhuis, WJ; Preijers, FW; Punt, CJ; Scharenborg, NM; van de Rakt, M; van Spronsen, DJ, 2010)
"In human colon cancer cell peritoneal xenografts, MTOB treatment decreased tumor burden and induced tumor cell apoptosis."( Grossman, SR; Kovi, RC; Lyle, S; Paliwal, S; Parker, D; Rajeshkumar, B; Schiffer, CA; Straza, MW; Trenh, P; Whalen, GF, 2010)
"We report a case of high CEA advanced colon cancer, which we were able to down stage after treatment with FOLFIRI-1."( Egawa, H; Kadokawa, Y; Kawabe, A; Nakajima, S; Sonoda, K; Yamamoto, T, 2010)
"HCT116 and HT29 colon cancer cells for cell viability assay were treated with PXD101 and/or SN-38, the active form of irinotecan."( Cho, DH; Hong, YS; Jang, SJ; Jung, KA; Kim, JC; Kim, SM; Kim, TW; Lee, JS; Moon, DH; Na, YS; Ryu, MH, 2011)
"Many patients with early-stage colon cancer are cured with surgery alone, even if the standard of care remains an uniform approach to adjuvant chemotherapy based primarily on tumour stage."( Cinieri, S; Colucci, G; Fazio, N; Lombardi, L; Maiello, E; Morelli, F; Orlando, L; Santini, D; Silvestris, N; Tonini, G, 2010)
"Recurrence of colon cancer, which affects nearly 50% of patients treated by conventional therapeutics, is thought to be due to re-emergence of chemotherapy-resistant cancer stem/stem-like cells (CSCs)."( Kanwar, SS; Majumdar, AP; Nautiyal, J; Padhye, S; Patel, BB; Sarkar, FH; Yu, Y, 2011)
"Five colon cancer and two adenoma cell lines, human ex vivo adenomas and normal colonic epithelium were treated with aspirin or sulindac combined with rhTRAIL."( de Jong, S; de Vries, EG; Heijink, DM; Hollema, H; Jalving, M; Kleibeuker, JH; Koornstra, JJ; Koster, R; Oosterhuis, D; Sloots, IA, 2011)
"Patients with colon cancer undergoing adjuvant therapy with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX) were randomly assigned to Ca/Mg (1g calcium gluconate plus 1g magnesium sulfate pre- and post-oxaliplatin) or placebo, in a double-blinded manner."( Alberts, SR; Chitaley, U; Dentchev, T; Grothey, A; Kugler, JW; Loprinzi, CL; Nikcevich, DA; Novotny, PJ; Silberstein, PT; Sloan, JA; Wender, DB, 2011)
"Treatment of HCT-116 human colon cancer cells with MCPP was found to induce a number of signature endoplasmic reticulum (ER) stress markers; and up-regulation of CCAAT/enhancer-binding protein homologous protein (CHOP) and glucose-regulated protein (GRP)-78, phosphorylation of eukaryotic initiation factor-2α (eIF-2α), suggesting the induction of ER stress."( Chang, CS; Chen, JH; Cheung, CW; Huang, SM; Ko, SH; Lin, YH; Liu, JF; Lu, DY; Tang, CH; Wong, KL, 2011)
"HCT-116 human colon cancer cells were treated with 0."( Kaneno, FM; Kaneno, R; Luo, J; Naiditch, H; Shurin, GV; Shurin, MR, 2011)
"Raman spectra of the cultured HCT116 colon cancer cells treated with roscovitine at different concentrations (0, 5, 10, 25 and 50 μM) were recorded in the range 400-1850 cm(-1)."( Akyuz, S; Akyuz, T; Arisan, ED; Balci, K; Coker, A; Ozalpan, A; Ozel, AE; Palavan-Unsal, N, 2011)
"We continued the chemotherapy for her colon cancer by prescribing S-1, it proved ineffective."( Hanatate, F; Kobayashi, K; Komaki, C, 2011)
"We treated colon cancer cell lines heterozygous for gain-of-function and wild-type β-catenin with sulindac."( Arlt, F; Fichtner, I; Herrmann, P; Lemm, M; Sack, U; Schlag, PM; Shoemaker, RH; Smith, J; Stein, U; Walther, W, 2011)
"The standard treatment for colon cancer is surgical excision."( , 2011)
"Finally, calcimycin treatment of human colon cancer cells inhibited metastasis formation in xenografted immunodeficient mice."( Aumann, J; Fichtner, I; Lemos, C; Sack, U; Schlag, PM; Scudiero, D; Selby, M; Shoemaker, RH; Stein, U; Walther, W, 2011)
"We report a case of undifferentiated colon cancer treated with FOLFIRI therapy."( Fujiwara, K; Iwashita, T; Nagayoshi, Y; Nakahara, C; Yamasaki, T, 2011)
"A patient with colon cancer who had received an overdose of fluorouracil was successfully treated with a five-day course of oral uridine triacetate."( McEvilly, M; Popelas, C; Tremmel, B, 2011)
"We examined ESA therapy in lung and colon cancer patients receiving chemotherapy in the VA from 2002 to 2008 to ascertain trends in and predictors of ESA use."( Browning, MM; Hynes, DM; Lee, TA; Michaelis, LC; Ozer, H; Stroupe, KT; Tarlov, E; Weichle, TW; Zhang, QL, 2012)
"Among 17,014 lung and 4,225 colon cancer patients, those treated after the March 2007 FDA decision had 65% (lung OR 0."( Browning, MM; Hynes, DM; Lee, TA; Michaelis, LC; Ozer, H; Stroupe, KT; Tarlov, E; Weichle, TW; Zhang, QL, 2012)
"Two human colon cancer cell lines SW480 and LOVO were treated with IFN-alpha alone or gefitinib alone or IFN-alpha plus gefitinib."( He, F; Huang, L; Wang, F; Yang, L, 2011)
"The present patient had metastatic colon cancer and was admitted to our hospital with a floating sensation and general malaise on day 4 after undergoing the last of 4 cycles of a 7th round of chemotherapy with XELOX."( Goto, H; Hara, K; Higuchi, K; Hijioka, S; Kawai, H; Kondo, S; Mizuno, N; Nakamura, M; Niwa, Y; Ogura, T; Sawaki, A; Tajika, M; Yamao, K, 2011)
"DCT treatment of human colon cancer cells resulted in time-dependent, 10-fold increased MMP1 expression, and DCT-induced cell invasion was also blocked by pre-treatment with anti-MMP1 antibody."( Belo, A; Chahdi, A; Cheng, K; Khurana, S; Raufman, JP; Saxena, N; Xie, G, 2011)
"Patients with advanced colon cancer who progressed after prior treatment regimens received intravenous patupilone (6."( Bennouna, J; Bridgewater, J; Campone, M; Casado, E; Cerman, J; Delord, JP; Dvorak, J; Melichar, B; Salazar, R; Sguotti, C; Tabernero, J; Tan, E; Urban, P; Viraswami-Appanna, K; Vitek, P, 2011)
"Two different human colon cancer cell lines were treated with AngII and Ang1-7."( Bellini, G; Bernardi, S; Buri, L; Burrell, LM; De Manzini, N; Fabris, B; Giacomel, G; Palmisano, S; Sabato, N; Toffoli, B; Velkoska, E; Zanconati, F; Zennaro, C, 2012)
"These effects were confirmed in vivo in colon cancer xenograft models with demonstrations that IGF-I receptor stimulation was sufficient to generate a 45% increase in tumor cell proliferation, along with a 25% to 50% increase in chemotherapy-induced tumor growth delay."( Baker, JH; Kyle, AH; Minchinton, AI, 2012)
"Moreover, Gli3 siRNA sensitized colon cancer cells to treatment with anti-cancer agents (5-FU and bevacizumab)."( Kang, HN; Kim, JS; Oh, SC; Yoo, YA, 2012)
"Understanding how colon cancer cells survive within the inflammatory milieu of a tumor, and developing approaches that increase their sensitivity to inflammatory cytokines, may ultimately lead to novel approaches for colon cancer therapy and prevention."( Giardina, C; Kuratnik, A; Mellone, BG; Senapati, VE; Vella, AT; Verma, R, 2012)
"Considering the increased colon cancer risk associated with chronic colitis, we have therefore examined the effects of long-acting hGly(2)GLP-2, as well as of endogenous GLP-2 using the antagonist hGLP-2(3-33) in two novel models of inflammation-associated colon cancer: rats fed the carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and a high-fat diet (HFD) for one or three cycles, and mice with chronic dextran sodium-sulfate (DSS)-induced colitis administered AOM."( Brubaker, PL; El-Zimaity, HM; Trivedi, S; Wiber, SC, 2012)
"Colitis-associated colon cancer was induced in mice by administration of azoxymethane, followed by 3 cycles of oral administration of dextran sodium sulfate."( Becker, C; Dornhoff, H; Markl, J; Mudter, J; Neufert, C; Neurath, MF; Rosfa, S; Siebler, J; Strand, D; Tenzer, S; Wirtz, S, 2012)
"HT-29 colon cancer cells and LT97 colorectal micro-adenoma cells derived from a patient with FAP, were exposed to low dose celecoxib and UDCA alone or in combination with tauro-cholic acid (CA) and tauro-chenodeoxycholic acid (CDCA), mimicking bile of FAP patients treated with UDCA."( Marian, B; Nagengast, FM; Peters, WH; Roelofs, HM; Te Morsche, RH; van Heumen, BW, 2012)
"Human colon cancer cell lines (HCT116, HT29, SW48, SW480) were treated with 5-aza-2'-deoxycytidine (DAC), as a DNA methyltransferase inhibitor, followed by trichostatin A (TSA), as a histone deacetylase inhibitor."( Ikehata, M; Iwakawa, S; Ueda, K, 2012)
"We used a rat model of the colon cancer induced by administration of azoxymethane followed by repeated dextran sodium sulfate ingestion which causes multiple tumor development."( Aktan, AO; Attaallah, W; Erdoğan, N; Yalçin, AS; Yilmaz, AM, 2012)
"LS174T, SW480 and DLD-1 colon cancer cell lines were treated with PP242 an ATP-competitive inhibitor of mTOR, NVP-BEZ235, a dual PI3K/mTOR inhibitor or rapamycin."( Blaser, B; Demartines, N; Dormond, O; Dormond-Meuwly, A; Dufour, M; Roulin, D; Waselle, L, 2012)
"Combined treatment of human HCT116 colon cancer cells with free celecoxib plus tributyrin emulsion inhibited the cellular proliferation more effectively than that of each drug alone, suggesting the possibility of tributyrin emulsion as a potential celecoxib carrier."( Hong, SS; Kang, SN; Lee, MK; Lim, SJ, 2012)
"In the colon cancer xenograft model, the volume of the tumor treated with deguelin was significantly lower than that of the control, and the apoptotic index for deguelin-treated mice was much higher."( Cha, MY; Jung, HC; Kang, HW; Kim, JM; Kim, JS; Song, IS, 2012)
"The proposed model of distal colon cancer is feasible, allows for easy monitoring of tumoral growth by both, macroscopically and molecular imaging, and is suitable for studying the evolution of tumor with implementation of cytotoxic therapy in vivo."( Abrantes, AM; Batista, JN; Botelho, MF; Cardinalli, IA; Neves, S; Priolli, DG, 2012)
"Nude mouse models bearing LoVo colon cancer xenograft were randomized into vehicle control group, untreated control group, axitinib-treated group, 5-FU-treated group and combined treatment group for corresponding treatments."( He, B; Xie, F; Zhao, J; Zhao, T, 2012)
"Human colon cancer DLD-1 cells were treated with 5-FU (10 μΜ) or chloroquine (100 μΜ), or a combination of both."( Choi, JH; Lee, YY; Park, BB; Won, YW; Yoon, JS, 2012)
"Adjuvant chemotherapy for stage III colon cancer is internationally accepted as standard treatment with established efficacy, but the usefulness of adjuvant chemotherapy for stage II colon cancer remains controversial."( Ishiguro, M; Ishikawa, T; Kanemitsu, Y; Kotake, K; Matsui, S; Mochizuki, H; Shimada, Y; Sugihara, K; Takahashi, K; Teramukai, S; Tomita, N; Ueno, H; Uetake, H; Watanabe, M, 2012)
"In conclusion, in colon cancer cells, cisplatin treatment enhances chemoresistance through FXR-dependent and FXR-independent mechanisms involving the expression of BCRP and MRP2, respectively."( Briz, O; Gonzalez-Sanchez, E; Herraez, E; Marin, JJ; Romero, MR; Serrano, MA; Vaquero, J, 2012)
"Two human colon cancer cell lines LOVO and SW480 were cultured and treated with IFN-α2a at a series of dosage, and fluorescence quantitative PCR was carried out to detect the TP mRNA expression levels in these 2 cell lines."( Wang, QW; Xia, Q; Zhang, JM, 2012)
"The loss of expression of miR-34 in colon cancer is in part due to promoter hypermethylation of miR-34, which can be re-expressed with our novel agent CDF, suggesting that CDF could be a novel demethylating agent for restoring the expression of miR-34 family, and thus CDF could become a newer therapeutic agent for the treatment of colon cancer."( Levi, E; Majumdar, AP; Roy, S; Sarkar, FH, 2012)
"This increased apoptosis in human colon cancer cells after RA or DZNep treatment was associated with a ~2."( Benoit, YD; Gudas, LJ; Laursen, KB; Lipkin, SM; Witherspoon, MS, 2013)
"In wild-type p53 colon cancer cells, topotecan treatment activated p53, upregulated the expression of sestrin 2, induced the phosphorylation of the AMPKα subunit at Thr172, and inhibited the mTORC1 pathway."( Chen, SP; Deng, R; Feng, GK; Jiang, S; Li, DD; Pan, JX; Sun, T; Wu, XQ; Zeng, YX; Zhang, XS; Zhu, XF, 2012)
"CT26 mouse colon cancer cells were treated with trichostatin A (TSA; apoptosis inducer) or doxorubicin (DXR; necrosis inducer)."( Chihara, Y; Fujii, K; Fujimoto, K; Fujiwara, R; Kuniyasu, H; Kuwada, M; Luo, Y; Ohmori, H; Sasahira, T, 2013)
"However, a sub-population of colon cancer patients do not respond to 5-FU and this treatment does not provide survival benefit due to chemo resistance."( Gao, H; Khan, AQ; Liang, B; Lin, P; Liu, E; Liu, S; Niu, J; Niu, W; Peng, C; Shahbaz, M; Wang, B; Wang, J, 2013)
"However, the treatment of colon cancer cells with a diet-compatible mixture of oxysterols does not elicit the same responses than individual components added to the cells at the same concentrations at which they are present in the mixture."( Biasi, F; Chiarpotto, E; Gamba, P; Gargiulo, S; Guina, T; Leonarduzzi, G; Maina, M; Mascia, C; Poli, G; Sottero, B; Testa, G, 2013)
"Human and murine colon cancer cell lines were subjected to mild hyperthermia (40-42°C), and treated with chemotherapy, similar to clinical protocols."( Clavien, PA; Gertsch, P; Graf, R; Humar, B; Jang, JH; Lehmann, K; Oberkofler, CE; Rickenbacher, A; von Boehmer, L; Vonlanthen, R, 2012)
"Treatment of colon cancer with an antagonist of growth hormone-releasing hormone (GHRH), JMR-132, results in a cell cycle arrest in S-phase of the tumor cells."( Block, NL; Buchholz, S; Datz, C; Hohla, F; Krishan, A; Rick, FG; Schally, AV; Seitz, S; Stadlmayr, A; Szalontay, L, 2012)
"Patients with resected stage III colon cancer aged ≥75 years diagnosed in 1997-2004 who received adjuvant chemotherapy (N = 216) were included as well as a random sample (N = 341) of patients who only underwent surgery."( Hoeben, KW; Janssen-Heijnen, ML; Rutten, HJ; van de Wouw, AJ; van Spronsen, DJ; van Steenbergen, LN, 2013)
"A total of 22 patients with colon cancer receiving chemotherapy were included in the efficacy analyses."( Nakayama, Y; Shinohara, Y; Takahashi, K; Torigoe, T; Yamaguchi, K, 2012)
"A total of 149 patients with advanced colon cancer undergoing curative resection followed by adjuvant chemotherapy(FOLFOX6 protocol) were included."( Cai, CN; Guan, XD; Jia, YB; Li, J; Li, PP; Xie, YY; Zhang, BM, 2012)
"Among 391 patients with Stage III colon cancer, 229 patients received adjuvant oxaliplatin, fluorouracil and leucovorin chemotherapy (87 (43."( Jang, NY; Kang, SB; Kim, DW; Kim, JH; Kim, JS; Kim, JY; Kim, YJ; Lee, HS; Lee, JS; Lee, KW, 2013)
"Therefore, for colon cancer patients aged ≥65, oxaliplatin, fluorouracil and leucovorin chemotherapy can be recommended as safe and effective adjuvant chemotherapy after curative surgery in Asia."( Jang, NY; Kang, SB; Kim, DW; Kim, JH; Kim, JS; Kim, JY; Kim, YJ; Lee, HS; Lee, JS; Lee, KW, 2013)
"CD133-positive cancer stem cells in colon cancer are resistant to conventional chemotherapy."( Deng, Y; Fu, X; Lin, EH; Mo, J; Su, Q; Zhang, Y, 2013)
"We report on an 86-year-old woman with colon cancer with liver metastasis who was treated with 5-fluorouracil, folinic acid, and bevacizumab."( Boudou-Rouquette, P; Brezault, C; Chaussade, S; Coriat, R; Dhooge, M; Dréanic, J; Goldwasser, F; Mir, O; Perkins, G, 2013)
"This study in 716 colon cancer patients evaluates if a combined instead of a single marker analysis of mismatch repair (MMR) status and thymidylate synthase (TS) expression could individualize the treatment decision."( Edler, D; Hallström, M; Karlberg, M; Öhrling, K; Ragnhammar, P, 2013)
"Data also indicate that MMR proficient colon cancer with high TS expression has a better response to adjuvant 5-FU-based chemotherapy."( Edler, D; Hallström, M; Karlberg, M; Öhrling, K; Ragnhammar, P, 2013)
"Stage III colon cancer patients aged 65+ years initiating chemotherapy between 2003 and 2006 were examined using cancer registry data linked with Medicare claims."( Brookhart, MA; Carpenter, WR; Glynn, RJ; Mack, CD; Meyer, AM; Sandler, RS; Stürmer, T, 2013)
"In vitro treatment of HCT-116 colon cancer cells with 3,4-DHPAA and EGCG exhibited an additive antiproliferative effect, while methylation of 3,4-DHPAA was significantly decreased."( Abgaryan, N; Aronson, WJ; Carpenter, CL; de Oliveira, DM; Heber, D; Henning, SM; Lee, RP; Vicinanza, R; Wang, P; Zhang, Y, 2013)
"3-Bromopyruvate inhibited colonic cancer cell proliferation, but the effect was not always additive to that of biguanides and an additive effect was more notable in combined treatment with 3-bromopyruvate and 2-deoxyglucose."( Buxhoeveden, M; Desbordes, C; Gengel, N; Kleinschmit, J; Lea, MA; Qureshi, MS, 2013)
"We report a case of recurrent colon cancer successfully treated by mFOLFOX6 and FOLFIRI, and maintaining a complete response(CR)over the long-term."( Hamada, T; Ohashi, S; Ohta, K; Taniguchi, E; Yamagami, Y; Yoshikawa, M, 2013)
"HT-29 and SW-480 colon cancer and normal CCD-18Co colon fibroblast cells were treated with curcuminoids previously analyzed by HPLC."( Angel-Morales, G; Jutooru, I; Mertens-Talcott, SU; Noratto, GD; Safe, S, 2013)
"To elevate MDA-7/IL-24 level for colon cancer treatment, we successfully developed a small-molecule compound SC144 with the ability to up-regulate MDA-7/IL-24 expression via direct binding and stabilizing MDA-7/IL-24 in human colon cancer cells."( Debnath, B; Garofalo, A; Grande, F; Imada, T; Masuda, M; Neamati, N; Oshima, T; Xu, S, 2013)
"Two hundred and thirty five colon cancer patients treated surgically in a community teaching hospital in Norway between 2007 and 2009 were prospectively examined."( Eide, GE; Fjørtoft, I; Furnes, B; Hausken, T; Storli, KE; Søndenaa, K, 2013)
"The cells of LS180 colon cancer cell line were tested upon treatment with roasted potato fiber extract (AM4) as well as with high (HMW) and low (LMW) molecular weight fractions isolated from the extract, since both may be regarded as/or contain melanoidins."( Kandefer-Szerszeń, M; Langner, E; Nunes, FM; Pierzynowski, SG; Pożarowski, P; Rzeski, W, 2013)
"MAT2A expression is increased in human colon cancer and in colon cancer cells treated with mitogens, whereas silencing MAT2A resulted in apoptosis."( Giordano, P; Lu, SC; Mato, JM; Ryoo, M; Skay, A; Tomasi, I; Tomasi, ML, 2013)
"Mice bearing human colon cancer LS-174T intraperitoneal xenografts were pre-treated with paclitaxel, followed by treatment with (212)Pb-TCMC-trastuzumab and compared with groups treated with paclitaxel alone, (212)Pb-TCMC-HuIgG, (212)Pb-TCMC-trastuzumab and (212)Pb-TCMC-HuIgG after paclitaxel pre-treatment."( Baidoo, KE; Brechbiel, MW; Milenic, DE; Yong, KJ, 2013)
"Mice bearing COLO 320DM human colon cancer xenografts (containing amplified c-MYC) were treated with a TFO targeted to c-MYC in combination with GEM."( Boulware, SB; Christensen, LA; Coghlan, L; Finch, RA; Thames, H; Vasquez, KM, 2014)
"p53-null colon cancer cell lines with different sets of mutations were used to validate the role of GSK3B in sustaining resistance and to characterize cell death mechanisms triggered by chemotherapy when GSK3B is silenced."( Bonin, S; Donada, M; Federzoni, E; Giovannoni, R; Grassilli, E; Helin, K; Ianzano, L; Lavitrano, M; Leone, BE; Masiero, L; Narloch, R; Pisano, F; Romano, G; Stanta, G, 2013)
"Treatment of colon cancer cells (HT29, SW480 and Caco-2) with epidermal growth factor (EGF) caused increased expression of miR-21 and inhibition of AR prevented it."( Ramana, KV; Saxena, A; Shoeb, M; Srivastava, SK, 2013)
"We report a case of advanced relapsed colon cancer, which had multiple liver and spleen metastasis, controlled for about two years by capecitabine therapy."( Hashimoto, T; Kimura, S; Toyono, M; Usuba, O; Yokoyama, M, 2013)
"Between 2002 and 2011, 333 Stage III colon cancer patients had surgery performed in our institute, and we studied 25 of them on our chemotherapy regimen."( Hanaoka, Y; Hashimoto, M; Kuroyanagi, H; Matoba, S; Moriyama, J; Toda, S; Tomizawa, K; Udagawa, H; Watanabe, G, 2013)
"While it protected mice from colon cancer in a model of inflammation-triggered carcinogenesis (azoxymethane and dextran sodium sulfate treatment), it promoted growth of xenografted tumor cells."( Brigelius-Flohé, R; Chu, FF; Esworthy, RS; Florian, S; Kipp, AP; Müller, MF; Osterhoff, M; Pommer, S, 2013)
"Future colon cancer therapeutic trials, with inclusion of correlative molecular markers, should be designed to permit evaluation of survival and/or response to treatment in women separately from men."( Atreya, CE; Bertagnolli, MM; Compton, CC; Donner, DB; Goldberg, RM; Mayer, RJ; Niedzwiecki, D; Saltz, LB; Warren, RS; Weinberg, VK; Ye, C; Zuraek, MB, 2013)
"In this study we used colon cancer cell lines to study the cellular and molecular events that take place during co-treatment with NaB, EC and EGCG."( Cascante, M; Centelles, JJ; Dudeja, PK; Sánchez-Tena, S; Vizán, P, 2013)
"Six months later, colon cancer was discovered and the patient underwent surgical procedure and chemotherapy with capecitabine thereafter."( Badzek, S; Bilic, E; Golem, H; Gorsic, I; Kekez, D; Librenjak, N; Miletic, V; Plestina, S; Prejac, J, 2013)
"Human colon cancer LoVo cells were divided into three groups: phorbol 12-myristate 13-acetate (PMA) was used to induce the activation of SphK1 in the PMA group, N,N-dimethylsphingosine (DMS) used to suppress the activity of SphK1 in DMS group, and the cells treated with equal amount of 0."( Huang, JA; Liu, SQ; Qin, MB; Su, YJ; Tang, GD, 2013)
"HCT-116 colon cancer cells were treated with CPT, OXP, and IL-6 separately or in combination in a time and dose-dependent manner and examined for phosphorylated and non-phosphorylated RKIP and STAT3 via Western blot analysis."( Brilliant, K; Chatterjee, D; Cross-Knorr, S; Guevara, S; Lu, S; Perez, K; Pisano, C; Quesenberry, PJ; Resnick, MB, 2013)
"Current treatment of colon cancer depends on traditional cytotoxic agents with limited effects."( Bode, AM; Chen, H; Dong, Z; Jung, SK; Kim, DJ; Lee, HJ; Lee, KW; Lee, MH; Lee, SY; Lim, TG; Shin, A; Surh, YJ, 2013)
"Contrarily, patients with colon cancer stage III are routinely offered chemotherapy, but due to expected adverse effects and frailty, elderly patients are often excluded from standard protocols."( Ågesen, TH; Guren, MG; Lothe, RA; Nesbakken, A; Skotheim, RI; Sveen, A; Tveit, KM, 2013)
"Treatment of a human colon cancer cell line (HCT116) with 100 μM sodium arsenite increased SRSF3-PTC mRNA levels without changing SRSF3-FL mRNA levels."( Akaike, Y; Kajita, K; Kano, S; Kita, K; Kurebe, H; Kurokawa, K; Kuwano, Y; Masuda, K; Nishida, K; Nishiyama, C; Rokutan, K; Tanahashi, T, 2014)
"In all, 353 patients with colon cancer undergoing adjuvant therapy with FOLFOX (fluorouracil, leucovorin, and oxaliplatin) were randomly assigned to intravenous calcium/magnesium before and after oxaliplatin, a placebo before and after, or calcium/magnesium before and placebo after."( Atherton, P; Dakhil, SR; Fehrenbacher, L; Flynn, KA; Grothey, A; Lewis, GC; Loprinzi, CL; Qamar, R; Qin, R; Seisler, D, 2014)
"Treatment of colon cancer cells with 3-AP or 3-AP-Me activated all three ER stress pathways (PERK, IRE1a, ATF6) by phosphorylation of eIF2α and upregulation of gene expression of activating transcription factors ATF4 and ATF6."( Berger, W; Enyedy, ÉA; Flocke, LS; Heffeter, P; Jakupec, MA; Jungwirth, U; Keppler, BK; Kowol, CR; Mair, GE; Steinborn, R; Trondl, R, 2014)
"The treatment of metastatic colon cancer (mCC) utilizes either combination therapies or sequential monotherapy followed by combination therapy in subsequent lines of treatment."( Ghosh, S; Loree, JM; Mulder, KE; Spratlin, JL, 2014)
"A 73-year-old male with sigmoid colon cancer and synchronous lung metastasis was treated with panitumumab, an alone anti-EGFR monoclonal antibody as the third-line therapy."( Ichikawa, K; Imai, H; Matsuhashi, N; Nonaka, K; Okumura, N; Osada, S; Sasaki, Y; Takahashi, T; Tanahashi, T; Tanaka, Y; Yamaguchi, K; Yawata, K; Yoshida, K, 2014)
"Adjuvant treatment of colon cancer relies on fluoropyrimidine-containing regimens as the intravenous formulation, 5-FU, or its oral prodrug, CA, combined with oxaliplatin (FOLFOX and CAPOX)."( Ghosh, S; Loree, JM; Mulder, KE; Spratlin, JL, 2014)
"Among 305 stage III colon cancers registered in a well-defined population in Burgundy between 2004 and 2009, 210 had adjuvant chemotherapy, including 156 with FOLFOX."( Bedenne, L; Bouvier, AM; Faivre, J; Hamza, S; Lepage, C; Rollot, F, 2014)
"Patients with stage IIB or III colon cancer who had undergone curative resection were randomly assigned to receive UFT (300 mg/m(2)) plus leucovorin (75 mg/day) for 6 months (control group, 4 weeks of treatment followed by a 1-week rest, five courses) or for 18 months (study group, 5 days of treatment followed by a 2-day rest, 15 courses)."( Baba, H; Hamada, C; Kakeji, Y; Katsumata, K; Koda, K; Kodaira, S; Kondo, K; Matsuoka, J; Morita, T; Nishimura, G; Sadahiro, S; Saji, S; Sasaki, K; Sato, S; Tsuchiya, T; Usuki, H; Yamaguchi, Y, 2014)
"The efficacy of 5-FU in colon cancer chemo treatment could be improved by nanoencapsulation and combinatorial approach."( Anitha, A; Chennazhi, KP; Jayakumar, R; Lakshmanan, VK; Sreeranganathan, M, 2014)
"Treatment of SW480 cells, a human colon cancer cells, with cucurbitacin-I decreased cell viability and cell proliferation in a concentration-dependent manner."( Kim, HJ; Kim, JK; Park, JH, 2014)
"Treatment of HCT-116 and Caco-2 colon cancer cells with the hypoxia mimic CoCl2 induced the formation of cells with larger cell and nuclear size (PGCCs), while the cells with normal morphology were selectively eliminated."( Aranda, E; De la Haba-Rodríguez, JR; Hernandez, V; Jimenez, C; Lopez-Pedrera, C; Lopez-Sánchez, LM; Martinez, A; Muñoz-Castañeda, JR; Peñarando, J; Rodriguez-Ariza, A; Valverde, A, 2014)
"The NCCN Guidelines for Colon Cancer address diagnosis, pathologic staging, surgical management, perioperative treatment, posttreatment surveillance, management of recurrent and metastatic disease,and survivorship."( Bekaii-Saab, T; Benson, AB; Chan, E; Chen, YJ; Cooper, HS; Engstrom, PF; Enzinger, PC; Fenton, MJ; Freedman-Cass, DA; Fuchs, CS; Gregory, KM; Grem, JL; Hunt, S; Kamel, A; Leong, LA; Lin, E; Messersmith, W; Mulcahy, MF; Murphy, JD; Nurkin, S; Rohren, E; Ryan, DP; Saltz, L; Sharma, S; Shibata, D; Skibber, JM; Sofocleous, CT; Stoffel, EM; Stotsky-Himelfarb, E; Venook, AP; Willett, CG, 2014)
"A total of 255 colon cancer patients treated at the Affiliated Tumor Hospital of Xinjiang Medical University from June 1(st) 2005 to June 1(st) 2008 were enrolled in the study."( Han, XN; Liu, YY; Qu, YL; Sun, ZQ; Tang, Y; Wang, HJ; Xu, RW; Yu, XB; Zhao, ZL, 2014)
"The development of colon cancer was induced in male BALB/c mice with a single intraperitoneal injection of azoxymethane (AOM, 10 mg/kg body weight) and subsequent treatment with 2% dextran sulfate sodium (DSS) in drinking water for 7 days for two cycles."( Chang, HK; Kang, SA; Kim, HY; Park, KY; Song, JL, 2014)
"Another common approach for colon cancer treatment is targeted therapy against the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway."( Chen, J; Gu, W; Li, L; Shao, R; Xu, ZP, 2014)
"Treatment of Caco-2 human colon cancer cells, used as a colon epithelial model, with 50 µM patulin decreased the level of density-enhanced phosphatase-1 (DEP-1) protein to 30% of the control level after 6 h."( Katsuyama, A; Kikuchi, H; Konno, T; Shimoyama, S, 2014)
"Kaplan-Meier plots from colon cancer patients showed a significant treatment benefit in patients with low maspin expression, but not for individuals with medium/high expression."( Brydøy, M; Dahl, O; Hestetun, KE; Myklebust, MP, 2015)
"In patients with colon cancer a low nuclear maspin expression was an independent predictor of benefit from adjuvant chemotherapy with 5-FU/Lev."( Brydøy, M; Dahl, O; Hestetun, KE; Myklebust, MP, 2015)
"In search for novel strategies in colon cancer treatment, we investigated the unique ability of platinum(IV) complex LA-12 to efficiently enhance the killing effects of tumor necrosis factor-related apoptosis inducing ligand (TRAIL), and compared it with the sensitizing action of cisplatin."( Ehrmann, J; Hofmanová, J; Hyršlová Vaculová, A; Jelínková, I; Kolář, Z; Kozubík, A; Moyer, MP; Šafaříková, B; Skender, B; Sova, P; Vondálová Blanářová, O, 2014)
"A 63-year-old woman with colon cancer who was treated with capecitabine as adjuvant chemotherapy presented with vertigo on day 5, and dysarthria and dysphagia on day 7 of the treatment."( Ban, T; Ikegaya, Y; Isogai, N; Kawachi, J; Miyake, K; Ogino, H; Shimoyama, R; Watanabe, K, 2014)
"Backround: Most solid cancers including colon cancer are believed to be initiated from and maintained by cancer stem cells (CSCs), that are responsible for treatment resistance, resulting in tumor relapse."( Batsaikhan, BE; Iwata, T; Kashihara, H; Kurita, N; Shimada, M; Takasu, C; Yoshikawa, K, 2014)
"We genotyped 2886 stage III colon cancer patients treated adjuvantly in a randomized phase III trial with FOLFOX or FOLFIRI, alone or combined with cetuximab, and tested the individual associations between functionally deleterious DPYD variants and toxicity."( Alberts, SR; Berenberg, JL; Diasio, RB; Goldberg, RM; Lee, AM; Pavey, E; Sargent, DJ; Shi, Q; Sinicrope, FA, 2014)
"The current treatment for colon cancer is more modest than had been hoped."( He, BC; Huang, J; Jin, JL; Sun, WJ; Wan, LH; Wang, DX; Wu, K; Wu, QX; Yang, JQ; Yuan, SX; Zhou, M, 2015)
"To compare XELOX and FOLFOX4 as colon cancer adjuvant chemotherapy based on MOSAIC and No."( Du, ZD; He, XF; Li, Q; Tang, RL; Wen, F; Yao, K; Zhang, PF, 2014)
"The human colon cancer SW620 cell line was pre-treated with the TLR4 inhibitor CRX-526 and stimulated with LPS."( Cao, CB; Huang, HY; Liu, FF; Peng, JQ; Qian, J; Ren, XJ; Wang, N; Zhang, ZJ, 2014)
"We describe the case of a colon cancer patient who underwent adjuvant treatment with capecitabine and oxaliplatin and was admitted to the hospital with seizures and brain edema."( Fennig, S; Greenberg, G; Leshem, Y; Talianski, E; Wolf, I, 2014)
"Human Caco-2 colon cancer cells were treated with DMEM (control), growth media alone (LB, TSB, MRS, and M17) or EcN SNs derived from these 4 media, in the presence and absence of 5-FU."( Bastian, SE; Howarth, GS; Lawrence, A; Wang, H, 2015)
"Finally, using a human colon cancer xenograft murine model, we found that the combined 5-FU and 10058-F4 treatment significantly decreased tumorigenicity in nude mice compared with 5-FU or 10058-F4 treatment alone."( Enoki, T; Hamano, K; Hosoyama, T; Kugimiya, N; Li, TS; Nishimoto, A; Ueno, K, 2015)
"Mice implanted with the human colon cancer cell line HT29 were administered 5-ALA and subsequently X-ray irradiated."( Fujiwara, H; Harada, K; Ichikawa, D; Ikoma, H; Kamada, Y; Komatsu, S; Kondo, Y; Konishi, H; Kuriu, Y; Morimura, R; Murayama, Y; Nakanishi, M; Nishimura, M; Okamoto, K; Otsuji, E; Sakakura, C; Shiozaki, A, 2014)
"Nude mice bearing flank HT29 colon cancer xenografts were then treated daily with either bumetanide or saline for a total of 3 weeks."( Haaga, J; Jin, E; Lu, ZR; Malamas, AS; Zhang, Q, 2015)
"Moreover, the mice subcutaneous CT26 colon cancer model was established to evaluate the therapy efficiency of Qu-M in detail, in which enhanced anti-colon cancer effect was proved in vivo: Qu-M were more efficacious in repressing the growth of colon tumor than free quercetin."( Gao, X; Gong, D; Gou, H; Huang, N; Ren, L; Shi, H; Xu, G, 2015)
"Chemoresistance of colon cancer cells to the chemotherapeutics is still a main obstacle in treatment of this malignancy."( Chai, J; Dong, W; Guo, HL; Han, DL; Wang, L; Wang, S; Xie, C; Zhang, ZL, 2015)
"For mechanistic studies, colon cancer cell lines HCT116 and HT29 were treated with triptolide and the effect on viability, caspase activation, annexin positivity, lactate dehydrogenase release, and cell cycle progression was evaluated."( Banerjee, S; Beyer, G; Chugh, R; Dawra, R; Dudeja, V; Li, L; Majumder, K; Oliveira, A; Saluja, A; Sangwan, V; Skube, SJ; Subramanian, S, 2015)
"Their prognostic impact on colon cancer patients receiving adjuvant chemotherapy has not been well established."( Chang, WC; Chen, CW; Fan, YC; Hsu, WH; Huang, CW; Lou, YT; Lu, CY; Wang, JY; Wu, IC, 2014)
"129 UICC stage III colon cancer patients who had received radical resection and FOLFOX adjuvant chemotherapy were enrolled."( Chang, WC; Chen, CW; Fan, YC; Hsu, WH; Huang, CW; Lou, YT; Lu, CY; Wang, JY; Wu, IC, 2014)
"Neoadjuvant chemotherapy in colon cancer is feasible and the results suggest that a major part of the patients can be spared adjuvant chemotherapy."( Andersen, F; Fischer, A; Jakobsen, A; Jensen, LH; Jørgensen, JC; Larsen, O; Lindebjerg, J; Pløen, J; Rafaelsen, SR; Vilandt, J, 2015)
"We administered chemotherapy for colon cancer using 5-fluorouracil plus Leucovorin(5-FU/LV), after which the CPK levels gradually decreased."( Ito, T; Kawamoto, Y; Okabe, M; Tsukumo, Y; Uchida, Y, 2015)
"We treated the human colon cancer cell lines LiM6 and DLD1 with the NK1R antagonist and the clinical drug aprepitant (AP) and analyzed both growth response and downstream mechanisms using MTT-assay, reverse phase protein array (RPPA), western blot, Super TOP/FOP, confocal microscopy, and sphere formation ability (SFA) assays."( Alt, E; Berger, M; Garnier, A; Hubertus, J; Ilmer, M; Kappler, R; von Schweinitz, D; Vykoukal, J, 2015)
"Stage III colon cancer is currently treated as an entity with a unified therapeutic principle."( Deng, G; He, J; Ma, J; Pei, H; Shen, H; Wu, X; Zeng, S; Zhang, S; Zhang, Y, 2015)
"There were 1 colon cancer patient, 1 retroperitoneal liposarcoma, 1 renal oncocytoma, 3 Kaposi sarcoma patients treated with cyclosporine; in those treated with Tac there were 1 basal cell carcinoma, 1 Kaposi sarcoma, 2 thyroid carcinoma, 1 breast carcinoma, 1 bladder carcinoma, 1 renal cell carcinoma, and 1 colon carcinoma patients."( Ata, P; Demir, T; Eriş, C; Gökçe, AM; Kara, M; Özdemir, E; Ozel, L; Titiz, MI, 2015)
"When SW 620 and HCT 116 human colon cancer cells were treated with 5µM 5Z-7-oxozeaenol, cell viability, growth, and clonogenic survival were significantly decreased."( Button, AM; Domann, FE; Fath, MA; Hrabe, JE; Mezhir, JJ; O'Leary, BR; Rodman, SN; Spitz, DR, 2015)
"In human colon cancers, it is not fully examined the role of ABCG2 in porphyrin-based photodynamic therapy."( Choi, MG; Hasan, T; Kim, IW; Kim, JH; Park, JM; Roh, YJ, 2015)
"We examined stage III colon cancer patients ages 65+ years initiating chemotherapy between 2003 and 2008 using US population-based cancer registry data linked with Medicare claims (N = 3,660)."( Brookhart, MA; Carpenter, WR; Glynn, RJ; Mack, CD; Meyer, AM; Sandler, RS; Stürmer, T, 2015)
"In vitro CRTC1 loss of function in colon cancer cell lines was associated with reduced viability and cell division rate as well as enhanced chemotherapy-induced apoptosis on PGE2 treatment."( Aparicio, T; Baraille, F; Dentin, R; Guilmeau, S; Martin, A; Ourabah, S; Postic, C; Schumacher, Y; Wind, P, 2016)
"The therapy of colon cancer (Cca) is poor currently."( Lan, B; Li, W; Lu, D; Zhang, J, 2016)
"A major issue in colon cancer treatment is drug-resistance and metastasis that have been ascribed to the cancer stem cells."( Chen, J; Gu, W; Li, F; Liu, JP; Monteiro, M; Shao, R; Xu, ZP, 2015)
"Patients with confirmed metastatic colon cancer treated at the Peking University Cancer Hospital between 2003 and 2012 were reviewed retrospectively."( Du, CZ; Gu, J; Li, ZM; Peng, YF, 2016)
"It could be a good adjuvant for colon cancer patients during the course of chemotherapy."( Chao, Y; Chaojie, W; Hongxiang, L; Junmin, S; Zhen, L, 2015)
"As a subset of colon cancer patients does not benefit from adjuvant chemotherapy, predictive biomarkers are desirable."( Benner, A; Bläker, H; Brenner, H; Burwinkel, B; Chang-Claude, J; Herpel, E; Hoffmeister, M; Jansen, L; Pfütze, K; Ulrich, A; Ulrich, CM; Yang, R, 2015)
"Here we examine the effect of wheat on colon cancer risk in early and late postinitiation stages in carcinogen-treated rats."( Gallaher, DD; Islam, A, 2015)
"Here, we report that treatment of colon cancer cell with 5-FU selects for cells with mesenchymal stem-like properties that undergo a metabolic reprogramming resulting in addiction to OXPHOS to meet energy demands."( Calvani, M; Caselli, A; Chiarugi, P; Cirri, P; Denise, C; Giannoni, E; Kazmi, SM; Kopetz, S; Landriscina, M; Paoli, P; Pettazzoni, P; Pia, MM; Sacco, E; Taddei, ML; Vanoni, M, 2015)
"Here, human colon cancer cells, HCT116 with wild-type, heterozygous and a functionally null p53, were treated by radiation and SN38."( Bisgin, A; Helmfors, L; Meng, WJ; Nandy, SK; Pathak, S; Ping, J; Sun, XF; Waldmann, P, 2015)
"S1P administration protected colon cancer cells from luteolin-induced apoptosis, most likely by an intracellular, receptor-independent mechanism."( Abdel Hadi, L; Di Vito, C; Ferraretto, A; Marfia, G; Riboni, L; Tringali, C; Viani, P, 2015)
"We used gastric and colon cancer cell lines to study the synergistic effect of As4S4 in combination with BRD4 inhibitor JQ1, or with chemotherapy drug cisplatin and irinotecan or with COX2 inhibitor celecoxib."( Chen, S; Pan, M; Tong, Y; Zhang, L; Zhang, X, 2015)
"The standard therapy for colon cancer is 5-FU-based regimen, although the current response rate to 5-FU is only 10-15%."( Chen, J; Han, M; Saif, MW, 2016)
"The combination treatment of colon cancer with endostatin and a chemotherapeutic agent, cyclophosphamide proves to be an efficient therapeutic strategy to inhibit the rapid vasculature formation confirmed by the differential expression of notch signaling components."( Hu, TY; Lv, JY; Wang, G; Wang, RY; Zhu, JM, 2016)
"To evaluate the impact of the 12-gene Colon Cancer Recurrence Score Assay-a clinically validated prognosticator in stage II colon cancer after surgical resection-on adjuvant treatment decisions in T3 mismatch repair proficient (MMR-P) stage II colon cancer in clinical practice."( Beny, A; Brenner, B; Chao, C; Dror, Y; Geva, R; Gluzman, A; Hubert, A; Idelevich, E; Liebermann, N; Man, S; Mishaeli, M; Purim, O; Rothney, M; Shacham-Shmueli, E; Shani, A; Shulman, K; Soussan-Gutman, L; Steiner, M; Tezcan, H, 2016)
"The drug 5-FU is commonly used in colon cancer treatment and was used as a reference."( Adachi, N; Aoyama, H; Fujibayashi, Y; Furukawa, T; Saga, T; Wakizaka, H; Yoshii, Y; Zhang, MR, 2016)
"BQC-G treatment of mice bearing human colon cancer xenografts with naturally or artificially elevated beta-glucuronidase activity produced significant antitumor activity, showing that BQC-G is a potent prodrug suitable for selective intratumoral drug activation."( Burnouf, PA; Chen, KC; Cheng, TL; Chou, HC; Huang, PT; Leu, YL; Prijovich, ZM; Roffler, SR, 2016)
"Deficient mismatch repair (dMMR) colon cancer (CC) is reportedly resistant to 5-fluorouracil (5FU) adjuvant chemotherapy while preliminary data suggest chemosensitivity to oxaliplatin."( Aparicio, T; Artru, P; Bonnetain, F; Boussaha, T; Cauchin, E; Coriat, R; Des Guetz, G; Ferru, A; Karayan-Tapon, L; Lécaille, C; Lecomte, T; Matysiak-Budnik, T; Michel, P; Mouillet, G; Pagès, JC; Sefrioui, D; Sickersen, G; Silvain, C; Taïeb, J; Tougeron, D; Trouilloud, I; Vernerey, D; Zaanan, A, 2016)
"Stem cell-like colon cancer cells (SCCs) pose a major challenge in colon cancer treatment because of their resistance to chemotherapy and radiotherapy."( Bang, SY; Heo, J; Jeong, SN; Kang, DH; Yoo, SY, 2016)
"A total of 60 colon cancer patients and 60 patients with benign colorectal disease who received surgical treatment in our hospital from January 2009 to June 2010 were selected as observation group and control group respectively."( Qi, Y; Ren, H; Wang, W; Xu, Q, 2016)
"L-Ascorbic acid treatment of human colon cancer cells that express a mutant KRAS differentially and synergistically induced cell death with cetuximab in a SVCT-2-dependent manner."( Gong, EY; Hong, SW; Hong, YS; Hwang, IY; Jin, DH; Jung, SA; Kim, JE; Kim, JH; Kim, KP; Kim, SM; Kim, T; Lee, DH; Lee, EY; Lee, JS; Lee, S; Lee, WJ; Moon, JH; Shin, JS; Shin, YJ, 2016)
"Irinotecan resistant (CPT-11-R) LoVo colon cancer cell line was previous constructed by step-wise CPT-11 challenges to un-treated parental LoVo cells and expresses EGFR/IKKα/β/NF-κB pathway."( Chen, MC; Chen, RJ; Ho, TJ; Hsu, HH; Huang, CY; Kuo, WW; Lee, NH; Lin, YM; Tu, CC; Viswanadha, VP, 2017)
"Patients with colon cancer in stage III who received adjuvant chemotherapy had a better overall survival."( Bellolio, F; Garrido, M; Leal, JL; Mondaca, S; Nervi, B; Padilla, O; Palma, S; Villalón, C; Zúñiga, Á, 2016)
"All stage III colon cancer patients aged ≥70 years diagnosed in the southeastern part between 2005 and 2012 and treated with CAPOX or CapMono were included."( Creemers, GJ; Janssen-Heijnen, ML; Lemmens, VE; Maas, HA; Pruijt, JF; Razenberg, LG; van Erning, FN, 2016)
"Patients diagnosed with stage II or III colon cancer from 2008 to 2012 and who received at least two cycle of adjuvant capecitabine were reviewed for treatment delays."( Amlani, A; Cheung, WY; Kumar, A; Ruan, JY, 2016)
"This implies that treating colon cancer patients with TGFβ inhibitors may result in a worse outcome by enhancing inflammatory responses."( Bauer, J; Dawson, DW; DeCant, B; Diaz, AM; Grippo, PJ; Jung, B; Khazaie, K; Mangan, RJ; Mascariñas, E; McKinney, RD; Munshi, HG; Pasche, B; Principe, DR; Staudacher, J; Vitello, D; Wayne, EA, 2017)
"CXCL12 treatment activated colon cancer cell EGFR signals, and CXCR4 or ADAM17 blockade reduced this activation."( Adhikari, S; Ayaloglu-Butun, F; Bissonnette, M; Dougherty, U; Fichera, A; Fletcher, M; Haider, HI; Hart, J; Joseph, L; Khalil, A; Konda, V; Li, YC; Meckel, K; Mustafi, D; Mustafi, R; Pekow, J; Sadiq, F, 2017)
"In a murine orthotopic colon cancer model, oral administration of SMA-PTX micelles at doses 30 mg/kg and 60 mg/kg reduced tumor weight by 54% and 69%, respectively, as compared to the control group, while no significant reduction in tumor weight was observed with 30 mg/kg of PTX (Ebewe)."( Greish, K; Highton, AJ; Kemp, RA; Nehoff, H; Norton, SE; Parayath, NN; Taurin, S, 2016)
"The treatment of splenic flexural colon cancer is not standardized because the lymphatic drainage is variable."( Ishibe, A; Masui, H; Nagahori, K; Ota, M; Suwa, Y; Watanabe, J, 2017)
"This approach was applied to colon cancer collection, from an adjuvant treatment randomized study."( Edler, D; Egevad, L; Glimelius, B; Hrynchyk, I; Karlberg, M; Mezheyeuski, A; Östman, A; Portyanko, A; Ragnhammar, P, 2016)
"In patients with stage III colon cancer treated with adjuvant FOLFOX, pT4 and pN2 was associated with reduced survival, but MSI status alone did not affect survival."( Hong, YS; Kim, CW; Kim, HJ; Kim, JC; Kim, JE; Kim, JH; Kim, KP; Kim, SY; Kim, TW; Lim, SB; Park, IJ; Yoon, YS; Yu, CS, 2017)
"Patients with resected stage III colon cancers were randomized to adjuvant FOLFOX (folinic acid [leucovorin calcium], fluorouracil, and oxaliplatin) chemotherapy with or without cetuximab (North Central Cancer Treatment Group N0147 trial) or adjuvant FOLFOX chemotherapy with or without bevacizumab (National Surgical Adjuvant Breast and Bowel Project C-08 trial)."( Alberts, SR; Allegra, CJ; Goldberg, RM; Meyers, JP; Pogue-Geile, KL; Sargent, DJ; Shi, Q; Sinicrope, FA; Smyrk, TC; Thibodeau, SN; Yothers, G, 2017)
"As GRM3 is upregulated in colon cancer, but rarely expressed in normal peripheral tissues, targeting GRM3 with such agents would not likely cause adverse neurological or peripheral side effects, making GRM3 an attractive and specific molecular target for colon cancer treatment."( Berim, L; Black, A; Geng, L; Talmon, G; Wang, J; Yi, H, 2017)
"The diagnosis and treatment for colon cancer have been greatly developed, but the prognosis remains unsatisfactory."( Chen, QZ; He, BC; He, F; Hu, XL; Huang, M; Li, Y; Liu, RX; Ren, WY; Shao, Y; Sun, WJ; Wu, K; Zeng, YH; Zhou, LY, 2017)
"Records of patients with stage III colon cancer who underwent curative surgery and adjuvant chemotherapy from April 2007 and September 2014 were retrospectively reviewed."( Hara, K; Ishii, T; Kondo, H; Shimizu, H; Suzuki, A; Takemoto, K; Tashiro, J; Yamaguchi, S, 2017)
"A total of 258 patients with stage III colon cancer received oral adjuvant chemotherapy with UFT/LV (n = 157, 61%) and CAPE (n = 101, 39%)."( Hara, K; Ishii, T; Kondo, H; Shimizu, H; Suzuki, A; Takemoto, K; Tashiro, J; Yamaguchi, S, 2017)
"Patients with locally advanced colon cancer (LACC) have a relatively poor prognosis despite radical resection and adjuvant chemotherapy."( Huang, CJ; Huang, CM; Huang, CW; Huang, MY; Ma, CJ; Tsai, HL; Wang, JY; Yeh, Y-, 2017)
"The study was performed on human colon cancer cell lines COLO 205, HT-29 and 3C-P treated with ACD and IFN in subtoxic concentrations."( Bezdenezhnykh, N; Kocherga, R; Kovalova, O; Kudryavets, Y; Lykhova, O; Maksimyak, GI; Vorontsova, A; Zhylchuk, V, 2017)
"Different strategies against colon cancer are accompanied by treatment failure, because of drug toxicity toward normal cells and cancer stem cells (CSCs) resistance."( Abu-Serie, MM; El-Rashidy, FH, 2017)
"GRP78 expression was suppressed in LoVo colon cancer cells by utilizing small-interfering RNA (si-GRP78), and the cells were subsequently used to study the antiproliferative and anticancer effects of 5-FU treatment."( Han, YS; Kim, S; Lee, JH; Lee, SH; Yun, S, 2017)
"Human colon cancer SW480 cells were transfected with CDH17 interference vector and treatment with 10 µmol/L noscapine."( Cai, Y; Chen, W; Han, Z; Huang, X; Liu, M; Liu, W; Tan, J; Tian, X; Wang, Y; Zhu, Q; Zou, Y, 2017)
"Two hundred thirty-one patients with colon cancers who underwent curative surgery and FOLFOX adjuvant chemotherapy between November 2005 and December 2011 were included."( Kim, YB; Noh, OK; Oh, SY; Suh, KW, 2017)
"The 5-year DFS rate was lower in colon cancer patients with low lymphocyte count during chemotherapy (61."( Kim, YB; Noh, OK; Oh, SY; Suh, KW, 2017)
"Restoring oxygen in metastatic colon cancer through ITPP inhibits tumor spread and markedly improves animal survival; an effect that is enhanced through the application of subsequent chemotherapy."( Clavien, PA; Graf, R; Humar, B; Kachaylo, E; Kron, P; Lehn, JM; Limani, P; Linecker, M; Nicolau, C; Schneider, MA; Tschuor, C; Ungethuem, U, 2017)
"A patient with colon cancer was treated with CapeOx (oxaliplatin 200mg, day 1; capecitabine 1."( Fang, W; Fu, Y; Wei, J, 2018)
"This study included 65 patients with colon cancer treated with neoadjuvant chemotherapy in a phase II trial."( Hansen, TF; Jakobsen, A; Jensen, LH; Kjær-Frifeldt, S; Lindebjerg, J; Rafaelsen, SR; Sørensen, FB, 2018)
"Among 2636 patients with stage III colon cancer treated with FOLFOX, MMR status was available for 2501."( Alberts, SR; Folprecht, G; Goldberg, RM; Julie, C; Laurent-Puig, P; Le Malicot, K; Meyers, JP; Mini, E; Sargent, DJ; Shi, Q; Sinicrope, FA; Smyrk, TC; Tabernero, J; Taieb, J; Van Laethem, JL; Zaanan, A; Zawadi, A, 2018)
"With regards to colon cancer, resistance to 5‑fluorouracil (5‑FU)‑based chemotherapy and cancer stem cells (CSCs) are considered important factors underlying therapy failure."( Cai, H; Du, B; Feng, S; Hu, Y; Ma, W; Miao, G; Wang, J; Wang, W; Zhang, L, 2017)
"In a colon cancer mouse model, we demonstrate that the combination of computed tomography imaging and gold nanoparticles conjugated to αPDL1 allowed prediction of therapeutic response, as early as 48 h after treatment."( Cohen, CJ; Meir, R; Motiei, M; Popovtzer, R; Sadan, T; Shamalov, K; Yaari, G, 2017)
"CTD treatment of mice implanted with colon cancer cells showed tumor growth inhibition and reduced TrxR1 activity and ROS level."( Bao, M; Chen, R; Dai, X; Dong, X; Liang, G; Shen, X; Sun, X; Vladimir, K; Zhuge, W; Zia, K, 2018)
"In Wnt-activated colon cancer cells, knockout of either PAD2 or β-catenin substantially increased resistance to NTZ treatment."( Brokstad, KA; Cheng, PF; Hoffman, PS; Kalland, KH; Ke, X; Levesque, MP; Olsen, JR; Oyan, AM; Qu, Y; Yuan, X; Zhang, W, 2018)
"In the present study, five human colon cancer cell lines were directly treated with a calpain-2 inhibitor and results showed increased cell death in 4 of 5 cell lines and decreased anchorage-independent growth for all cell five lines."( Bertino, P; Hashimoto, AS; Hoffmann, FW; Hoffmann, PR; Horio, DT; Marciel, MP; Martinez, V; Rose, AH, 2018)
"We enrolled 26 consecutive colon cancer patients, who had undergone surgical treatment."( Aoki, J; Ikeda, H; Kurano, M; Nishikawa, T; Saigusa, D; Sato, M; Uranbileg, B; Watanabe, T; Yatomi, Y, 2018)
"Human colon cancer HT-29 cells were treated with curcumin (2."( Hoffman, RM; Qiu, J; Song, Y; Sun, YU; Tang, J; Tao, Y; Wang, D; Wang, H; Wang, X; Yang, G; Yang, Z, 2018)
"Emerging treatment options for colon cancer are needed to overcome the limitations regarding the side effects of current chemotherapeutics and drug resistance."( Banciu, M; Licarete, E; Luput, L; Patras, L; Porfire, A; Rauca, V; Sesarman, A; Sylvester, B; Tefas, L, 2018)
"As adjuvant chemotherapy for stage III colon cancer, mFOLFOX6/XELOX regimens are acceptable."( Ishibashi, K; Ishida, H; Kato, H; Kato, R; Koda, K; Kosugi, C; Mori, M; Narushima, K; Oya, M; Shuto, K; Tanaka, S; Yoshimatsu, K, 2018)
"We used two human colon cancer cell lines SW480 and SW620 of different malignancies which were treated with a sublethal PDT protocol."( Czuba, Z; Kawczyk-Krupka, A; Krammer, B; Latos, W; Sieroń, A; Verwanger, T; Wasilewska, K, 2018)
"LXR agonist-treated-colon cancer cells exhibited translocation of calreticulin (CRT) and release of HMGB1 and ATP into the medium."( Chen, K; Feng, F; Ju, X; Ren, M; Wang, Q, 2018)
"Among patients with stage III colon cancer receiving adjuvant therapy with FOLFOX or CAPOX, noninferiority of 3 months of therapy, as compared with 6 months, was not confirmed in the overall population."( Andre, T; Boukovinas, I; Grothey, A; Iveson, T; Kerr, R; Labianca, R; Meyerhardt, JA; Meyers, JP; Niedzwiecki, D; Paul, J; Renfro, LA; Sargent, DJ; Saunders, M; Shi, Q; Shields, AF; Sobrero, AF; Souglakos, J; Taieb, J; Torri, V; Vernerey, D; Watanabe, T; Yamanaka, T; Yoshino, T, 2018)
"JQ-1 was used to treat SW480 colon cancer mouse xenografts."( Liu, C; Song, H; Tian, S; Xiong, J; Zhang, Y; Zhou, Y, 2018)
"Using colon cancer cells, ICG uptake and anti-tumor effects were examined between the treatments of ICG and sCA-ICG."( Doki, Y; Haraguchi, N; Hata, T; Inoue, A; Matsuda, C; Miyoshi, N; Mizushima, T; Mori, M; Nishimura, J; Ota, M; Takahashi, H; Tamai, K; Wu, X; Yamamoto, H; Yokoyama, Y, 2018)
"To explore a role of neem in CRC, human colon cancer cell lines HCT116 and HT29 cells were treated with purified Super Critical Neem Extract (SCNE) or the neem liminoid, nimbolide."( Cabang, AB; Morris, J; Mukhopadhyay, KD; Patel, MJ; Tripathy, S; Wangjam, T; Wargovich, MJ, 2018)
"Patients with metastatic colon cancer can be treated with alternating courses of FOLFOX6 and FOLFIRI in order to reduce their adverse events."( Ohara, H; Yamamoto, H, 2018)
"When human colon cancer HCT116, CX-1, and LS174T cells were treated with ferroptotic agents such as sorafenib (SRF), erastin, and artesunate, data from immunoblot assay showed that ferroptotic agents induced endoplasmic reticulum (ER) stress and the ER stress response-mediated expression of death receptor 5 (DR5), but not death receptor 4."( Bartlett, DL; Choudry, HA; Jeong, SY; Lee, DH; Lee, YJ; Lee, YS; Oh, SC; Park, SH; Park, YS; Yu, J, 2019)
"Although it is well established that colon cancer is one of the many gastrointestinal manifestations associated with systemic lupus erythematous, the diagnosis and treatment remains complex due to adrenal insufficiency symptoms."( Chang, Q; Chen, Y; Fei, J; Shen, L; Shi, J; Wan, B; Yi, Q, 2018)
"Intensive study on pathogenesis of colon cancer has been made to decipher the mechanisms underlying the development and progress of the disease so as to develop effective treatment."( Iqbal, Z; Mishra, H; Mishra, PK; Siddiqui, L; Talegaonkar, S, 2018)
"Human colon cancer cells and human melanoma cells were cultured and then treated with 1 mM bupivacaine or levobupivacaine for up to 24 or 48 h."( Chen, L; Han, C; Hirota, K; Li, T; Ma, D; Masters, J; Wu, L; Zhao, H, 2019)
"Targeted drug delivery to colon cancer cells can significantly improve the efficiency of treatment."( Li, X; Liu, W; Liu, X; Pan, W; Pang, J; Wang, F; Zhu, Y, 2018)
"Gastric and colon cancers have been the leading causes of cancer mortality in the world with limited therapy."( Chen, S; Kang, T; Tan, Z; Zhang, L; Zhang, X, 2018)
"After curative resection of stage II colon cancer, adjuvant chemotherapy with 5-fluorouracil/leucovorin (FL) or capecitabine is selectively recommended."( Cho, S; Jeong, SY; Kim, MJ; Kwon, YH; Lee, KY; Park, JW; Park, KJ; Ryoo, SB, 2019)
"Human HT-29 colon cancer cell-line was used for in vitro assays and in vivo studies were performed in Wistar rats to assess the usefulness and effectiveness of the formulation for colon cancer therapy."( Asnani, GP; Kokare, CR, 2018)
"In conclusion, miR-214 sensitizes colon cancer cells to 5-FU by targeting Hsp27, indicating a significant role for this miRNA in colon cancer chemotherapy."( Bao, Y; Du, LJ; Ma, ZH; Wan, J; Yang, GK; Yang, Y, 2019)
"Although colon cancer is one of the most important triggers of cancer related mortality, a few therapeutic options exist for this disease, including combination chemotherapy, anti-EGFR and anti-angiogenic agents."( Azizi, G; Ghalamfarsa, G; Hojjat-Farsangi, M; Jadidi-Niaragh, F; Karpisheh, V; Namdar, A; Nikkhoo, A; Sabz, G; Yousefi, B; Yousefi, M, 2019)
"In pursuit of a novel approach in colon cancer therapy, we explored the ability of ruthenium baicalein complex to eradicate colon cancer by efficiently targeting various apoptotic pathways on human colon cancer cell line and on a DMH and DSS induced murine model of colorectal cancer."( Bian, L; Chakraborty, T; Chanda, P; Ghosh, T; Roy, S; Wang, Y, 2019)
"Patients with stage III colon cancer homogeneously treated with surgery followed by FOLFOX chemotherapy between Jan 2007 and Aug 2013 were included retrospectively."( Baik, SH; Cha, YJ; Kang, J; Lee, KY; Park, EJ, 2019)
"Globally, colon cancer is a predominant cause of increased morbidity and mortality annually; therefore, in addition to traditional treatments, new protocols are under continuous investigation."( Alnaggar, M; Chen, Y; Xiao, H, 2019)
"Forty PDOX mouse models with colon cancer growing on the peritoneum were divided into 4 groups of 10 mice each by measuring the tumor size and fluorescence intensity: untreated control; 5-fluorouracil (5-FU) (50 mg/kg, once a week for two weeks, ip) and oxaliplatinum (OXA) (6  mg/kg, once a week for two weeks, ip); o-rMETase (100 units/day, oral 14 consecutive days); combination 5-FU + OXA and o-rMETase."( Bouvet, M; Clary, B; Han, Q; Higuchi, T; Hoffman, RM; Park, JH; Singh, SR; Sugisawa, N; Tan, Y; Yamamoto, J; Yoon, SN; Zhao, M, 2019)
"Anthos and ExoAnthos treatment of colon cancer cells showed dose-dependent decreases in cell viability."( Egilmez, NK; Gu, T; Gupta, RC; Jeyabalan, J; Mudd, AM; Munagala, R, 2020)
"CEA in patients with colon cancer, which express SGLT2 but not UGT1A9, and type 2 diabetes mellitus was treated by dapagliflozin alone after radiation therapy was decreased but started to rise after cessation of dapagliflozin (case 2)."( Nakajima, Y; Okada, J; Okada, S; Osaki, A; Ozawa, A; Pessin, JE; Saito, T; Shimoda, Y; Yamada, E; Yamada, M; Yokoo, H, 2020)
"In comparison with the control, both colon cancer and treated groups showed invasion of the colonic tissue by pleomorphic branching colonic glands of variable shapes and sizes lined with dysplastic elongated hyperchromatic nuclei with frequent mitotic figures or stratified multi-layered crowded nuclei with an extremely significant (p < 0."( Abd El-Hady El-Safti, FE; Abdel-Rahman, SA; Badr El-Kholy, W; Mohey Issa, N, 2021)
"However, colon cancer is difficult to treat due to its resistance to TRAIL."( Kim, B; Lee, KY; Park, B; Seo, JH, 2020)
"Therefore, it is necessary to treat colon cancer and its thrombosis complications simultaneously."( Huang, M; Ji, Y; Li, T; Liu, M; Liu, Y; Lü, S; Qi, T; Yan, J; Zhang, SF, 2020)
"Subcutaneous mouse models of colon cancer cell line LS174T were used to determine the optimal dose of administration and timing of imaging."( Amirfakhri, S; Bouvet, M; Filemoni, F; Hoffman, RM; Hollandsworth, HM; Molnar, J; Yazaki, PJ, 2020)
"Treatment of colon cancer cells with α-methyltryptophan (α-MT), a blocker of SLC6A14, induces amino acid deprivation, decreases mTOR activity, increases autophagy, promotes apoptosis, and suppresses cell proliferation and invasion."( Bhutia, YD; Brown, TP; Ganapathy, V; Sikder, MOF; Sivaprakasam, S; Thangaraju, M, 2020)
"Human colon cancer cell line SW480 was divided into a control group, 3 propofol treatment groups (with 2, 4 and 8 μg/mL propofol treatment, respectively), and a propofol+colivelin group."( Dong, T; Liang, B, 2020)
"Early diagnosis and treatment of colon cancer is of great significance for cancer therapy."( Chen, M; Fang, L; Feng, HT; Lee, MH; Tang, BZ; Xiong, F; Zou, S, 2020)
"Adjuvant treatment for stage II colon cancer remains debated."( André, T; Benhaim, L; Chauvenet, M; Emile, JF; Geillon, F; Laurent Puig, P; Le Malicot, K; Lepage, C; Manfredi, S; Taïeb, J; Taly, V; Tougeron, D, 2020)
"The incidence of colon cancer increased worldwide in 2019 and its treatment is urgent from a quality of life perspective."( Baba, K; Kimura, Y; Kiyoi, T; Sumiyoshi, M, 2020)
"Our analysis confirms that women with colon cancer receiving adjuvant fluoropyrimidine-based chemotherapy are at increased risk of toxicity."( Alberts, SR; Allegra, CJ; Andre, T; Blanke, CD; de Gramont, A; Dixon, JG; Francini, E; George, TJ; Goldberg, RM; Grothey, A; Haller, DG; Kerr, R; Marsoni, S; O'Connell, MJ; Saltz, LB; Seitz, JF; Shi, Q; Taieb, J; Twelves, C; VanCutsem, E; Wagner, AD; Wolmark, N; Yothers, G, 2021)
"In stage III colon cancer, randomised clinical trials and meta-analyses of modulated 5-fluorouracil (5-FU) based chemotherapy versus surgery scored ESMO-MCBS grade A and randomised controlled trials (RCTs) and meta-analyses comprising oxaliplatin added to this 5-FU backbone showed a more modest additional overall survival benefit (grade A and B)."( Cherny, NI; Dafni, U; de Groot, DJ; de Vries, EGE; Douillard, JY; Knapen, DG; Latino, NJ; Zygoura, P, 2020)
"Chemotherapy of colon cancer needs improvement to mitigate the severe adverse effects (AEs) associated with the cytotoxic drugs."( Duan, J; Li, X; Yang, XD; Yu, Z, 2020)
"Rats chemically initiated for colon cancer were either non-treated or post-treated with highly saturated ASCex for 32 weeks after initiation, other groups of rats were administered ASCex without cancer initiation or served as normal controls."( Abdelhady, HA; El-Gamal, MM; Mona, MM; Salim, EI, 2020)
"Indomethacin [IND] is reported to treat colon cancer."( Devaraj, H; Seetha, A; Sudhandiran, G, 2021)
"The current treatment options for colon cancer patients include chemotherapy, surgery, radiotherapy, immunotherapy, and targeted therapy."( Beyzai, B; Edalati, M; Hojjat-Farsangi, M; Jadidi-Niaragh, F; Joshi, N; Karpisheh, V; Namdar, A; Zekiy, AO, 2020)
"After simulation of colon cancer, the animals were intragastrically administered entorosorbent at a dose of 1 ml of suspension (corresponding to 0."( Fira, D; Fira, L; Kachur, O; Kramar, S; Lykhatskyi, P, 2020)
"We report a case of transverse colon cancer with intestinal malrotation treated with laparoscopic surgery using the ICG fluorescence method."( Aoki, H; Arata, T; Katsuda, K; Kimura, Y; Nagahisa, S; Tanakaya, K; Taniguchi, F; Une, Y; Utsumi, M; Watanabe, M, 2020)
"First, colon cancer cell lines (HCT116 and SW480 cells) were treated with different doses of TEC (0-200 μM)."( Gao, D; Guo, W; Qu, Y; Wang, J; Xiong, L; Yang, Y; Zhang, Y, 2021)
"The survival of colon cancer cells was decreased, whereas the apoptosis of colon cancer cells was increased by PTX treatment in a dose-dependent manner."( Li, HX; Xiao, ZS; Yin, ZH; Zhang, XN; Zhao, L, 2021)
"In this study, human colon cancer cells (COLO 225) were treated with gossypol."( Cao, F; Cao, H; Sethumadhavan, K; Wang, TTY, 2021)
"In a CT26 mouse syngeneic colon cancer model, cachexia was predominantly induced by chemotherapy with 5-fluorouracil (5-FU) than by tumor growth."( Im, M; Kim, HJ; Kim, JK; Kim, JY; Kim, SJ; Kim, ST; Park, SK; Woo, CW; Woo, DC; Yoo, HJ, 2021)
"Among patients with stage III colon cancer, the addition of celecoxib for 3 years, compared with placebo, to standard adjuvant chemotherapy did not significantly improve disease-free survival."( Bendell, JC; Bertagnolli, M; Blanke, C; Couture, F; Fuchs, CS; Goldberg, RM; Grothey, A; Guthrie, KA; Hochster, HS; Kuebler, P; Kumar, P; Kumthekar, P; Lewis, D; Meyer, J; Meyerhardt, JA; Niedzwiecki, D; O'Reilly, EM; Shi, Q; Shields, AF; Tan, B; Venook, A; Zemla, T, 2021)
"Human colon cancer cell lines, proficient (HT29) and deficient (HCT116) in MMR, were treated with 5-FU and Olaparib."( Bencke Grudzinski, P; da Costa Ghignatti, PV; de Castro E Gloria, H; Guecheva, TN; Jesuíno Nogueira, L; Motta Leguisamo, N; Saffi, J, 2021)
"The current colon cancer therapy mainly revolves around chemotherapy, radiotherapy and surgery, but the search continues for more effective interventions."( Albalawi, R; Khan, FA; Pottoo, FH, 2022)
"In this study, one out of five colon cancer patients were hospitalized during adjuvant chemotherapy."( Abdel-Rahman, O; Koski, S; Tang, PA, 2021)
"The LoVo colon cancer cell line forming spheroids, treated with crizotinib (CZB) an ATP-competitive small-molecule inhibitor of the receptor tyrosine kinases, was employed to study and assess the correlation between biophysical and morphological parameters in both live and fixed cells."( Bacchi, F; Bonetti, S; Cavallo, C; Filardo, G; Gazzola, D; Lauriola, M; Mazzeschi, M; Musmeci, F; Pasqua, S; Santi, S; Sargenti, A, 2021)
"Traditionally, adjuvant treatment for colon cancer has been 6 months of combination chemotherapy."( Hanna, C; Iveson, P; Iveson, T; Levasseur, A; Meyerhardt, J; Zhang, S, 2021)
"In this study, human colon cancer oxaliplatin-resistant cells were treated with oxaliplatin combined with the natural product erianin."( Cao, Y; Lei, M; Liu, J; Liu, S; Ma, X; Su, C, 2021)
"Only 50-70% of elderly colon cancer patients could complete the recommended 6 months of postoperative chemotherapy."( Chen, J; Chen, W; Dong, H; Wang, G; Wang, W, 2021)
"A total of 1217 surgery-treated colon cancer patients between August 1, 2013, and September 1, 2019, were reviewed, and 257 stage III and high-risk stage II patients aged ≥ 70 were enrolled."( Chen, J; Chen, W; Dong, H; Wang, G; Wang, W, 2021)
"However, the treatment strategies for colon cancer remain unsatisfactory for patients, especially for those with advanced or recurrent colon cancer."( Bao, Y; Li, W; Li, Z; Wang, Y; Wang, Z; Zhou, X; Zhu, Z, 2021)
"Herein, colon cancer targeting calcium phosphate nanoparticles were developed to carry PSVII to treat drug-resistant colon cancer."( Bai, S; Cheng, Y; Ji, Q; Jiang, C; Liu, D; Liu, M; Mei, Q; Sun, Y; Ye, W; Zhang, B; Zhou, S, 2021)
"The main therapy for colon cancer with liver metastasis is chemotherapy based on 5-fluorouracil combined with targeted drugs."( Chen, S; Guo, S; Huang, Z; Li, J; Liu, Y; Wang, P; Wang, X; Yue, T; Zhu, J, 2022)
"To evaluate PTX effects on colon cancer patients treated with chemotherapy."( Baider, L; Barak, V; Meirovitz, A; Peretz, T; Stephanos, S, 2021)
"Forty metastatic colon cancer patients receiving chemotherapy were enrolled in this randomized study."( Baider, L; Barak, V; Meirovitz, A; Peretz, T; Stephanos, S, 2021)
"PTX treatment of colon cancer patients, in addition to chemotherapy, significantly improved survival rates, induced weight gain and reduced stomatitis occurrence -all important parameters of cachexia."( Baider, L; Barak, V; Meirovitz, A; Peretz, T; Stephanos, S, 2021)
"Cordycepin is able to suppress colon cancer cell proliferation, likely mediated by the MYC/miR-26a pathway, supporting its potential for the treatment of colon cancer."( Li, K; Liu, Y; Zhang, Z; Zheng, Z, 2022)
"The drug resistance in the treatment of colon cancer is most reduced in patients carrying allele 10 and methylated in KCNQ1OT1 promoter."( Wang, Y; Zhang, C, 2022)
"Current therapies for colon cancer are hindered by treatment failure and recurrence, mainly due to colon cancer stem cells (CSCs)."( Deng, T; Du, B; Fu, F; Qiu, F; Wang, Z; Xi, X; Zhu, Y, 2022)
"Treatment of colon cancer cells with GZ17-6."( Booth, L; Dent, P; Von Hoff, D; West, C, 2022)
"Apoptosis is de-regulated in colon cancer and is one key mechanism of cancer treatment."( Deng, YY; Fu, J; Pan, SL; Qin, XJ; Zhang, YH; Zhang, ZJ, 2022)
"Since colon cancer stem cells (CSCs) play an important role in chemoresistance and in tumor recurrence and metastasis, targeting of CSCs has emerged as a sophisticated strategy for cancer therapy."( Ahn, YH; Fei, X; Jo, MK; Jung, SA; Kim, EJ; Kim, M; Kim, SE; Kim, TI; Kwon, JH; Moon, CM; Mun, YC; Seo, SY, 2022)
"plantarum-12 could ameliorate the colon cancer symptoms of azoxymethane (AOM)/DSS-treated C57BL/6 mice."( Jiang, S; Ma, F; Mu, G; Qian, F; Song, Y; Sun, M; Tuo, Y; Wang, A, 2022)
"In this study, we hypothesized that colon cancer cells with the stem cell feature of CD133 expression have increased proton leakage that influences glucose metabolism and offers protection against reactive oxygen species (ROS)-inducing treatment."( Cho, YS; Jung, KH; Kim, M; Lee, EJ; Lee, JH; Lee, KH; Park, JW, 2022)
"Patients with stage II colon cancer were randomly assigned in a 2:1 ratio to have treatment decisions guided by either ctDNA results or standard clinicopathological features."( Burge, M; Cohen, JD; Day, F; Dobbyn, L; Gibbs, P; Harris, M; Harris, S; Hayes, T; Hruban, R; Khattak, A; Kinzler, KW; Kosmider, S; Lahouel, K; Lee, B; Lee, M; Lennon, AM; Lo, SN; Lynam, J; McLachlan, SA; Nott, L; Papadopoulos, N; Popoli, M; Ptak, J; Shapiro, J; Silliman, N; Tie, J; Tomasetti, C; Vogelstein, B; Wang, Y; Wong, R, 2022)
"Patients with colon cancer who prematurely discontinue postoperative chemotherapy may have an increased risk of disease recurrence and death."( Brown, JC; Caan, BJ; Cespedes Feliciano, EM; Cheng, E; Meyerhardt, JA, 2022)
"Among patients with stage II-III colon cancer who initiate postoperative chemotherapy, excess visceral and intramuscular adiposity may be risk factors for the premature discontinuation of chemotherapy."( Brown, JC; Caan, BJ; Cespedes Feliciano, EM; Cheng, E; Meyerhardt, JA, 2022)
"Drug resistance of colon cancer cells is the key to affect the efficacy of colon cancer chemotherapy and lead to chemotherapy failure."( Chen, G; Huang, J; Wei, X; Yang, Z, 2022)
"After simulation of colon cancer, the animals were intragastricly administered entorosorbent at a dose of 1 ml of suspension (corresponding to 0."( Fira, D; Fira, L; Garlitska, N; Kachur, O; Lykhatskyі, P, 2022)
"Drug resistance in colon cancer is gradually affecting the treatment."( Chen, X; Guo, M; Li, B; Lin, C; Qiu, H, 2022)
"Finally, we subdivided the colon cancer patients into four groups to explore combination immunotherapy."( Fang, D; Liu, H; Xu, J; Ye, J; Zhang, C; Zhao, S; Zhao, Z; Zhou, X, 2022)
"Treatment with PTZ and TFP inhibited colon cancer cells growth in a dose-dependent manner."( Mohd Sani, MH; Muhamad Salih, FA; Palasuberniam, P; Suali, L; Sudi, S; Sunggip, C; Thomas, FM, 2022)
"Current cancer treatment fails to treat colon cancer completely due to the remains of Cancer Stem Cells (CSCs)."( Agarwal, S; Gor, R; Karri, U; Madhavan, T; Pachaiappan, R; Ramalingam, S; Saha, L; Sohani, A, 2022)
"The human colon cancer cell lines HCT-116 and Caco-2 were subjected to stimulation with interleukin-6 (IL-6) as well as tumor necrosis factor alpha (TNF-α), with subsequent treatment using the NF-κB pathway-specific inhibitor ammonium pyrrolidinedithiocarbamate (PDTC)."( Chen, XQ; Han, TT; Li, JN; Li, WB; Lv, K; Mao, JY; Wang, CS, 2022)
"Of patients with colon cancer treated with an initial lower 5-FU dose, 18% had a therapeutic 5-FU blood level."( Baranseh, J; Khatib, AW; Selub, SM; Shai, A; Uryvaey, A, 2023)
"15-PGDH inhibition increased colon cancer metastasis by inducing changes in EMT-related genes via an increase in PGE2 expression and could be a promising biomarker for anticancer treatment."( Bae, KB; Baik, H; Hur, DY; Kang, MS; Kim, SH; Song, SE, 2022)
"Forty patients with metastatic colon cancer receiving chemotherapy, were randomized in this study."( Baider, L; Barak, V; Meirovitz, A; Peretz, T; Stephanos, S, 2022)
"High malignancy and mortality in colon cancer require clarifying the underlying mechanisms of colon cancer carcinogenesis and exploring new targets or drugs for the clinical treatment of colon cancer."( Deng, Y; He, B; Luo, H; Qin, X; Yao, X; Zhang, J, 2022)
"58 patients with stage II-III colon cancer treated with surgery and chemotherapy."( Berger, AM; Goldner, W; Hammer, MJ; Klute, K; Langenfeld, SJ; Rasmussen Mandolfo, N; Shade, MY; Struwe, LA, 2022)
"58 patients with stage II-III colon cancer treated with surgery and chemotherapy."( Berger, AM; Goldner, W; Hammer, MJ; Klute, K; Langenfeld, SJ; Rasmussen Mandolfo, N; Shade, MY; Struwe, LA, 2022)
"58 patients with stage II-III colon cancer treated with surgery and chemotherapy."( Berger, AM; Goldner, W; Hammer, MJ; Klute, K; Langenfeld, SJ; Rasmussen Mandolfo, N; Shade, MY; Struwe, LA, 2022)
"Human colon cancer HCT116 cells were treated with different concentrations of β-elemene."( Chen, G; Deng, H; Zhang, J, 2023)
"Human colon cancer HCT116 cells were treated with different concentrations of β-elemene."( Chen, G; Deng, H; Zhang, J, 2023)
"The current colon cancer treatment strategies assure partial or even complete tumour regression but loco-regional relapse or distant metastasis is the major cause of death despite combination therapy."( Banerjee, R; Chilakamarthi, U; Giribabu, L; Koteshwar, D; Krishna, NV; Mahadik, NS, 2023)
"The current colon cancer treatment strategies assure partial or even complete tumour regression but loco-regional relapse or distant metastasis is the major cause of death despite combination therapy."( Banerjee, R; Chilakamarthi, U; Giribabu, L; Koteshwar, D; Krishna, NV; Mahadik, NS, 2023)
"Lipid metabolic reprogramming in colon cancer shows a potential impact on tumor immune microenvironment and is associated with response to immunotherapy."( Chao, D; Chen, H; Chen, X; He, N; Liu, L; Mo, M; Wang, Y; Yang, J; Yuan, X; Zhang, N; Zhang, Y, 2023)
"Here, colonic cancer cells were cultured in the ECIS array before being treated with RA, and any changes in response to RA were monitored after treatment."( Bates, DO; Benest, AV; Marva, G; Ordóñez-Morán, P; Ünsal, S, 2023)
"Mouse colon cancer cells(CT26) were transplanted into the mice except for those in the normal group to construct the tumor-bearing mouse model by subcutaneous injection, and 5-FU chemotherapy and BSP treatment were carried out from the second day of modeling."( Cui, YR; He, TH; Liu, P; Wang, WL; Xie, XX; Yu, J; Zhang, JT, 2023)
"Accurate staging of colon cancer is imperative in directing treatment and prognostication."( Gao, Y; Gauci, CM; Kim, TJ; Perera, DS, 2023)
"For patients with resected stage III colon cancer, 6 months of adjuvant fluoropyrimidine-based chemotherapy has been the standard of care."( Ahn, DH; Alese, OB; Bekaii-Saab, TS; Draper, A; Griswold, CR; Kang, S; Larson, JJ; Ou, FS; Patel, B; Raman, P; Sonbol, MB; Ueberroth, BE; Walden, DJ; Wu, CS, 2023)
"A total of 399 patients with stage III colon cancer who received adjuvant chemotherapy were included in the analysis."( Ahn, DH; Alese, OB; Bekaii-Saab, TS; Draper, A; Griswold, CR; Kang, S; Larson, JJ; Ou, FS; Patel, B; Raman, P; Sonbol, MB; Ueberroth, BE; Walden, DJ; Wu, CS, 2023)
"In vitro studies using colon cancer cell lines showed that RC48 effectively impeded the proliferation of HER2-positive cells, indicating its potential as a treatment for HER2-positive colon cancer."( Gu, Y; Guo, W; Han, X; Li, X; Liu, W; Wang, W; Wu, X; Xu, L; Xu, Q; Zhang, W; Zhou, Y, 2023)
"Treatment options for advanced colon cancer are mainly combinations of chemotherapy and targeted drugs."( Guo, Y; Liu, F; Nian, J; Xu, Y; Yang, G, 2023)
"Treating colon cancer cells with a DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine (DAC), led to elevated expression levels of CYP1B1 and CYP3A4 through demethylation of the promoter regions of related genes."( Ozawa, S, 2023)

Research

Studies (24,884)

TimeframeStudies, This Condition (%)All Conditions %
pre-19905144 (20.67)23.3326
1990's4891 (19.66)12.5806
2000's6179 (24.83)18.1394
2010's6581 (26.45)28.8240
2020's2089 (8.39)9.53
DrugIndicatedRelationship StrengthStudiesTrials
acetylcarnitine0low30
dinitrochlorobenzene0low190
ethylene dichloride0low10
alpha-hydroxyglutarate0low20
2,3-diphosphoglycerate0low10
protocatechuic acid0medium72
3-hydroxyanthranilic acid0low10
phosphoserine0low80
3-phenylpropionic acid0low10
cysteine sulfinic acid0low10
gamma-aminobutyric acid0low60
4-hydroxybenzyl alcohol0low10
4-hydroxyphenylacetic acid0medium11
4-hydroxybenzoic acid0low10
aminolevulinic acid0low620
5-hydroxytryptophan0medium11
ethylene glycol0medium32
acetic acid0medium211
acetaldehyde0low60
acetamide0low10
acetone0low80
adenine0low270
agmatine0low60
allantoin0low10
ammonium hydroxide0medium203
anthranilic acid0low10
arsenic acid0low10
quinacrine0low60
beta-alanine0low50
benzene0low30
benzoic acid0low10
betaine0medium51
1-butanol0low50
butyric acid0low1450
cadaverine0low50
carbamates0medium232
ureidosuccinic acid0low10
carbon monoxide0low50
formic acid0low10
aminooxyacetic acid0low20
carnitine0low70
catechol0low10
methane0medium453
choline0medium191
citric acid, anhydrous0medium163
chlorine0medium1152
hydrochloric acid0low40
coumarin0low60
salicylic acid0low200
phloroglucinol0low120
4-methylumbelliferyl acetate0low20
gallic acid0medium221
octanoic acid0low30
hydrogen sulfide0medium292
dihydrolipoic acid0low10
trimethylenediamine0low20
3-hydroxybutyric acid0medium61
guaiacol0low50
hippuric acid0medium21
2-keto-4-methylthiobutyric acid0low30
n(1)-acetylspermidine0low50
n(g),n(g')-dimethyl-l-arginine0low30
malic acid0low20
phosphonoacetic acid0medium284
3,4-dihydroxyphenylacetic acid0medium31
3-methylthiopropionate0low10
aminocaproic acid0low10
creatine0low40
cytosine0low270
lactic acid0low920
5,6-dihydroorotate0low10
dihydrouracil0low10
diacetyl0low10
dimethyl sulfoxide0medium373
ethanolamine0low20
formaldehyde0medium731
glycine0medium351
glycerol0medium142
glycolic acid0low20
glyoxylic acid0low10
carbonic acid0low10
hydrogen carbonate0low140
dalteparin0medium102
histamine0medium342
homogentisic acid0low10
hydrogen0medium163
hydroquinone0low30
hydroxylamine0low20
imidazole0low20
indole0low30
indoleacetic acid0low10
iodine0low170
itaconic acid0low10
dihydroxyphenylalanine0medium51
kynurenine0low130
2,3,4,5-tetrahydroxypentanal0low30
thioctic acid0low80
malonic acid0low10
racemethionine0low10
methylmercaptan0low10
pyruvaldehyde0low10
methanol0low390
phytic acid0low480
inositol0low110
melatonin0medium442
n'-acetylspermine0low10
naphthalene0low10
naringenin0low10
nickel0medium202
niacinamide0medium262
niacin0low90
nitrates0medium531
nitric acid0low30
nitroxyl0low30
nitrites0low340
nitrous oxide0low80
1-octanol0low10
hydroxide ion0low20
orotic acid0low30
oxamic acid0low20
4-aminobenzoic acid0low20
4-nitrophenol0low20
palmitic acid0low160
phenol0low70
phenylacetic acid0low10
phenethylamine0low10
phosphoenolpyruvate0low10
phosphorylcholine0low120
picolinic acid0low30
porphobilinogen0low10
propylene glycol0low10
propionic acid0low60
pteridines0low60
purine0low10
putrescine0medium531
pyrazinamide0low10
pyrazinoic acid0low10
pyridine0low10
pyridoxal0low20
pyridoxal phosphate0low70
pyridoxine0low70
pyrogallol0low50
pyruvic acid0low70
quinolinic acid0low10
thiosulfates0low10
dithionite0low10
sarcosine0low20
selenic acid0low20
selenious acid0low10
sulfites0medium202
spermidine0medium471
spermine0medium603
succinic acid0low30
sulfur dioxide0low10
taurine0medium431
thiamine0low20
thymine0medium504
toluene0low80
trimethyloxamine0medium11
uracil0medium22037
uric acid0low110
urea0medium433
vanillin0low10
xanthine0low30
vanilmandelic acid0low10
menthol0medium11
perillic acid0low20
1,10-phenanthroline0low20
1,2-dimethylhydrazine0medium7861
1,2-dioctanoylglycerol0low10
1,3-dipropyl-8-cyclopentylxanthine0low20
s,s'-1,4-phenylene-bis(1,2-ethanediyl)bis-isothiourea0low30
pk 111950low40
1-anilino-8-naphthalenesulfonate0low90
1-o-hexadecyl-2-o-methylglycerol0low10
edelfosine0low20
pd 1730740low10
n-(3-(aminomethyl)benzyl)acetamidine0low10
hoe 333420low10
2,4,5-trichlorophenoxyacetic acid0low10
2,4-dichlorophenoxyacetic acid0low10
2,4-dinitrophenol0low60
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine0low840
2-aminofluorene0low10
mercaptoethanol0low40
2-nitro-4-carboxyphenyl-n,n-diphenylcarbamate0low10
5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid0low10
2-aminoethoxydiphenyl borate0low10
zopolrestat0low10
3,4-methylenedioxyamphetamine0low10
3-aminobenzamide0low10
3-methylcholanthrene0low270
ro 5-48640low10
4-(2-aminoethyl)benzenesulfonylfluoride0low10
4-aminopyridine0low20
p-chloromercuribenzoic acid0low10
4-diphenylacetoxy-1,1-dimethylpiperidinium0low10
5,5-dimethyl-1-pyrroline-1-oxide0low10
phenytoin0low50
5-(n,n-hexamethylene)amiloride0low30
ethylisopropylamiloride0low50
hydroxyindoleacetic acid0low100
phenanthridone0low10
oxyquinoline0medium72
tacrine0low10
ro 48-80710low10
aa 8610low20
2,2'-azobis(2-amidinopropane)0low30
acemetacin0low10
acetaminophen0medium182
salophen0low10
acetazolamide0medium41
acridone0low20
ethacridine0low10
tyrphostin ag 10240low10
tyrphostin 250low20
5-aminoisoquinolinone0low40
albendazole0low50
alendronate0low10
alpha-cyano-4-hydroxycinnamate0low10
altretamine0low40
am 2510low20
amantadine0low50
ambroxol0low10
ametantrone0low40
diatrizoic acid0low110
amifostine anhydrous0medium61
aminoglutethimide0low10
pimagedine0low20
theophylline0low110
amiodarone0medium61
amitriptyline0low20
amlodipine0low10
amsacrine0low220
anastrozole0low20
anethole trithione0low20
antipyrine0low30
2-amino-4-phosphonobutyric acid0low10
n'-(3-aminopropyl)homospermidine0low20
acetovanillone0low30
apraclonidine0low10
aristolochic acid i0low20
aspirin0medium28012
atenolol0low30
aurintricarboxylic acid0low10
azasetron0low10
azathioprine0low230
azelastine0low10
azobenzene0low20
baclofen0low10
bay-k-86440low10
benextramine0low10
benserazide0low20
benzamide0low20
benzamidine0low10
benzethonium0low10
benzo(a)pyrene0low380
benzothiazide0low20
benzyl isothiocyanate0low50
bepridil0low10
berberine0low350
beta-naphthoflavone0low70
propiolactone0low10
bethanechol0low30
2,5-di-tert-butylhydroquinone0low10
bicalutamide0low10
bisacodyl0medium63
bisbenzimidazole0low50
bisindolylmaleimide i0low100
bisoprolol0low10
buformin0low20
bumetanide0low130
bupivacaine0medium154
busulfan0low30
caffeine0medium302
verapamil0medium761
calmidazolium0low10
camostat0low20
camphor, (+-)-isomer0low10
carbamazepine0low20
carbazilquinone0medium21
carmofur0medium289
carmustine0medium746
carbonyl cyanide m-chlorophenyl hydrazone0low70
cefuroxime0medium43
celecoxib0medium1193
cefixime0low10
cetyltrimethylammonium ion0low20
chetomin0low10
chelerythrine0low30
chloral hydrate0low20
chlorambucil0low160
chloroquine0low310
chloroxylenol0low10
chlorpheniramine0low30
chlorpromazine0low40
chlorpropamide0low20
ci 9940low40
ciglitazone0low90
cilostazol0low20
cimetidine0medium273
eucalyptol0low10
ciprofloxacin0medium141
cisapride0low10
citalopram0low10
5,7-dimethoxycoumarin0low10
clofazimine0low20
clofibrate0low20
clonidine0medium131
clotrimazole0low70
4-cresol0low10
cyclocreatine0low20
cycloleucine0low10
cyproheptadine0low40
cystamine0low20
danthron0low50
dantrolene0low20
dapi0low120
decanoic acid0low10
deferoxamine0low160
dequalinium0low20
desipramine0low50
eflornithine0medium808
diazepam0low80
diclofenac0low240
ddt0low20
dichlorphenamide0low10
pentetic acid0low400
diflunisal0low10
3,3'-diindolylmethane0low150
dipalmitoylphosphatidic acid0low10
diphenhydramine0low30
diphenyleneiodonium0low50
benzophenone0low10
dipyridamole0medium211
disulfiram0low120
ditercalinium0low10
valproic acid0low220
p-chloroamphetamine0low10
1-phenyl-2-palmitoylamino-3-morpholino-1-propanol0low10
2,3-dimethoxy-1,4-naphthoquinone0low10
domperidone0low10
donepezil0low10
droperidol0low10
dup 6970low10
ebselen0low10
econazole0low10
9-(2-hydroxy-3-nonyl)adenine0low10
ellipticine0low50
embelin0low40
emodin0low150
endothall0low20
erythrosine0medium522
etanidazole0low60
ethacrynic acid0low90
ether0low20
ethoxyquin0low20
ethoxyresorufin0low10
ethoxzolamide0low10
ethylenediamine0low10
etodolac0low110
carbonyl cyanide p-trifluoromethoxyphenylhydrazone0low50
felodipine0low10
fenbufen0low10
fenofibrate0low20
fentanyl0medium184
fluconazole0low20
flucytosine0medium321
flufenamic acid0low20
fluphenazine0low40
flumazenil0low10
flunitrazepam0low20
fluorouracil0medium3,658584
fluoxetine0low110
flurbiprofen0low90
fluspirilene0low10
flutamide0low40
furosemide0low120
gabapentin0low10
gabexate0low40
gemfibrozil0low10
gentamicin0medium154
2,5-dihydroxybenzoic acid0low10
glutaral0low80
glyburide0low40
go 69760low40
gossypol0low120
guaifenesin0low570
guanethidine0low10
guanidine0low20
1-(5-isoquinolinesulfonyl)-2-methylpiperazine0low110
fasudil0low10
ha14-10low20
haloperidol0low20
halothane0low40
hexachlorophene0low10
miltefosine0low10
hexahydrosiladifenidol0low10
4-fluorohexahydrosiladifenidol0low20
beta-thujaplicin0low20
hexamethylene bisacetamide0low110
ethidium0low80
hycanthone0low10
hydralazine0low80
hydrochlorothiazide0low10
hydroxychloroquine0low40
hydroxyurea0medium385
hypericin0low220
mk 4730low10
ibudilast0low10
ibuprofen0medium303
phenelzine0low10
lidocaine0medium112
ifosfamide0medium152
imipramine0low40
amrinone0low10
indole-3-carbinol0low160
indomethacin0low1090
iohexol0medium101
iomeprol0medium31
iopromide0low30
iothalamic acid0low30
ioversol0low10
ioxaglate0low20
irsogladine0low10
1-methyl-3-isobutylxanthine0low80
isoflurane0medium53
isoguvacine0low10
isoniazid0low30
2-propanol0low30
isoproterenol0low90
juglone0low60
staurosporine aglycone0low10
ketamine0medium51
ketanserin0low10
ketoconazole0low40
ketoprofen0low20
ketorolac0low30
khellin0low10
kinetin0low10
kynurenic acid0low30
mimosine0low20
lansoprazole0low10
beta-lapachone0low50
lauric acid0low30
leflunomide0low10
letrozole0low30
lomustine0medium4711
loperamide0medium32
loratadine0low20
losartan0low30
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one0medium431
6-anilino-5,8-quinolinedione0low20
edaravone0low10
mebendazole0medium61
mecamylamine0low20
mechlorethamine0medium304
meclizine0low10
meclofenamic acid0low20
mefenamic acid0low40
memantine0low10
vitamin k 30low100
meperidine0medium103
mesalamine0medium441
metformin0medium513
methacrylic acid0low10
methadone0low10
methazolamide0low10
methoxyamine0low50
methoxsalen0low10
nocodazole0low300
methyl parathion0low10
methyl salicylate0low40
methyl methanesulfonate0low150
methylphenidate0low10
metoclopramide0low30
metolachlor0low10
metoprolol0low20
metronidazole0medium5319
metyrapone0medium31
mexiletine0low10
mianserin0low20
miconazole0low10
midazolam0medium92
mirtazapine0low30
2,7-diaminomitosene0low10
mitoxantrone0low470
mofezolac0low10
molsidomine0low10
monodansylcadaverine0low10
entinostat0low130
muscimol0low10
myristicin0low10
n(1),n(11)-diethylnorspermine0medium61
n(1), n(12)-diethylspermine0low10
deet0low10
n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide0low10
ethylmaleimide0low40
clorgyline0low10
fenamic acid0low30
apnea0medium21
nabumetone0low70
nafamostat0low40
nalidixic acid0low10
activins0low170
nefopam0medium11
neostigmine0low10
nialamide0low10
nicardipine0low20
niclosamide0low110
nifedipine0low120
niflumic acid0low10
nimesulide0low140
nimodipine0low10
nitrendipine0low10
nitroglycerin0low70
masoprocol0low10
norfloxacin0low10
5-nitro-2-(3-phenylpropylamino)benzoic acid0low110
ns 20280low10
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide0low390
o(6)-benzylguanine0low130
ofloxacin0low30
omeprazole0medium141
ondansetron0low40
oxonic acid0medium7910
1,2-cyclohexanediamine0low20
oxamniquine0medium31
oxidopamine0low10
oxybutynin0low20
aminosalicylic acid0low30
quinone0low30
4-nitrophenylacetic acid0low10
palmidrol0low30
pamidronate0low20
pantoprazole0low20
papaverine0low30
pargyline0low20
patulin0low10
pd 1530350low30
pd1683930low10
pd 980590low490
pentamidine0medium21
pentobarbital0low30
pentoxifylline0medium72
phenobarbital0low130
phenolsulfonphthalein0low10
phenoxybenzamine0low10
4-phenylbutyric acid0low30
oxophenylarsine0low20
phenyl biguanide0low20
phenylbutazone0low10
phenylmethylsulfonyl fluoride0low20
phloretin0low30
phthalylsulfathiazole0medium11
o-phthalaldehyde0low10
pifithrin0low50
pioglitazone0low110
piperazine0low10
pirenzepine0low20
potassium chloride0low120
potassium iodide0low30
4-aminobenzoic acid0low30
ag 18790low50
ono 10780low10
praziquantel0low10
prazosin0low30
primaquine0low10
proadifen0low20
probenecid0low30
probucol0low10
procainamide0low10
procaine0low20
procarbazine0medium61
prochlorperazine0medium22
proglumide0low100
promethazine0low20
propafenone0low10
propantheline0low20
propidium0low170
propofol0medium236
propranolol0medium91
propyl gallate0low30
protopine0low10
protoporphyrin ix0low360
puupehenone0low10
pyrilamine0low20
pyrimethamine0low10
rabeprazole0low10
opc 127590medium21
resorcinol0low50
1,6-bis(cyclohexyloximinocarbonyl)hexane0low10
ro 31-82200low30
rofecoxib0low110
rolipram0low20
roxatidine acetate0low10
butyl phosphorotrithioate0low10
etiron0low10
saccharin0low30
sanguinarine0low20
salicylsalicylic acid0low10
sb 2021900low50
scriptaid0low10
semustine0medium11851
sennoside a&b0medium83
sevoflurane0medium105
sulfadiazine0medium22
linsidomine0low10
sobuzoxane0low10
sodium fluoride0low40
fluoroacetic acid0low10
stearic acid0low50
streptonigrin0low30
vorinostat0medium341
succinylacetone0low20
succinylcholine0low30
succinylsulfathiazole0low10
sulfamethazine0low10
sulfanilamide0low10
sulfaphenazole0low10
sulfapyridine0low30
sulfasalazine0low280
sulfobromophthalein0low10
sulforaphane0low430
suramin0low280
1,4-bis(2-(3,5-dichloropyridyloxy))benzene0low10
tegafur0medium30657
temozolomide0medium212
terazosin0low10
tetracaine0low10
tetraethylammonium0low40
thalidomide0low180
theobromine0low20
2,4-thiazolidinedione0low70
thioridazine0low10
thiotepa0medium305
thymeleatoxin0low20
ticlopidine0low100
tinidazole0medium11
tolazoline0low10
tolmetin0low30
n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine0low40
bromoform0low20
2,2',2''-trichlorotriethylamine0low10
triclosan0medium72
trifluoperazine0low50
trigonelline0low20
trimebutine0low10
trimetrexate0medium91
troglitazone0low260
thenoyltrifluoroacetone0low10
tyramine0low40
talactoferrin alfa0low10
urethane0low70
usnic acid0low30
w 70low40
2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide0low20
xylazine0low10
1,4-phenylenebis(methylene)selenocyanate0low70
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole0low10
zardaverine0low10
zinc chloride0low60
zolpidem0low10
mitomycin0medium38354
corticosterone0low70
prednisolone0low410
estriol0low10
reserpine0low60
cephaloridine0medium11
phentolamine0low20
sorbitol0low60
alloxan0low10
thymidine0medium2185
floxuridine0medium29733
triethylenemelamine0low10
bromouracil0low40
hydroxyproline0low90
thyroxine0low110
carbachol0low490
spironolactone0low10
aldosterone0low70
penicillamine0low30
prednisone0medium592
estrone0low80
androsterone0low10
etiocholanolone0low20
dehydroepiandrosterone0low140
dichlororibofuranosylbenzimidazole0low40
2-acetylaminofluorene0low30
penicillin g0low30
idoxuridine0low280
metaraminol0low10
pilocarpine0low10
triiodothyronine0low140
diethylnitrosamine0low120
biguanides0low50
carbon tetrachloride0low10
cantharidin0low30
alanine0medium262
serine0medium501
benz(a)anthracene0low40
4-nitroquinoline-1-oxide0low90
chloramphenicol0low60
aspartic acid0medium516
glutamine0medium687
lysine0medium611
allyl isothiocyanate0low10
cyanides0low20
dimazine0low50
vincristine0low10
physostigmine0low10
sulfamic acid0low10
sucrose0low250
9,10-dimethyl-1,2-benzanthracene0low230
apomorphine0low10
aminopyrine0low10
adenosine diphosphate0low160
cephalothin0medium53
2,3,4,6-tetrachlorophenol0low30
uridine0medium681
uridine monophosphate0low50
uridine diphosphate0low30
kanamycin a0medium94
bromodeoxyuridine0medium1042
galactose0medium443
carbostyril0medium224
phenylephrine0low10
levodopa0low20
edetic acid0medium341
tributyrin0low60
p-dimethylaminoazobenzene0low30
phenylethyl alcohol0low220
tyrosine0low1050
cysteamine0low10
monomethylhydrazine0low70
phlorhizin0low50
adenosine monophosphate0low170
methicillin0low10
niridazole0medium31
methylene blue0medium284
leucine0medium503
berlition0low10
ethyl methanesulfonate0low10
aniline0low20
2-aminoisobutyric acid0low10
dimethylnitrosamine0low200
androstenedione0low30
cytidine monophosphate0low10
uridine triphosphate0low110
lactose0low160
methionine0medium782
1,2-dipalmitoylphosphatidylcholine0low30
phenylalanine0low210
desoxycorticosterone0low30
colchicine0low470
cytidine0low160
cytidine triphosphate0low50
strophanthidin0low10
cycloheximide0low780
egtazic acid0low240
chloroform0medium91
dimethyl sulfone0low20
gliotoxin0low20
dimethylformamide0low340
triaziquone0low40
tubercidin0low40
ampicillin0medium62
mannitol0medium252
cytarabine0medium767
dithionitrobenzoic acid0low20
trifluridine0medium6112
ornithine0medium141
dinitrofluorobenzene0low10
asparagine0low130
histidine0low110
1,1,1-trichloroethane0low10
medroxyprogesterone acetate0medium61
valine0medium154
threonine0low180
alizarin0low20
chlorquinaldol0medium22
cordycepin0low60
tryptophan0low320
isoleucine0low20
arginine0medium711
ethane0low30
acetylene0low40
methylamine0low20
boranes0low50
propane0low10
vinyl chloride0low10
ethylamine0low10
acetonitrile0low10
methylene chloride0low30
carbon disulfide0low10
ethylene oxide0low20
bromodichloromethane0low10
tetramethylammonium0low10
dichlorodimethylsilane0low10
tert-butylhydroperoxide0low50
trichloroacetic acid0low40
trifluoroacetic acid0low10
triamcinolone acetonide0low30
fluoxymesterone0low10
gibberellic acid0low10
phencyclidine0low90
dimethyl sulfate0low20
tromethamine0low10
quinic acid0low30
tetraethyl lead0low10
triparanol0low10
linalool0low20
isoprene0low30
trichloroethylene0low10
acrylamide0low60
chloroacetamide0low10
acrylic acid0low50
isobutyric acid0low40
methacrylamide0low10
dichloroacetic acid0low20
bisphenol a0low100
cumene hydroperoxide0low10
taurocholic acid0low100
rhodamine b0low30
pyridoxic acid0low10
cyclizine0low10
skatole0low20
methylprednisolone0medium112
lawsone0low20
rotenone0low130
9,10-phenanthrenequinone0low10
phthalimide0low10
phthalic anhydride0low10
1-naphthoic acid0low10
salicylanilide0low10
isosorbide dinitrate0low20
phthalide0low10
penicillanic acid0low10
xylitol0low20
n-vinyl-2-pyrrolidinone0medium82
2-nitrotoluene0low10
thymol0low20
resacetophenone0low10
salicylaldehyde0low20
1-naphthol0low60
aminacrine0low90
xanthone0low40
quinoxalines0low320
1,2,3,4-tetrahydroisoquinoline0low10
quinoline0low40
isatin0low40
2-naphthylamine0low20
3,3'-diaminobenzidine0low20
tolonium chloride0low20
proflavine0low10
4-biphenylamine0low20
xanthenes0medium491
phenothiazine0low10
benzidine0low10
quinaldic acid0low20
methyleugenol0low20
styrene glycol0low10
fenoprop0low10
benzanilide0low10
propylparaben0low10
2-methyl-4-chlorophenoxyacetic acid0low10
benzothiazole0low20
2-toluidine0low10
2,4,5-trichlorophenol0low10
dilactide0low20
methyl acrylate0medium11
4-butyrolactone0low240
lactobionic acid0low10
1,3-ditolylguanidine0low10
phosphoribosyl pyrophosphate0medium81
furaldehyde0low20
pyrrolidonecarboxylic acid0low70
3-hydroxybenzoic acid0low10
trehalose0low30
carvone0low10
4-cymene0low10
benzonitrile0low10
quinuclidines0medium21
cyclamic acid0low10
triclocarban0low20
dicyclohexylamine0low10
boric acid0low10
benzonatate0low10
4-phenylenediamine0low10
epichlorohydrin0low20
acrolein0low120
propionitrile0low10
acrylonitrile0low40
2-methylpentane0low40
2-pentanone0low10
acetic anhydride0low10
succinic anhydride0low10
maleic anhydride0low30
melamine0low10
cyclohexanol0low20
cyclohexanone0low10
pentane0low30
pyrroles0medium974
tetrahydrofuran0low20
thiophenes0medium814
2,5-hexanedione0low10
n,n'-methylenebisacrylamide0low10
n-hexane0low10
cyclohexane0low10
piperidine0low10
morpholine0low20
diethylenetriamine0low10
diethanolamine0low10
estradiol dipropionate0low20
phenformin0low70
linalyl acetate0low10
2-methylbutanoic acid0low10
diethylhexyl phthalate0low20
framycetin0medium419
dibenzoylmethane0low10
n-methylpyrrolidine0low10
3-tert-butyl-4-hydroxyanisole0low10
vanillic acid0low10
sulfan blue0medium101
1-hydroxyanthraquinone0low60
pyrazolanthrone0low150
iodoantipyrine0low10
1,4-naphthoquinone0low30
diatrizoate meglumine0low140
meglumine0low100
2,2',4,4'-tetrahydroxybenzophenone0low10
uridine diphosphate glucose0low40
fluorodeoxyuridylate0medium552
2-naphthol0low140
oxythiamine0low10
shikimic acid0medium22
zephiramine0low10
nitrilotriacetic acid0low20
ethyl acrylate0low10
n-butyl acrylate0low10
ethyl acetate0low70
diallyl glycol carbonate0low10
n-heptane0low10
yohimbine0low80
3-o-methylglucose0low20
2-chloroadenosine0low30
diphenhydramine hydrochloride0low20
nafcillin0low10
ditiocarb0low50
catechin0medium1162
homoarginine0low20
diazooxonorleucine0low90
benzo(e)pyrene0low10
perylene0low220
fluoranthene0low20
quinazolines0medium1886
acridines0medium301
indazoles0medium211
benzofuran0low10
benzoxazoles0low50
adamantane0low100
cyclopentane0medium151
isoxazoles0medium271
oxazoles0low240
thiazoles0low1500
1,2,4-triazole0low20
pyrimidine0low60
pyrazines0medium451
1,2,4,5-tetrazine0low10
nitroblue tetrazolium0low20
calcium gluconate0medium31
diiodotyrosine0low10
hydrazine0medium861
thiocyanate0low10
4-hydroxyphenyllactic acid0low20
paraoxon0low10
hemicholinium 30low20
evans blue0low10
testosterone enanthate0low10
5-fluorouridine0medium221
aminophylline0low10
azacitidine0medium871
6-aminonicotinamide0low20
nornitrogen mustard0low10
methylthioinosine0low10
perfluorobutane0low20
perflexane0low10
fluocinonide0low10
galantamine0low10
aminoimidazole carboxamide0low80
methysergide0low30
thymidine monophosphate0low40
citrulline0low60
betamethasone0low10
silicon carbide0low10
perflubron0low30
cyproterone acetate0low20
beta-cyclocitral0low10
lithocholic acid0medium542
nandrolone0low20
2-aminopurine0low10
4-methylcatechol0low10
2-fluoroethylamine0low10
hydantoins0low30
fluorobenzenes0low10
dextropropoxyphene0low10
limestone0medium71
chenodeoxycholic acid0low430
glycocholic acid0low30
liriodenine0low10
fusarium0low20
corydine0low10
rhein0low20
indirubin0low10
plumbagin0low50
cepharanthine0low20
aloe emodin0low20
chrysophanic acid0low10
menadiol0low10
imperatorin0low20
emetine0low30
osthol0low20
bicuculline0low10
flavanone0low20
kainic acid0low10
topanol 3540low10
thymoquinone0low150
benzohydroxamic acid0low10
butenolide0low10
carvacrol0low30
indophenol0low10
4-hydroxyphenylethanol0low10
phloretic acid0low10
azomethane0low140
orcinol0low10
alpha-aminopyridine0low180
thiazolidines0low110
cyanogen bromide0low60
thioacetic acid0low10
oleanolic acid0low210
dihydroergotamine0medium11
periplogenin0low10
hematoxylin0low200
podophyllotoxin0medium224
hesperidin0low190
medroxyprogesterone0medium61
dihydrotestosterone0low110
luminol0medium62
physcione0low10
apiole0low10
dimenhydrinate0low30
flavone0low80
gluconic acid0low50
copper gluconate0low50
azomycin0medium181
uridine diphosphate n-acetylglucosamine0low20
3',5'-dichloromethotrexate0low50
herniarin0low10
tropolone0low30
perillyl alcohol0low30
evernic acid0low10
oxophenarsine0low10
tricaprylin0low10
cetyl palmitate0low10
aminoacetonitrile0low10
maleimide0low40
malondialdehyde0medium383
ethyl isothiocyanate0low10
myristic acid0low50
triethylenephosphoramide0low10
magnesium carbonate0low10
trinitrobenzenesulfonic acid0low130
eosine yellowish-(ys)0low180
violacein0low20
lucanthone hydrochloride0low10
gentian violet0low50
resazurin0low20
paeonol0low30
hematoporphyrin0low250
neutral red0low50
aniline mustard0low30
4-chloromercuribenzenesulfonate0low10
tristearin0low10
tripalmitin0low10
trimyristin0low10
glycylglycine0low20
malachite green0low20
congo red0low10
docusate0low10
3-hydroxyflavone0medium231
alpha-hydroxy-gamma-methylmercaptobutyric acid0low10
succinimide0low10
diphenylamine0medium81
butyl isothiocyanate0low20
allyl sulfide0low100
megestrol acetate0low40
triphenylphosphine0low10
alpha-naphthoflavone0low30
toyocamycin0low20
2-nitrofluorene0low10
galactitol0medium11
2-anthramine0low10
nitrosomethylurethane0low90
trimecaine0low10
acetylcysteine0medium503
ethyl pyruvate0low10
2,6-dichloro-4-nitrophenol0low10
3-hydroxybenzeneacetic acid0medium21
ethyl propiolate0low10
ethylurea0low10
1,1,3,3-tetramethylurea0low10
dicarbethoxydihydrocollidine0low10
c.i. 425100medium389
ethyl tert-butyl ether0low10
glycochenodeoxycholic acid0low20
benzydamine0medium11
erythromycin0medium93
dehydroepiandrosterone sulfate0low30
homoserine0low30
nitrosoguanidines0low220
2-piperidone0low110
perfluoropentane0low10
methylnitrosourea0low1010
2-hydroxy-1-naphthaldehyde0low10
sterculic acid0low10
ethylnitrosourea0low80
porfiromycin0low40
methylphosphate0low10
calcium citrate0low10
calcium lactate0low10
4-methylimidazole0low10
4-nitrophenyl acetate0low10
alpha-fluoro-beta-alanine0low20
hydroxyethyl methacrylate0low20
deoxycytidine0medium29934
deoxyuridine0low220
2,6-dichloroindophenol0low30
2'-deoxyadenosine0low20
2,4,6-triaminopyrimidine0low10
heptachlor epoxide0low10
acetylhydrazine0low20
pyridine-2-carboxaldehyde0low10
tetramethylpyrazine0low10
phenazocine0low10
ethidium bromide0low10
carmine0medium32
durapatite0low40
cadmium sulfide0low10
potassium hydroxide0low10
sodium hydroxide0low10
manganese dioxide0low10
zinc oxide0medium112
thorium dioxide0low10
lead sulfide0low10
molybdenum disulfide0low10
cupric sulfide0low20
monolaurin0low10
arsenic trioxide0low110
hydrofluoric acid0low20
vancomycin0low90
nsc 653460low40
glycyrrhizic acid0low50
d-alpha tocopherol0medium1096
tocopherols0low180
pseudouridine0low60
selenomethionine0low110
1,2-diethylhydrazine0low10
methyl tert-butyl ether0low10
meturedepa0low10
1-methyl-2-nitroimidazole0low20
digoxigenin0low60
5-chlorouracil0low10
2-hydroxyethyl disulfide0low10
ethyldimethylaminopropyl carbodiimide0low20
tetrachloroisophthalonitrile0medium11
paraquat0low10
s,n,n'-tripropylthiocarbamate0low10
2-tert-butylhydroquinone0low70
ethoglucid0low10
dronabinol0low40
methionine sulfoximine0low190
calotropin0low10
amiloride0low350
diallyl trisulfide0low60
diallyl disulfide0low200
n-isopropylacrylamide0low10
phenethyl isothiocyanate0low160
glaucine0low10
oxyclozanide0low10
fluorescein0medium223
5-fluorocytidine0low10
alpha-terpineol0low10
fucose0low430
tetrapentylammonium0low10
sulfur hexafluoride0medium51
7,12-dihydroxymethylbenz(a)anthracene0low10
acadesine0low10
thiocholchicine0low20
2-(dimethylamino)ethyl methacrylate0low10
thymine glycol0low10
methyl methanethiosulfonate0low20
benzyl thiocyanate0low20
doxifluridine0medium917
didodecyldimethylammonium0low10
2,2-bis(bromomethyl)-1,3-propanediol0medium11
fluorescein-5-isothiocyanate0low400
sabinene0low470
improsan0medium11
mannose0low350
dithiothreitol0medium82
palmatine0low20
megestrol0low30
phenoxyacetic acid0low10
ecdysone0low10
streptomycin0low40
carbonates0low20
butylhydroxybutylnitrosamine0low50
Brilliant Blue0low10
2,3-hexanedione0low10
l 4511670low10
3-o-methylgallic acid0medium21
2-amino-1,3,4-thiadiazole0medium21
bitoscanate0low10
mitomycin a0low10
dideoxyadenosine0low10
pn 4010low10
quinacrine mustard0low10
cladribine0low40
hyaluronoglucosaminidase0low10
nitracrine0low10
buthionine sulfoximine0low310
5,6-dihydroxytryptamine0low10
vidarabine0low50
1-nitrosopiperazine0low10
iodinated glycerol0low100
limonene0low60
di-n-propyl trisulfide0low10
olsalazine0low20
acetoxyacetylaminofluorene0low20
4-(4-dimethylaminophenylazo)benzoic acid0low10
enbucrilate0low10
3-deazaadenosine0low10
helenalin0low20
1-phenyl-3,3-dimethyltriazene0low10
dysprosium0low10
iridium0medium72
lanthanum0low30
lutetium0medium251
manganese0medium171
mercury0medium111
molybdenum0low60
neodymium0medium91
neon0low10
niobium0low10
osmium0low40
palladium0low120
platinum0low360
promethium0low10
rhenium0medium281
rhodium0low40
ruthenium0low190
samarium0low50
silver0medium512
tantalum0low10
technetium0medium1162
thorium0low20
titanium0medium271
tungsten0low10
actinium0low10
argon0low40
cadmium0medium101
cerium0low10
chromium0low140
erbium0low40
europium0medium42
gadolinium0medium161
gold0medium853
hafnium0low10
helium0low110
holmium0low10
uranium0low20
vanadium0low70
xenon0low10
ytterbium0low20
yttrium0medium121
zirconium0low70
zalcitabine0low10
magnesium sulfate0medium103
mercuric chloride0low10
6-nitrochrysene0low20
acetylglucosamine0low200
meladrazine0low10
galactosamine0low100
phosphoric acid, trisodium salt0medium71
palladium chloride0low10
cesium chloride0low10
hypochlorous acid0low50
camptothecin0medium72168
ferric chloride0low10
ferrous sulfate0low30
phosphine0low40
isopentenyladenosine0low30
bromine0low10
barium sulfate0medium54210
zinc sulfate0low60
potassium nitrate0low10
sodium sulfate0medium82
calcium phosphate, dibasic, anhydrous0medium31
calcium phosphate, monobasic, anhydrous0medium31
tricalcium phosphate0medium121
chromates0low10
copper sulfate0medium31
metoprine0low10
silver nitrate0low30
sodium thiosulfate0low10
calcium sulfate0low20
deuterium0low70
fluorine0low160
chlorine0low200
nitrous acid0low40
deuterium oxide0low40
thallium chloride0low20
glycerol 1-stearate0low10
galactose0low140
poloxalene0low10
hexadimethrine bromide0low10
vasotocin0low10
sizofiran0low20
ozone0low20
aluminum sulfate0low10
radon0low10
sodium selenite0medium161
cadmium chloride0low20
4-chloro-7-nitrobenzofurazan0low30
ancitabine0medium31
barium chloride0low10
trolamine salicylate0medium291
ferric nitrate0low10
phenacid0low10
rhamnose0low10
clodronic acid0low10
chloramine0low20
coformycin0low40
chrysotile0low20
ammonium chloride0low120
ethionine0low30
arabinofuranosylcytosine triphosphate0low10
2',3-dimethyl-4-aminobiphenyl0low120
manganese chloride0medium11
titanium dioxide0low80
beryllium sulfate0low10
misonidazole0medium111
mopidamol0medium22
1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea0low40
tiletamine hydrochloride0low60
origen0low10
urobilinogen0low10
levamisole0medium21064
cycasin0low50
ab 1630low10
thiamphenicol0low10
1-(2,6-dichlorophenyl)indolin-2-one0low10
pizotyline0low10
cephalexin0low10
vinyl carbamate0low20
cromolyn sodium0low10
isosorbide-5-mononitrate0low20
ferric nitrilotriacetate0low20
tetradecanoylphorbol acetate0medium1651
sodium bisulfide0low20
ornidazole0medium31
fluoroboric acid0low10
gold tetrachloride, acid0low10
fluorides0low50
acridine half-mustard0low20
danazol0low10
dioxidine0low10
clonixin0low10
cresyl violet0medium11
chromium0low20
keracyanin0low20
oryzalin0low10
1-deoxynojirimycin0low30
taurolidine0medium181
iodine0low100
daunorubicin0medium574
razoxane0medium1510
fludarabine phosphate0low20
cyanazine0low10
phosphotyrosine0low220
bromocriptine0low10
zingerone0low40
phenyl acetate0medium522
cetylpyridinium chloride anhydrous0low110
methylformamide0medium291
tris(2,3-dibromopropyl)phosphate0low10
tetrachloroethylene0low10
dimethylacetamide0low10
ursodeoxycholic acid0medium522
pregnanolone0low10
pyrene0low20
isothiuronium0low10
rafoxanide0low10
4-methoxyamphetamine0low70
8-bromo cyclic adenosine monophosphate0medium201
transferrin0medium591
normeperidine0low10
fanft0low10
tridemorph0low100
alkenes0low60
glutamic acid0medium142
glucaric acid0low70
alovudine0low70
azoxymethane0medium1,1041
sodium azide0low30
azides0low130
adenosine diphosphate ribose0low40
amoxicillin0low40
penfluridol0low10
tramadol0low10
gallium citrate0low30
nigericin0low20
prednimustine0low20
vidarabine phosphate0low20
zidovudine0low110
7-ethoxycoumarin0low10
acetylgalactosamine0low310
5,7-dihydroxytryptamine0low10
flubendazole0low10
4-vinyl-2,6-dimethoxyphenol0low10
tobramycin0low20
paclitaxel0medium2438
etoposide0medium1264
substance p0low150
acetosulfame0low10
ribavirin0low100
lentinan0medium112
amikacin0medium21
phorbol 12,13-dibutyrate0low80
10-carboxymethyl-9-acridanone0low10
n-(2-hydroxypropyl)methacrylamide0low20
triazinate0medium74
bezafibrate0low30
spirogermanium0low60
diltiazem0low40
nimustine0medium102
lonidamine0low90
vecuronium bromide0medium53
ng-nitroarginine methyl ester0low130
deoxynivalenol0low30
phenthiazamine0low10
pirfenidone0low10
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid0low20
pinaverium0low10
diisopropanolnitrosamine0low20
vindesine0medium141
3,3',5,5'-tetramethylbenzidine0low10
7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide0low40
acodazole0low10
5'-palmitoyl cytarabine0low10
nitazoxanide0low40
sufentanil0low20
epirubicin0medium608
cefmetazole0medium32
methyl(acetoxymethyl)nitrosamine0low170
desflurane0medium63
diaziquone0medium81
elliptinium acetate0low10
elliptinium0low10
dinaline0low50
enkephalin, methionine0low90
idarubicin0low90
lidofenin0low10
eniluracil0medium41
propiconazole0low20
nitrosobis(2-oxopropyl)amine0low50
piperacillin0medium31
cefotiam0medium11
paroxetine0low20
captopril0low10
staurosporine0low20
4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone0low50
oltipraz0low90
atracurium0low30
triflumuron0low10
moxalactam0medium33
fazarabine0medium41
bw-755c0low20
colforsin0low670
2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole0low50
iso-sulfan blue0medium238
buserelin0low10
fialuridine0low20
amonafide0low30
pimonidazole0low60
pefloxacin0low10
alfentanil0medium11
bisantrene0low70
fomesafen0low20
fenoxycarb0low20
swainsonine0low30
cefotetan0low30
lovastatin0medium291
2-amino-3-methylimidazo(4,5-f)quinoline0low320
levocabastine0low10
castanospermine0low20
simvastatin0low170
balsalazide0medium21
pravastatin0low40
imazethapyr0low10
raloxifene hydrochloride0low30
5-benzylacyclouridine0low30
ilmofosine0low10
mifepristone0low50
itraconazole0low50
gusperimus0low40
1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea0low80
flavone acetic acid0low350
lm 9850low40
iopentol0low10
antineoplaston a100low10
fluorodopa f 180low10
bmy 250670low10
brequinar0low60
fura-20low90
crisnatol0medium11
rodorubicin0low10
imiquimod0low60
cyclodisone0low20
esmolol0medium22
adapalene0low10
sulofenur0low60
sparfloxacin0low10
zileuton0low20
tebufelone0low10
clopidogrel0low80
liarozole0low10
topotecan0medium413
gemcitabine hydrochloride0low10
gemcitabine0medium986
temoporfin0low170
technetium tc 99m mertiatide0low30
u 777790low40
remifentanil0medium21
atorvastatin0low130
lamivudine0low10
irinotecan0medium54856
3-iodobenzylguanidine0low30
adefovir dipivoxil0low10
bisnafide0low30
capecitabine0medium33463
lurtotecan0low20
adenosine0low610
3-methyl-1,2-cyclopentanedione0low10
2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone0low10
ferric citrate0low20
gadolinium chloride0low40
nitrogen trioxide0low10
gallium nitrate0low10
vanadates0low130
ruthenium chloride (rucl3)0low10
dimethylhydrazines0medium7443
2-amino-3,4-dimethylimidazo(4,5-f)quinoline0low70
2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline0low120
acridine orange0low90
trifluoromethanesulfonic acid0low10
isothiocyanic acid0low10
chromic phosphate0low30
carbogen0low90
caloreen0low30
daunorubicin hydrochloride0low10
2-amino-9h-pyrido(2,3-b)indole0low10
colestipol0low10
cisatracurium0low20
venlafaxine hydrochloride0low10
trazodone hydrochloride0medium484
nelfinavir0low20
2,4-diamino-5-adamantyl-6-methylpyrimidine0low10
methionine methyl ester0low10
glucose, (beta-d)-isomer0low420
mevastatin0low40
chloroquine diphosphate0low10
fenofibric acid0low10
2',7'-dichlorofluorescein0low10
ursolic acid0low90
norharman0low30
thiazolyl blue0low620
thymidine 5'-triphosphate0low80
3-methylhistidine0low20
betulinic acid0low70
arctigenin0low30
baicalin0low70
plerixafor0low10
amprenavir0low10
1-aminooxy-3-aminopropane0low10
allicin0low60
5-methylcytosine0low130
diacetylfluorescein0low20
2'-deoxyuridylic acid0low70
epigallocatechin gallate0medium752
deoxyuridine triphosphate0low20
cholesteryl sulfate0low30
fluorexon0low80
gallocatechol0low70
2'-deoxycytidine 5'-triphosphate0low40
25-hydroxycholesterol0low30
10,10'-dimethyl-9,9'-biacridinium0low10
chlorin0low90
phosphoramidic acid0low20
aica ribonucleotide0low50
2',3'-dideoxythymidine0low10
thomsen-friedenreich antigen0low320
salvin0low40
1,2-distearoyllecithin0low60
2',5'-dideoxyadenosine0low10
5-bromo-4-chloro-3-indolyl beta-galactoside0low10
nile red0low10
metaperiodate0low80
lissamine rhodamine b0low80
1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose0low30
aristeromycin0low10
2-oxothiazolidine-4-carboxylic acid0low30
o-(6)-methylguanine0low250
5'-amino-2',5'-dideoxythymidine0low10
pyrrolidine dithiocarbamate0low50
o-4-methylthymine0low20
peroxynitric acid0low60
glutathione disulfide0medium81
2-acrylamido-2-methylpropanesulfonate0low10
baccatin iii0low10
bathophenanthroline disulfonic acid0low10
secoisolariciresinol0low10
3'-azido-3'-deoxythymidine 5'phosphate0low10
hypusine0low10
4-nitrobenzylthioinosine0low50
glyceryl methacrylate0low10
iopamidol0medium102
cephalosporin c0medium84
tetraiodothyroacetic acid0low30
2,2'-dithiodiethanesulfonic acid0low10
aloxistatin0low10
caroverine0low10
rutecarpine0low10
flomoxef0medium11
web 20860low20
methoxy-morpholinyl-doxorubicin0medium11
emitefur0low10
tallimustine0low30
intoplicine0low10
iobitridol0low10
telmisartan0low30
methacycline0low90
erbium chloride0low10
iridium radioisotopes0low40
xenon radioisotopes0low20
edoxudin0low30
2-ethyl-2-oxazoline0low10
2-methoxyestradiol0low40
naphthalimides0low60
toxoflavin0low10
16-fluoroestradiol0low10
fast blue bb0low10
bromosuccinimide0low10
phenoxazine0low10
benzophenothiazine0low20
1,7-phenanthroline0low60
triazoles0medium382
1h-tetrazole0low10
1,2,4-triazine0low10
3-fluoropyruvate0low10
lupulon0low40
atranorin0low10
pinocembrin0low20
tangeretin0low50
isopimpinellin0low10
2,4,6-trihydroxybenzaldehyde0low10
isocoumarins0low20
5-hydroxyflavone0low10
delphinidin0low160
sesamol0low20
1,2-dithiol-3-thione0low10
alpha-methylene gamma-butyrolactone0low10
fluorodeoxyglucose f180medium2298
sertraline0low20
picosulfate sodium0medium93
zoledronic acid0low90
glutaurine0low10
talinolol0low10
schizandrol b0low10
artemisinin0low50
4-hydroxyquinoline0low10
beta-hydroxyisovaleric acid0low10
1,2,3,4-tetrahydroquinoline0low10
5-fluoropyrimidine0medium101
5-iodouracil0low10
5-fluoroorotic acid0low10
8-hydroxyoctanoic acid0low20
n-methylsuccinimide0low10
5-hydroxymethylcytosine0low60
5-aminoisoquinoline0low10
hydroxyaniline mustard0low10
n-methylscopolamine0low30
fosquidone0low10
masoprocol0low90
tocophersolan0low50
trichlorosucrose0low20
bay i 74330medium11
voriconazole0low10
enocitabine0medium22
ranimustine0low20
bay h 20490low30
mitozolomide0low40
dw a 2114r0low30
datelliptium chloride0low20
quindoxin0low30
prednisolone phosphate0low40
bw 12c790low10
ubenimex0low20
avarol0low10
zidovudine triphosphate0low10
7-hydroxystaurosporine0medium131
epicatechin0low20
gallocatechol0low10
hesperetin0low100
illimaquinone0low20
magnolol0low50
honokiol0low90
sesamin0low30
coptisine0low10
betulin0low10
nobiletin0low130
n-myristoylglycine0low10
narciclasine0low10
lycorine0low20
5-iminodaunorubicin0low20
9-aminocamptothecin0low80
10,11-methylenedioxy-20-camptothecin0low20
teleocidin b-40low10
leupeptin0low40
picropodophyllin0low10
3-deazaaristeromycin0low10
phleomycins0low10
pacein0low10
alantolactone0low30
3-aminophenoxazone0low20
alpha-lapachone0low10
cyclopentenyl cytosine0low20
neplanocin a0low20
xylenol orange0low10
tetrandrine0low70
3-deazaneplanocin0low20
beta-amyrin0low10
lobaric acid0low10
(-)-catechin0low10
pinostrobin0low10
5-ethyluracil0low10
hederagenin0low10
o(6)-methyl-2'-deoxyguanosine0low10
alborixin0low10
calpeptin0low30
gliclazide0low10
dauricine0low10
brusatol0low20
panaxadiol0low20
corilagin0low20
sakuranetin0low20
bilobalide0low10
homoeriodictyol0low10
maslinic acid0low70
thiazole-4-carboxamide adenine dinucleotide0low20
oxazolidin-2-one0low10
ceric oxide0low10
2,2,2-trifluoroethanesulfonyl chloride0low10
perfluorooctane sulfonic acid0low10
atovaquone0low20
dicetylphosphate0low10
1-(2-chloroethyl)-1-nitrosourea0low40
4-nitrophenyl butyrate0low10
adipostatin a0low20
6-carboxyfluorescein0low30
3-methylflavone-8-carboxylic acid0low10
bendamustine hydrochloride0low10
2',7'-dichlorodihydrofluorescein diacetate0low10
ribose-5-phosphate0low10
rosiglitazone0low160
7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6h)-one0low10
erucin0low10
indazole-3-carboxylic acid0low10
methacrylylcholine0low10
fc 750low20
phenylglycine chloride0low10
3-amino-1,2,4-benzotriazine-1-oxide0low10
5,7,4'-trimethylapigenin0low10
n-hydroxysuccinimide0low10
2,6-dimethylacetaminophen0low10
3,7-dimethyl-7-octen-1-ol0low10
4-(n,n-dimethylaminoazobenzene)-4'-isothiocyanate0low10
2-aminoimidazole0low10
cryptolepine0low10
bexarotene0low30
glucose-1,6-bisphosphate0low20
3,4-dihydroxyphenylethanol0low100
propagermanium0low30
4-(methylthio)benzoic acid0low10
5-(biotinamido)pentylamine0low10
clarithromycin0low40
asperuloside0low10
cp0940low10
coenzyme a0low10
4,5-dimethoxy-2-nitrobenzaldehyde0low10
kampirone0low10
5,7-dimethoxyflavone0low10
tretazicar0low80
dihydroisotanshinone i0low10
mebeverine0low20
nicotine0low160
nsc-1727550low10
n-methylglycinamide0low10
fibrinogen0medium323
hecogenin0low10
beta-thujone0low10
equol0low40
cholest-4-en-3-one0low10
5-bromouridine0low10
homocysteine0low200
4-methylumbelliferyl glucuronide0low10
methylglucoside0low30
8-((4-chlorophenyl)thio)cyclic-3',5'-amp0low20
9-hydroxyellipticine0low10
delta-tocopherol0low20
acetoacetyl coa0low10
fluoromisonidazole0low10
7-amino-4-methylcoumarin0low10
levobupivacaine0low30
3-aminobenzeneboronic acid0low10
mci 90380low10
gamma-tocopherol0medium101
annatto0low10
glycyltyrosine0medium11
glycylleucine0low10
rac-glycerol 1-monodecanoate0low10
firefly luciferin0low40
norcantharidin0low40
glycidyl nitrate0low30
di-tert-butylperoxy-3,3,5-trimethylcyclohexane peroxide0low10
isohumulone0low10
glycylsarcosine0low80
dansyl fluoride0low20
4-desacetylvinblastine-3-carboxhydrazide0low10
dithiobis(succinimidylpropionate)0low10
3'-(4-morpholinyl)-3'-deaminodaunorubicin0low40
cv 65040low10
2,6-dihydroxynaphthalene0low10
viridin0low10
pyrimidine dimers0low10
widdrol0low30
6-paradol0low10
pyrroline0low10
1-(2-pyridinyl)piperazine0low10
5-Methoxyflavone0low10
sesaminol0low10
glucuronic acid0low170
ethylenimine quinone0low20
6-bromoisatin0low10
6-ethylguanine0low20
6-n-propyluracil0low10
septacidin0low10
olivacine0low10
3-(2,4-dihydroxyphenyl)propionic acid0low10
2,3-naphthalenedicarboxaldehyde0low10
8-azaadenosine0low10
gardenin b0low30
10-hydroxycamptothecin0low60
5-iodotubercidin0low10
Koenimbine0low10
hedamycin0low10
5-formyl-2'-deoxyuridine0low10
diosgenin0low100
2,2,5,7,8-pentamethyl-1-hydroxychroman0low10
3,7-dimethyl-1-propargylxanthine0low10
lecanoric acid0low10
hydroperoxyisophosphamide0low20
phorbolol myristate acetate0low10
pyrimidin-2-one beta-ribofuranoside0low30
nimbolide0low40
foxes0low30
kemptide0low20
benzylidene glucose0low10
1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol0low10
combretastatin0low10
acetomycin0low20
fangchinoline0low20
8-chloro-cyclic adenosine monophosphate0medium81
aeroplysinin i0low10
cb 37030low10
coumarin 60low10
isophosphamide mustard0low10
4'-o-methyldoxorubicin0low10
10-deazaaminopterin0low10
arctiin0low10
karanjin0low10
clomesone0low30
diphenylditelluride0low10
n-hydroxysuccinimide suberic acid ester0low20
succinimidyl 4-(4-maleimidophenyl)butyrate0low10
n-succinimidyl 3-(2-pyridyldithio)propionate0low10
s-adenosyl-3-thio-1,8-diaminooctane0low10
obovatol0low20
cyclic dtpa anhydride0low10
dicentrine0low10
benzyl selenocyanate0low50
cholesteryl butanoate0low20
sesamolin0low10
tetrahydrodeoxycorticosterone0low10
pregnanetriol0low10
n-methyladenosine0medium132
4-nitrophenyl-2-acetamido-2-deoxy-beta-d-glucopyranoside0low10
1,2-distearoylphosphatidylethanolamine0low30
2,3-bis(4-hydroxyphenyl)-propionitrile0low10
4-(methylthio)-3-butenyl isothiocyanate0low10
cobalt0medium251
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine0low20
fulvestrant0low40
mafosfamide0low10
uftoral0medium277
hydrogen sulfite0low70
1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid0low100
tritium oxide0low10
yttrium radioisotopes0medium601
mizoribine0low10
chromium-510low10
u 731220low30
fotemustine0low10
arginyl-glycyl-aspartic acid0low250
wr 10650low10
vitamin b 60low130
1,4-dihydropyridine0low10
imipenem, anhydrous0low10
cremophor el0low20
quin20low10
sn 380low30
sr1417160low20
s-nitrosoglutathione0low30
bosentan anhydrous0low40
diacetyldichlorofluorescein0low40
eudragit rs0low10
ly 1170180low10
2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine0low20
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole0low20
sr 489680low10
fluo-30low10
laurdan0low10
1,n(6)-ethenoadenine0low10
paxilline0low200
prolinedithiocarbamate0low40
beauvericin0low10
fructose 2,6-diphosphate0low30
artesunic acid0low70
cyanates0low120
fura-2-am0low20
12-deoxyphorbolphenylacetate0low10
1,n(6)-ethenodeoxyadenosine0low10
valylvaline0low10
3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate0low20
altertoxin ii0low10
aldophosphamide0low20
3,n(4)-ethenodeoxycytidine0low20
arginyl-glycyl-aspartyl-serine0low30
1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol0low10
saikosaponin d0low20
n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide0low50
geniposide0low10
phorbol-12-myristate0low10
afdx 1160low20
procyanidin0low160
s 97880low10
epicatechin gallate0low70
2'-5'-oligoadenylate trimer0low60
asulacrine0low50
deguelin0low30
1,9-dideoxyforskolin0low20
fingolimod hydrochloride0low40
daidzin0low10
triptolide0low150
ramosetron0low10
n-chlorotaurine0low10
alpha-methylphenylalanine0low10
proanthocyanidin0low10
parthenolide0low40
tryptoquivaline0low10
tesmilifene0low10
schizandrin b0low10
sch 280800low10
carboxyamido-triazole0low30
ecteinascidin 7430low50
kt 61490low60
kt 58230low30
1-hexadecyl-2-acetyl-glycero-3-phosphocholine0low70
4'-deoxy-4'-iododoxorubicin0low20
sr 1403330low10
ci 9880low10
n-hydroxy-3,2'-dimethyl-4-aminobiphenyl0low10
deoxyglucose0low380
tadalafil0low30
3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione0medium11
1-phenyl-2-decanoylamino-3-morpholino-1-propanol0low30
2,3-bis(3'-hydroxybenzyl)butyrolactone0low40
ta 09100low10
6-phenylhexyl isothiocyanate0low20
indolo(3,2-b)carbazole0low10
3',4'-dichlorobenzamil0low10
valerates0low40
monobromobimane0low10
florfenicol0low10
selenomethylselenocysteine0low50
dechloroethylcyclophosphamide0low10
aluminum phthalocyanine0low30
thromboxanes0low50
monochlorobimane0low20
landiolol0low10
tephrosin0low10
tanshinone0low140
1-(carboxymethylthio)tetradecane0low30
sc 419300low10
soyasapogenol b0low10
pterosin b0low10
geraniin0low20
ponasterone a0low40
icrf 1930low10
5-(tetradecyloxy)-2-furancarboxylic acid0low10
sc 581250low30
taraxasterol0low10
sophocarpine0low20
8-azidoadenosine-3',5'-monophosphate0low10
ingenane0low10
2-iodomelatonin0low10
bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)0low10
me 23030low20
cubebin0low10
marimastat0medium21
nitroaspirin0low70
asiatic acid0low50
obacunone0low20
stichoposide0low10
1'-acetoxychavicol acetate0low20
dechloroethylifosfamide0low10
ak 21230low10
clofarabine0low20
silicon phthalocyanine pc40low10
sr 486920low20
1-o-hexyl-2,3,5-trimethylhydroquinone0low20
hydrangenol0low10
dioscin0low60
cucurbitacins0low10
bw 245c0low10
foropafant0low10
elacridar0low20
nitroflurbiprofen0low10
caprylates0low70
1,3,4-thiadiazole0low20
rhein-9-anthrone0low10
ah 68090low10
muricholic acid0low10
n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea0low40
mosapride0medium43
dt 54610low10
valdecoxib0low30
parecoxib0medium41
validol0low10
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid0low100
calpain inhibitor 20low10
alliin0low10
dansyllysine0low10
5-fluorodihydrouracil0medium31
bw a868c0low10
n-myristoyl glycinal diethylacetal0low20
soyasaponin bb0low10
phytosphingosine0low10
rc 30950low20
gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate0low20
hydroxysuccinimidyl-4-azidobenzoate0low10
luzindole0low10
tryptophan methyl ester0low10
muristerone a0low10
dansylarginine n-(3-ethyl-1,5-pentanediyl)amide0low20
benzyl-alpha-n-acetylgalactosamine0low70
5-chloromethylfluorescein diacetate0low20
pyroglutamyl-histidyl-glycine0low30
celastrol0low70
aromadedrin0low10
carbene0low20
peroxynitrous acid0low60
2-palmitoylglycerol0low10
fullerene c600low40
imatinib mesylate0low280
mk 06630low60
tazobactam0low10
gefitinib0low430
n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine0low40
n(8)-acetylspermidine0low20
3-iodo-alpha-methyltyrosine0low20
4-carboxyfluorescein0low10
neurotensin (8-13)0low10
ru-283620low20
n(6)-carboxymethyllysine0low20
technetium tc 99m hydroxymethylene diphosphonate0low60
angiotensin ii, des-phe(8)-0low10
23-seleno-25-homotaurocholic acid0low10
n,n-dimethylarginine0low30
hoe 6940low10
n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine0low10
antibiotic g 4180low20
interleukin-1beta (163-171)0low20
1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone0low20
bq 6100low10
lysyl-aspartyl-glutamyl-leucine0low10
glycylglutamine0medium21
dodecyloctaethyleneglycol monoether0low10
methyl 4-mercaptobutyrimidate0low10
5-((4,6-dichloro-1,3,5-triazin-2-yl)amino)fluorescein0low10
alanylglutamine0medium64
6-methoxy-n-(3-sulfopropyl)quinolinium0low20
vadimezan0medium331
27-hydroxycholesterol0low10
e 640low20
ru 269880low10
dehydroalanine0low10
proanthocyanidin a20low10
glabridin0low10
rubiadin0low10
tetrahydrocurcumin0low20
desloratadine0low10
n-(6-phenylhexyl)-5-chloro-1-naphthalenesulfonamide0low10
1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid0low30
genkwadaphnin0low10
iguratimod0low10
1,4,7-triazacyclononane-n,n',n''-triacetic acid0low20
4-carbamoylimidazolium 5-olate0low20
nsc 2240700low10
n-acetyl-demethylmuramyl-alanyl-isoglutamine0low10
2-(n-myristoylamino)-1-phenyl-1-propanol0low10
imidazolium-bis(imidazole)tetrachlororuthenate(iii)0low10
6,6'-dicorynomycolyl trehalose0low10
glycerophosphoinositol 4,5-bisphosphate0low40
n-(4-carboxycyclohexylmethyl)maleimide n-hydroxysuccinimide ester0low10
5-carbamoyl-1h-imidazol-4-yl-piperonylate0low10
n-(4-(2-chlorophenyl)-6,7-dimethyl-3-quinolyl)-n'-(2,4-difluorophenyl)urea0low10
502u830medium11
3'-deamino-3'-hydroxydaunorubicin0low10
3-(4-carboxybenzoyl)-2-quinolinecarboxaldehyde0low10
5-aza-2'-deoxycytidine-5'-monophosphate0low20
1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene0low40
(hexadecanoyl)aminofluorescein0low10
glicentin0medium11
5-aza-2'-deoxycytidine-5'-triphosphate0low10
benastatin a0low10
lestaurtinib0low10
2'-deoxy-3',5'-di-o-acetyl-5-fluoro-3-(3-methylbenzoyl)uridine0low10
ay 255450low10
ethazolastone0low10
methotrexate0medium25533
terpentecin0low10
acetyl hypofluorite0low10
n-(5-(2,3-dihydrobenzofuryl)sulfonyl)-n'-(3,4-dichlorophenyl)urea0low20
ro 32-04320low10
2-methyl-4,6-bis(n,n-dimethylaminophenyl)pyrylium0low10
pseudomonas aeruginosa autoinducer0low20
3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5h)-furanone0low10
alanyl-alanyl-phenylalanine chloromethyl ketone0low10
1-phthalidyl-5-fluorouracil0low10
bromofosfamide0low10
cci 103f0low20
alanylglutamic acid0medium11
delphinidin0low30
cyanidin0low50
4-bromomethyl-6,7-dimethoxycoumarin0low10
eudistomin e0low10
xaliproden0low10
n-((2-dimethylamino)ethyl)-9-aminoacridine-4-carboxamide0low30
clitocine0low20
tamsulosin0low10
6-(4-bromoacetamidobenzyl)-1,4,8,11-tetraazacyclotetradecane-n,n',n'',n'''-tetraacetic acid0low10
4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid0low20
6-n-aziridinyl-3-hydrox-7-methyl-2,3-dihydro-1h-pyrrolo(1,2-a)benzimidazole-5,8-dione 3-acetate0low10
tyrosyl-glycyl-tryptophyl-methionyl-aspartyl-phenylalanyl-glycine0low20
4-hydroxy-25-desoxyneorollinicin0low30
dioctadecylamidoglycylspermine0low10
snp nonapeptide0low10
ly 1954480low10
4-aminophenylethyl-1,4,7,10-tetraazacyclodecane-n,n',n'',n'''-tetraacetic acid0low30
pak 104p0low10
n-(3-phenyl-n-propyl)-1-phenyl-2-aminopropane0low20
bn 522050low10
bn 522110low10
l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine0low20
1-methylspermidine0low10
c 13110low50
c 13100low10
n',n''-diacetylspermine0medium51
osw 10low10
l 7330600low20
omega-n-methylarginine0low120
ml-30000low40
imidazolecarboxamide0low10
8-chloroadenosine-3',5'-cyclic monophosphorothioate0low10
pixantrone0low10
4-methylumbelliferylguanidinobenzoate0low20
triiodothyronine0low10
aspartame0low10
podophyllic acid0low10
pomalidomide0low10
cycloastragenol0low20
s-(5'-deoxyadenosyl-5')-s-methylthioethylhydroxylamine0low10
xylose0medium11
valerylsalicylate0low10
quinone methide0low10
5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone0low30
beta-lactams0low20
perrhenate0low10
proline0low100
cucurbitaceae0low40
2-quinolinecarboxamide0low10
betamethasone-17,21-dipropionate0low10
1-methyl-2-nitrosoimidazole0low10
aminotris(methylenephosphonato)diamminoplatinum (ii)0low10
cryptoporic acid e0low10
8-chloroadenosine0low10
docetaxel anhydrous0medium522
3,4-dihydro-5-methyl-1(2h)-isoquinolinone0low10
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a0low90
perifosine0low30
irofulven0low40
tariquidar0low10
cositecan0low20
peptide elongation factor 20low20
levofloxacin0low10
aclacinomycin0low10
4-boronophenylalanine0low40
5-fluorouridine 5'-phosphate0low20
4-n-bis(2-chloroethyl)aminobenzoylglutamic acid0low10
dx 89510medium41
cariporide0low10
vatalanib0low40
evodiamine0low80
zinc glycinate0low10
moxifloxacin0low10
cyc 6820low10
9-(4'-aminophenyl)-9h-pyrido(3,4-b)indole0low30
bazedoxifene0low20
rp 734010low10
phorbols0low100
4-methoxyhonokiol0low10
schizandrin a0low20
spinosin0low10
atractylenolide iii0low10
naproxen0low80
canertinib dihydrochloride0low10
canertinib0low10
cinacalcet0low10
hydroxyl radical0medium132
lactitol0low20
naphthalenediimide0low10
triflimide0low10
lubiprostone0low10
methyl 5-aminolevulinate0low20
nps-5680low10
jte 5220low50
rhodioloside0low10
bacteriochlorin a0low10
malvidin0low10
tipifarnib0low20
yttria0low10
atrasentan0low10
resiquimod0low20
singlet oxygen0low160
baldrinal0low10
2,5-dimethyl-3,6-diaziridinyl-1,4-benzoquinone0low50
fidarestat0low70
ukrain0low20
miltirone0low10
cryptotanshinone0low70
4,4'-(2,2-bis((4-(aminoiminomethyl)-2-bromophenoxy)methyl)-1,3-propanediyl)bis(oxy))bis(3-bromobenzenecarboximidamide0low10
cyc 2020low100
cycloartane0low30
ar-turmerone0low10
phenylethyl isocyanate0low10
questin0low10
ly 1819840low30
nevadensin0low10
zinc hematoporphyrin0low10
agrimonolide0low10
pyropheophorbide a0low10
3'-fucosyllactose0low20
purpurin 180low10
ampelopsin0low30
methylselenic acid0low20
hydroxysitosterol0low30
xanthenone-4-acetic acid0low130
8-aminohexylamino camp0low10
aloenin0low10
isovitexin0low10
iodonium thiophene0low10
glyceollin0low10
butyroxan0low10
pyrenedecanoic acid0low10
technetium tc 99m n-(methylamino)methylene diphosphonate0low10
sclareol0low40
cgp 68090low10
iron-ethylenediamine-n,n'-bis(2-hydroxyphenylacetic acid)0low10
folligen0low10
sialyl-le(a) oligosaccharide0low20
atx 700low20
n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid0low30
calcium pyrophosphate0medium31
tetraphenylphosphonium0low10
proximadiol0low10
histidinol0low10
cysteinesulfenic acid0low10
4'-galactooligosaccharide0low10
paromomycin0low40
technetium tc 99m pentetate0low60
metaperiodate0low20
taxusin0low10
lanthanum carbonate0low10
boswellic acid0low20
bisdechlorogeodin0low10
beta-solamarine0low10
adenosine 2',5'-diphosphate0low10
sophoramine0low10
aminopterin0low40
4-(2-aminoethyl)benzenesulfonamide0low10
galactosyl-1,3-n-acetylglucosamine0low10
methyl protodioscin0low10
biotin0medium472
isofuranodiene0low10
bw 501c0low10
angiotensin ii0low260
methyl 4-azidophenylacetimidate0low10
atropine0low200
galactosucrose0low10
lignin0low150
ropivacaine0medium84
sb 2035800low170
sb 2167630low40
enzastaurin0low50
paris saponin vii0low10
erlotinib hydrochloride0medium243
cilengitide0low10
4'-o-methylepigallocatechin0low10
2'-hydroxyflavanone0low10
s 16020-20low20
piboserod0low10
organophosphonates0low80
top 530low10
ly 2931110low10
isoxanthochymol0low20
limonin0low50
cucurbitacin r0low10
psyllium0medium81
5-heptadecylresorcinol0low10
nantenine, (+-)-isomer0low10
arnicolide d0low10
3-(piperidine-1-yl)propyl 4-amino-5-chloro-2-methoxybenzoate hydrochloride0low10
3'-demethylnobiletin0low10
aezs 1240low10
6-acetonyldihydrochelerythrine0low10
scutellarin0low30
propargylglycine0low20
pefabloc0low10
aflatoxin b10low70
2,5-dihydroxybenzyl alcohol0low10
octadeca-5,8-dienoic acid0low10
7-methoxyheptaphylline0low10
etravirine0low10
nantenine0low10
gossypolone0low10
fe(iii)-edta0low10
(-)-gallocatechin gallate0low10
troleandomycin0low10
mcc-5550low10
alyssin0low10
lapatinib0low80
2-(4-morpholinoanilino)-6-cyclohexylaminopurine0low30
dofequidar0low10
ilaprazole0low10
taspine0low30
dabigatran0low10
sorafenib0medium172
lenalidomide0low30
n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide0low20
diflomotecan0low10
alanyl-glutamyl-aspartyl-glycine0low20
1-methylpropyl-2-imidazolyl disulfide0low20
N-hydroxy-2-phenylacetamide0low10
demecolcine0low70
cholic acid0medium402
sitosterol, (3beta)-isomer0low10
deoxycholic acid0medium1604
cortisone0low90
gossypol acetic acid0low10
stenbolone0low10
2-(4-aminophenyl)benzothiazole0low20
3-nitrotyrosine0low150
5-hydroxymethylfurfural0low20
2,3-dihydro-1h-imidazo(1,2-b)pyrazole0low10
blastmycin0low10
lanosterol0low40
nogalamycin0low20
mitopodozide0low20
pheophorbide a0low20
anisomycin0low10
benzofurans0medium351
estramustine0low40
cyclovirobuxine d0low10
metribolone0low30
solanine0low10
withaferin a0low30
23,24-dihydrocucurbitacin b0low10
noscapine0low40
homoharringtonine0low70
acivicin0low90
elesclomol0low10
diospyrin0low10
wortmannin0low160
ibogaine0low20
menogaril0medium42
2-oxindole0low20
2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one0low10
mitonafide0low20
pifithrin mu0low10
withanolides0low40
sorbinil0low20
nsc 3661400medium31
dentatin0low10
illudin m0low10
anthricin0low10
acronine0low30
3,4-dihydroxyphenylpropionic acid0low10
gitoxigenin0low10
2'-fluorothymidine0low10
4-oxy-6-(4-oxybezoyloxy)dauc-8,9-en0low10
3,5-bis(benzylidene)-4-piperidone0low10
erianin0low30
adozelesin0low50
trimethoprim, sulfamethoxazole drug combination0low20
5-demethylnobiletin0low40
diethoxy-(1-phenyl-1,3-butanedionato)titanium (iv)0low10
curcuphenol0low10
demethyleneberberine0low10
acylfulvene0low10
(4-methoxyphenyl)(3,4,5-trimethoxyphenyl)methanone0low10
be 4-4-4-40low10
paullone0low20
5-Hydroxy-7-methoxy-6-methylflavone0low10
o-(chloroacetylcarbamoyl)fumagillol0low140
lobetyolin0low10
2,5-bis(5-hydroxymethyl-2-thienyl)furan0low20
murrayafoline a0low10
5,7-dimethoxy-2-phenyl-3,4-dihydro-2H-1-benzopyran-4-one0low10
tris(2-pyridylmethyl)amine0low20
piperitenone0low10
cryptophycin0low10
nsc 6744950low10
5-methylxanthen-9-one-4-acetic acid0low40
ochraceolide a0low10
taurochenodeoxycholic acid0low50
bortezomib0low280
2-(2-nitro-1h-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoropropyl)acetamide0low50
calcein am0low30
ritonavir0low40
jib-040low10
sjg 1360medium21
acetogenins0low20
fti 2760low10
cap1-6d0low20
5f-2030low10
4-amino-5-benzoyl-2-(4-methoxyphenylamino)thiazole0low30
n-methoxyindole-3-carbinol0low20
Bardoxolone0low10
bardoxolone methyl0low20
n,n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium0low20
dihydropyridines0low80
povidone-iodine0medium122
methyl angolensate0low10
gant 610low70
nsc 1415370low30
secalonic acid0low10
leupeptins0low330
carboplatin0medium557
lithium chloride0low130
macbecin ii0low10
eurycomanone0low10
9-deazaadenosine0low10
leptomycin b0low20
xr59440low20
s-adenosylhomocysteine0low90
5'-methylthioadenosine0low30
glycogen0low280
sorbose0low10
arabinose0low10
n-acetylneuraminic acid0low470
mannose-6-phosphate0low10
fibrin0low160
bradykinin0medium111
canavanine0low40
amylopectin0low30
glucosamine0low340
polygalacturonic acid0low10
elastin0low50
carnosine0low50
mevalonic acid0medium172
ribose 1-phosphate0low20
raffinose0low30
naringenin0low130
epiglucan0low100
deoxyglucose0low10
n-acetyllactosamine0low30
oxytocin0low10
laminaran0low30
pantetheine0low10
theanine0low10
3,4-dihydroxyphenyllactic acid0low10
inositol 1,4,5-trisphosphate0low80
ouabain0low180
puromycin0low50
stachyose0low10
taxifolin0low10
tosylphenylalanyl chloromethyl ketone0low20
tartaric acid0low20
pentostatin0low60
taurolithocholic acid0low20
n-glycolylneuraminic acid0low40
nitroarginine0low60
5-methyldeoxycytidine0low20
inositol 3-phosphate0low20
cortodoxone0medium21
eriodictyol0low10
pelargonidin0low10
arbutin0low10
fructans0low90
cellulase0low20
strychnine0low40
quinidine0low60
meropenem0low10
griseofulvin0low10
monensin0low210
cefoxitin0medium21
digitoxin0low20
saquinavir0low20
pentazocine0low10
rocuronium0low20
hyperforin0low60
mometasone furoate0low10
phalloidine0low60
indican0low20
pancratistatin0low30
convallatoxin0low10
neriifolin0low10
deltonin0low10
beta-hederin0low10
carnosol0low50
columbin0low10
brucine0low20
decursin0low20
parthenin0low10
genipin0low30
naringin0low50
valtrate0low10
ochratoxin a0low20
xanthochymol0low20
gingerol0low80
trifolirhizin0low10
yatein0low10
securinine0low20
alpha-chaconine0low10
cyclopamine0low90
lignans0medium481
acriflavine0low20
acetylleucyl-leucyl-norleucinal0low10
6-prenylchrysin0low10
n-formylmethionine leucyl-phenylalanine0low70
plasminogen activator inhibitor 20low10
sodium arsenite0low80
fengycin0low10
epiafzelechin0low10
doxorubicin hydrochloride0low50
erythromycin ethylsuccinate0low20
tibolone0medium21
ao 1280low10
betadex0low220
sucrose octasulfate0low10
acetyl coenzyme a0low50
e-z cinnamic acid0low20
ergosterol0low70
trichostatin a0low650
tretinoin0medium942
aurovertin b0low10
arachidonic acid0low740
elinafide0low30
farnesol0low50
phosphoramidon0low10
resveratrol0medium1151
(north)-methanocarbathymidine0low10
retinol0medium913
1,2-dilauroylphosphatidylcholine0low10
cyanoginosin lr0low20
palmitoleic acid0low20
oleic acid0low150
tacrolimus0low170
farnesyl pyrophosphate0medium21
ferulic acid0low90
pectins0medium631
cerivastatin0low10
cocaine0low20
eicosapentaenoic acid0medium431
thapsigargin0low170
cgs 27023a0medium31
mycophenolic acid0low50
tetragastrin0low40
clindamycin0medium91
keratan sulfate0low30
brivudine0low40
lycopene0medium253
zithromax0low10
pd 1739550low10
formycin0low10
phenylalaninol0low10
cefoxitin0medium241
geranylgeranyl pyrophosphate0medium51
obeticholic acid0low10
desoxyepothilone b0low10
t09013170low30
epothilone b0medium62
n-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea0low10
y 276320low100
methylproamine0low10
prostaglandin d20low330
diethylstilbestrol0low130
epothilone a0medium93
zeatin0low10
alitretinoin0low40
roflumilast0low10
h 890low60
afimoxifene0low20
imidazolidines0low100
aclarubicin0medium71
thymopentin0medium11
sulfolithocholic acid0low20
decitabine0low680
d-glucaro-delta-lactam0low10
pantethine0low10
texas red0low30
trachelogenin0low20
iridoids0low80
troxacitabine0low20
kt 57200low20
laminaran0low40
ketoconazole0low20
purvalanol a0low50
cefamandole0medium22
dactinomycin0low710
conidendrin0low10
gamma-sitosterol0low120
tiazofurin0low70
aphidicolin0low180
3-(1-deoxyribofuranosyl)benzamide0low10
arsphenamine0low10
azaserine0medium51
melphalan0medium597
enkephalin, leucine0low40
benzyloxycarbonylleucyl-leucyl-leucine aldehyde0low270
tenofovir0low10
prinomastat0low10
l 743,8720low10
negletein0low10
rubitecan0low40
cinnamtannin b-10low10
terameprocol0low10
shikonin0low70
8-prenylnaringenin0low20
6,8-diprenylgenistein0low10
licoricidin0low10
pmx 4640low40
riboflavin0medium51
maltitol0low10
5-fluoro-2'-deoxycytidine0medium11
potassium permanganate0low10
sodium bicarbonate0medium41
sodium acetate, anhydrous0low20
sodium cyanate0low30
ammonium acetate0low10
zn(ii)-phthalocyanine0low50
dipyrone0low10
sodium perchlorate0low10
thiacremonone0low20
bromochloroacetic acid0medium1516
11-mercaptoundecanoic acid0low10
2-tetradecylcyclobutanone0low10
4-(4-chloro-2-methylphenoxy)-n-hydroxybutanamide0low10
pyrrolopyrimidine0low10
tolfenamic acid0low50
cabreuvin0low10
zapotin0low10
5,7,3',4'-tetramethylluteolin0low10
carbenoxolone sodium0low30
cefpiramide0low10
alpha-asarone0low10
varitriol0low10
nemorosone0low10
communic acid0low10
hirsutanone0low10
calebin-a0low10
cinnamaldehyde0low70
elaidic acid0low20
trans-4-coumaric acid0low50
geraniol0low50
dimethyl fumarate0low40
glycosides0low310
4-oxothiazolidine0low10
chalcone0low120
sinapinic acid0low30
isomethyleugenol0medium1212
isosafrole0low10
piplartine0low40
7-methoxyisoflavone0low20
beta-ionone0low20
piperine0low50
retinol acetate0low10
squalene0low60
stilbenes0low1410
2'-hydroxychalcone0low10
2,2'-dihydroxychalcone0low10
isoliquiritigenin0low80
antofine0low10
trichodermamide b0low10
xanthohumol0low50
4-dimethylaminostilbene0low10
dibenzylidene acetone0low10
picibanil0medium414
thiopyran0low10
4-stilbazole0low10
2-methoxycinnamaldehyde0low10
p-hydroxycinnamaldehyde0low30
cardamonin0low30
hirsutanol a0low10
citraconic acid0low10
floxuridine0low10
flavin-adenine dinucleotide0low30
cannabidiol0low70
malonyl coenzyme a0low20
buprenorphine0low10
arginine vasopressin0low10
pyrophosphate0low30
gw96620low80
dodecylphosphocholine0low10
acetyl-aspartyl-glutamyl-valyl-aspartal0low10
azidopine0low40
amygdalin0low50
mezlocillin0medium33
lanatoside c0low10
polidocanol0low20
iothalamate meglumine0low10
tropisetron0low10
sodium metabisulfite0medium22
tram 340low10
isopropyl thiogalactoside0low50
leuprolide0low10
fludarabine0low50
propylthiouracil0low20
nsc 43470low30
sesquiterpenes0medium911
mercaptopurine0medium123
3,3',4,5'-tetrahydroxystilbene0low60
benzoylacrylic acid0low10
alpha-methyltryptophan, (l)-isomer0low10
1-methyltryptophan0low50
thioinosine0low50
caffeic acid0low100
3-(4-methylbenzoyl)acrylic acid0low10
4-methoxycinnamic acid0low30
(1E,4E)-1,5-bis(4-methoxyphenyl)penta-1,4-dien-3-one0low10
3-(3,4-dimethoxyphenyl)propenoic acid0low10
isoferulic acid0low10
urocanic acid0low10
4-iodo-6-phenylpyrimidine0low10
(1e,4e)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one0low10
isoeugenol0low10
cotinine0low20
(4-(3-chlorophenyl)piperazin-1-yl)(2-ethoxyphenyl)methanone0low10
virosecurinine0low10
flunarizine0low10
dieldrin0low10
curcumin0low2430
brd 73890low10
ucf 1010low10
thiazoline-2-thione0low10
rhodanine0low10
benztropine0low10
3-cyano-4-phenyl-6-(3-bromo-6-hydroxyphenyl)-2-pyridone0low10
thiouracil0low10
5-(4-ethylbenzylidene)-2-thioxothiazolidin-4-one0low10
Src Inhibitor-10low10
sulindac0medium1554
cis-resveratrol0low10
capsaicin0low120
enclomiphene0low10
metiamide0low10
epalrestat0low10
aurapten0low100
3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone0low10
caryophyllene oxide0low10
chlorogenic acid0low180
benzotript0low30
thioguanine anhydrous0medium183
neotetrazolium0low30
thiourea0low130
sodium propionate0low10
indigo carmine0medium399
D-fructopyranose0medium161
potassium oxonate0medium11
ferric ferrocyanide0low10
digoxin0low70
capsazepine0low10
fumonisin b10low20
2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide0low10
tamoxifen0medium381
sodium taurodeoxycholate0low90
4-methylumbelliferyl glucoside0low10
tocopherylquinone0low10
nadp0low170
1,1-diphenyl-2-picrylhydrazyl0low170
hc-0670470low10
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2h-tetrazolium0low10
t 00709070low20
stattic0low40
krn 70000low80
sirtinol0low10
methyl-thiohydantoin-tryptophan0low10
4,6-dimorpholino-n-(4-nitrophenyl)-1,3,5-triazin-2-amine0low10
1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane0low20
monastrol0low20
fusidic acid0low30
lincomycin0medium31
beta-2'-deoxythioguanosine0medium32
valinomycin0low50
thiopental0low30
ranitidine0medium72
schizandrin0low10
maraviroc0low10
nsc733060low10
2'-deoxy-2'-methylenecytidine0medium11
u 01260low190
dieckol0low10
pica0low10
glycylproline0low10
2-(allylthio)pyrazine0low10
lithium0low60
alpha-sarcin0low30
cobaltous chloride0medium101
nitrogen dioxide0medium42
maneb0low20
dermatan sulfate0low90
mannomustine0low10
monooctanoin0low10
orlistat0low40
carzelesin0low20
quinine0low60
nsc 2902050low20
manool0low20
mitragynine0low10
1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester0low40
indium oxine0low30
2-nitro-3-methylimidazo(4,5-f)quinoline0low10
tauro-24,25-dihydrofusidate0low10
amrubicin0low20
mdl 725270low70
rtki cpd0low110
2'-cyano-2'-deoxyarabinofuranosylcytosine0low10
brassinin0low30
didimethylsulfoxide dichloroplatinum(ii)0low10
1-(2-(2-(4-pyridyl)-2-imidazoline-1-yl)ethyl)-3-(4-carboxyphenyl)urea0low10
e 70100low30
win 333770low10
2-(4-isothiocyanatobenzyl)-6-methyldiethylenetriaminepentaacetic acid0low10
cystine0low80
methenolone0low10
tandutinib0low10
rasagiline0low10
safingol0low60
dasatinib0low60
erysolin0low10
bigelovin0low10
oxalylglycine0low10
bio acrylic resin0low10
lysine clonixinate0low10
1-(3-chloro-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone0low10
zd 64740low90
molybdocene dichloride0low10
2-fluoro-2-deoxyglucose-6-phosphate0low20
nitinol0medium102
ki 81100low10
spinorphin0low10
1,12-dimethylspermine0low10
perophoramidine0low10
desmethylanethol trithione0low10
oxychlorosene0low10
amanitins0low20
cytellin0low170
verticillins0low40
paulownin0low10
wogonoside0low10
momilactone b0low10
salinomycin0low10
2'-deoxy-5-ethyl-5'-uridylic acid0low10
ginsenosides0low210
silybin0low10
phosphothreonine0low20
ovalbumin0low130
sw0332910low10
1,8-dinitro-4,5-dihydroxyanthraquinone0low10
ua 627840low10
sb 2180780low10
sodium dodecyl sulfate0low160
fh5350low20
blister0low20
crocin0low50
mtt formazan0low80
chloramine-t0low20
l 6635360low20
mrs 15230low10
flavan-3-ol0low10
zinc protoporphyrin ix0low20
3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3h)-quinazolinone0low10
4-phenyl-2-propionamidotetraline0low10
alpha-chymotrypsin0low180
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione0low10
17-ketosteroids0low30
naphthoquinones0low360
sc 5600low40
sodium borohydride0low10
alpha-carotene0medium62
digitoxigenin0low10
ver-490090low10
osteoprotegerin0low30
cathepsin g0low20
3,4-ethylenedioxythiophene0low10
icodextrin0low20
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide0low40
rhodamine 1230low240
myelin basic protein0low50
alsterpaullone0low10
imd 03540low10
2-mercaptoacetate0low10
isoselenocyanic acid0low10
noxythiolin0low10
dimethyl maleate0low10
diethyl maleate0low30
ginkgetin0low10
resveratrol-4'-o-glucuronide0low30
cinnamamide0low10
fraxetin0low20
quercetin 3-o-glucuronide0low10
isoliensinine0low10
catechin gallate0low10
ku 559330low10
sphingosine0low500
quercetin0low1110
bilirubin0low260
dinoprostone0medium2955
dinoprost0low140
biochanin a0low30
formononetin0low20
vitexin0low10
apigenin0low240
luteolin0low290
7,3'-dihydroxy-4'-methoxyisoflavone0low10
linoleic acid0low450
calcitriol0medium1122
pinosylvin0low10
psychosine0low10
quercitrin0low10
ubiquinone 90medium11
vitamin k semiquinone radical0low140
beta carotene0medium6710
leukotriene b40low210
leukotriene c40low20
thromboxane a20low50
retinol palmitate0low20
hymecromone0low60
daphnetin0low10
8,11,14-eicosatrienoic acid0low60
rumenic acid0low30
15-keto-13,14-dihydroprostaglandin e20low10
15-ketoprostaglandin e20low10
alprostadil0low110
5-hydroxy-6,8,11,14-eicosatetraenoic acid0low10
vitamin d 20low40
stigmasterol0low40
cholecalciferol0medium312
rutin0low140
kaempferol0low130
20-carboxyleukotriene b40low10
leukotriene d40low70
prostaglandin a20low10
prostaglandin g20low10
9-deoxy-delta-9-prostaglandin d20low20
9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin d20low10
6-ketoprostaglandin f1 alpha0low50
zeaxanthin0medium71
gamma-linolenic acid0medium81
alpha-linolenic acid0low200
prostaglandin e30low10
prostaglandin f10low20
harmine0low30
naringenin chalcone0low10
genistein0medium561
amphotericin b0low150
pulmicort0low60
pyrvinium0low40
montelukast0medium31
kava0low30
entacapone0low10
paricalcitol0low10
11-octadecenoic acid0low10
2-hexenal, z-isomer0low10
butein0low10
astaxanthine0low90
canthaxanthin0low20
capsanthin0low10
cryptoxanthins0medium81
fucoxanthin0low70
lutein0medium102
polydatin0low10
cucurbitacin b0low40
nsc 1063990low10
cucurbitacin i0low50
spinasterol0low10
geranylgeraniol0low20
genistin0low10
mezerein0low10
harman0low10
daphnoretin0low10
esculetin0low60
esculin0low10
7-hydroxycoumarin0low10
xanthatin0low40
humulene0low40
trichothecin0low10
oleuropein0low10
garcinol0low80
zearalenone0low70
amentoflavone0low10
baicalein0low70
chrysin0low60
diosmin0low20
fisetin0low70
galangin0low30
gossypin0low10
hinokiflavone0low10
hyperoside0low10
mangiferin0low20
mangostin0low100
3-methylquercetin0low40
norlichexanthone0low10
kaempferide0low20
morin0low70
myricetin0low90
robustaflavone0low10
scutellarein0low30
tricin0low30
wogonin0low30
7-hydroxy-6,4'-dimethoxyisoflavone0low10
coumestrol0low10
daidzein0low80
trans-2,3',4,5'-tetrahydroxystilbene0low10
pterostilbene0low120
epsilon-viniferin0low10
chicoric acid0low10
echinacoside0low10
3,4-di-o-caffeoylquinic acid0low20
caffeic acid phenethyl ester0low120
rosmarinic acid0low80
salvianolic acid a0low10
shogaol0low80
prunetin0low20
psoralidin0low10
tectoridin0low10
maytansine0medium91
rottlerin0low90
ellagic acid0low220
ginkgolic acid0low10
sdz psc 8330low40
7-hydroxyflavone0low10
prostaglandin a10low10
coenzyme q100low20
tectochrysin0low30
anandamide0low70
cerulenin0low60
gamma-oryzanol0low10
geranylgeranylacetone0low30
tranilast0low10
4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid0low30
4,4'-dinitro-2,2'-stilbenedisulfonic acid0low10
8-epi-prostaglandin f2alpha0low40
glyceryl 2-arachidonate0low20
n,n-dimethylsphingenine0low50
tocotrienol, delta0low40
etretinate0low10
isotretinoin0low60
misoprostol0low10
olopatadine hydrochloride0low10
ozagrel0low10
fondaparinux0low20
pitavastatin0low30
zinostatin0medium181
ethamolin0low10
hydrocortisone valerate0low10
9,11-linoleic acid0low40
trans-10,cis-12-conjugated linoleic acid0low10
13-hydroxy-9,11-octadecadienoic acid0low50
16,16-dimethylprostaglandin e20low60
thromboxane b20low100
20-hydroxy-5,8,11,14-eicosatetraenoic acid0low10
arachidonic acid 5-hydroperoxide0low10
4-hydroxy-2-nonenal0low180
n-oleoylethanolamine0low10
1-monooleoyl-rac-glycerol0low10
menaquinone 60low10
sphingosine 1-phosphate0low240
n-palmitoylsphingosine0low30
ceramide 1-phosphate0low10
cholesteryl oleate0low10
fucosterol0low10
3-ketolithocholic acid0low10
codeine0medium11
mitolactol0low30
phenylephrine hydrochloride0low40
phenylethyl 3-methylcaffeate0low20
sarcophytol a0low10
beta-nitrostyrene0low10
3-amino-1,4-dimethyl-5h-pyrido(4,3-b)indole0low10
3-amino-1-methyl-5h-pyrido(4,3-b)indole0low20
cyproterone0low20
granisetron0medium11
hydromorphone0low30
ly 1638920low10
naloxone0low40
oxycodone0low10
vitamin k 10low40
acepreval0low10
proscillaridin0low20
sirolimus0low490
topiramate0low10
brefeldin a0low130
alvocidib0low80
seocalcitol0medium41
fenretinide0low100
geldanamycin0low10
ic 2610low10
kh 10600low10
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin0low20
morphine0medium466
peridinin0low20
su 54020low10
su 95160low20
adp beta s0low10
bibp 32260low10
deamino arginine vasopressin0low20
dexmedetomidine0medium51
endomorphin 20low10
sb 2770110low10
herbimycin0low60
pd 1809700low20
kallidin0low30
goserelin0low10
preclamol0low10
l 3652600low50
15-deoxy-delta(12,14)-prostaglandin j20low140
enprostil0low10
lysophosphatidic acid0low260
lysophosphatidylcholines0low70
n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester0low40
cytochalasin b0low120
neurokinin a0low40
neurokinin b0low20
n-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide0low10
11-dehydrocorticosterone0low10
sr 1429480low10
vinorelbine0low10
ro 41-52530low10
kn 930low10
kn 620low10
su 66560low10
10-hydroxy-2-decenoic acid0low20
casticin0low30
bisdemethoxycurcumin0low20
cannabigerol0low10
collinin0low10
glycitein0low20
heptaphylline0low10
hexahydrocurcumin0low10
3',4'-didemethylnobiletin0low20
(E)-3-(2-Hydroxyphenyl)-2-propenal0low20
ginnalin a0low10
andrographolide0low190
desmethylicaritin0low10
isorhamnetin 3-o-glucoside0low20
koumine0low10
icariin0low20
licochalcone a0low50
sappanchalcone0low10
3-deoxysappanchalcone0low10
nerolidol0low10
5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one0low50
artemetin0low10
rhapontigenin0low10
atractylenolide i0low20
fluvoxamine0low10
casein kinase ii0low200
cymal-50low10
pd 0898280low10
pd 1668660low10
pd 1615700low10
ag-4900low50
ag 300low10
bosutinib0low30
semaxinib0medium71
orantinib0low90
su 112480low210
palbociclib0low20
nifuroxazide0low10
mitoguazone0medium51
bisantrene0low10
fosbretabulin0low80
fosbretabulin0low180
ergosterol-5,8-peroxide0low10
ermanin0low10
stellettin b0low10
guttiferone e0low20
lead0medium92
tin0low20
sulindac sulfide0low370
12-hydroxy-5,8,10,14-eicosatetraenoic acid0low50
15-hydroxy-5,8,11,13-eicosatetraenoic acid0low30
bay 11-70820low80
bay 11-70850low10
carboxycinnamic acid bishydroxamide0low10
5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine0low20
diamide0low20
2,4,3',5'-tetramethoxystilbene0low10
15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid0low10
methyl-3-methoxy-4-hydroxystyryl ketone0low10
antimony0low30
cesium0low30
8-hydroxyadenine0low10
barium0medium331
cinnamoylhydroxamic acid0low10
4-(2-hydroxyphenyl)but-3-en-2-one0low10
8-oxo-7,8-dihydrodeoxyguanine0low20
styrylquinoline0low20
Isoliquiritigenin 4,4'-dimethyl ether0low10
rubidium0low100
aluminum0low120
strontium0medium51
bismuth0low130
thallium0low20
alternariol0low20
arsenic0low280
indium0medium271
naltrexone0low40
alternariol monomethyl ether0low10
gallium0low160
batimastat0low40
indinavir sulfate0low10
sulfur0low260
methylazoxymethanol acetate0low460
ethyl oleate0low10
geldanamycin0low140
costunolide0low30
grifolin0low20
diphenylhexatriene0low20
aldosterone0low10
urolithin b0low20
2-formylpyridine thiosemicarbazone0low10
puerarin0low30
eleostearic acid0low50
ajoene0low20
3,3',4,5'-tetramethoxy-trans-stilbene0low10
3,4',5-trimethoxystilbene0low50
dmu-2120low10
1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene0low20
enalapril0low40
americanin a0low10
sinomenine0low20
dimyristoylphosphatidylcholine0low80
ecdysterone0low40
deoxyribose0low20
fumarates0low40
phycocyanobilin0low10
2-deoxyribose 1-phosphate, (alpha-d-erythro)-isomer0low30
beryllium0low10
astatine0low60
bleomycin0low10
turanose0low10
cysteine0medium592
thyronines0low10
silicon0low110
indium0low10
phosphorus0medium192
boron0low110
heroin0low10
2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid0low20
n-hydroxy-n'-aminoguanidine0low10
4',7,8-trihydroxyisoflavone0low20
mofarotene0low10
concanamycin b0low10
bakuchiol0low10
s-trans,trans-farnesylthiosalicylic acid0low20
demethoxycurcumin0low10
panaxynol0low20
zerumbone0low90
poricoic acid a0low10
poricoic acid g0low10
artepillin c0low20
sulindac sulfone0low280
pinostilbene0low20
pepstatin0low20
phytochlorin0low120
cefepime0medium32
artonin e0low10
urolithin d0low10
ici 1185510low10
metaproterenol0low10
benzoporphyrin d0low10
lespenefril0low10
strontium radioisotopes0low30
sinigrin0low20
3,3'-dipropyl-2,2'-thiadicarbocyanine0low20
troxerutin0low20
talaporfin0low10
cgp 526080low30
citrusinine i0low10
3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one0low80
alvimopan anhydrous0medium11
uroguanylin0low90
chlorin p60low20
hydnocarpin0low10
guanylin0low130
n(6)-((dimethylamino)methylene)mitomycin c0low40
aliskiren0low10
vx6800low10
n-acetylsphingosine0low100
crotonyl-coenzyme a0low10
triolein0low10
gedunin0low10
epicinchonine0low20
bafilomycin a0low10
n-caproylsphingosine0low30
2,3-n-octanoylsphingosine0low10
3,3'-dihexyl-2,2'-oxacarbocyanine0low20
carbocyanines0low260
25-hydroxyvitamin d 20low30
salubrinal0low10
cefotaxime0medium53
deglycobleomycin0low10
urobilin0low10
apaziquone0low100
2',5'-dihydroxychalcone0low10
1,2-dielaidoylphosphatidylethanolamine0low20
geiparvarin0low20
benzyl caffeate0low10
su 49840low10
masticadienonic acid0low10
derricidin0low10
indicaxanthin0low10
ammonium sulfate0low80
magnesium citrate0medium63
ajmaline0low10
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid0low90
proguanil0low10
3,5-dihydroxy-4'-methoxystilbene0low10
flavokawain C0low20
ma-10medium3611
monorden0low20
coomassie brilliant blue0low30
tetrodotoxin0low20
deoxyelephantopin0low10
apratoxin a0low10
germanium0low80
selenium0medium942
selenocysteine0low50
methaneselenol0low30
tellurium0low20
selenourea0low10
radium0low70
thorium x0low10
oxalates0low50
ara-cdp-1-s-octadecyl-2-o-palmitoyl-1-thioglycerol0low10
palonosetron0medium11
(3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid0low20
maxacalcitol0low10
psammaplin a0low10
diacetylmonoxime0low10
mevalonolactone0low10
dihydroergotoxine0low10
dizocilpine maleate0low10
antimycin a0low30
pregnanediol0low10
cholestanol0low140
5-aminolevulinic acid hexyl ester0low30
methylazoxymethanol0low150
sulphoraphene0low10
dolichols0low10
hygromycin a0low20
simethicone0medium53
24,25-dihydroxyvitamin d 30low20
cilastatin0low20
ro 15-15700low10
tezacitabine0low30
temarotene0low10
bafilomycin a10low80
falcarindiol0low10
himbacine0low10
carboprostacyclin0low10
terrein0low10
1-oleoyl-2-acetylglycerol0low20
1-(1-glycero)dodeca-1,3,5,7,9-pentaene0low80
involucrin0low10
15-hydroperoxy-5,8,11,13-eicosatetraenoic acid0low10
verrucosidin0low10
manoalide0low10
1,2-dioleoyloxy-3-(trimethylammonium)propane0low70
1-(1-glycero)tetradeca-1,3,5,7,9-pentaene0low40
(2e,4e,6e,10e)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid0low20
piericidin a0low10
1,1'-((4,4,7,7-tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidine)quinolinium, tetraiodide0low10
manumycin0low50
plastochromanol 80low60
n-(1-(2,3-dioleyloxy)propyl)-n,n,n-trimethylammonium chloride0low10
bwa 4c0low20
op 25070low10
5-(2-iodovinyl)-2'-deoxyuridine0low10
1,25(oh)2-16-ene-23-yne-d30low30
thermozymocidin0low10
cryptophycin 10low10
2-cyano-3-(1-phenylindol-3-yl)acrylate0low10
cholesteryl oleyl ether0low10
tussilagone0low10
ditetradecylindocarbocyanine0low10
kyn 540low20
lactosyl lysosphingolipid0low10
pregna-4,17-diene-3,16-dione0low20
krn 55000low40
goniothalamin0low20
bacteriochlorophylls0low10
5-geranyloxy-7-methoxycoumarin0low10
everolimus0low90
alloxanthin0low10
bengamide b0low10
mkt 0770low30
laq8240low40
4-oxo-2-nonenal0low10
ixabepilone0medium41
ekb 5690low10
u 753020low10
a 83586c0low10
cdw17 antigen0low50
trisialoganglioside gt10low10
ganglioside, gd20low30
asialo gm1 ganglioside0low220
sialosylparagloboside0low10
axitinib0medium32
ovatodiolide0low10
salvianolic acid B0low10
i(3)so3-galactosylceramide0low10
l 7448320low20
indigo carmine0low10
hylin0low10
beta-escin0low20
panduratin a0low10
tanespimycin0low200
verlukast0low30
beta-escin0low620
glucoraphanin0low10
4,5-diaminofluorescein diacetate0low10
s-nitroso-n-acetylpenicillamine0low20
cr 29450low10
cgk 7330low10
lactacystin0low40
gw 6100low10
4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone0low10
shellac0low10
peplomycin0low40
butylscopolammonium bromide0medium113
gadolinium dtpa0medium323
morphinans0low20
adenosine-3',5'-cyclic phosphorothioate0low10
sq-233770low280
fostriecin0low10
fk 8660low20
fumagillin0low10
nocloprost0low10
teroxirone0low10
tubulazole0low10
artesunate0low10
edatrexate0low30
beraprost0low10
morpholinoanthracycline mx20low10
etoposide phosphate0low30
dexniguldipine0low20
ciclesonide0low10
perfosfamide0low10
d-phenylalanyl-cysteinyl-tyrosyl-tryptophyl-lysyl-cysteinyl-threoninamide0low20
ski 2053r0low20
soblidotin0low40
eleutherobin0low10
bay 12-95660medium11
beta-elemene0low30
pki 1660low10
ac 77000low10
brostallicin0low20
idn 51090low10
pd 1843520medium51
laulimalide0low10
bms1887970low10
jwh-1330low20
omtriptolide0low10
talabostat0low10
bms-2751830medium11
belinostat0low40
pep0050low40
corosolic acid0low20
panobinostat0low50
rebaudioside a0low10
tryptophanol0low10
bromopyruvate0low80
arginyl-glutamine0low10
eupatorin-5-methyl ether0low10
staurosporine0medium491
galbanic acid0low10
bufalin0low60
1,25-dihydroxyergocalciferol0low10
shu 5080low30
hypericum0low60
phosphocreatine0low60
glucoiberin0low10
drimane0low10
bacteriochlorin0low40
cholanic acid0low20
taxane0low60
chlorhexidine0medium31
10-hydroxystearic acid0low20
mannich bases0low10
formazans0low80
10(9)-hydroxystearic acid0low70
cefmenoxime0medium11
gemifloxacin0low10
3-aminopyridine-2-carboxaldehyde thiosemicarbazone0low40
fenpyroximate0low10
triacsin c0low20
cgp 486640medium11
st 14810low20
poloxin0low10
s-allylcysteine0low30
s-allylmercaptocysteine0low40
ave-80630low10
am 555s0low50
n-(2-amino-5-fluorobenzyl)-4-(n-(pyridine-3-acrylyl)aminomethyl)benzamide0low30
8-bromoadenosine-3',5'-cyclic monophosphorothioate0low10
gw 5015160low10
polyporenic acid c0low10
braco-190low10
edotecarin0low40
5,10,15,20-tetrakis(m-hydroxyphenyl)bacteriochlorin0low20
dolastatin 100low40
ggti 2980low10
cemadotin0low10
variolin b0low10
calothrixin b0low10
ncx 40400low30
spc-8390low10
au 0060medium11
lenvatinib0low20
ono 87110low30
platyphylloside0low10
pd 03259010medium51
midostaurin0low20
jasplakinolide0low10
ro 28-26530low20
efatutazone0low10
sincalide0low70
tapentadol0low10
technetium tc 99m diphosphonate0low20
etomoxir0low20
1-(2-deoxy-beta-ribofuranosyl)-5-iodo-2-pyrimidinone0low20
cg1006490low10
pr-104a0low10
ursodoxicoltaurine0low40
px-8660low10
jorumycin0low10
dsb 1200low10
ki230570low10
ginsenoside m10low70
gambogic acid0low20
pentagastrin0low190
cangrelor0low10
elisidepsin0low10
kla peptide0low10
valencene0low10
knk 4370low10
nu 70260low10
fr 1480830low10
ibuprofen arginine0low10
pbox-60low10
mocetinostat0medium262
sc 2360low60
alloin0low10
carbobenzoxy-leucyl-leucyl-norvalinal0low10
nik 121920low10
ticagrelor0low20
tmc-95a0low10
rivaroxaban0low10
bacopaside ii0low10
bleomycin a60low30
lipid a0medium121
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid0low10
treosulfan0low10
ecomustine0low10
naproxen-n-butyl nitrate0low20
pi1030low10
3,5-bis(2-fluorobenzylidene)piperidin-4-one0low10
dapagliflozin0low30
sr 59230a0low10
arc1110low10
ngb 29040low10
lamellarin d0low20
gw 40640low10
ipi 4930low10
zd 61260low20
idn 53900low10
mart-1 antigen0medium81
ginsenoside rb10low10
g(m2) ganglioside0low70
zd 83210low10
tivozanib0low10
hki 2720low10
nb 5060low10
secoisolariciresinol diglucoside0low40
ginsenoside rg30low60
dolastatin 150low40
sorbitan monooleate0low30
bibr 15320low10
hypothemycin0low20
tocotrienols0medium51
cediranib0medium21
gw07420low20
ono 87130low10
cryptophycin 520low10
samarium0low10
cc 10650low10
neuromedin n0low40
pasireotide0low10
zeolites0medium52
azonafide0low10
cp 313980low40
recoflavone0low10
tetramethylrhodamine0low10
dimethoxycurcumin0low30
aq4n0low10
chir 990210low10
benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal0low20
l-1619820low10
ubiquinol0low20
g(m1) ganglioside0low350
3',5'-o-dipalmitoyl-5-fluoro-2'-deoxyuridine0low10
aluminum oxide0low10
sch 513440low10
cladosporol0low10
lupalbigenin0low10
nutlin 10low10
mithramycin sk0low30
1-hydroxyvitamin d50low10
cgc 110930low10
osu 030120low10
actein0low10
fidaxomicin0low10
3'-hydroxypterostilbene0low20
6-hydroxytaxol0low10
kigamicin d0low10
masitinib0low10
vorapaxar0low10
halichondrin b0low10
phosphoramidite0low10
ly-21572990low20
fiscalin b0low10
2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone0low10
givinostat hydrochloride0low10
oblongifolin c0low10
cystathionine0low10
as 6012450low10
pazopanib0low10
sepantronium0low20
azd 62440low100
prasugrel hydrochloride0low30
dimethylarginine0low10
apixaban0low20
bibw 29920low10
bay 61-36060low10
gw 7993880low10
artenimol0low70
licoflavone c0low10
bryonolic acid0low10
5-fluorouridine 5'-triphosphate0low30
dicerandrol a0low10
edoxaban0low10
trans-sodium crocetinate0low10
binimetinib0medium31
aee 7880low60
saracatinib0low10
alpha-synuclein0low20
sd-2080low10
demethylzeylasteral0low10
haouamine a0low10
7-aminoactinomycin d0low10
2-acetylfuranonaphthoquinone0medium22
bavachinin0low10
ngr peptide0low30
aristolactam aiiia0low10
(1,2-bis(1,2-benzisoselenazolone-3(2h)-ketone))ethane0low10
2-furoyl-ligrlo-amide0low20
denbinobin0low10
bms 5996260low10
plakortide f0low10
volasertib0low10
2'-benzoyloxycinnamaldehyde0low10
5s,12r,18r-trihydroxy-6z,8e,10e,14z,16e-eicosapentaenoic acid0low10
renieramycin m0low10
3-dihydroxy-6-methyl-7-(phenylmethyl)-4-propylnaphthalene-1-carboxylic acid0low10
oxadiazoles0low90
tmc-95b0low10
curacin d0low10
pramanicin0low10
vinflunine0low30
homocamptothecin0low40
spliceostatin a0low20
apicularen a0low20
5,15-diphenylporphine0low10
ucn 1028 c0low70
cypate0low10
ribose0medium71
trichodermamide a0low10
acebutolol0medium82
migrastatin0low10
lactulose0medium134
azd 77620low10
copalic acid0low10
regorafenib0medium578
acetyl-11-ketoboswellic acid0low20
hypoestoxide0low10
erastin0low40
epoxomicin0low10
abt-7370low90
brivanib0medium11
px 4780low10
brimonidine tartrate0low30
icg 0010low10
euphorbia factor l10low20
pyrrophenone0low10
cardanol0low10
fucoxanthinol0low10
nystatin a10medium71
pirarubicin0medium101
nu 74410low10
at 75190low10
marizomib0low20
cyt9970low10
bi 25360low40
linoleic acid hydroperoxide0low30
potassium cyanate0low10
3-o-acetyl-beta-boswellic acid0low10
karwinskia toxin t-5140low10
Dihydrotanshinone I0low30
technetium tc 99m disofenin0low20
nutlin-3a0low120
danusertib0low10
alogliptin0low10
episilvestrol0low10
nvp-aew5410low20
abt 8690low10
arq 1970low10
lbw2420low10
amooranin0low20
nsc 7257760low10
dorsomorphin0low20
quisinostat0low10
oleandrin0low30
monomethyl auristatin e0low30
hu 3080low10
carfilzomib0low10
sitagliptin phosphate0low20
gw95080low10
veratridine0low20
incb36190low10
idelalisib0low10
crizotinib0low80
as 2524240low10
ly23347370low10
zstk4740low10
ly21097610low20
fostamatinib0low10
gw11000low10
3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin0low40
trametinib0low100
jbt-30020low10
mln80540low30
2-(2,6-diisopropylphenyl)-5-hydroxy-1h-isoindole-1,3-dione0low10
physalin b0low10
gpi 154270low10
deoxyarbutin0low10
abexinostat0low10
losartan potassium0medium194
amrubicinol0low10
silvestrol0low10
alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc0low440
td-51080low10
empagliflozin0low10
palmitoylcarnitine0low20
technetium tc 99m exametazime0low40
at 133870low10
ly26036180low10
calcimycin0low280
dextrothyroxine0low30
veliparib0low20
delta-1-pyrroline-5-carboxylate0low10
sepharose0low210
halocynthiaxanthin0low20
indocyanine green0medium785
scopolamine hydrobromide0low10
cinobufagin0low10
dactolisib0low100
bgt2260medium11
pituitrin0low80
ra v0low10
podophyllin0low40
th 3020low20
bsc21180low10
n-monoacetylcystine0low10
tubulysin d0low10
chidamide0low10
arabinofuranosyluracil0low50
demethylcantharidin0low20
6-o-angeloylprenolin0low20
phytosterols0low110
cannogenin thevetoside0low10
rifamycins0low20
ethidium homodimer0low10
neoxanthin0low10
soyasapogenol a0low10
verrucarin j0low10
clove0low70
acid phosphatase0low310
esorubicin0medium122
mefloquine0medium21
asterina0low20
bleomycetin0low10
tetrahydrouridine0medium21
rosmanol0low10
bengazole a0low10
riccardin d0low10
7-n-(4-hydroxyphenyl)mitomycin c0low50
curcumol0low10
butaprost0low10
periplocin0low20
discodermolide0low10
icatibant0low20
6-methoxydihydrosanguinarine0low10
o-methylmurrayamine a0low10
tangutorine0low10
aflatoxin m10medium11
farnesiferol c0low10
shamixanthone0low10
cyanidin-3-o-beta-glucopyranoside0low40
homopropargylglycine0low10
nad0low230
dianhydrogalactitol0low10
rrx-0010low10
3-o-methylfluorescein phosphate0low10
jorunnamycin a0low10
unbs 51620low10
cytochrome c-t0low1340
3,6-anhydrogalactose0low10
myxochelin a0low10
chaetominine0low10
cosyntropin0medium11
melitten0low40
cholecystokinin0low70
motilin0medium32
atrial natriuretic factor0low20
tannins0low10
dermaseptin s0low10
thymalfasin0low30
(dtpa-phe(1))-octreotide0low10
renin inhibitory peptide0low10
bombesin, tyr(4)-0low20
hes1 protein, human0low130
glycoprotein e2, hepatitis c virus0medium11
alamethicin0low10
gastrins0medium1441
glucagon0medium241
big gastrin0low160
beta-endorphin0medium51
viscotoxin0low10
thymosin beta(4)0low90
neuropeptide y0low70
peptide phi0low40
iberiotoxin0low10
lactoferricin b0low10
angiotensinogen0low10
forapin0low10
bim 230560low10
irl 16200low10
tannins0low170
oligonucleotides0medium581
anticodon0low10
liraglutide0low10
glucagon-like peptide 10low20
alx-06000low10
tigapotide0low10
c-peptide0low70
gastrin 170low160
eriocalyxin b0low10
cellulose0medium1113
endothelin-10low150
phosphatidylcholines0low330
hs 17930low10
guttiferone k0low10
3-methylbutanoic acid [(2R,3S,6S,7R)-3-[[(3-formamido-2-hydroxyphenyl)-oxomethyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] ester0low20
(9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one0low10
n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine0low20
gdc-09730low40
mk-87760low10
buparlisib0low20
azd 14800low10
chlorophyll a0medium221
ceragenin csa-130low20
phenylmercuric acetate0low10
4-aminophenylmercuriacetate0low10
thimerosal0low10
pevonedistat0low10
dihydroceramide0low30
sipholenol a0low10
adenosine kinase0low20
boc-d-fmk0low10
hoe 333420low110
jsh 230low10
sodium salicylate0low60
sphingosine kinase0low220
ubiquinone0medium71
pinoresinol0low20
ono ae 2480low10
igk0low10
alpha-amanitin0low20
n-(2-methylbenzyl)linoleamide0low10
dinophysistoxin 10low10
calpain0low190
lucifer yellow0low40
kx1-0040low10
sapogenins0low50
n,n'-bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine n,n'-diacetic acid0low10
bitucarpin a0low10
drupacine0low20
4'-hydroxy-5,6,7,8,3'-pentamethoxyflavone0low20
ganoderic acid t0low10
23-hydroxybetulinic acid0low10
biotinyltyramide0low20
chitosan0low890
ph 7978040low10
technetium tc 99m sestamibi0low80
15-amino-4,7,10,13-tetraoxapentadecanoic acid0low10
2,6-bis(4-aminophenyl)-4-(4-(dimethylamino)phenyl)thiopyrylium0low10
lumin0low10
15-deoxyprostaglandin j20low70
s-nitro-n-acetylpenicillamine0low10
1-phospho-5-s-methylthioribulose0low10
kx-010low10
mesna0medium52
sodium oxybate0low30
bucladesine0low190
wr 779130low10
sodium bisulfite0low70
sodium lactate0low10
sodium nitrite0low30
raltegravir potassium0low10
holothurin a0low10
xk 4690low20
sodium glutamate0low40
merocyanine dye0low40
ro13-99040medium62
sodium pertechnetate tc 99m0medium122
sodium ethylxanthate0medium131
mersalyl0low10
piperacillin, tazobactam drug combination0low10
chiniofon0low40
phenolphthalein glucuronide0low10
arginine0medium132
echinomycin0low10
olaparib0low50
thiostrepton0low20
hygromycin b0low20
plx 47200low10
n-acetyldaunomycin0low10
methyl jasmonate0low10
rubusoside0low10
lcl1610low10
amorfrutin b0low10
cx 49450low10
largazole0low30
s-adenosylmethionine0low220
mln 82370low20
tenovin-60low10
snx 21120low10
4,7-dimethoxy-5-methyl-1,3-benzodioxole0low10
gdc 04490low20
bms 7548070low10
gdc-00680low10
picrotoxin0low10
cink40low10
ponatinib0low20
ethyl cellulose0low10
asta z 75570low10
insulin, isophane0low10
arabinogalactan0low20
intrinsic factor0low40
crx-5260low10
mk-17750low30
oxymatrine0low30
1229u910low10
antroquinonol d0low10
fluorocoxib a0low10
dolichol monophosphate0low10
clomiphene citrate0low10
tak 7330medium11
mk 22060low20
navitoclax0medium71
pervanadate0low40
sns 3140low10
jzl 1840low10
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene0low10
doxo-emch0low10
ter 1990low10
cardiovascular agents0low20
trelstar0low10
neurotensin0low420
fibrinopeptide a0low20
ovurelin0low10
neurotensin, iodo-tyr(3)-0low10
hainanolide0low10
cabozantinib0medium31
incb-0184240low20
mannans0medium271
pexidartinib0low20
pf 38450low10
oxt-3280low30
gsk 1838705a0low10
ixazomib0low20
ver 1550080low10
pf 37583090low10
cx 54610low10
(5-(2,4-bis((3s)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol0low10
mahanine0low10
4'-geranyloxyferulic acid0low20
lysophosphatidylserine0low10
plx40320medium211
2,3-bis(2-hydroxyethylsulfanyl)-(1,4)naphthoquinone0low10
brartemicin0low10
garcinone c0low10
glycolipids0low1180
v1584110low20
elafin0low30
sar 0201060low10
4-[6-[4-(methoxycarbonylamino)phenyl]-4-(4-morpholinyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinecarboxylic acid methyl ester0low10
piperidines0medium721
resolvin d10low20
cyanidin 3-galactoside0low10
bryostatin 10medium41
(4-(n-hydroxyamino)-2r-isobutyl-3s-methylsuccinyl)-l-phenylglycine-n-methylamide0low10
thymosin0low180
5-hydroxymethyl-2'-deoxyuridine0low10
galactocerebroside0low10
interleukin-80medium1534
vpc321830low10
sansalvamide a0low40
dabrafenib0low40
hmpl-0130medium72
cblc1370low10
geoditin a0low10
hamamelitannin0low10
punicalagin0low10
psammaplysin a0low10
humantenine0low10
ribociclib0low10
aceroside viii0low10
clavosolide a0low10
4-fluoroglutamine0low10
lb-1000low10
apatinib0medium111
gx 15-0700low30
colistin0low10
aigialomycin d0low10
exenatide0low40
ophiopogonin b0low10
14-o-phosphonooxymethyltriptolide0low30
abemaciclib0low20
unc 06380low10
wzb1170low10
xmd 8-920low10
lrrk2-in10low10
gsk9232950low10
unc 03210low10
mpi-04796050low10
uridine diphosphate n-acetylgalactosamine0low20
lgk9740low10
destruxin e0low10
chymostatin0low10
fructose-1,6-diphosphate0low20
gsk525762a0low10
bix 012940low10
calcipotriene0low50
birinapant0low30
vaticanol c0low20
encorafenib0medium147
gsk21417950low10
methylcellulose0low60
butyrolactone i0low20
isoquercitrin0low40
oligomycin a0low20
vasoactive intestinal peptide0low960
unc 06310low10
natriuretic peptide, brain0low10
heme0medium282
bp-1-1020low10
chondroitin0low20
heparitin sulfate0low290
tuftsin0low10
neuromedin b0low20
2,4-bis(p-hydroxyphenyl)-2-butenal0low10
o-(2-fluoroethyl)tyrosine0low20
ascorbic acid0medium1029
novobiocin0low30
tetracycline0medium211
chlortetracycline0low10
oxytetracycline, anhydrous0medium32
minocycline0low30
salicylates0low190
dicumarol0low110
piroxicam0medium382
acenocoumarol0low10
mobic0low40
warfarin0medium852
metastat0low20
gimeracil0medium21
6-o-palmitoylascorbic acid0low10
demeclocycline0low10
phenprocoumon0low10
zilascorb0low10
teriflunomide0low10
3-deazauridine0low20
hispidin0low10
lfm a130low10
a 7696620low10
s 1 (combination)0medium769
ew-71970low10
cheliensisin a0low20
nk 1210low10
carboxyphthalato-1,2-diaminocyclohexaneplatinum0low30
n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid0low40
betalains0low20
epidermal growth factor0medium2161
zhengguangmycin0low10
gastrin-releasing peptide0low180
kaolinite0low10
clay0low10
charybdotoxin0low40
rhodostomin0low30
lead radioisotopes0low80
transforming growth factor beta0low3450
phytoestrogens0medium191
epz0047770low10
okadaic acid0low80
jy-1-1060low10
phosphatidylethanol0low10
pg 5450low10
brine0low10
brass0low10
sybr green i0low10
amg 2320low10
urolithin c0low20
cefuroxime axetil0low10
globotriaosylceramide0low50
g007-lk0low20
gsk-28161260low20
3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester0low20
lys010low10
diaporthein b0low10
(Z)-6,6',7,3'a-Diligustilide0low10
thiocoraline0low10
gsk3430low10
men 49010low20
thymic factor, circulating0low10
kiss1 protein, human0low20
timosaponin aiii0low20
fti 2770low30
pravastatin0low10
curcumin glucuronide0low10
trp-lys-tyr-met-val-met0low10
platonin0low10
rome0low30
sklb10020low10
agar0low280
cb-8390low10
arsenic trisulfide0low30
technetium tc 99m lidofenin0low30
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide0low20
ziyuglycoside ii0low10
cobra cardiotoxin proteins0low10
ro 24-55310low20
hirudin0low70
ephrin-a50low10
glutaminase0low70
cyclin d10medium2571
1,25(oh)2-16-ene-23-yne-26,27-hexafluoro-19-nor-d30low10
fluconazole0low10
ganoderic acid0low10
alcohol oxidase0low10
qs 210low30
lysophosphatidylinositol0low10
lysophosphatidylethanolamine0low10
waixenicin a0low10
caseins0low300
ter 2860low10
nattokinase0low10
thearubigin0low20
ly 3557030low10
technetium tc 99m sulfur colloid0low170
CCT2515450low10
oligomycins0low40
calcium fructoborate0low10
ellagitannin0low40
praliciguat0medium11
tetracarboxyphenylporphine0low10
asbestos, crocidolite0low20
phthalocyanine0low110
tetraphenylporphine0low10
azd94960low10
carubicin0low10
g(m3) ganglioside0low110
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone0low170
s-nitroglutathione0low10
nitrophenols0low160
lewis x antigen0medium421
1 alpha,24-dihydroxyvitamin d30low40
carboxypeptidase b0low20
neuropeptide y, leu(31)-pro(34)-0low10
glucagon-like peptide 20low80
calpastatin0low10
kaliotoxin0low10
tws 1190low10
angiotensin i0low20
ferric oxide, saccharated0low10
contrast agent p7920low10
coprostanone0low20
gadoxetic acid disodium0low20
dinophysistoxin 20low10
cobamamide0low10
hyaluronoglucosaminidase0low90
adrenomedullin0low30
flexibilide0low10
epoetin alfa0low10
aristoforin0low20
lipofectamine0low30
diospyros0low20
ergost-7,22-diene-3-ol0low10
bombesin(6-14), hca(6)-leu(13)-psi(ch2n)-tac(14)-0low10
ganoderic acid d0low10
oridonin0low40
morroniside0low10
gibberellins0low10
isomurisolenin0low10
voacamine0low10
t-2 toxin0low20
copper bis(3,5-diisopropylsalicylate)0low10
daptomycin0low10
aldrin0low10
nifedipine0low20
sanggenone c0low10
vitamin b 120low240
yuanhuacin0low10
ferric ammonium citrate0low20
humulin s0low10
insulin glargine0low10
argentatin a0low10
ggti-21330low10
sermorelin0low30
11-acetyl-8-carbamoyloxymethyl,4-formyl-6-methoxy-14-oxa-1,11-diazatetracyclo(7.4.1.0.0)tetradeca-2,4,6-trien-9-yl acetate0low20
oxyntomodulin0medium51
transforming growth factor alpha0medium971
as 14110low60
monomethylauristatin f0low10
dodecaborate0low10
cyclosporine0medium331
silybin0low250
cytochalasin d0low130
apicidin0low10
peptide yy0low120
lactoferrin0medium361
digitonin0low30
protopanaxadiol0low20
catalpol0medium31
masticadienolic acid0low10
gracillin0low10
icg 0010low20
tomatine0low10
sparsomycin0low10
phenanthroindolizidine0low10
2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone0low20
asbestos, amosite0low20
orabase0low60
technetium tc 99m medronate0low240
apyrase0low90
thromboplastin0low220
muramidase0low240
cord factors0low10
ansamitocins0low10
chromomycins0low30
rhamnogalacturonan i0low30
nedaplatin0medium32
lewis y antigen0low70
lutetium lu 177 dotatate0low10
9-(2'-hydroxyethylamino)-4-methyl-1-nitroacridine0low10
chondroitin sulfates0low190
imuvert0low10
exudates0low70
angiogenin0low140
ganglio-n-triaosylceramide0low10
plicamycin0low60
bixin0low10
mrk 0030low10
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one0low10
fucosyl gm1 ganglioside0low10
tetra(4-n-methylpyridyl)porphine0low20
acyclovir0low50
stf 0830100low10
osi 0270low20
nu 10250low10
levoleucovorin0medium1,054275
cyclic gmp0low660
sepiapterin0low10
deoxyguanosine0medium392
deoxyinosine0low20
2'-deoxyguanosine 5'-phosphate0low10
deoxyguanosine triphosphate0low10
7,8-dihydroneopterin0low10
dihydrofolate0low30
guanosine diphosphate0low20
guanosine monophosphate0low40
guanosine triphosphate0low190
guanine0medium782
guanosine0low80
hypoxanthine0low110
inosinic acid0low30
inosine0medium81
sapropterin0low20
folic acid0medium2035
3-methyladenine0low120
cyclic imp0low10
queuine0low10
guanosine 5'-o-(3-thiotriphosphate)0low10
7-methylguanine0low20
pheophytin a0low10
neopterin0medium71
rifampin0low120
dacarbazine0medium387
didanosine0medium11
ganciclovir0low460
valacyclovir0low10
olanzapine0low10
penciclovir0low10
pteroic acid0low10
oxypurinol0low20
raltitrexed0medium424
nolatrexed0low60
5,10-methylenetetrahydrofolic acid0medium151
ici 1985830low10
ro 33060low10
allopurinol0medium342
2,2'-(hydroxynitrosohydrazono)bis-ethanamine0low20
azaguanine0low10
guanylyl imidodiphosphate0low20
hematein0low10
1843u890low60
5,10-methenyltetrahydrofolate0low10
8-hydroxyguanosine0low10
5,11-methenyltetrahydrohomofolate0low10
alanosine0medium21
3,4,5-trihydroxybenzamidoxime0low10
pemetrexed0medium202
loxoribine0low10
cytarabine0low20
bropirimine0low40
tirapazamine0low110
nc 1900low10
lometrexol0low30
sildenafil citrate0low60
aprepitant0low20
fosaprepitant0low10
pyrazofurin0medium11
vardenafil dihydrochloride0low10
5,6,7,8-tetrahydrofolic acid0medium41
quazinone0low10
xav9390low40
8-bromocyclic gmp0low40
ag-8790low20
8-hydroxyguanine0low60
trypan blue0low120
nintedanib0medium31
n-(4-((3-(2,4-diamino-1,6-dihydro-6-oxo-5-pyrimidinyl)propyl)amino)benzoyl)glutamic acid0low20
zd 93310medium31
methylnitronitrosoguanidine0low910
bis(3',5')-cyclic diguanylic acid0low10
8-hydroxy-2'-deoxyguanosine0low350
coelenterazine0low10
8-((4-chlorophenyl)thio)cyclic-3',5'-gmp0low10
7-methylguanosine0low10
inosine pranobex0low10
5,8-dideazaisofolic acid0low60
10-formyltetrahydrofolate0low20
debromohymenialdisine0low10
prodigiosin0low20
fast red s0low10
ag 20340low20
3,n(4)-ethanocytosine0low20
formycins0low10
8-nitroguanine0low20
galloflavin0low10
5-methyltetrahydrofolate0medium123
fr 1676530low10
9-(4-fluoro-3-hydroxymethylbutyl)guanine0low20
papa nonoate0low10
cytidylyl-3'-5'-guanosine0low90
capromab pendetide0low10
enng0low60
ganciclovir triphosphate0low10
alpha-(4-pyridyl-1-oxide)-n-tert-butylnitrone0low10
cyclic guanosine monophosphate-adenosine monophosphate0low20
darbufelone0low10
sta 90900low10
bmn 6730low10
4-deoxybostrycin0low10
pp2420low30
7-methyl-2-deoxyguanosine0low10
dibutyryl cyclic gmp0low30
2'-carbodeoxyguanosine0low10
n-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine0low10
dy-6760low30
cyanine dye 30low30
temoporfin0low10
alcian blue0low70
sotorasib0low10
lipoteichoic acid0low30
cholestyramine resin0medium121
eye0low50
fructooligosaccharide0low20
zinc(ii) phthalocyanine trisulfonic acid0low10
colibactin0low130
chromomycin a30low20
flutax 20low10
maltodextrin0low20
n-glycolylneuraminyllactosylceramide0low10
ferric carboxymaltose0low20
versipelostatin0low10
acetylcellulose0low10
soyasaponin iii0low10
frondoside a0low10
ganodermanontriol0low10
vinzolidine0low20
pseudolaric acid b0low10
concanavalin a0low470
trypsinogen0low60
metallothionein0medium241
vescalagin0low10
ra xii0low10
dinitrobenzenes0low10
chloroaluminum tetrasulfophthalocyanine0low40
aluminum tetrasulfophthalocyanine0low30
2',7'-bis-(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester0low10
aluminum phthalocyanine disulfonate0low20
2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein0low20
phosphorus radioisotopes0low140
thrombin aptamer0low10
leptin0low500
pyrimidinones0medium281
sinoporphyrin sodium0low10
filipin0low20
phenanthrenes0low370

Protein Targets (5,573)

ProteinPotency MeasurementsInhibition MeasurementsActivation MeasurementsDrugs
Maltase-glucoamylase, intestinal0909
Prostaglandin G/H synthase 1066572
Lysosomal alpha-glucosidase010010
Glucose-6-phosphate 1-dehydrogenase0606
Sucrase-isomaltase, intestinal0707
Mu-type opioid receptor07919113
Delta-type opioid receptor0591285
Kappa-type opioid receptor0671193
6-phosphogluconate dehydrogenase, decarboxylating010010
Beta-secretase 1039141
Probable maltase-glucoamylase 20606
Sialidase-2017017
Genome polyprotein 012518
Heat shock protein HSP 90-beta0191641
Hepatocyte growth factor receptor02491116
Proteasome subunit beta type-5031033
Alpha-synuclein77291107
Dual specificity tyrosine-phosphorylation-regulated kinase 1A01692108
Sigma non-opioid intracellular receptor 1027431
Enoyl-acyl-carrier protein reductase 022022
3-oxoacyl-acyl-carrier protein reductase 013013
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein)013013
Thioredoxin reductase 1, cytoplasmic010010
Thioredoxin reductase 1, cytoplasmic09010
Thioredoxin reductase 30606
Thioredoxin reductase 2, mitochondrial0606
Nuclear factor erythroid 2-related factor 2031120
Cytochrome P450 2C9 01428155
Chain A, Beta-lactamase20000200
thioredoxin reductase34100341
TDP1 protein74700747
Smad320200202
thyroid stimulating hormone receptor29200292
nonstructural protein 112500125
67.9K protein23000230
IDH119900199
ras-related protein Rab-9A13000130
geminin60400604
survival motor neuron protein isoform d26800268
lamin isoform A-delta1045500455
neuropeptide S receptor isoform A990099
TAR DNA-binding protein 4315320155
Interstitial collagenase025128
72 kDa type IV collagenase037039
Stromelysin-1020323
PPM1D protein24400244
Bone morphogenetic protein receptor type-1B029294
Membrane-associated progesterone receptor component 1006161
Serine/threonine-protein kinase PLK401296108
ATP-dependent RNA helicase DDX3X008484
Pyridoxal kinase008486
Citron Rho-interacting kinase029496
Serine/threonine-protein kinase Chk101796113
Aurora kinase A02896124
Cyclin-G-associated kinase0596101
Ephrin type-B receptor 6008888
Peroxisomal acyl-coenzyme A oxidase 3008484
Receptor-interacting serine/threonine-protein kinase 201194105
Mitotic checkpoint serine/threonine-protein kinase BUB1007676
Dynamin-like 120 kDa protein, mitochondrial008484
Eukaryotic translation initiation factor 5B005959
Rho-associated protein kinase 2069399
Serine/threonine-protein kinase ULK1019091
Serine/threonine-protein kinase/endoribonuclease IRE1069298
Ribosomal protein S6 kinase alpha-50595100
U5 small nuclear ribonucleoprotein 200 kDa helicase008484
Ribosomal protein S6 kinase alpha-4019495
Serine/threonine-protein kinase 16019596
Serine/threonine-protein kinase 10039497
Serine/threonine-protein kinase D301496111
Structural maintenance of chromosomes protein 2008484
Mitogen-activated protein kinase kinase kinase 6019091
Mitogen-activated protein kinase kinase kinase kinase 4039497
Serine/threonine-protein kinase LATS1019495
Serine/threonine-protein kinase PAK 40894102
Tyrosine-protein kinase ABL1055100161
Epidermal growth factor receptor010897205
Interferon beta51200512
High affinity nerve growth factor receptor0108999
Guanine nucleotide-binding protein G(i) subunit alpha-2006666
ADP/ATP translocase 2008484
Protein kinase C beta type02587113
Insulin receptor02594120
Tyrosine-protein kinase Lck04196138
Tyrosine-protein kinase Fyn04395138
Cyclin-dependent kinase 105684145
Glycogen phosphorylase, liver form018485
Tyrosine-protein kinase Fes/Fps029496
Adenine phosphoribosyltransferase006464
Tyrosine-protein kinase Yes01394107
Tyrosine-protein kinase Lyn01494108
Proto-oncogene tyrosine-protein kinase receptor Ret02594119
Insulin-like growth factor 1 receptor02596121
Signal recognition particle receptor subunit alpha007272
Cytochrome c1, heme protein, mitochondrial008181
Tyrosine-protein kinase HCK01294106
Platelet-derived growth factor receptor beta04394138
Serine/threonine-protein kinase A-Raf038386
Glycogen phosphorylase, brain form018485
Breakpoint cluster region protein02088114
Serine/threonine-protein kinase pim-102198122
Fibroblast growth factor receptor 103795137
DNA topoisomerase 2-alpha01973112
Cyclin-dependent kinase 403792132
ADP/ATP translocase 3008484
Inosine-5'-monophosphate dehydrogenase 2067683
Proto-oncogene tyrosine-protein kinase Src06094155
cAMP-dependent protein kinase type II-alpha regulatory subunit008080
Serine/threonine-protein kinase B-raf02097119
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform019596
Ribosyldihydronicotinamide dehydrogenase [quinone]01986105
Tyrosine-protein kinase Fer029496
Protein kinase C alpha type03590128
cAMP-dependent protein kinase catalytic subunit alpha02094114
General transcription and DNA repair factor IIH helicase subunit XPD008484
Casein kinase II subunit alpha'03096126
Ras-related protein Rab-6A007878
Ephrin type-A receptor 1028587
Multifunctional protein ADE2008484
cAMP-dependent protein kinase catalytic subunit gamma0156883
cAMP-dependent protein kinase catalytic subunit beta01594109
Ferrochelatase, mitochondrial008686
Ribosomal protein S6 kinase beta-1068692
Tyrosine-protein kinase JAK10896104
Cyclin-dependent kinase 2063100166
Beta-adrenergic receptor kinase 1038689
Probable ATP-dependent RNA helicase DDX6008282
Mitogen-activated protein kinase 3 01294107
MAP/microtubule affinity-regulating kinase 3019495
Deoxycytidine kinase028494
Phosphatidylinositol 3-kinase regulatory subunit alpha013216
Mitogen-activated protein kinase 102894122
Ephrin type-A receptor 201094104
Ephrin type-B receptor 20997106
Non-receptor tyrosine-protein kinase TYK20696102
UMP-CMP kinase 005254
Phosphatidylethanolamine-binding protein 1006868
Wee1-like protein kinase019495
Heme oxygenase 2008080
S-adenosylmethionine synthase isoform type-2017576
DnaJ homolog subfamily A member 1008484
RAC-alpha serine/threonine-protein kinase02796123
RAC-beta serine/threonine-protein kinase0995104
Dual specificity protein kinase TTK047882
DNA replication licensing factor MCM4008282
Myosin-10016566
Dual specificity mitogen-activated protein kinase kinase 201394107
Receptor-type tyrosine-protein kinase FLT304694141
Bone morphogenetic protein receptor type-1A039497
Activin receptor type-1B059499
TGF-beta receptor type-101295107
TGF-beta receptor type-2049195
Electron transfer flavoprotein subunit beta007272
Tyrosine-protein kinase CSK01094104
Glycine--tRNA ligase008484
Protein kinase C iota type01594110
Exosome RNA helicase MTR4008484
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform0294778
Serine/threonine-protein kinase mTOR0264269
Tyrosine-protein kinase Tec039497
Tyrosine-protein kinase ABL2049498
Tyrosine-protein kinase FRK049498
G protein-coupled receptor kinase 6055055
Tyrosine-protein kinase SYK015102117
26S proteasome regulatory subunit 6B028486
Mitogen-activated protein kinase 80896104
Mitogen-activated protein kinase 90895103
Dual specificity mitogen-activated protein kinase kinase 4036467
Dual specificity mitogen-activated protein kinase kinase 3029496
Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha106970
Casein kinase I isoform alpha0893102
Casein kinase I isoform delta0994104
MAP kinase-activated protein kinase 20793100
Elongation factor Tu, mitochondrial008484
Cysteine--tRNA ligase, cytoplasmic006969
Casein kinase I isoform epsilon0995104
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial008484
Dual specificity protein kinase CLK1059196
Dual specificity protein kinase CLK2048690
Glycogen synthase kinase-3 alpha02794121
Glycogen synthase kinase-3 beta05297149
Cyclin-dependent kinase 701994114
Cyclin-dependent kinase 902294117
Ras-related protein Rab-27A007979
Interleukin-1 receptor-associated kinase 1019293
Ribosomal protein S6 kinase alpha-3059499
Serine/threonine-protein kinase Nek20694100
Serine/threonine-protein kinase Nek3019293
Dual specificity mitogen-activated protein kinase kinase 6029496
LIM domain kinase 1029496
LIM domain kinase 2029496
Mitogen-activated protein kinase 1002793120
Tyrosine--tRNA ligase, cytoplasmic008282
5'-AMP-activated protein kinase subunit gamma-1038993
Ephrin type-B receptor 3029496
Ephrin type-A receptor 5019495
Ephrin type-B receptor 401094104
Ephrin type-A receptor 4029496
Adenylate kinase 2, mitochondrial008385
Adenosine kinase078493
Ras-related protein Rab-10008282
Actin-related protein 3018283
Actin-related protein 2008181
GTP-binding nuclear protein Ran008484
Casein kinase I isoform gamma-2048690
Cyclin-dependent kinase 3039094
Cyclin-dependent kinase 601984105
Cyclin-dependent-like kinase 5 02594120
Cyclin-dependent kinase 16029598
Cyclin-dependent kinase 17028992
ATP-dependent 6-phosphofructokinase, platelet type007676
Dual specificity mitogen-activated protein kinase kinase 102894122
DNA topoisomerase 2-beta0788108
Protein kinase C theta type01891110
Activin receptor type-1059499
Macrophage-stimulating protein receptor059297
Focal adhesion kinase 10894102
Protein kinase C zeta type0194969
Protein kinase C delta type02497122
Tyrosine-protein kinase BTK0994103
Activated CDC42 kinase 1039598
Epithelial discoidin domain-containing receptor 1059499
Potassium voltage-gated channel subfamily H member 201680172
Mitogen-activated protein kinase kinase kinase kinase 2029294
Serine/threonine-protein kinase 4029597
5'-AMP-activated protein kinase catalytic subunit alpha-10398102
Dual specificity mitogen-activated protein kinase kinase 5019293
Mitogen-activated protein kinase 7029395
Serine/threonine-protein kinase PAK 2028991
Serine/threonine-protein kinase 3029496
Mitogen-activated protein kinase kinase kinase 1019293
Integrin-linked protein kinase008080
Rho-associated protein kinase 1079299
Non-receptor tyrosine-protein kinase TNK1019596
Serine/threonine-protein kinase ATR083442
Calcium/calmodulin-dependent protein kinase type II subunit gamma049499
Calcium/calmodulin-dependent protein kinase type II subunit delta049499
Activin receptor type-2B009494
Bone morphogenetic protein receptor type-2029496
Protein-tyrosine kinase 6039497
cGMP-dependent protein kinase 1 039497
Cyclin-dependent kinase 13029194
Inhibitor of nuclear factor kappa-B kinase subunit epsilon039497
Protein-tyrosine kinase 2-beta029496
Maternal embryonic leucine zipper kinase049498
Structural maintenance of chromosomes protein 1A007777
Chromodomain-helicase-DNA-binding protein 4007777
Peroxisomal acyl-coenzyme A oxidase 1007272
Ephrin type-A receptor 7018384
Delta(24)-sterol reductase008484
Ribosomal protein S6 kinase alpha-10794101
Dual specificity testis-specific protein kinase 1018788
Myosin light chain kinase, smooth muscle0994103
Mitogen-activated protein kinase 1101095105
Serine/threonine-protein kinase STK11039295
Serine/threonine-protein kinase N1049498
Serine/threonine-protein kinase N2049498
Mitogen-activated protein kinase 1406097157
Calcium/calmodulin-dependent protein kinase type IV019394
Mitogen-activated protein kinase kinase kinase 11029496
Discoidin domain-containing receptor 20794101
AP2-associated protein kinase 1039598
Myosin light chain kinase 3029092
Putative heat shock protein HSP 90-beta 2008181
Rab-like protein 3007171
Serine/threonine-protein kinase MRCK alpha019495
Serine/threonine-protein kinase MRCK gamma018889
Acyl-CoA dehydrogenase family member 10007575
Serine/threonine-protein kinase N3015657
Serine/threonine-protein kinase ULK3019293
Rapamycin-insensitive companion of mTOR0404
Uncharacterized protein FLJ45252008484
Acyl-CoA dehydrogenase family member 11007777
Serine/threonine-protein kinase/endoribonuclease IRE2018283
Serine/threonine-protein kinase MARK2019596
ATP-dependent RNA helicase DHX30005757
Serine/threonine-protein kinase TAO1019293
STE20-related kinase adapter protein alpha008484
Myosin-14007878
AarF domain-containing protein kinase 1008484
ATP-dependent RNA helicase DDX42007171
Mitogen-activated protein kinase kinase kinase kinase 3029496
MAP kinase-activated protein kinase 5059095
Regulatory-associated protein of mTOR0707
Misshapen-like kinase 1026567
Atypical kinase COQ8A, mitochondrial009494
Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma009292
Mitogen-activated protein kinase 15019495
Serine/threonine-protein kinase Nek9019495
Serine/threonine-protein kinase Nek7007373
ATP-dependent RNA helicase DDX1008282
Mitogen-activated protein kinase kinase kinase kinase 1019394
Aurora kinase B04295137
MAP/microtubule affinity-regulating kinase 4028789
Serine/threonine-protein kinase Nek1029496
PAS domain-containing serine/threonine-protein kinase016667
Calcium/calmodulin-dependent protein kinase kinase 2029597
EKC/KEOPS complex subunit TP53RK008484
Dual specificity testis-specific protein kinase 2005050
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase01194105
Mitogen-activated protein kinase kinase kinase 5019495
Mitogen-activated protein kinase kinase kinase 3019293
Target of rapamycin complex 2 subunit MAPKAP10404
Eukaryotic translation initiation factor 2-alpha kinase 1009292
Target of rapamycin complex subunit LST80707
Nucleolar GTP-binding protein 1008080
Serine/threonine-protein kinase D2019495
NUAK family SNF1-like kinase 2019091
RNA cytidine acetyltransferase008484
Serine/threonine-protein kinase SIK2029496
STE20-like serine/threonine-protein kinase 029597
Serine/threonine-protein kinase TAO3019293
dCTP pyrophosphatase 1028486
Dual specificity protein kinase CLK4027880
Casein kinase I isoform gamma-1059499
Serine/threonine-protein kinase PAK 6037174
Phenylalanine--tRNA ligase beta subunit008484
Isoleucine--tRNA ligase, mitochondrial005353
BMP-2-inducible protein kinase009696
Obg-like ATPase 1006868
Midasin008383
Interleukin-1 receptor-associated kinase 4029294
Mitogen-activated protein kinase kinase kinase 20019495
Cyclin-dependent kinase 12038488
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13017980
Serine/threonine-protein kinase pim-2047478
Serine/threonine-protein kinase 26019394
Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial006767
Serine/threonine-protein kinase NLK029496
5'-AMP-activated protein kinase subunit gamma-2018688
Serine/threonine-protein kinase TBK1079299
Septin-9008484
Ribosomal protein S6 kinase alpha-6019495
TRAF2 and NCK-interacting protein kinase029496
Serine/threonine-protein kinase TAO2019293
Serine/threonine-protein kinase ICK018788
RAC-gamma serine/threonine-protein kinase0795102
Serine/threonine-protein kinase 38-like016566
Serine/threonine-protein kinase SIK3029294
Mitogen-activated protein kinase kinase kinase 2019293
Thyroid hormone receptor-associated protein 3006868
Dual specificity tyrosine-phosphorylation-regulated kinase 1B055762
Mitogen-activated protein kinase kinase kinase kinase 5029496
Receptor-interacting serine/threonine-protein kinase 3038487
Serine/threonine-protein kinase MRCK beta019495
Interleukin-1 receptor-associated kinase 3009494
Serine/threonine-protein kinase 24028385
Casein kinase I isoform gamma-3019495
Mitogen-activated protein kinase kinase kinase 4009494
chromobox protein homolog 139500395
Polyphenol oxidase 2063179
G2/mitotic-specific cyclin-B2021025
G2/mitotic-specific cyclin-B1041045
G2/mitotic-specific cyclin-B013013
G1/S-specific cyclin-D1030031
G2/mitotic-specific cyclin-B3021025
Cyclin-dependent kinase 1013013
Chain A, THYMIDINE KINASE0101
Chain A, THYMIDINE KINASE0101
Thymidine kinase, cytosolic011022
Chain A, TYROSYL-DNA PHOSPHODIESTERASE24800248
Chain A, Ferritin light chain19800198
Microtubule-associated protein tau35800359
aldehyde dehydrogenase 1 family, member A147000470
regulator of G-protein signaling 425100251
glucocerebrosidase11500115
euchromatic histone-lysine N-methyltransferase 255300553
vitamin D3 receptor isoform VDRA28500285
Cytochrome P450 3A4017212201
Short transient receptor potential channel 60101
apical membrane antigen 1, AMA1850085
Alpha-1B adrenergic receptor011412126
Alpha-2B adrenergic receptor0421254
Alpha-2C adrenergic receptor0401252
Alpha-2A adrenergic receptor0411253
Alpha-1D adrenergic receptor0551268
Alpha-1A adrenergic receptor011813131
Phospholipase D10303
glp-1 receptor, partial18100181
RAR-related orphan receptor gamma49100491
GLI family zinc finger 351300513
AR protein66600666
estrogen receptor 2 (ER beta)31400314
nuclear receptor subfamily 1, group I, member 343200432
progesterone receptor33400334
glucocorticoid receptor [Homo sapiens]48600486
retinoid X nuclear receptor alpha42600426
estrogen-related nuclear receptor alpha60800608
pregnane X nuclear receptor46200462
estrogen nuclear receptor alpha76400764
peroxisome proliferator-activated receptor delta32100321
peroxisome proliferator activated receptor gamma37500375
vitamin D (1,25- dihydroxyvitamin D3) receptor32200322
thyroid stimulating hormone receptor21300213
v-jun sarcoma virus 17 oncogene homolog (avian)24500245
thyroid hormone receptor beta isoform 248800488
nuclear factor erythroid 2-related factor 2 isoform 151900519
Voltage-dependent calcium channel gamma-2 subunit28600286
Cellular tumor antigen p5347250477
Glutamate receptor 230675321
nuclear receptor ROR-gamma isoform 132300323
Serine/threonine-protein kinase PAK 1084250
Tubulin alpha-1A chain019425
Tubulin beta-4A chain0231036
Tubulin beta chain0231036
Tubulin alpha-3C chain0231036
Tyrosinase014014
Tubulin alpha-1B chain0231036
Tubulin alpha-4A chain0231036
Tubulin beta-4B chain0231036
Tubulin beta-3 chain0241037
Tubulin beta-2A chain0231036
Tubulin beta-8 chain0231036
Tubulin beta-2B chain022228
Tubulin alpha-3E chain0231036
Tubulin alpha-1A chain0231036
Similar to alpha-tubulin isoform 1 020226
Similar to alpha-tubulin isoform 1 020125
Tubulin alpha-1C chain0231036
Tubulin beta-6 chain0231036
Tubulin beta-2B chain0231036
Tubulin beta-1 chain0231036
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE36200362
ATAD5 protein, partial28200282
GLS protein25100251
Parkin820082
bromodomain adjacent to zinc finger domain 2B13800138
nuclear factor erythroid 2-related factor 2 isoform 218900192
huntingtin isoform 2950095
serine/threonine-protein kinase mTOR isoform 110500105
urokinase-type plasminogen activator precursor14800148
plasminogen precursor14800148
urokinase plasminogen activator surface receptor precursor14800148
D(1A) dopamine receptor554059
Ataxin-228300283
ATP-dependent phosphofructokinase23300233
Chain A, HADH2 protein23600236
Chain B, HADH2 protein23600236
Chain A, Cruzipain14100141
USP1 protein, partial32400324
arylsulfatase A17900179
Bloom syndrome protein isoform 120600206
cellular tumor antigen p53 isoform a16200162
cytochrome P450 2C9 precursor16500165
thyroid hormone receptor beta isoform a20100201
DNA polymerase beta10200102
peptidyl-prolyl cis-trans isomerase NIMA-interacting 112500125
M-phase phosphoprotein 812400124
histone acetyltransferase KAT2A isoform 122300223
muscarinic acetylcholine receptor M114500145
Polyunsaturated fatty acid lipoxygenase ALOX15B151130164
Histamine H2 receptor25983278
Peroxisome proliferator-activated receptor alpha16112048
Ornithine decarboxylase224027
Chain B, pheromone binding protein0011
Chain A, pheromone binding protein0011
Chain A, JmjC domain-containing histone demethylation protein 3A16400164
Chain A, RNA-directed RNA polymerase NS50909
acid sphingomyelinase440044
importin subunit beta-1 isoform 1970097
flap endonuclease 117700177
serine/threonine-protein kinase PLK1760177
snurportin-1970097
GTP-binding nuclear protein Ran isoform 1530053
DNA polymerase eta isoform 1950095
DNA polymerase iota isoform a (long)27100271
DNA polymerase kappa isoform 121600216
fibroblast growth factor 22 isoform 1 precursor0004
Mitogen-activated protein kinase 13093948
Beta-lactamase017017
Transthyretin0172346
Fatty acid-binding protein, intestinal013316
Fatty acid-binding protein, adipocyte010515
Cyclin-A2031133
Cannabinoid receptor 1026632
Choline O-acetyltransferase0404
Mitogen-activated protein kinase 12094453
Guanine nucleotide-binding protein G980098
Fatty acid-binding protein 50628
Fatty acid-binding protein 50033
farnesoid X nuclear receptor32100321
Choline O-acetyltransferase 0608
Alpha-mannosidase0202
alpha-galactosidase710071
Trehalase 0101
lysosomal alpha-glucosidase preproprotein660066
Trehalase0101
Trehalase 0101
Lysosomal acid glucosylceramidase0415
Alpha-galactosidase A0101
Alpha-glucosidase MAL620101
Lactase-phlorizin hydrolase0101
Beta-glucosidase A0101
Sucrase-isomaltase, intestinal010010
Beta-glucosidase0101
Protein-lysine 6-oxidase0303
Alpha-mannosidase 20101
Glycogen debranching enzyme0101
Glycogen debranching enzyme0202
Alpha-glucosidase MAL320303
Oligo-1,6-glucosidase IMA10404
Alpha-glucosidase MAL120909
Oxysterols receptor LXR-beta06815
Spike glycoprotein2361223271
Alpha-amylase 0101
Trehalose synthase/amylase TreS0101
Lactase-phlorizin hydrolase 0101
Oxysterols receptor LXR-alpha051117
Neutral alpha-glucosidase AB0303
Ceramide glucosyltransferase0101
Lysosomal acid glucosylceramidase0101
Beta-glucosidase 0101
Lysosomal alpha-glucosidase0707
Cytosolic beta-glucosidase0101
Non-lysosomal glucosylceramidase0202
Putative alpha-glucosidase0101
Platelet-activating factor receptor96016
Inositol monophosphatase 112700127
Chain A, High-affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A0101
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D0101
Chain A, Phosphodiesterase 9A0101
Chain A, Class I phosphodiesterase PDEB10101
Chain A, High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A0101
Chain A, cGMP-dependent 3',5'-cyclic phosphodiesterase0101
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera0101
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera0101
Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A0101
Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A0101
Phosphodiesterase 0505
mitogen-activated protein kinase 121400214
cytochrome P450 3A4 isoform 136300363
cGMP-dependent 3',5'-cyclic phosphodiesterase018018
Gamma-aminobutyric acid receptor subunit pi3634511420
Monocarboxylate transporter 40305
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A010010
cGMP-specific 3',5'-cyclic phosphodiesterase028130
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A0303
Renin014216
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A 0808
cAMP-specific 3',5'-cyclic phosphodiesterase 4D 0607
cAMP-specific 3',5'-cyclic phosphodiesterase 4C0607
cAMP-specific 3',5'-cyclic phosphodiesterase 4B0608
Gamma-aminobutyric acid receptor subunit beta-13634511420
Gamma-aminobutyric acid receptor subunit delta3634511420
Gamma-aminobutyric acid receptor subunit gamma-23634513422
Gamma-aminobutyric acid receptor subunit alpha-53634511420
Gamma-aminobutyric acid receptor subunit alpha-33634511420
Gamma-aminobutyric acid receptor subunit gamma-13634611421
Gamma-aminobutyric acid receptor subunit alpha-23634511420
Adenosine receptor A1650368
Gamma-aminobutyric acid receptor subunit alpha-43634511420
Gamma-aminobutyric acid receptor subunit gamma-33634511420
Adenosine receptor A3020020
Adenosine receptor A2a0451063
Adenosine receptor A2b013424
Adenosine receptor A2b017327
Gamma-aminobutyric acid receptor subunit alpha-63634511420
Adenosine receptor A1041858
Adenosine receptor A2a047566
Sodium-dependent serotonin transporter044449
Adenosine receptor A2a0415
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'0314
cAMP-specific 3',5'-cyclic phosphodiesterase 4A0607
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A09010
Gamma-aminobutyric acid receptor subunit alpha-13634813425
Gamma-aminobutyric acid receptor subunit beta-33634511420
Gamma-aminobutyric acid receptor subunit beta-23634513422
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B0808
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B012013
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B0404
cAMP-specific 3',5'-cyclic phosphodiesterase 4B024128
cAMP-specific 3',5'-cyclic phosphodiesterase 4D030132
cGMP-inhibited 3',5'-cyclic phosphodiesterase B018019
Voltage-dependent L-type calcium channel subunit alpha-1C051052
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A0606
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C012013
cGMP-inhibited 3',5'-cyclic phosphodiesterase A020021
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C0404
Phosphodiesterase 0101
GABA theta subunit3634511420
Phosphodiesterase 0404
Gamma-aminobutyric acid receptor subunit epsilon3634511420
cAMP-specific 3',5'-cyclic phosphodiesterase 7B0707
Solute carrier family 22 member 107010
Solute carrier family 22 member 2036048
Solute carrier family 22 member 1 071092
Solute carrier family 22 member 20507
Solute carrier family 22 member 3023027
Solute carrier family 22 member 30306
POU domain, class 2, transcription factor 20004
Sodium-dependent serotonin transporter01138121
Solute carrier family 22 member 1034044
Solute carrier family 22 member 2027033
Fumarate hydratase23500235
EWS/FLI fusion protein40000401
polyprotein23500235
Spike glycoprotein0122335
Replicase polyprotein 1ab0302454
Transmembrane protease serine 20142337
Procathepsin L0252348
Replicase polyprotein 1a0272451
Replicase polyprotein 1ab0172340
Replicase polyprotein 1ab07329102
Replicase polyprotein 1ab010432136
Thioredoxin0202
Angiotensin-converting enzyme 2 0172441
Dihydrofolate reductase033037
Indoleamine 2,3-dioxygenase 1033237
Indoleamine 2,3-dioxygenase 1012012
Tryptophan 2,3-dioxygenase0101
Indoleamine 2,3-dioxygenase 20404
Diacylglycerol kinase alpha0101
Luciferase29800298
retinoic acid nuclear receptor alpha variant 150100501
aryl hydrocarbon receptor29300293
Histone H2A.x23900239
Prostaglandin G/H synthase 1 023026
Prostaglandin G/H synthase 2 011013
DNA repair and recombination protein RadA0033
Cytochrome P450 1A201232131
Cytochrome P450 2A6021426
Polyunsaturated fatty acid 5-lipoxygenase028036
Cytochrome P450 2A50607
UDP-glucuronosyltransferase 1A1 024035
activating transcription factor 623700237
heat shock protein beta-121300213
hypoxia-inducible factor 1 alpha subunit18600186
SMAD family member 219400194
SMAD family member 319400194
caspase 7, apoptosis-related cysteine protease11900119
caspase-311900119
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a36200362
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a22500225
phosphopantetheinyl transferase25900259
G-protein coupled receptor 8405713
Cannabinoid receptor 1035851
Cannabinoid receptor 2 025839
Cannabinoid receptor 20707
Chain A, Putative fructose-1,6-bisphosphate aldolase15900159
Chain A, 2-oxoglutarate Oxygenase26800268
endonuclease IV840084
acetylcholinesterase20700207
15-lipoxygenase, partial16500165
pregnane X receptor800080
NFKB1 protein, partial10200102
Thrombopoietin940094
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)15800158
nonstructural protein 10707
heat shock protein 900088
TPA: protein transporter TIM100909
TPA: protein transporter TIM230707
Caspase-7650065
cytochrome P450 2D6 isoform 116100161
peripheral myelin protein 22 isoform 113400134
tumor necrosis factor160016
runt-related transcription factor 1 isoform AML1b160016
caspase-3650065
histone deacetylase 9 isoform 3950095
core-binding factor subunit beta isoform 2160016
heat shock protein HSP 90-alpha isoform 2012026
muscleblind-like protein 1 isoform 110900109
exodeoxyribonuclease V subunit RecD0606
exodeoxyribonuclease V subunit RecB0606
exodeoxyribonuclease V subunit RecC0606
Galanin receptor type 20112
Carboxypeptidase A10303
Thermolysin0708
Amyloid-beta precursor protein1947473
Integrin beta-3122132137
Integrin alpha-IIb12291132
C-C chemokine receptor type 10112
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha08110
Protein farnesyltransferase subunit beta0719
Nuclear receptor ROR-gamma12066132
C-C chemokine receptor type 50438
C-C chemokine receptor type 80011
Metallo-beta-lactamase VIM-1302010
ATPase family AAA domain-containing protein 520900209
Snake venom metalloproteinase neuwiedase0101
Collagenase ColG0303
Beta-lactamase VIM-1 02010
heat shock protein 90, putative00014
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 122500225
Chain A, ATP-DEPENDENT DNA HELICASE Q112000120
thioredoxin glutathione reductase960096
pyruvate kinase PKM isoform a160016
histone-lysine N-methyltransferase 2A isoform 2 precursor750075
Vif0708
Tat0606
DNA dC->dU-editing enzyme APOBEC-3G isoform 14310053
replicative DNA helicase00014
recombinase A001415
Coagulation factor XII015015
Papain010010
Cholinesterase051153
Receptor-type tyrosine-protein phosphatase C0404
Tyrosine-protein phosphatase non-receptor type 1070578
Acetylcholinesterase01064113
Liver carboxylesterase 1021031
Adenosine receptor A10808
Genome polyprotein 011011
Tyrosine-protein phosphatase non-receptor type 220303
Phenylethanolamine N-methyltransferase0606
Phenylethanolamine N-methyltransferase0303
CD44 antigen0011
CD44 antigen0112
Amine oxidase [flavin-containing] A087189
Amine oxidase [flavin-containing] B071173
Nicotinamide N-methyltransferase0505
Genome polyprotein 0516
Prothrombin 0707
Coagulation factor X018018
Genome polyprotein0202
Alpha-amylase 1A 0808
5-hydroxytryptamine receptor 2A064974
5'-nucleotidase0708
Squalene monooxygenase 0506
Ectonucleoside triphosphate diphosphohydrolase 10303
Anthrax toxin receptor 2012012
Xanthine dehydrogenase/oxidase028134
Neuraminidase 0101
5'-nucleotidase0404
5-hydroxytryptamine receptor 1A0341044
Adenosine receptor A3088597
Vasopressin V2 receptor0003
Adenosine receptor A10426
Adenylate cyclase type 50607
Adenylate cyclase type 10115
polyadenylate-binding protein 10606
Rev0101
Female germline-specific tumor suppressor gld-10101
Cocaine esterase018019
Integrin beta-10707
Muscarinic acetylcholine receptor M1037951
Polyunsaturated fatty acid 5-lipoxygenase065270
Muscarinic acetylcholine receptor M2036950
Integrin alpha-40404
C-8 sterol isomerase0808
Delta-type opioid receptor038444
Mu-type opioid receptor050861
Kappa-type opioid receptor015420
Glutamate receptor ionotropic, NMDA 1 233851
Kappa-type opioid receptor033345
Mu-type opioid receptor047755
Glutamate receptor ionotropic, NMDA 2A 130645
Glutamate receptor ionotropic, NMDA 2B135752
Glutamate receptor ionotropic, NMDA 2C131647
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase09110
Sigma intracellular receptor 20606
Sigma intracellular receptor 2013013
Glutamate receptor ionotropic, NMDA 2D129644
Vesicular acetylcholine transporter0404
Glutamate receptor ionotropic, NMDA 3B129644
Sigma non-opioid intracellular receptor 1181589
Sigma non-opioid intracellular receptor 1016724
Glutamate receptor ionotropic, NMDA 3A129644
corticotropin-releasing hormone receptor 20459
corticotropin releasing factor-binding protein0459
thyrotropin-releasing hormone receptor460046
DNA topoisomerase 1018844
Carbon monoxide dehydrogenase small chain0022
Dual specificity protein phosphatase 10404
M-phase inducer phosphatase 2012012
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 10718
Dual specificity protein phosphatase 60404
Histone-lysine N-methyltransferase EHMT2017119
Histone-lysine N-methyltransferase EHMT10808
Cytochrome P450 1A1055460
Cytochrome P450 1B1065269
Beta-lactamase 0202
lethal factor (plasmid)18502187
botulinum neurotoxin type A0022
botulinum neurotoxin type F, BoNT/F0022
LIP1, secretory lipase 0101
Fatty-acid amide hydrolase 1013013
Phosphatidylserine lipase ABHD16A0202
Fatty-acid amide hydrolase 1224027
Platelet-activating factor acetylhydrolase0507
Neutral cholesterol ester hydrolase 10202
Lysophosphatidylserine lipase ABHD120303
Diacylglycerol lipase-beta0202
Diacylglycerol lipase-alpha0404
nuclear factor NF-kappa-B p105 subunit isoform 1350237
Genome polyprotein0628
G32400324
Stimulator of interferon genes protein0011
peripheral myelin protein 2224800248
Trypsin011013
HLA class I histocompatibility antigen, B alpha chain 32400324
Stimulator of interferon genes protein0178
Inositol hexakisphosphate kinase 132400324
cytochrome P450 2C9, partial32400324
Dihydrofolate reductase011013
Dihydrofolate reductase07010
hemoglobin subunit beta240024
caspase-1 isoform alpha precursor390039
Caspase-7361040
Neuropeptide Y receptor type 40202
prostaglandin E2 receptor EP2 subtype3006
Transient receptor potential cation channel subfamily A member 1033340
Peroxisome proliferator-activated receptor gamma0233864
Lysine-specific demethylase 6B0505
Lysine-specific demethylase 4B0303
Heat shock protein HSP 90-alpha0212447
Cholesteryl ester transfer protein0325
5-hydroxytryptamine receptor 1A09511110
Lysine-specific demethylase 5A0606
Endoplasmin06410
Hypoxia-inducible factor 1-alpha016421
Endothelial PAS domain-containing protein 1010415
Lysine-specific demethylase 4C0505
Chain A, THYMIDYLATE SYNTHASE0101
Thymidylate synthase 0303
Thymidylate synthase014015
Dihydrofolate reductase012518
Folylpolyglutamate synthase, mitochondrial0108
Bifunctional dihydrofolate reductase-thymidylate synthase0606
Tubulin beta chain014418
Aminopeptidase N0505
Aminopeptidase N0808
Dipeptidyl peptidase 4024130
Matrix metalloproteinase-9030131
Neutrophil collagenase0808
Collagenase 3017019
Chain A, Serine/threonine-protein Kinase 12-a0101
Dual specificity mitogen-activated protein kinase kinase 10202
Serine/threonine-protein kinase PLK103377111
Aurora kinase C0104454
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-10202
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-10202
Chain A, Methyltransferase Wbdd0101
cytochrome P450 2C19 precursor16000160
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform0204364
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha0505
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta053944
Bromodomain-containing protein 4013923
5-hydroxytryptamine receptor 401075112
Neuronal acetylcholine receptor subunit alpha-42121447
Neuronal acetylcholine receptor subunit beta-22119445
Proteinase-activated receptor 10529
Bromodomain-containing protein 20516
5-hydroxytryptamine receptor 2A01124121
5-hydroxytryptamine receptor 2C01232126
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform0101
Type-1 angiotensin II receptor08311
5-hydroxytryptamine receptor 2B01311133
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform 0202
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform0204265
Serine/threonine-protein kinase mTOR0202
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform 0254268
Casein kinase II subunit beta030232
Casein kinase II subunit alpha0364581
DNA-dependent protein kinase catalytic subunit024226
Serine-protein kinase ATM011011
Bromodomain-containing protein 30314
Serine/threonine-protein kinase pim-3034346
Phosphoinositide 3-kinase regulatory subunit 50404
Serine/threonine-protein kinase PLK30184462
Serine/threonine-protein kinase PLK20164056
Acid ceramidase0404
Alkaline ceramidase 20101
Aldo-keto reductase family 1 member B101330133
Alpha-2A adrenergic receptor012012137
Sodium-dependent noradrenaline transporter 012418142
Retinal dehydrogenase 10404
Signal transducer and activator of transcription 3016522
Protein cereblon021534
Pteridine reductase 10606
Metabotropic glutamate receptor 80303
Metabotropic glutamate receptor 60247
Metabotropic glutamate receptor 40124
Carbonic anhydrase 101622197
Carbonic anhydrase 201796219
Carbonic anhydrase 5A, mitochondrial064284
polyunsaturated fatty acid lipoxygenase ALOX12530053
Transient receptor potential cation channel subfamily M member 20718
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1017118
Transient receptor potential cation channel subfamily V member 10121331
Transient receptor potential cation channel subfamily V member 30113
Transient receptor potential cation channel subfamily V member 20214
ClpP280028
NPC intracellular cholesterol transporter 1 precursor10300103
large T antigen028129
Chain A, Arginase-10101
Chain A, Arginase-10101
Arginase-10202
Nitric oxide synthase, brain 011013
Nitric oxide synthase, inducible024025
Proton-coupled amino acid transporter 1019020
Phosphatidylinositol 4-kinase alpha09010
Xanthine dehydrogenase/oxidase043043
Phosphatidylinositol 4-kinase type 2-beta0708
Phosphatidylinositol 4-kinase type 2-alpha0809
Phosphatidylinositol 4-kinase beta0113951
BRCA1380038
potassium voltage-gated channel subfamily H member 2 isoform d18100181
DNA dC->dU-editing enzyme APOBEC-3F isoform a280028
NPYLR7B001414
vasopressin V1b receptor4004
glycogen synthase kinase-3 beta isoform 1002121
eukaryotic translation initiation factor 2-alpha kinase 3 isoform 1 precursor0022
relaxin receptor 1 isoform 1110011
high affinity choline transporter 1 isoform a0909
relaxin receptor 2 isoform 14004
Endoplasmin06411
Adenosine deaminase 07014
Proteinase-activated receptor 20213
Melatonin receptor type 1A08210
Melatonin receptor type 1A0314
Melatonin receptor type 1B0628
Melatonin receptor type 1C0314
Melatonin receptor type 1B0314
C-terminal-binding protein 20314
C-terminal-binding protein 190110
interferon gamma precursor00018
atrial natriuretic peptide receptor 2 precursor550055
Sex hormone-binding globulin032023
Prostaglandin D2 receptor0303
Prostaglandin D2 receptor 20516
Solute carrier family 22 member 20015015
Solute carrier family 22 member 6015015
Sulfotransferase 1A1 0005
Sulfotransferase 1E10001
Sulfotransferase 1A10215
Sulfotransferase 2A10001
Neutrophil cytosol factor 10617
interleukin 8840084
transcriptional regulator ERG isoform 3500050
Rap guanine nucleotide exchange factor 3800080
Phenol oxidase 0303
Chymase0303
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial0415
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial0404
Fatty acid-binding protein, liver0707
Chain A, Acetoacetate decarboxylase0101
Alcohol dehydrogenase E chain0707
Alcohol dehydrogenase S chain0707
Peptidyl-prolyl cis-trans isomerase FKBP50235
cytochrome P450 family 3 subfamily A polypeptide 443500435
cytochrome P450 2D629500295
Nuclear receptor subfamily 1 group I member 2053035
Tyrosinase024024
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)960096
Glycoprotein hormones alpha chain240024
Beta-glucuronidase0505
Substance-P receptor021028
Quinone oxidoreductase00014
Polyphenol oxidase 10202
Estrogen receptor1571679
Estrogen receptor beta1361452
hexokinase-4 isoform 1250025
glucokinase regulatory protein250025
eyes absent homolog 2 isoform a250025
Dual specificity mitogen-activated protein kinase kinase 7034043
M-phase inducer phosphatase 1010010
Single-stranded DNA cytosine deaminase190019
Pyruvate dehydrogenase E1 component subunit alpha, mitochondrial0101
Pyruvate dehydrogenase E1 component subunit beta, mitochondrial0101
parathyroid hormone/parathyroid hormone-related peptide receptor precursor12000120
Androgen receptor084186
Chain A, Sarcoplasmic/endoplasmic reticulum calcium ATPase 10011
alternatively spliced Trp40022
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 0202
Sarcoplasmic/endoplasmic reticulum calcium ATPase 20404
Sarcoplasmic/endoplasmic reticulum calcium ATPase 30404
Carbonic anhydrase 12073293
Matrilysin012012
Prolyl 4-hydroxylase subunit alpha-1014014
Carbonic anhydrase 7063280
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT60505
Alpha-(1,3)-fucosyltransferase 70505
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 10505
Carbonic anhydrase 90922113
Carbonic anhydrase 14043159
ORF73001011
AAA family ATPase 0003
Reverse transcriptase/RNaseH 0291256
Chain A, Protein (thymidylate Synthase)0011
Chain A, Thymidylate Synthase0011
Chain A, Thymidylate Synthase0011
Chain A, Thymidylate Synthase0011
Chain A, Thymidylate Synthase0011
Chain A, Thymidylate Synthase0011
Chain A, Thymidylate Synthase0011
Chain A, Thymidylate Synthase0011
Chain A, Thymidylate Synthase0011
Chain A, Thymidylate Synthase0011
Chain A, Thymidylate Synthase0011
Thymidylate synthase 0506
Thymidylate synthase07111
Thymidylate synthase014019
Thymidylate kinase0306
Gonadotropin-releasing hormone receptor0415
Thymidylate kinase011014
Thymidylate synthase 0101
Deoxyuridine triphosphatase, putative 0101
Nrf2400040
pyruvate kinase330033
serine-protein kinase ATM isoform a260026
Acetylcholinesterase0909
Endothelin receptor type B114015
Endothelin-1 receptor114116
Androgen receptor1441278
Corticosteroid 11-beta-dehydrogenase isozyme 10617
Aldo-keto reductase family 1 member C3022022
Thymidine kinase 2 0303
Thymidine phosphorylase0103
Thymidine kinase, cytosolic 0306
Glycogen phosphorylase, muscle form017017
Alpha-crystallin B chain0022
3-hydroxy-3-methylglutaryl-coenzyme A reductase013114
Integrin alpha-V 0617
Glutamate receptor ionotropic, NMDA 1012416
Sterol regulatory element-binding protein 20101
Glutamate receptor ionotropic, NMDA 2A012416
Glutamate receptor ionotropic, NMDA 2B011516
Oxysterol-binding protein 20011
NPC1-like intracellular cholesterol transporter 10033
Cystic fibrosis transmembrane conductance regulator0369
NACHT, LRR and PYD domains-containing protein 3 0505
Prostaglandin G/H synthase 1085086
Prostaglandin G/H synthase 2010641150
chaperonin-containing TCP-1 beta subunit homolog120012
WRN360036
hypothetical protein, conserved430043
P53240024
FAD-linked sulfhydryl oxidase ALR0006
Guanylate cyclase soluble subunit beta-20113
Guanylate cyclase soluble subunit alpha-20113
Guanylate cyclase soluble subunit alpha-10124
Guanylate cyclase soluble subunit beta-10124
Histone acetyltransferase p3000819
CREB-binding protein55111
5-hydroxytryptamine receptor 407310
Bifunctional dihydrofolate reductase-thymidylate synthase0404
Poly [ADP-ribose] polymerase 20404
Poly [ADP-ribose] polymerase 1023730
Poly [ADP-ribose] polymerase 1 0303
Transporter027129
Beta-lactamase0307
Beta-lactamase07015
Angiotensin-converting enzyme09110
Beta-lactamase TEM07013
Ectonucleotide pyrophosphatase/phosphodiesterase family member 20808
alkaline phosphatase, intestinal0257
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein0527
intestinal alkaline phosphatase precursor0527
glyceraldehyde-3-phosphate dehydrogenase isoform 16006
lethal(3)malignant brain tumor-like protein 1 isoform I340034
Vpr410041
alkaline phosphatase, germ cell type preproprotein0257
HSP40, subfamily A [Plasmodium falciparum 3D7]00011
Ribonucleoside-diphosphate reductase subunit M20102
CDGSH iron-sulfur domain-containing protein 1022022
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-10101
Baculoviral IAP repeat-containing protein 50011
5-hydroxytryptamine receptor 3A0235
Chain A, INOSINE-ADENOSINE-GUANOSINE-PREFERRING NUCLEOSIDE HYDROLASE0101
Adenosylhomocysteinase011016
Histone-lysine N-methyltransferase EZH20708
Neuraminidase 022023
Calpain-1 catalytic subunit0606
L-lactate dehydrogenase A chain010212
L-lactate dehydrogenase A chain0101
L-lactate dehydrogenase B chain0606
4-hydroxy-tetrahydrodipicolinate synthase0202
Chain A, Phenazine biosynthesis protein phzF0011
Caspase 6, apoptosis-related cysteine peptidase0006
isocitrate dehydrogenase 1, partial160016
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase0808
glucose-6-phosphate 1-dehydrogenase isoform b0808
Caspase-90506
Chain A, PROTOCATECHUATE 3,4-DIOXYGENASE0404
Chain M, PROTOCATECHUATE 3,4-DIOXYGENASE0404
Chain A, PROTOCATECHUATE 3,4-DIOXYGENASE0404
Chain M, PROTOCATECHUATE 3,4-DIOXYGENASE0404
Chain A, PROTOCATECHUATE 3,4-DIOXYGENASE0404
Chain M, PROTOCATECHUATE 3,4-DIOXYGENASE0404
Chain A, PROTOCATECHUATE 3,4-DIOXYGENASE0404
Chain M, PROTOCATECHUATE 3,4-DIOXYGENASE0404
Chain A, PROTOCATECHUATE 3,4-DIOXYGENASE0404
Chain M, PROTOCATECHUATE 3,4-DIOXYGENASE0404
Chain A, Protocatechuate 3,4-dioxygenase0404
Chain M, Protocatechuate 3,4-dioxygenase0404
Calcium/calmodulin-dependent protein kinase type II subunit alpha0505
Tetraspanin0101
Vitamin D3 receptor0121330
Carbonic anhydrase 6062278
Carbonic anhydrase012012
Hydroxycarboxylic acid receptor 20448
Hydroxycarboxylic acid receptor 10011
Protein skinhead-10505
Monocarboxylate transporter 20404
ATP-dependent translocase ABCB1011227177
Calmodulin-1011213
Pyruvate kinase PKM020222
Polyunsaturated fatty acid lipoxygenase ALOX15014015
Polyunsaturated fatty acid lipoxygenase ALOX12010011
Fatty acid synthase021021
Dipeptidyl peptidase 3011011
dopamine D1 receptor310031
POU domain, class 2, transcription factor 10003
Ubiquitin carboxyl-terminal hydrolase 20606
G-protein coupled bile acid receptor 1052530
Liver carboxylesterase 10606
Chain A, DNA-3-methyladenine glycosylase I0011
Chain A, DNA-3-METHYLADENINE GLYCOSYLASE I0011
Chain A, Dna-3-methyladenine Glycosylase I0011
Cytochrome b0202
Aryl hydrocarbon receptor0157
Pancreatic triacylglycerol lipase021023
Carbonic anhydrase 40901106
Aldo-keto reductase family 1 member B10505
Inositol polyphosphate multikinase0909
Inositol hexakisphosphate kinase 20909
Tubulin--tyrosine ligase0202
Prostaglandin E synthase018119
Chain A, Aspartate Aminotransferase0011
Chain B, Aspartate Aminotransferase0011
Chain A, Aspartate Aminotransferase0011
Chain B, Aspartate Aminotransferase0011
Chain A, Aspartate aminotransferase0011
Chain B, Aspartate aminotransferase0011
Chain A, Aspartate aminotransferase0011
Chain A, Aspartate aminotransferase0011
Chain A, Aspartate aminotransferase0011
Chain B, Aspartate aminotransferase0011
Kelch-like ECH-associated protein 10246
Rap guanine nucleotide exchange factor 4600060
DNA topoisomerase type IB small subunit0011
DNA topoisomerase I 0011
Aryl hydrocarbon receptor0123
G-protein coupled receptor 840011
Calcium dependent protein kinase0101
luciferase130013
D(1A) dopamine receptor10300103
atrial natriuretic peptide receptor 1 precursor500050
dual specificity tyrosine-phosphorylation-regulated kinase 1A00015
glycogen synthase kinase-3 alpha00015
serine/threonine-protein kinase 33 isoform a0079
endoribonuclease toxin MazF0044
Dipeptidyl peptidase 40606
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 10909
Lactoylglutathione lyase021021
Arginase-10404
phosphoglycerate kinase280028
Broad substrate specificity ATP-binding cassette transporter ABCG2083795
rac GTPase-activating protein 1 isoform a0808
Aldo-keto reductase family 1 member B10031031
Aldo-keto reductase family 1 member B1062164
Dihydroorotate dehydrogenase 016016
Protein mono-ADP-ribosyltransferase PARP100437
Protein mono-ADP-ribosyltransferase PARP110202
Chain A, Penicillin Amidohydrolase0505
Chain B, Penicillin Amidohydrolase0505
Chain A, Penicillin Amidohydrolase0505
Chain B, Penicillin Amidohydrolase0505
Chain A, Penicillin Amidohydrolase0505
Chain B, Penicillin Amidohydrolase0505
Chain A, Penicillin Amidohydrolase0505
Chain B, Penicillin Amidohydrolase0505
Chain A, Penicillin Amidohydrolase0505
Chain B, Penicillin Amidohydrolase0505
Chain A, Penicillin Amidohydrolase0505
Chain B, Penicillin Amidohydrolase0505
Chain A, Penicillin Amidohydrolase0505
Chain B, Penicillin Amidohydrolase0505
Chain A, Protocatechuate 3,4-dioxygenase0011
Chain M, Protocatechuate 3,4-dioxygenase0011
Olfactory receptor class A-like protein 10044
RGS12160016
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1140014
POsterior Segregation001515
Zinc finger protein mex-5001415
3-oxoacyl-0101
mothers against decapentaplegic homolog 3 isoform 10202
5-hydroxytryptamine receptor 2C045653
Sodium-dependent dopamine transporter034438
5-hydroxytryptamine receptor 1B065469
5-hydroxytryptamine receptor 1D017421
5-hydroxytryptamine receptor 1F017421
5-hydroxytryptamine receptor 2B041647
5-hydroxytryptamine receptor 608412
5-hydroxytryptamine receptor 7 015419
5-hydroxytryptamine receptor 5A08412
5-hydroxytryptamine receptor 5B08412
5-hydroxytryptamine receptor 3A019524
Sodium-dependent dopamine transporter 01044108
5-hydroxytryptamine receptor 4 011518
5-hydroxytryptamine receptor 3B019524
Aryl hydrocarbon receptor0202
Transient receptor potential cation channel subfamily A member 10111122
Inhibitor of nuclear factor kappa-B kinase subunit beta0113850
RAF proto-oncogene serine/threonine-protein kinase0174362
Vascular endothelial growth factor receptor 206745117
5'-AMP-activated protein kinase subunit beta-10359
NAD(P)H dehydrogenase [quinone] 100011
Integrase 037240
S100A4, partial0003
tumor susceptibility gene 101 protein190019
Carboxypeptidase G20001
Carbonic anhydrase 00010
Carbonic anhydrase 021021
Carbonic anhydrase 012012
Carbonic anhydrase 018018
Carbonic anhydrase018018
Carbonic anhydrase0808
Carbonic anhydrase 3039153
Carbonic anhydrase 5A, mitochondrial0707
Delta-type opioid receptor040551
Carbonic anhydrase037043
Carbonic anhydrase012019
Carbonic anhydrase 011011
Beta-carbonic anhydrase 1019019
Carbonic anhydrase 2015015
Carbonic anhydrase, alpha family 014014
Carbonic anhydrase 014021
Carbonic anhydrase016024
Carbonic anhydrase017025
Carbonic anhydrase 012012
Delta carbonic anhydrase012012
Carbonic anhydrase 010017
Carbonic anhydrase 4019024
Carbonic anhydrase 15039046
Carbonic anhydrase 13040055
Carbonic anhydrase 5B, mitochondrial048168
LMP1 [Human herpesvirus 4]0007
protein artemis isoform a0101
M1-family alanyl aminopeptidase0505
Hsf1 protein001216
Chain A, TGF-beta receptor type-10101
tyrosine-protein kinase Yes720072
Serine/threonine-protein kinase 25014243
Serine/threonine-protein kinase RIO3004242
Serine/threonine-protein kinase DCLK1024244
Muscle, skeletal receptor tyrosine-protein kinase014243
3-phosphoinositide-dependent protein kinase 10124355
Death-associated protein kinase 3024345
NUAK family SNF1-like kinase 1064248
Tyrosine-protein kinase JAK20136376
Serine/threonine-protein kinase PAK 3024244
Serine/threonine-protein kinase 17B024244
Cyclin-dependent kinase 14034246
Receptor tyrosine-protein kinase erbB-20444488
Macrophage colony-stimulating factor 1 receptor0174259
Proto-oncogene tyrosine-protein kinase ROS044246
Tyrosine-protein kinase Fgr045963
Mast/stem cell growth factor receptor Kit0354782
Myosin light chain kinase, smooth muscle032225
Insulin receptor-related protein014243
Platelet-derived growth factor receptor alpha0334376
Vascular endothelial growth factor receptor 1 0294272
Interferon-induced, double-stranded RNA-activated protein kinase044246
Cyclin-dependent kinase 11B014244
Fibroblast growth factor receptor 20144258
Fibroblast growth factor receptor 40134257
Fibroblast growth factor receptor 30154360
Protein kinase C eta type0184564
Activin receptor type-2A004242
Ephrin type-A receptor 3014445
Ephrin type-A receptor 8014243
Leukocyte tyrosine kinase receptor024244
Tyrosine-protein kinase receptor UFO084250
Mitogen-activated protein kinase 4004242
Tyrosine-protein kinase receptor Tie-1004242
Vascular endothelial growth factor receptor 30224265
Serine/threonine-protein kinase receptor R3035255
Tyrosine-protein kinase TXK034245
Tyrosine-protein kinase ZAP-70074249
Cyclin-dependent kinase 8094252
Dual specificity protein kinase CLK3037174
Tyrosine-protein kinase Blk044246
Cytoplasmic tyrosine-protein kinase BMX064248
cAMP-dependent protein kinase catalytic subunit PRKX014243
Tyrosine-protein kinase JAK30194362
Death-associated protein kinase 10154257
5'-AMP-activated protein kinase catalytic subunit alpha-2024548
Ephrin type-B receptor 1014243
Serine/threonine-protein kinase SIK1034245
Tubulin alpha-1A chain002222
Phosphatidylinositol 5-phosphate 4-kinase type-2 beta004242
SRSF protein kinase 2014243
Mitogen-activated protein kinase kinase kinase 9024244
Protein kinase C epsilon type0234569
Angiopoietin-1 receptor0144458
Mitogen-activated protein kinase kinase kinase 10024244
Tyrosine-protein kinase receptor TYRO3024244
Cyclin-dependent kinase 18024750
Tyrosine-protein kinase ITK/TSK064248
Myotonin-protein kinase034245
Tyrosine-protein kinase Mer045862
cGMP-dependent protein kinase 2014243
Receptor-interacting serine/threonine-protein kinase 1064349
Calcium/calmodulin-dependent protein kinase type II subunit beta054248
Calcium/calmodulin-dependent protein kinase type 1024345
Serine/threonine-protein kinase D10164461
Ribosomal protein S6 kinase alpha-2014344
NT-3 growth factor receptor014243
BDNF/NT-3 growth factors receptor044347
Mitogen-activated protein kinase 6004242
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform014243
Serine/threonine-protein kinase TNNI3K014243
Serine/threonine-protein kinase Nek5014243
Serine/threonine-protein kinase tousled-like 2014243
Serine/threonine-protein kinase 32C014243
Myosin light chain kinase family member 4014243
Calcium/calmodulin-dependent protein kinase type 1D024345
Serine/threonine-protein kinase BRSK2024244
Serine/threonine-protein kinase DCLK2014344
Calcium/calmodulin-dependent protein kinase kinase 1014243
Casein kinase I isoform alpha-like014243
Myosin-IIIa014243
Ankyrin repeat and protein kinase domain-containing protein 1004242
Serine/threonine-protein kinase BRSK1014243
Myosin-IIIb014243
Atypical kinase COQ8B, mitochondrial004242
Calcium/calmodulin-dependent protein kinase type 1G014950
SRSF protein kinase 1014243
Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha004242
Serine/threonine-protein kinase RIO1004242
MAP kinase-interacting serine/threonine-protein kinase 1044246
Cyclin-dependent kinase 19044247
Testis-specific serine/threonine-protein kinase 1014243
Serine/threonine-protein kinase 33014243
Serine/threonine-protein kinase DCLK3004242
Myosin light chain kinase 2, skeletal/cardiac muscle014243
Tyrosine-protein kinase Srms014243
MAP kinase-interacting serine/threonine-protein kinase 2044347
Serine/threonine-protein kinase Nek6034245
Serine/threonine-protein kinase LATS2014243
Serine/threonine-protein kinase 36014243
Serine/threonine-protein kinase 32B014243
Serine/threonine-protein kinase MARK1014243
Serine/threonine-protein kinase PAK 5034245
eIF-2-alpha kinase GCN2004242
Serine/threonine-protein kinase 17A014344
Ephrin type-A receptor 6014243
Death-associated protein kinase 2014344
Serine/threonine-protein kinase tousled-like 1014243
ALK tyrosine kinase receptor0185068
Cyclin-dependent kinase 11A004242
Calcium/calmodulin-dependent protein kinase type II subunit alpha084251
Inhibitor of nuclear factor kappa-B kinase subunit alpha063844
Thiopurine S-methyltransferase0303
Succinate-semialdehyde dehydrogenase, mitochondrial0505
4-aminobutyrate aminotransferase, mitochondrial0607
Dihydropteroate synthase 0011
Chain A, Toluene-4-monooxygenase system protein A0101
Potassium channel subfamily K member 2091221
Potassium voltage-gated channel subfamily A member 30617
Acetylcholinesterase011011
Potassium voltage-gated channel subfamily A member 10527
[tau protein] kinase 0404
cAMP-dependent protein kinase catalytic subunit alpha014014
Beta-casein0202
Protein kinase C alpha type010010
Protein kinase C delta type010010
Protein kinase C epsilon type010010
Protein kinase C zeta type010010
Protein kinase C gamma type010010
Protein kinase C beta type012012
Protein kinase C eta type010010
Protein kinase C theta type010010
UDP-glucuronosyltransferase 1A409025
Secreted chorismate mutase0606
D(1A) dopamine receptor071480
Toll-like receptor 2 0202
Chain A, Phenylethanolamine N-methyltransferase0022
Chain A, Phenylethanolamine N-methyltransferase0022
Chain A, Phenylethanolamine N-methyltransferase0022
Chain A, Phenylethanolamine N-methyltransferase0022
Chain A, Phenylethanolamine N-methyltransferase0022
Chain A, Phenylethanolamine N-methyltransferase0022
Chain A, Phenylethanolamine N-methyltransferase0022
Chain A, Phenylethanolamine N-methyltransferase0022
Chain A, Phenylethanolamine N-methyltransferase0022
Chain A, Phenylethanolamine N-methyltransferase0022
Chain A, Phenylethanolamine N-methyltransferase0022
Chain A, Phenylethanolamine N-methyltransferase0022
Chain A, Phenylethanolamine N-methyltransferase0022
Cationic trypsin013013
Tryptase beta-20101
Histone acetyltransferase KAT80101
Macrophage migration inhibitory factor027229
Gamma-aminobutyric acid receptor subunit alpha-10321749
Gamma-aminobutyric acid receptor subunit beta-20281543
Prostaglandin G/H synthase 2032033
Fatty acid synthase0909
Fatty acid synthase 0202
Glutaminyl-peptide cyclotransferase0909
Multidrug resistance-associated protein 402770283
Equilibrative nucleoside transporter 1013013
Solute carrier family 28 member 30808
Adenosine kinase0103
Chain A, Sulfotransferase 1A10101
Chain A, Sulfotransferase 1A10101
Endolysin0066
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain A, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Chain B, AROMATIC AMINO ACID AMINOTRANSFERASE0011
Histone deacetylase 3053564
Histone deacetylase 4050562
Histone deacetylase 1059975
Histone deacetylase 7047558
Histone deacetylase 2058873
Polyamine deacetylase HDAC10041451
Histone deacetylase 11 041451
Histone deacetylase 8055768
NAD-dependent protein deacylase sirtuin-5, mitochondrial010112
Histone deacetylase 6058771
Histone deacetylase 9047457
Histone deacetylase 5050460
nuclear receptor subfamily 1, group I, member 2770077
Urease subunit alpha018018
Urease subunit beta018018
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 30101
transient receptor potential cation channel subfamily V member 19009
Prothrombin024935
Plasminogen013114
Urokinase-type plasminogen activator012012
Tissue-type plasminogen activator010010
Coagulation factor XI0202
Plasma kallikrein07115
Vitamin K-dependent protein C0505
Urokinase-type plasminogen activator0606
Trypsin-1017017
Trypsin-2014014
Sodium/hydrogen exchanger 10808
Sodium/hydrogen exchanger 30505
Trypsin-3014014
Sodium channel protein type 5 subunit alpha036036
Sodium/hydrogen exchanger 50606
90-kda heat shock protein beta HSP90 beta, partial012012
MPI protein0707
histone-lysine N-methyltransferase NSD2 isoform 10004
Poly [ADP-ribose] polymerase 1 0202
Uridine phosphorylase 10101
Uridine phosphorylase 10014
Glutathione S-transferase P0505
ubiquitin carboxyl-terminal hydrolase 2 isoform a740074
Disintegrin and metalloproteinase domain-containing protein 17549063
Chain A, Deoxycytidine kinase0101
Chain A, Deoxycytidine kinase0101
Chain A, 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase0011
Chain C, 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase0011
Chain A, 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase0011
Chain A, 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase0011
Chain C, 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase0011
Chain A, 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase0011
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase0011
Janus kinase 2 (a protein tyrosine kinase)0101
Orotidine 5'-phosphate decarboxylase0404
Uridine 5'-monophosphate synthase0404
P2Y purinoceptor 201910
P2Y purinoceptor 40044
Thymidine phosphorylase02111
Glucocorticoid receptor148982
Chain A, Mitogen-activated protein kinase 30101
Adenosine kinase0101
Adenosine kinase0303
Adenosine kinase0202
Histone-lysine N-methyltransferase, H3 lysine-79 specific09312
Dihydropyrimidine dehydrogenase [NADP(+)]0202
Cytochrome P450 2D601254131
Potassium voltage-gated channel subfamily A member 20011
Potassium voltage-gated channel subfamily A member 30011
Potassium voltage-gated channel subfamily A member 60011
Potassium voltage-gated channel subfamily A member 50415
Cytochrome P450 2C19088292
Potassium voltage-gated channel subfamily C member 10011
Pannexin-10303
Canalicular multispecific organic anion transporter 1010014
Trifunctional purine biosynthetic protein adenosine-30606
Bifunctional purine biosynthesis protein ATIC0809
Bifunctional purine biosynthesis protein ATIC0101
Signal transducer and activator of transcription 1-alpha/beta0123
CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase 0001
Dihydroorotate dehydrogenase (quinone), mitochondrial0001
Catechol O-methyltransferase0416
Cyclic AMP-responsive element-binding protein 10002
Genome polyprotein0303
nuclear receptor subfamily 0 group B member 1010010
steroidogenic factor 10909
Dihydrofolate reductase0202
Cytochrome P450 11B1, mitochondrial 0404
Histidine decarboxylase0235
Dihydrofolate reductase0707
Protein arginine N-methyltransferase 50415
Indolethylamine N-methyltransferase0202
Catechol O-methyltransferase0404
S-methyl-5'-thioadenosine phosphorylase0001
Methylosome protein 500213
Spermidine synthase 0101
5-methylthioadenosine/S-adenosylhomocysteine deaminase0003
MSH0004
Heat shock protein hsp-16.20202
Nuclear hormone receptor family member daf-120336
oxysterols receptor LXR-beta isoform 10336
Translation factor GUF1, mitochondrial0101
Methylated-DNA--protein-cysteine methyltransferase0305
Dehydrogenase/reductase SDR family member 90202
Solute carrier organic anion transporter family member 2A104010
Hypoxanthine-guanine phosphoribosyltransferase0309
Pancreatic alpha-amylase0404
60 kDa chaperonin028028
60 kDa heat shock protein, mitochondrial036036
Caspase-1518125
10 kDa heat shock protein, mitochondrial036036
Thiosulfate sulfurtransferase034034
60 kDa chaperonin 037037
10 kDa chaperonin 037037
Cytochrome P450 2E10707
Cytochrome P450 2C8023125
Cytochrome P450 2B6021223
PINK1210021
streptokinase A precursor003434
Sialidase011011
kallikrein-7 isoform 1 preproprotein0011
Glyceraldehyde-3-phosphate dehydrogenase, glycosomal0505
ERAP1 protein0002
Acetylcholinesterase048252
Glyceraldehyde-3-phosphate dehydrogenase0808
Seed linoleate 13S-lipoxygenase-1019027
Small conductance calcium-activated potassium channel protein 30516
Cholinesterase037039
Sorbitol dehydrogenase0707
Induced myeloid leukemia cell differentiation protein Mcl-1023124
Zn finger protein 0202
Aromatase060068
17-beta-hydroxysteroid dehydrogenase type 109010
Aldo-keto reductase family 1 member B1013013
Testosterone 17-beta-dehydrogenase 3012012
17-beta-hydroxysteroid dehydrogenase type 2012012
cAMP-specific 3',5'-cyclic phosphodiesterase 4A025228
cAMP-specific 3',5'-cyclic phosphodiesterase 4C019019
Chain A, Avidin0022
Chain A, Avidin0022
Chain B, Avidin0022
Olfactory receptor 51E201910
Voltage-dependent T-type calcium channel subunit alpha-1G0314
Voltage-dependent T-type calcium channel subunit alpha-1H0314
Coagulation factor VII015015
Tissue factor020021
Oxoeicosanoid receptor 10202
Adenosine deaminase0304
Thymidine kinase0506
PAX800022
photoreceptor-specific nuclear receptor0606
transactivating tegument protein VP16 [Human herpesvirus 1]012012
Ubiquitin carboxyl-terminal hydrolase isozyme L30404
Sphingosine-1-phosphate receptor 40101
PTK2B protein tyrosine kinase 2 beta0202
Valosin-containing protein0505
Phospholipase C, gamma 10202
Apoptotic peptidase activating factor 10303
Phospholipase C, beta 3 (phosphatidylinositol-specific)0202
galactokinase120012
phospholipase A2 precursor0303
perilipin-5014014
nuclear receptor corepressor 2 isoform 20202
fructose-bisphosphate aldolase A7007
perilipin-1014014
caspase-9 isoform alpha precursor0303
sphingosine 1-phosphate receptor 10101
caspase-3 isoform a preproprotein0404
protein-arginine deiminase type-40303
cysteine protease ATG4B isoform a0303
peroxisome proliferator-activated receptor gamma isoform 20202
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a014014
tyrosyl-DNA phosphodiesterase 20101
4-(cytidine 5'-phospho)-2-C-methyl-D-erithritol kinase4004
Telomerase reverse transcriptase014115
Protein S100-A40011
putative polyprotein0303
5'-AMP-activated protein kinase subunit beta-20135
5'-AMP-activated protein kinase catalytic subunit alpha-10011
5'-AMP-activated protein kinase subunit gamma-30124
Polyunsaturated fatty acid 5-lipoxygenase0404
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase0101
M17 leucyl aminopeptidase0303
Cell division cycle 7-related protein kinase024648
Cyclin-T1021021
Cyclin-K0404
Cyclin-dependent kinase-like 5006060
G1/S-specific cyclin-E1021021
G1/S-specific cyclin-D309010
Choline-phosphate cytidylyltransferase A004747
Cyclin-H017017
CDK-activating kinase assembly factor MAT1014014
Cyclin-dependent kinase 5 activator 1026026
MAP kinase-activated protein kinase 3012930
Uncharacterized aarF domain-containing protein kinase 5005151
Homeodomain-interacting protein kinase 1043842
Leukotriene A-4 hydrolase018220
Nuclear receptor corepressor 2016016
Leukotriene C4 synthase003838
Peripheral plasma membrane protein CASK003838
Mitogen-activated protein kinase kinase kinase 13003838
Mitogen-activated protein kinase kinase kinase 7034144
Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma003838
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma003838
Serine/threonine-protein kinase OSR1003838
Serine/threonine-protein kinase Chk2073845
Wee1-like protein kinase 2004040
Uncharacterized serine/threonine-protein kinase SBK3003838
Serine/threonine-protein kinase MAK013839
Receptor tyrosine-protein kinase erbB-3053843
G protein-coupled receptor kinase 4013839
Megakaryocyte-associated tyrosine-protein kinase013839
Serine/threonine-protein kinase Nek4013839
Hormonally up-regulated neu tumor-associated kinase003838
Receptor-interacting serine/threonine-protein kinase 4003838
Cell division control protein 2 homolog003838
Calcium-dependent protein kinase 1013839
Serine/threonine-protein kinase PknB003838
Cyclin-dependent kinase-like 1003838
Mitogen-activated protein kinase kinase kinase 12013839
Serine/threonine-protein kinase PRP4 homolog003838
Serine/threonine-protein kinase 38015152
Receptor tyrosine-protein kinase erbB-40103848
Rhodopsin kinase GRK1033841
Serine/threonine-protein kinase SBK1013839
Mitogen-activated protein kinase kinase kinase 19013839
Leucine-rich repeat serine/threonine-protein kinase 2083846
Dual serine/threonine and tyrosine protein kinase023840
Mitogen-activated protein kinase kinase kinase 15003838
Serine/threonine-protein kinase VRK2013839
Cyclin-dependent kinase-like 3013839
Serine/threonine-protein kinase NIM1023840
Serine/threonine-protein kinase ULK2013839
Homeodomain-interacting protein kinase 4023840
Serine/threonine-protein kinase Nek11013839
Serine/threonine-protein kinase 35003838
Rhodopsin kinase GRK7013839
Serine/threonine-protein kinase 32A003838
Dual specificity tyrosine-phosphorylation-regulated kinase 2033841
Cyclin-dependent kinase-like 2003838
Serine/threonine-protein kinase Sgk3013839
Cyclin-dependent kinase 15013840
Smoothened homolog0639
Serine/threonine-protein kinase RIO2003838
Transient receptor potential cation channel subfamily M member 6003838
Homeodomain-interacting protein kinase 2023941
Homeodomain-interacting protein kinase 3033841
SNF-related serine/threonine-protein kinase013839
STE20/SPS1-related proline-alanine-rich protein kinase013839
Long-chain-fatty-acid--CoA ligase 5006060
SRSF protein kinase 3013839
Microtubule-associated serine/threonine-protein kinase 1003838
Chain A, Apoptosis regulator Bcl-X0101
Bcl-2-like protein 110203
Apoptosis regulator Bcl-2018624
BH3-interacting domain death agonist0404
Induced myeloid leukemia cell differentiation protein Mcl-1 homolog0011
Apoptosis regulator BAX 0112
Bcl-2-like protein 1015419
Aspartyl/asparaginyl beta-hydroxylase0707
Bcl-2-related protein A10213
Bcl-2 homologous antagonist/killer0415
Bcl-2-like protein 20707
Bcl2-associated agonist of cell death 0505
Bcl-2-binding component 3, isoforms 1/20101
Bcl-2-like protein 100202
cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 70009
Potassium voltage-gated channel subfamily E member 1012012
Potassium voltage-gated channel subfamily KQT member 1012012
Potassium voltage-gated channel subfamily D member 30606
ATP-binding cassette sub-family C member 302690269
Solute carrier family 22 member 6031035
UDP-glucuronosyltransferase 1A904017
Bile salt export pump049052
Bile salt export pump04030407
Cytochrome P450 2B10405
Cytochrome P450 1A10001
Myoglobin0101
Polyunsaturated fatty acid lipoxygenase ALOX15031031
UDP-glucuronosyltransferase 1-6011016
Arachidonate 5-lipoxygenase-activating protein0617
Cytochrome P450 2J2051051
Canalicular multispecific organic anion transporter 102620263
toxin B0001
Chain A, CARBONIC ANHYDRASE II0011
Chain A, CARBONIC ANHYDRASE II0011
Chain A, CARBONIC ANHYDRASE II0011
Chain A, Carbonic Anhydrase Ii0011
Chain A, Carbonic Anhydrase Ii0011
Chain A, Endochitinase0202
Chain A, Endochitinase0202
Chain A, Endochitinase0202
Chain A, Class Iii Chitinase Chia10101
Chain A, Carbonic anhydrase 130101
Chain A, Carbonic anhydrase II0202
Chain A, Carbonic anhydrase 20202
Chain A, Carbonic anhydrase 20202
Chain A, Carbonic anhydrase 20202
Chain A, Carbonic anhydrase 20202
Chain A, Carbonic anhydrase 20202
Chain A, Carbonic anhydrase 20202
Chain A, Carbonic anhydrase 20202
Chain A, Carbonic anhydrase 20202
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase0101
Chain B, Carbonic anhydrase0101
Chain A, Carbonic anhydrase 20101
GALC protein520052
Prolyl endopeptidase0606
Carbonic anhydrase-related protein 110103
Carbonic anhydrase 20314
Cathepsin B0303
Steryl-sulfatase0405
Translocator protein016522
Serum paraoxonase/arylesterase 1010010
Endochitinase0202
Carbonic anhydrase0202
Corticosteroid 11-beta-dehydrogenase isozyme 10415
D(2) dopamine receptor054764
Squalene synthase0506
Neuronal acetylcholine receptor subunit alpha-7011416
Carbonic anhydrase 3016016
Renin0202
Endochitinase A10202
Multidrug resistance-associated protein 10101
Carbonic anhydrase 13017223
Acidic mammalian chitinase0202
Carbonic anhydrase 70101
Carbonic anhydrase 011011
Carbonic anhydrase 0101
Carbonic anhydrase 2, isoform A 0101
Free fatty acid receptor 30044
Free fatty acid receptor 20235
Fibrinogen C domain-containing protein 10202
Chain A, 2-ENOYL-COA HYDRATASE0101
Chain B, 2-ENOYL-COA HYDRATASE0101
N-alpha-acetyltransferase 500022
Prolyl endopeptidase011011
Chain A, caspase-3, p17 subunit0101
Chain B, caspase-3, p12 subunit0101
Chain A, caspase-3, p17 subunit0101
Chain B, caspase-3, p12 subunit0101
Chain A, caspase-3, p17 subunit0101
Chain B, caspase-3, p12 subunit0101
Caspase-30808
Caspase-20123
Caspase-60101
Caspase-80101
Putative glycosyltransferase WbgO0001
Killer cell lectin-like receptor subfamily B member 1A0101
Early activation antigen CD690101
Calpain small subunit 10101
Cathepsin B015015
Calpain-1 catalytic subunit0303
karyopherin alpha 2 (RAG cohort 1, importin alpha 1), isoform CRA_b0022
Chain E, Purine nucleoside phosphorylase0101
Thymidine kinase 0809
Purine nucleoside phosphorylase0507
Purine nucleoside phosphorylase0066
Solute carrier family 22 member 6028038
Thymidine kinase 0101
Solute carrier family 22 member 8022032
Prostaglandin reductase 10204
Retinoic acid receptor alpha07819
Retinoic acid receptor beta07819
Retinoic acid receptor gamma 08820
Aspartate aminotransferase, cytoplasmic0202
Glycine receptor subunit alpha-102911
Chain A, MTA/SAH nucleosidase0101
Chain A, Ribosome-inactivating protein alpha-trichosanthin0011
Chain A, Ricin A chain0011
Chain A, Ribosome-inactivating protein 30011
Protein mono-ADP-ribosyltransferase PARP150606
Chain A, Membrane lipoprotein tmpC0033
Chain A, Membrane lipoprotein tmpC0033
Chain A, Membrane lipoprotein tmpC0033
Chain A, Structure of PAE2307 in complex with adenosine0011
Chain B, Structure of PAE2307 in complex with adenosine0011
Chain A, ADENOSINE RECEPTOR A2A0101
Chain A, ADENOSINE RECEPTOR A2A0101
Chain A, tRNA (guanine-N(1)-)-methyltransferase0011
Chain A, Uncharacterized protein MJ08830011
signal transducer and activator of transcription 6, interleukin-4 induced120012
Sodium/nucleoside cotransporter 10505
Calcium dependent protein kinase0101
Sodium/nucleoside cotransporter 20606
Phosphoglycerate kinase 1 0101
Avidin0011
Adenosine deaminase0203
Phosphoglycerate kinase 20101
Heat shock 70 kDa protein 1A 0426
Heat shock cognate 71 kDa protein0156
Inosine-5'-monophosphate dehydrogenase 1 0506
Streptavidin0022
Adenylate kinase 2, mitochondrial0203
Adenylate kinase isoenzyme 1 0203
Equilibrative nucleoside transporter 20404
Adenosine transporter 10102
Chain A, Heat Shock Protein 900011
Chain A, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE0011
Chain B, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE0011
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN0101
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN0101
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN0101
Chain A, Myosin Ie Heavy Chain0011
Chain A, Preprotein translocase secA0011
Chain A, Ribonuclease pancreatic0101
Chain A, Ribonuclease pancreatic0101
Chain A, Ribonuclease pancreatic0101
Chain A, Ribonuclease pancreatic0101
Chain A, Ribonuclease pancreatic0101
Chain A, Phosphoribosylformylglycinamidine synthase0101
Chain A, nucleoside diphosphate kinase A0011
Chain B, nucleoside diphosphate kinase A0011
Chain D, DNA polymerase III subunit gamma0011
Chain D, DNA polymerase III subunit gamma0011
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 30011
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 30011
Chain A, Kinesin-like protein KIF110101
HPr kinase/phosphorylase0011
ATP-dependent molecular chaperone HSP820326
2-dehydropantoate 2-reductase0246
Endoplasmic reticulum chaperone BiP0426
Pyruvate kinase PKM 0001
Pyruvate kinase PKLR 0001
Heat shock cognate 71 kDa protein0011
5'-nucleotidase0505
P2X purinoceptor 10044
P2Y purinoceptor 10156
P2Y purinoceptor 10044
P2X purinoceptor 10224
P2X purinoceptor 40134
P2X purinoceptor 50022
P2X purinoceptor 60022
P2X purinoceptor 30336
Heat shock protein 75 kDa, mitochondrial0606
P2Y purinoceptor 60156
P2Y purinoceptor 110156
P2Y purinoceptor 120437
Sensor protein kinase WalK0101
P2X purinoceptor 20123
Chain A, Glycogen Phosphorylase B0011
Chain B, Glycogen Phosphorylase B0011
Chain A, ADP-dependent glucokinase0101
Chain A, Ribonuclease pancreatic0202
Chain A, Ribonuclease pancreatic0202
Chain A, phosphodiesterase-nucleotide pyrophosphatase0101
Chain A, GLYCOGEN PHOSPHORYLASE B0011
Chain B, GLYCOGEN PHOSPHORYLASE B0011
Chain A, GLYCOGEN PHOSPHORYLASE B0011
2'-deoxynucleoside 5'-phosphate N-hydrolase 10101
2'-deoxynucleoside 5'-phosphate N-hydrolase 10101
Adenylate kinase isoenzyme 10002
Fructose-1,6-bisphosphatase 10303
Alkaline phosphatase, tissue-nonspecific isozyme0809
Fructose-1,6-bisphosphatase 10708
Inosine-5'-monophosphate dehydrogenase0102
Amine oxidase [flavin-containing] B022022
GTP:AMP phosphotransferase AK3, mitochondrial0001
Glycine--tRNA ligase0101
Adenosine deaminase-like protein0001
Protease 021742
Histamine H3 receptor3419
P2X purinoceptor 20123
P2X purinoceptor 40325
Muscarinic acetylcholine receptor M2082796
Muscarinic acetylcholine receptor M4081389
Muscarinic acetylcholine receptor M30321147
Muscarinic acetylcholine receptor M4030842
Muscarinic acetylcholine receptor M5031843
Muscarinic acetylcholine receptor M10878104
Muscarinic acetylcholine receptor DM10404
Muscarinic acetylcholine receptor M3080488
Muscarinic acetylcholine receptor M20217
ubiquitin-conjugating enzyme E2 N0808
Phospholipase D20101
Estrogen-related receptor gamma0325
Acetylcholinesterase015116
Chain A, Lck Kinase0101
Chain A, BCL-2-RELATED PROTEIN A100811
Chain A, Tyrosine-protein kinase Lyn0101
Chain A, Tyrosine-protein kinase Lyn0101
Skn7p0004
LAP40022
RPL19A0033
amino acid transporter AGP10011
Proto-oncogene tyrosine-protein kinase Src014317
Proto-oncogene tyrosine-protein kinase LCK 0404
Tyrosyl-DNA phosphodiesterase 1010010
pyruvate kinase PKM isoform b220022
Ephrin type-A receptor 30101
Polyamine oxidase 10101
Nischarin0404
Deoxyhypusine synthase0101
Prostaglandin E2 receptor EP1 subtype0527
Prostaglandin E2 receptor EP4 subtype0516
Prostaglandin E2 receptor EP3 subtype0527
Prostaglandin E2 receptor EP2 subtype0415
Prostacyclin receptor0527
Histidine triad nucleotide-binding protein 10011
Glutathione reductase, mitochondrial014019
Transcriptional activator protein LasR0202
Trypanothione reductase016021
Regulatory protein RhlR0203
Alanine racemase, biosynthetic0001
5-hydroxytryptamine receptor 1D010015
Adenosine deaminase0102
Transcriptional activator Myb0303
UDP-N-acetylglucosamine 1-carboxyvinyltransferase0202
UDP-N-acetylglucosamine 1-carboxyvinyltransferase0202
Glutamate receptor 109211
Glutamate receptor 209211
Glutamate receptor 30729
Glutamate receptor ionotropic, kainate 3111013
Solute carrier family 15 member 1033641
Glutamate receptor 409110
Methionine aminopeptidase0303
Corticosteroid-binding globulin014014
Mineralocorticoid receptor 113723
Mineralocorticoid receptor0303
Solute carrier organic anion transporter family member 1A1010021
Chain A, farnesyl pyrophosphate synthase0101
Geranylgeranyl pyrophosphate synthase0406
Farnesyl pyrophosphate synthase0819
Hypoxanthine-guanine phosphoribosyltransferase0202
Farnesyl pyrophosphate synthase 0404
Farnesyl pyrophosphate synthase 0202
Pepsin A0303
Renin-1 0101
Renin 0101
Cathepsin D 0404
Renin 0101
Protease 022429
retinoic acid receptor alpha isoform 10202
retinoic acid receptor RXR-alpha isoform a0202
Retinoic acid receptor alpha0336
Retinoic acid receptor gamma0235
Retinoic acid receptor RXR-alpha0111531
Retinoic acid receptor beta0235
Nuclear receptor subfamily 4 group A member 10022
Cellular retinoic acid-binding protein 20033
Retinoic acid receptor RXR-alpha03710
Retinoic acid receptor RXR-beta06511
Retinoic acid receptor RXR-beta0268
Retinoic acid receptor RXR-gamma0268
Cellular retinoic acid-binding protein 10304
Retinoic acid receptor RXR-gamma06511
Type-2 angiotensin II receptor0628
Cellular retinoic acid-binding protein 10033
Retinoic acid receptor RXR-alpha0022
kelch-like ECH-associated protein 10007
Gag-Pol polyprotein0707
D(3) dopamine receptor030030
Glutamate receptor 1237538
Glutamate receptor 3237538
Glutamate receptor 4237538
RmtA0303
Protein arginine N-methyltransferase 10707
Transient receptor potential cation channel subfamily V member 109514
Transient receptor potential cation channel subfamily A member 1001010
Cysteine protease 0606
Mitochondrial 2-oxodicarboxylate carrier0202
Bifunctional epoxide hydrolase 2030030
5-lipoxygenase 0808
P2Y purinoceptor 12014014
Thioredoxin reductase 2, mitochondrial0707
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase 0202
Nuclear receptor ROR-gamma0101
Shiga toxin subunit A0202
Histamine H3 receptor05013
Chain A, Xcogt0011
Chain A, Xcogt0011
Chain A, Xcogt0011
Transient receptor potential cation channel subfamily M member 80112
Tissue alpha-L-fucosidase0505
Prolyl endopeptidase FAP0303
Dipeptidyl peptidase 80303
Dipeptidyl peptidase 90303
Dipeptidyl peptidase 20303
calpain II, partial0202
Cathepsin G0606
Cathepsin G0101
Neutrophil elastase0101
Myeloblastin0101
Botulinum neurotoxin type A 0606
Nitric oxide synthase, endothelial0909
Nitric oxide synthase, brain016118
Nitric oxide synthase, inducible012117
Tyrosine-protein kinase 0011
3-hydroxy-3-methylglutaryl-coenzyme A reductase0202
Methylcytosine dioxygenase TET20314
Free fatty acid receptor 10179
Free fatty acid receptor 40044
Carboxylic ester hydrolase 0101
Cytochrome P450 3A60101
UDP-glucuronosyltransferase 2B7010025
Substance-K receptor054055
Thromboxane-A synthase 028028
Multidrug resistance-associated protein 1 022130
UDP-glucuronosyltransferase 2B10 0808
Prostaglandin E2 receptor EP3 subtype0303
Prostaglandin E2 receptor EP4 subtype0314
Prostaglandin E2 receptor EP1 subtype0303
Nuclear receptor subfamily 4 group A member 201910
Nuclear receptor subfamily 4 group A member 20022
Nuclear receptor subfamily 4 group A member 20022
Prostaglandin E2 receptor EP2 subtype0314
Solute carrier organic anion transporter family member 2A10409
Solute carrier organic anion transporter family member 2B10204
Solute carrier organic anion transporter family member 3A10002
Chain A, Glycogen Synthase Kinase-3 Beta0202
Chain B, Glycogen Synthase Kinase-3 Beta0202
Chain A, Glycogen Synthase Kinase-3 Beta0202
Glycogen synthase kinase-3 beta013013
MO15-related protein kinase Pfmrk 013013
fMet-Leu-Phe receptor0303
Chain A, Protein (glycogen Phosphorylase)0101
Glycogen synthase kinase-3 beta 0606
[Tau protein] kinase 0606
G1/S-specific cyclin-E20909
Protein kinase C gamma type020324
Nucleoside diphosphate kinase B0055
Dual specificity protein kinase CLK10303
G1/S-specific cyclin-D20203
Cyclin-A1018120
Cyclin homolog0707
Cyclin-dependent kinase 10013133
La-related protein 70101
Dual specificity tyrosine-phosphorylation-regulated kinase 1A0606
putative alpha-glucosidase3003
Glutamate receptor ionotropic, NMDA 2D07310
Glutamate receptor ionotropic, NMDA 3B07310
Matrix protein 20112
Matrix protein 20123
Glutamate receptor ionotropic, NMDA 2C07310
Glutamate receptor ionotropic, NMDA 3A07310
Multidrug and toxin extrusion protein 1040040
Mcl-1013013
hypothetical protein SA14220202
Gamma-aminobutyric acid receptor subunit pi024024
Gamma-aminobutyric acid receptor subunit delta024024
Group 10 secretory phospholipase A20101
Phospholipase A20101
Estrogen receptor021417
Neutrophil elastase022022
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-10202
Phospholipase A2, membrane associated0405
Vascular endothelial growth factor A0011
Gamma-aminobutyric acid receptor subunit beta-1026430
Gamma-aminobutyric acid receptor subunit gamma-20281543
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-10101
Gamma-aminobutyric acid receptor subunit beta-3029736
Gamma-aminobutyric acid receptor subunit alpha-50271037
Gamma-aminobutyric acid receptor subunit alpha-3027835
D(3) dopamine receptor01055115
Cytosolic phospholipase A20202
Gamma-aminobutyric acid receptor subunit alpha-2027835
Cannabinoid receptor 20459
Gamma-aminobutyric acid receptor subunit alpha-4026430
Placenta growth factor0011
Gamma-aminobutyric acid receptor subunit epsilon024024
Delta-type opioid receptor0101
5-hydroxytryptamine receptor 1D0202
Gamma-aminobutyric acid receptor subunit alpha-6027431
Estrogen receptor beta011416
Gamma-aminobutyric acid receptor subunit gamma-1024024
Gamma-aminobutyric acid receptor subunit gamma-3024024
Poly [ADP-ribose] polymerase 208614
Gamma-aminobutyric acid receptor subunit theta024024
Protein Mdm40303
E3 ubiquitin-protein ligase Mdm2111214
Aminoglycoside 3'-phosphotransferase 0002
Chain U, UROKINASE-TYPE PLASMINOGEN ACTIVATOR0202
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR0202
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR0202
Membrane primary amine oxidase 0303
Sodium/hydrogen exchanger 10303
Amiloride-sensitive sodium channel subunit alpha0101
5-hydroxytryptamine receptor 7032033
Sodium/hydrogen exchanger 20505
Acid-sensing ion channel 10303
Acid-sensing ion channel 30101
Sodium/hydrogen exchanger0202
Chain A, PLASMINOGEN0011
Chain A, PLASMINOGEN0011
Chain A, Apolipoprotein0011
Sterol O-acyltransferase 10505
Cholesterol side-chain cleavage enzyme, mitochondrial 0112
Triosephosphate isomerase0404
Steroid 17-alpha-hydroxylase/17,20 lyase0909
Cholesterol side-chain cleavage enzyme, mitochondrial0101
Aromatase0224
Cytochrome P450 11B2, mitochondrial0101
aryl hydrocarbon receptor nuclear translocator0002
transforming acidic coiled-coil-containing protein 30002
Guanine deaminase0405
Gamma-aminobutyric acid receptor subunit rho-10157
Solute carrier family 15 member 1013014
Solute carrier family 15 member 2020022
Cystathionine gamma-lyase0719
Cystathionine beta-synthase0404
Folylpolyglutamate synthase, mitochondrial0206
Solute carrier organic anion transporter family member 1A305012
Nicotinate phosphoribosyltransferase012012
microphthalmia-associated transcription factor isoform 90404
Voltage-dependent L-type calcium channel subunit alpha-1C018018
Solute carrier organic anion transporter family member 1A4010019
Voltage-dependent L-type calcium channel subunit alpha-1F038038
Lysine-specific demethylase PHF20101
Thyroid hormone receptor alpha0101
ATP-dependent translocase ABCB1026026
Beta-1 adrenergic receptor035944
Muscarinic acetylcholine receptor M5072379
Thyroid hormone receptor alpha05510
Thyroid hormone receptor beta05510
Beta-3 adrenergic receptor036743
D(2) dopamine receptor079692
Lethal factor0707
Alpha-2B adrenergic receptor01048116
Thyroid hormone receptor beta0404
ATP-dependent translocase ABCB1027735
D(4) dopamine receptor041348
Carnitine O-palmitoyltransferase 2, mitochondrial0303
Histamine H2 receptor049352
Endothelin-1 receptor011112
B2 bradykinin receptor0619
Melanocortin receptor 40808
Melanocortin receptor 5018018
Sodium channel protein type 1 subunit alpha011011
Sodium channel protein type 4 subunit alpha013015
Squalene synthase0102
C-C chemokine receptor type 2011011
Melanocortin receptor 3010010
5-hydroxytryptamine receptor 6073176
Carnitine O-palmitoyltransferase 1, liver isoform0303
C-C chemokine receptor type 40606
Sodium channel protein type 7 subunit alpha010010
Voltage-dependent L-type calcium channel subunit alpha-1D 038038
Voltage-dependent L-type calcium channel subunit alpha-1S038038
Squalene monooxygenase0101
Sodium channel protein type 9 subunit alpha017017
Lysine-specific demethylase 7A0202
Carnitine O-palmitoyltransferase 1, muscle isoform0202
Sodium channel protein type 2 subunit alpha012012
NAD-dependent protein deacetylase sirtuin-3, mitochondrial06410
Sodium channel protein type 3 subunit alpha013013
Sodium channel protein type 11 subunit alpha0909
Histone lysine demethylase PHF80303
Sodium channel protein type 8 subunit alpha010010
Sodium channel protein type 10 subunit alpha0909
Albumin001212
Angiotensin-converting enzyme060061
Alpha-2C adrenergic receptor08610100
D(1B) dopamine receptor012015
Alpha-1D adrenergic receptor082995
Histamine H1 receptor012214
Histamine H1 receptor059868
UDP-glucuronosyltransferase 1A300010
Voltage-dependent N-type calcium channel subunit alpha-1B0718
Nuclear receptor subfamily 3 group C member 3 051051
Histamine H3 receptor011213
NEDD8-activating enzyme E1 regulatory subunit isoform a0202
NEDD8-conjugating enzyme Ubc120202
Voltage-dependent L-type calcium channel subunit alpha-1C015016
Alpha-1A adrenergic receptor0271349
Alpha-1B adrenergic receptor0241240
Potassium channel subfamily K member 2 0404
Peroxisome proliferator-activated receptor delta091122
Beta-lactamase 0105
Beta-lactamase 0108
Beta-lactamase 0008
Beta-lactamase 01010
Beta-lactamase 0005
Beta-lactamase SHV-10106
Beta-lactamase SHV-102011
Beta-lactamase01011
B2 metallo-beta-lactamase 0009
Solute carrier family 15 member 2015016
Beta-lactamase 0106
Beta-lactamase 0006
Beta-lactamase 0106
Beta-lactamase 0008
Synaptojanin-20606
Synaptojanin-10606
Chain A, Mutant Al2 6e7p9g0011
Beta-lactamase 0409
Beta-lactamase 0209
Beta-lactamase 0109
Metallo-beta-lactamase type 201212
Metallo-beta-lactamase VIM-11 0008
Metallo-beta-lactamase VIM-20008
Beta-lactamase 0008
Metallo-beta-lactamase0008
Beta-lactamase 0209
Beta-lactamase OXA-70004
Beta-lactamase 0005
Beta-lactamase 0005
Beta-lactamase 0005
Efflux transporter 0004
Beta-lactamase 0108
Beta-lactamase Toho-10005
Beta-lactamase 0004
Class D beta-lactamase0105
Metallo-beta-lactamase0007
Beta-lactamase 0108
Beta-lactamase 02310
Metallo-b-lactamase 00012
Carbapenem-hydrolyzing beta-lactamase KPC02011
Beta-lactamase class B VIM-2 01215
Chain A, Pol Polyprotein0011
Chain B, Pol Polyprotein0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0101
Chain B, Protease0101
Chain A, protease0101
Chain B, protease0101
Chain A, protease0101
Chain B, protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, Protease0101
Chain B, Protease0101
Chain A, gag-pro-pol polyprotein0101
Chain B, gag-pro-pol polyprotein0101
Chain A, gag-pro-pol polyprotein0101
Chain B, gag-pro-pol polyprotein0101
Chain A, gag-pro-pol polyprotein0101
Chain B, gag-pro-pol polyprotein0101
Albumin0182961
Gag-Pol polyprotein0808
Gag-Pol polyprotein0303
Gag-Pol polyprotein0404
Gag polyprotein0303
Gag-Pol polyprotein0505
Cathepsin D0506
Gag-Pol polyprotein010111
Cytochrome P450 3A5014217
Gag-Pol polyprotein0505
Thromboxane-A synthase0206
Inner centromere protein0202
DNA polymerase III, partial230023
Aldehyde oxidase 10404
Aldehyde oxidase014018
Aldehyde oxidase 1 0707
Fatty-acid amide hydrolase 10203
Potassium channel subfamily K member 30707
Cannabinoid receptor 10629
Corticotropin-releasing factor receptor 20404
Lanosterol 14-alpha demethylase016219
Transient receptor potential cation channel subfamily V member 2011415
Amine oxidase [flavin-containing] A 015217
Nuclear factor NF-kappa-B p105 subunit020124
Hexokinase-20202
Bile acid receptor0121225
Beta-glucuronidase0303
Gastrin/cholecystokinin type B receptor113318
Chain A, retinol dehydratase0101
Glucose-6-phosphate 1-dehydrogenase011011
Triosephosphate isomerase, glycosomal0101
Atrial natriuretic peptide receptor 30202
Type-1A angiotensin II receptor 2529
Type-1 angiotensin II receptor0011
Type-1B angiotensin II receptor2608
Type-1 angiotensin II receptor08415
Type-2 angiotensin II receptor29011
Steroid C26-monooxygenase0099
Cytochrome P450 1300033
Cytochrome P450 1300033
hepatitis C virus polyprotein1001
caspase recruitment domain family, member 150202
receptor-interacting serine/threonine-protein kinase 2 isoform 10202
bcl-2-like protein 11 isoform 10088
Glucose transporter0404
Hexose transporter 1 0404
Solute carrier family 2, facilitated glucose transporter member 1010111
Beta lactamase (plasmid)0505
Ornithine decarboxylase0004
30S ribosomal protein S609111
30S ribosomal protein S709111
50S ribosomal protein L1509111
50S ribosomal protein L1009111
50S ribosomal protein L1109111
50S ribosomal protein L7/L1209111
50S ribosomal protein L1909111
50S ribosomal protein L109111
50S ribosomal protein L2009111
50S ribosomal protein L2709111
50S ribosomal protein L2809111
50S ribosomal protein L2909111
50S ribosomal protein L3109111
50S ribosomal protein L31 type B09111
50S ribosomal protein L3209111
50S ribosomal protein L3309111
50S ribosomal protein L3409111
50S ribosomal protein L3509111
50S ribosomal protein L3609111
30S ribosomal protein S1009111
30S ribosomal protein S1109111
30S ribosomal protein S1209111
30S ribosomal protein S1309111
30S ribosomal protein S1609111
30S ribosomal protein S1809111
30S ribosomal protein S1909111
30S ribosomal protein S2009111
30S ribosomal protein S209111
30S ribosomal protein S309111
30S ribosomal protein S409111
30S ribosomal protein S509111
30S ribosomal protein S809111
30S ribosomal protein S909111
50S ribosomal protein L1309111
50S ribosomal protein L1409111
50S ribosomal protein L1609111
50S ribosomal protein L2309111
30S ribosomal protein S1509111
50S ribosomal protein L1709111
50S ribosomal protein L2109111
50S ribosomal protein L3009111
50S ribosomal protein L609111
30S ribosomal protein S1409111
30S ribosomal protein S1709111
30S ribosomal protein S109111
50S ribosomal protein L1809111
50S ribosomal protein L209111
50S ribosomal protein L309111
50S ribosomal protein L2409111
50S ribosomal protein L409111
50S ribosomal protein L2209111
50S ribosomal protein L509111
30S ribosomal protein S2109111
50S ribosomal protein L2509111
50S ribosomal protein L36 209111
Protein farnesyltransferase subunit beta0101
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha0101
DNA polymerase catalytic subunit0202
DNA polymerase catalytic subunit0202
DNA polymerase beta011011
DNA polymerase beta0606
DNA polymerase catalytic subunit0202
DNA polymerase catalytic subunit0202
DNA polymerase alpha catalytic subunit0314
DNA polymerase delta catalytic subunit0202
DNA polymerase catalytic subunit0101
DNA polymerase subunit gamma-10112
DNA polymerase lambda0303
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0303
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0303
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0303
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0303
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0303
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0303
Chain A, Transthyretin0055
Chain A, Transthyretin0055
Chain A, Transthyretin0055
Chain A, Transthyretin0055
Chain B, Transthyretin0055
Chain A, Transthyretin0055
Chain B, Transthyretin0055
Chain A, Casein kinase II subunit alpha0202
Chain A, Casein kinase II subunit alpha0202
Chain A, Casein Kinase Ii Subunit Alpha0202
Poly [ADP-ribose] polymerase tankyrase-1011314
Lysozyme C-10202
Myeloperoxidase016016
Beta-glucuronidase0303
Mucin-10101
Peroxisome proliferator-activated receptor gamma011516
Homeobox protein Nkx-2.5 0202
Estrogen receptor0022
Lactoperoxidase04011
Transcription factor GATA-4 0202
Substance-K receptor015015
Casein kinase II subunit alpha 3019221
Myocilin0011
Prenyltransferase homolog0005
Poly [ADP-ribose] polymerase tankyrase-2011718
Carboxylic ester hydrolase 0709
NADPH oxidase 40505
Estrogen receptor beta0022
Short transient receptor potential channel 50606
2,3-bisphosphoglycerate-independent phosphoglycerate mutase140014
Chain A, Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Stuart-Prower factor)0101
Coagulation factor X0101
Tryptophan 5-hydroxylase 10707
D031032
D(2) dopamine receptor0707
D(1B) dopamine receptor019019
D(4) dopamine receptor020121
D0202
D0404
Substance-P receptor018321
Neuromedin-K receptor0538
Substance-P receptor0101
Chain A, ADIPOCYTE LIPID-BINDING PROTEIN0011
Chain A, SERUM ALBUMIN0022
Chain A, SERUM ALBUMIN0022
Calmodulin 0359
Solute carrier organic anion transporter family member 1B3062073
Cytosolic phospholipase A2 gamma0202
Solute carrier organic anion transporter family member 1B1062073
Taste receptor type 2 member 160024
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN0033
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN0033
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN0033
Nitric oxide synthase, endothelial0518
Cationic amino acid transporter 30202
Vasopressin V2 receptor06310
Oxytocin receptor0347
Vasopressin V1a receptor0134
Vasopressin V1a receptor011415
Vasopressin V1b receptor0336
Vasopressin V2 receptor0011
Vasopressin V1b receptor0214
Translocator protein0305
Oxytocin receptor0213
Vasopressin V2 receptor 0325
Integrin alpha-50303
Integrin beta-50202
Integrin alpha-20101
Integrin alpha-30101
Integrin beta0112
Glycoprotein IIb0112
NS5 0044
Adenosylhomocysteinase0101
NAD-dependent protein deacetylase sirtuin-2018119
NAD-dependent protein deacetylase sirtuin-1016119
Nuclear factor NF-kappa-B p100 subunit 017019
Transcription factor p65025230
Chain A, Hyaluronidase, phage associated0101
Albumin0315
Urease0607
Prolyl 4-hydroxylase subunit alpha-10001
Hyaluronate lyase0101
Prolyl hydroxylase EGLN20146
Egl nine homolog 104611
Prolyl hydroxylase EGLN30045
Hypoxia-inducible factor 1-alpha inhibitor0405
Solute carrier family 23 member 10101
Pancreatic alpha-amylase08012
Tyrosine-protein phosphatase non-receptor type 2015015
DNA repair protein RAD52 homolog0909
Neutral amino acid transporter A0505
Neutral amino acid transporter B(0)0505
Carbonic anhydrase-like protein, putative00010
Amino acid transporter0505
Excitatory amino acid transporter 40202
Glutamate transporter homolog0011
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase0202
Excitatory amino acid transporter 10304
Excitatory amino acid transporter 20304
Excitatory amino acid transporter 30304
Metabotropic glutamate receptor 10124
Metabotropic glutamate receptor 20124
Chain A, Phospholipase A2 isoform 30011
GTP-binding protein (rab7)0066
ras protein, partial0066
Rac1 protein0066
cell division cycle 42 (GTP binding protein, 25kDa), partial0066
Prostaglandin-H2 D-isomerase0202
Fatty acid-binding protein, liver015318
Glutathione hydrolase 1 proenzyme0101
Urotensin-2 receptor0202
4-aminobutyrate aminotransferase, mitochondrial0202
Ras-related protein Rab-2A0066
Rho-associated protein kinase 20505
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial0505
Cyclin-Y0202
Beta-1 adrenergic receptor 0169
Beta-2 adrenergic receptor024934
Beta-2 adrenergic receptor06513
Solute carrier organic anion transporter family member 2B1 014020
Insulin receptor 0909
Dipeptidyl peptidase 40202
3-hydroxy-3-methylglutaryl-coenzyme A reductase 0808
Dihydroorotate dehydrogenase 0505
Dihydroorotate dehydrogenase (fumarate)0303
Dihydroorotate dehydrogenase (quinone), mitochondrial010112
Dihydroorotate dehydrogenase 0606
Dihydroorotate dehydrogenase (quinone), mitochondrial0405
Sterol O-acyltransferase 20202
Sterol O-acyltransferase 10505
Endothelin receptor type B0516
Endothelin receptor type B0101
Atrial natriuretic peptide receptor 10213
Atrial natriuretic peptide receptor 1 0011
cystic fibrosis transmembrane conductance regulator0505
short transient receptor potential channel 6 isoform 10011
Muscarinic acetylcholine receptor M10338
Muscarinic acetylcholine receptor M40315
Muscarinic acetylcholine receptor07210
NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial0101
Cytochrome c oxidase subunit NDUFA40101
Acyl carrier protein, mitochondrial0101
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10101
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial0101
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial0101
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 30101
NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial0101
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 0101
NADH dehydrogenase [ubiquinone] iron-sulfur protein 50101
NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial0101
NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial0101
NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial0101
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10101
NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial0101
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 60101
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 30101
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 0101
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial0101
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial0101
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 70101
NADH dehydrogenase [ubiquinone] 1 subunit C20101
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial0101
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 100101
NADH-ubiquinone oxidoreductase chain 10101
NADH-ubiquinone oxidoreductase chain 20101
NADH-ubiquinone oxidoreductase chain 30101
NADH-ubiquinone oxidoreductase chain 4L0101
NADH-ubiquinone oxidoreductase chain 40102
NADH-ubiquinone oxidoreductase chain 50101
NADH-ubiquinone oxidoreductase chain 60101
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 70101
NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial0101
NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial0101
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial0101
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 80101
NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial0101
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 60101
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 50101
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial0101
Amine oxidase [flavin-containing] A0303
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 110101
Amine oxidase [flavin-containing] B0606
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 20101
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 30101
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 20101
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial0101
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 40101
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 120101
Complex I intermediate-associated protein 30, mitochondrial0101
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 90101
Chain A, Breast cancer type 1 susceptibility protein150015
Myc proto-oncogene protein0304
Complement component C90101
Cruzipain015015
DNA-(apurinic or apyrimidinic site) endonuclease0415
DNA-3-methyladenine glycosylase0303
Ribonuclease T0003
Cell death-related nuclease 40003
Cystathionine gamma-lyase0101
DNA polymerase iota0202
DNA polymerase eta0202
Cysteine protease ATG4B0505
Sterol O-acyltransferase 20101
Sterol O-acyltransferase 10101
Sterol O-acyltransferase 10303
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 20303
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 20303
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 20303
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 20303
Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 20303
Eukaryotic peptide chain release factor GTP-binding subunit ERF3B002222
DNA (cytosine-5)-methyltransferase 1010010
Microphthalmia-associated transcription factor0004
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, isoform CRA_a0033
Protein-arginine deiminase type-4015015
Signal transducer and activator of transcription 5A0101
Progesterone receptor020730
Gamma-aminobutyric acid type B receptor subunit 20224
Gamma-aminobutyric acid type B receptor subunit 20404
Gamma-aminobutyric acid type B receptor subunit 10224
Gamma-aminobutyric acid type B receptor subunit 10303
V-type proton ATPase subunit S10101
Vacuolar proton pump subunit B 0101
Lysine-specific demethylase 4E012012
Lysine-specific histone demethylase 1A025025
Cytochrome P450 11B1, mitochondrial0505
Sodium- and chloride-dependent GABA transporter 1013013
Sodium- and chloride-dependent GABA transporter 2012012
Sodium- and chloride-dependent GABA transporter 3012012
5-hydroxytryptamine receptor 7029130
Prostaglandin G/H synthase 2 015019
Linoleate 9S-lipoxygenase-40303
1-deoxy-D-xylulose 5-phosphate reductoisomerase0505
Sodium- and chloride-dependent betaine transporter012012
Receptor-type tyrosine-protein phosphatase S0303
Prostaglandin G/H synthase 1 016020
Polyunsaturated fatty acid lipoxygenase ALOX15B0101
G-protein coupled receptor 350151429
Nucleoside diphosphate kinase, mitochondrial0011
Glutaryl-CoA dehydrogenase, mitochondrial0011
Nuclear factor erythroid 2-related factor 20003
Ghrelin O-acyltransferase0606
Kelch-like ECH-associated protein 10002
Nuclear factor erythroid 2-related factor 20001
Ghrelin O-acyltransferase0101
Ubiquitin carboxyl-terminal hydrolase 70202
5-hydroxytryptamine receptor 3E012418
5-hydroxytryptamine receptor 3B013520
Low affinity immunoglobulin epsilon Fc receptor0101
Metabotropic glutamate receptor 50325
5-hydroxytryptamine receptor 3A021629
Matrix metalloproteinase-140707
Snake venom metalloproteinase BaP10101
5-hydroxytryptamine receptor 3D012418
5-hydroxytryptamine receptor 3C012418
NACHT, LRR and PYD domains-containing protein 3 0808
Class A sortase SrtA 0303
Voltage-dependent L-type calcium channel subunit alpha-1D0809
Voltage-dependent L-type calcium channel subunit alpha-1S0809
Histone deacetylase 0505
Neuropeptide Y receptor type 10517
Neuropeptide Y receptor type 50202
Zinc finger protein mex-50011
Poly(ADP-ribose) glycohydrolase0101
Chain A, TRYPSIN0101
Chain H, Thrombin heavy chain0101
Chain H, Thrombin heavy chain0101
Chain A, PROTEIN (TRYPSIN)0101
Chain A, PROTEIN (TRYPSIN)0101
Chain A, PROTEIN (TRYPSIN)0101
Chain A, PROTEIN (TRYPSIN)0101
Chain B, PROTEIN (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)0101
Chain B, PROTEIN (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)0101
Chain B, PROTEIN (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)0101
Chain A, PROTEIN (TRYPSIN)0101
Chain A, TRYPSIN IVA0101
Chain A, trypsin II, anionic0101
Chain A, Trypsin II, anionic0101
Chain A, Trypsin II, anionic0101
Chain T, Trypsin II, anionic0101
Chain A, trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain T, Trypsin0101
Chain A, PROTEIN (TRYPSIN)0101
Coagulation factor X0101
Acrosin0202
Suppressor of tumorigenicity 14 protein0505
Branched-chain-amino-acid aminotransferase, mitochondrial0101
Chain A, Integrase0101
Chain A, Integrase0101
Chain A, T4 LYSOZYME0011
Chain A, GCN4P10011
Chain B, GCN4P10011
Chain C, GCN4P10011
Chain A, T4 LYSOZYME0011
Chain A, T4 LYSOZYME0011
Chain A, Replicase polyprotein 1ab0101
Chain A, 3C-like proteinase0101
Chain A, Mandelate racemase0101
Chain C, Mandelate racemase0101
Chain A, Mandelate racemase0101
Chain C, Mandelate racemase0101
Polymerase acidic protein0336
Mandelate racemase0101
Chain A, Oxygen-insensitive Nad(p)h Nitroreductase0101
Chain B, Oxygen-insensitive Nad(p)h Nitroreductase0101
D-amino-acid oxidase0213
D-amino-acid oxidase0415
Metabotropic glutamate receptor 50135
Monocarboxylate transporter 10205
D-aspartate oxidase0404
Serine racemase0404
Chain A, ODORANT-BINDING PROTEIN0202
Chain A, ODORANT-BINDING PROTEIN0202
Chain B, Odorant-binding Protein0202
Chain A, ODORANT-BINDING PROTEIN0202
Chain A, ODORANT-BINDING PROTEIN0202
Chain A, ODORANT-BINDING PROTEIN0202
Mu-type opioid receptor014423
Integrin beta-20213
Intercellular adhesion molecule 10213
Integrin alpha-L0527
Histamine H2 receptor0202
Cholecystokinin receptor type A0909
Proteasome subunit beta type-1011013
Proteasome subunit beta type-2011013
Proteasome subunit beta type-110607
Calpain-90404
Proteasome subunit alpha type-70607
Calpain-2 catalytic subunit0303
Proteasome subunit alpha type-10607
Proteasome subunit alpha type-20607
Proteasome subunit alpha type-30607
Proteasome subunit alpha type-40607
NF-kappa-B inhibitor alpha0011
Proteasome subunit beta type-80607
Proteasome subunit beta type-90607
Proteasome subunit alpha type-50607
Proteasome subunit beta type-40607
Proteasome subunit beta type-60607
Proteasome subunit beta type-100607
Cathepsin K0303
Proteasome subunit beta type-30607
Proteasome subunit alpha type-60629
Proteasome subunit alpha-type 80607
Proteasome subunit beta type-70607
Gamma-secretase subunit PEN-20415
Envelope glycoprotein0044
Neuraminidase0303
Neuraminidase0707
Aldo-keto reductase family 1 member C2 012012
core protein, partial0101
Sodium- and chloride-dependent GABA transporter 10202
Sodium- and chloride-dependent GABA transporter 20303
Sodium- and chloride-dependent GABA transporter 30303
Sodium- and chloride-dependent betaine transporter0101
Sodium- and chloride-dependent GABA transporter 30202
Sodium- and chloride-dependent GABA transporter 20202
Tyrosyl-DNA phosphodiesterase 20202
NAD0409
NADPH--cytochrome P450 reductase0101
Protein-glutamine gamma-glutamyltransferase 20707
Receptor-type tyrosine-protein phosphatase eta0404
Receptor protein-tyrosine kinase 0505
Mucosa-associated lymphoid tissue lymphoma translocation protein 10202
E3 ubiquitin-protein ligase Mdm2 isoform a0112
protein Mdm4 isoform 10101
Breast cancer type 1 susceptibility protein0101
BRCA1-associated RING domain protein 10101
Chain A, D-MALTODEXTRIN BINDING PROTEIN0011
Chain A, Limit Dextrinase0011
Chain A, Solute-binding protein0011
Chain A, Solute-binding protein0011
Chain B, SusD0011
Chain A, SusD0011
Chain A, SusD0011
Chain A, Alpha-hemolysin0011
Chain B, Alpha-hemolysin0011
Chain C, Alpha-hemolysin0011
Chain D, Alpha-hemolysin0011
Chain E, Alpha-hemolysin0011
Chain F, Alpha-hemolysin0011
Chain G, Alpha-hemolysin0011
Chain A, Betaine ABC transporter permease and substrate binding protein0011
Chain A, Osmoprotection protein (ProX)0011
Chain A, Glycine betaine/carnitine/choline-binding protein0022
Chain A, Glycine betaine/carnitine/choline-binding protein0022
Chain A, Glycine betaine/carnitine/choline-binding protein0022
Chain A, Glycine betaine/carnitine/choline-binding protein0022
galanin receptor type 30202
Glycine receptor subunit alpha-1039039
Glycine receptor subunit beta038038
Glycine receptor subunit alpha-2038038
Glycine receptor subunit alpha-3038038
Sodium/bile acid cotransporter010112
Ubiquitin-like modifier activating enzyme 20404
SUMO1 activating enzyme subunit 10404
SUMO-conjugating enzyme UBC90404
Zinc finger protein GLI10404
Env polyprotein 0033
Phosphodiesterase isozyme 4 0101
Transmembrane prolyl 4-hydroxylase0246
Non-structural protein 1 0404
Cytochrome P450 26A10314
Cytochrome P450 26B10202
Peroxisome proliferator-activated receptor alpha02810
Peroxisome proliferator-activated receptor delta0044
Transcription initiation factor TFIID subunit 10112
Nucleosome-remodeling factor subunit BPTF0011
Bromodomain testis-specific protein0358
Neuropeptide Y receptor type 20505
NPY-Y2 receptor 0101
Neuropeptide FF receptor 10112
Neuropeptide FF receptor 20112
Dipeptidyl peptidase 10303
Progesterone receptor0202
Glucocorticoid receptor0528
Androgen receptor0224
Progesterone receptor0213
STAT3, partial0314
signal transducer and activator of transcription 1-alpha/beta isoform alpha0314
transcription factor p65 isoform 10022
Estrogen receptor beta0225
Carbonyl reductase [NADPH] 1010012
Estrogen receptor0225
Chain A, Avidin0011
Chain A, Protein (streptavidin)0011
Chain B, Protein (streptavidin)0011
Chain A, Streptavidin0011
Chain D, Streptavidin0011
Chain A, Streptavidin0011
Chain D, Streptavidin0011
Chain A, Streptavidin0011
Chain D, Streptavidin0011
Chain A, Streptavidin Complex With Biotin0011
Chain D, Circularly Permuted Core-streptavidin E51/a460011
Chain A, Core-streptavidin0011
Chain D, Core-streptavidin0011
Chain A, Core-streptavidin0011
Chain D, Core-streptavidin0011
Chain A, Core-streptavidin0011
Chain D, Core-streptavidin0011
Chain A, Core-streptavidin0011
Chain D, Core-streptavidin0011
Chain A, Avidin0011
Chain A, Streptavidin0011
Chain B, Streptavidin0011
Chain A, Streptavidin0011
Chain B, Streptavidin0011
green fluorescent protein, partial0202
insulin-degrading enzyme isoform 10033
Receptor-type tyrosine-protein phosphatase beta0004
E3 ubiquitin-protein ligase XIAP06410
Baculoviral IAP repeat-containing protein 30123
Baculoviral IAP repeat-containing protein 20336
Baculoviral IAP repeat-containing protein 70112
Stimulator of interferon genes protein0369
RocR0101
G-protein coupled receptor 35 isoform a0101
G-protein coupled receptor 550314
CPG DNA methylase0202
Multidrug resistance protein CDR10101
Chain A, Protein kinase C, iota0101
Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform0101
cAMP-dependent protein kinase catalytic subunit alpha 0303
Serine/threonine-protein kinase LMTK30303
Beta-1 adrenergic receptor0415
Chain A, Estrogen-related receptor gamma0011
Chain A, Estrogen-related receptor gamma0011
Chain A, Estrogen-related receptor gamma0011
Chain A, Estrogen-related receptor gamma0011
GTPase KRas0516
GTP-binding protein Rheb0011
Bleomycin hydrolase0001
Myosin-2 heavy chain, non muscle0101
Myosin-2 heavy chain0101
Myosin IC heavy chain0101
Myosin-90101
Unconventional myosin-X0101
Myosin-70101
Unconventional myosin-Ib0101
Myosin-40101
Myosin-140101
Nonmuscle myosin heavy chain0101
Unconventional myosin-Va0101
Myosin heavy chain, non-muscle0101
Unconventional myosin-XV0101
Protein mono-ADP-ribosyltransferase PARP140213
Protein mono-ADP-ribosyltransferase PARP80022
Protein mono-ADP-ribosyltransferase PARP160235
Protein mono-ADP-ribosyltransferase PARP120213
Protein mono-ADP-ribosyltransferase PARP40336
Protein mono-ADP-ribosyltransferase PARP30369
RAC-alpha serine/threonine-protein kinase 0101
Insulin-like growth factor 1 receptor0101
Chain H, Proteasome component PUP10101
Chain I, Proteasome component PUP30101
Chain K, Proteasome component PRE20101
Chain L, Proteasome component C50101
Chain K, Proteasome component PRE20101
Chain L, Proteasome component C50101
26S proteasome non-ATPase regulatory subunit 110202
26S proteasome non-ATPase regulatory subunit 120202
26S proteasome non-ATPase regulatory subunit 140303
26S proteasome non-ATPase regulatory subunit 30202
Chymotrypsinogen A014015
Lysosomal protective protein0303
Chymotrypsinogen B0707
26S proteasome regulatory subunit 6A0202
Proteasome subunit beta type-80101
26S proteasome regulatory subunit 70202
Lon protease homolog, mitochondrial0101
26S proteasome non-ATPase regulatory subunit 80202
26S proteasome non-ATPase regulatory subunit 70202
26S proteasome non-ATPase regulatory subunit 40202
26S proteasome complex subunit SEM10202
26S proteasome regulatory subunit 40202
26S proteasome regulatory subunit 80202
26S proteasome regulatory subunit 10B0202
26S proteasome non-ATPase regulatory subunit 20202
26S proteasome non-ATPase regulatory subunit 60202
Proteasomal ubiquitin receptor ADRM10202
ATP-dependent Clp protease proteolytic subunit0224
26S proteasome non-ATPase regulatory subunit 10202
26S proteasome non-ATPase regulatory subunit 130202
Endothelin receptor type B0011
Deoxyhypusine synthase0101
Endothelin-1 receptor0303
Nucleophosmin0404
Glycogen phosphorylase, muscle form0202
Tyrosine-protein kinase Blk0202
Platelet-derived growth factor receptor alpha0505
Synaptic vesicular amine transporter0404
Platelet-derived growth factor receptor beta0505
Signal transducer and activator of transcription 3 0102
Protection of telomeres protein 10101
Angiotensin-converting enzyme 018120
B2 bradykinin receptor0101
B1 bradykinin receptor0202
major prion protein preproprotein Prp precursor0202
Vascular endothelial growth factor receptor 20707
Thymidine kinase0304
Thymidine kinase0005
Chain A, Dihydroneopterin aldolase0101
Chain A, Dihydroneopterin aldolase0101
Chain A, Dihydroneopterin aldolase0101
Chain A, Dihydroneopterin aldolase0101
Chain A, Dihydroneopterin aldolase0101
Chain A, Dihydroneopterin aldolase0101
Chain A, Dihydroneopterin aldolase0101
Taste receptor type 2 member 100035
cAMP-dependent protein kinase type I-alpha regulatory subunit0011
cAMP-dependent protein kinase type II-beta regulatory subunit0011
cAMP-dependent protein kinase catalytic subunit beta isoform 10011
cAMP-dependent protein kinase catalytic subunit beta isoform 30011
Cytochrome P450 3A70303
Solute carrier family 12 member 20101
Chain A, Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform0101
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform0202
Phosphatidylinositol 3-kinase catalytic subunit type 30415
Serine/threonine-protein kinase mTOR 0202
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform0202
Potassium channel subfamily K member 30101
Potassium channel subfamily K member 90101
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI0808
Mu-type opioid receptor0112
Chain A, Nitrile Hydratase alpha subunit0101
Chain B, Nitrile Hydratase beta subunit0101
Methyl-accepting chemotaxis protein NahY0033
Leukotriene B4 receptor 1110214
Leukotriene B4 receptor 216210
UDP-glucuronosyltransferase 1A100309
Acyl-CoA desaturase 10303
Kinesin-1 heavy chain0505
Coiled-coil domain-containing protein 60606
SAFB-like transcription modulator0101
RNA polymerase beta subunit (EC 2.7.7.6), partial0505
Lipoxygenase 0202
Neuraminidase0202
Tyrosine-protein phosphatase non-receptor type 70505
Dual specificity protein phosphatase 30606
Hyaluronidase-10404
BiP isoform A0101
Aldo-keto reductase family 1 member A10606
Aldo-keto reductase family 1 member C40707
Aldo-keto reductase family 1 member C10909
Chain A, Glycogen Phosphorylase0101
Chain A, Glycogen phosphorylase, liver form0022
Chain A, glycogen phosphorylase, liver form0022
Chain A, Glycogen phosphorylase, liver form0022
Chain A, Glycogen phosphorylase, liver form0022
Chain A, Chitinase0101
Glycogen phosphorylase, liver form0303
Glycogen phosphorylase, muscle form0101
Chitotriosidase-10415
Adenosine receptor A2b0114
Palmitoleoyl-protein carboxylesterase NOTUM0235
Endochitinase B10415
electroneutral potassium-chloride cotransporter KCC20022
TSHR protein8008
LacZ protein (plasmid)0134
XBP10303
type-1 angiotensin II receptor0303
apelin receptor0404
DNA damage-inducible transcript 3 protein0303
Chain A, Vitamin D Nuclear Receptor0011
Vitamin D3 receptor0011
Vitamin D-binding protein0011
Vitamin D3 receptor0113
Vitamin D3 receptor0022
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial0516
Vitamin D3 receptor0112
Transporter0505
Vitamin D3 receptor A0022
Neurogenic locus notch homolog protein 10101
Serine protease hepsin0707
Furin0202
Hepatocyte growth factor activator0415
Multidrug and toxin extrusion protein 2022022
Transmembrane protease serine 60303
DNA topoisomerase 0101
Type-2 restriction enzyme ScaI0101
Deoxyribonuclease-2-alpha0101
Deoxyribonuclease-10101
Type-2 restriction enzyme PstI0101
Type-2 restriction enzyme EcoRI0101
DNA ligase0202
Heterogeneous nuclear ribonucleoprotein A10022
Type-2 restriction enzyme BamHI0101
Somatostatin receptor type 10202
Somatostatin receptor type 20202
Somatostatin receptor type 40202
Somatostatin receptor type 30202
Somatostatin receptor type 50202
Type-2 restriction enzyme HindIII0101
Ribonuclease pancreatic0303
DNA topoisomerase 10315
DNA topoisomerase 10101
DNA topoisomerase type IB small subunit 0011
Cytochrome P450 2C11 0303
Steroid 17-alpha-hydroxylase/17,20 lyase 0303
N-acylethanolamine-hydrolyzing acid amidase0202
Heat sensitive channel TRPV30123
Transient receptor potential cation channel subfamily M member 80527
Transient receptor potential cation channel subfamily V member 40437
G-protein coupled receptor 550134
Inhibin alpha chain0101
Transient receptor potential cation channel subfamily M member 80338
Transient receptor potential cation channel subfamily V member 40213
Protein phosphatase 1B0202
Serine/threonine-protein phosphatase PP1-gamma catalytic subunit0202
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B 0303
Chain A, Beta-lactoglobulin0011
Chain A, Beta-lactoglobulin0011
UDP-3-O-acyl-N-acetylglucosamine deacetylase0011
NADH-ubiquinone oxidoreductase chain 10404
Chain A, angiotensin converting enzyme0101
Chain A, angiotensin converting enzyme0101
Neprilysin0202
Neprilysin0303
EEF1AKMT4-ECE2 readthrough transcript protein0202
Leukotriene A-4 hydrolase0101
Endothelin-converting enzyme 10202
Succinyl-diaminopimelate desuccinylase0404
Beta-lactamase 0305
Beta-lactamase 0303
Neuronal acetylcholine receptor subunit alpha-306310
Neuronal acetylcholine receptor subunit alpha-20438
Neuronal acetylcholine receptor subunit beta-30438
Neuronal acetylcholine receptor subunit beta-406310
Neuronal acetylcholine receptor subunit alpha-50438
Neuronal acetylcholine receptor subunit alpha-606310
Neuronal acetylcholine receptor subunit alpha-90438
Muscarinic acetylcholine receptor M30126
Neuronal acetylcholine receptor subunit alpha-100438
Major prion protein0077
Sodium channel protein type 1 subunit alpha1607
Sodium channel protein type 2 subunit alpha1809
Sodium channel protein type 3 subunit alpha1506
Frizzled-80011
Chain A, PAPAIN2002
Chain A, serum paraoxonase0101
COUP transcription factor 2 isoform a0202
ATP-diphosphohydrolase 10101
Proteasome subunit beta type-20101
Proteasome subunit beta type-10101
Glutathione S-transferase omega-10606
Sodium/hydrogen exchanger 10303
Sodium/hydrogen exchanger 30101
Sodium/hydrogen exchanger 30101
Sodium/hydrogen exchanger 20101
Tyrosine-protein phosphatase 10303
Acid ceramidase0101
Sulfide:quinone oxidoreductase, mitochondrial0101
Glutathione reductase0303
Solute carrier family 22 member 50002
Solute carrier family 22 member 50203
Solute carrier family 22 member 160001
Solute carrier family 22 member 210001
Solute carrier family 22 member 50002
Pancreatic triacylglycerol lipase0404
Chain A, Protein kinase CK2, alpha Subunit0101
Chain A, PROTEIN KINASE CK2, alpha SUBUNIT0101
Chain A, Protein Kinase Ck2, Alpha Subunit0101
Serine/threonine-protein kinase Sgk10303
Casein kinase II subunit alpha 0202
Casein kinase II subunit beta0202
Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase0022
Arginase 010011
Chain A, Neutrophil gelatinase-associated lipocalin0011
3-dehydroquinate synthase0203
Potassium-transporting ATPase subunit beta0304
Potassium-transporting ATPase alpha chain 10304
Autoinducer 2-binding periplasmic protein LuxP0505
Glutaminase kidney isoform, mitochondrial0101
Glutaminase kidney isoform, mitochondrial0112
DNA (cytosine-5)-methyltransferase 3A0112
Cyclin-C0617
Protein Wnt-3a0202
Cyclin-dependent kinase 190011
Cyclin-dependent kinase 80011
Solute carrier family 22 member 708014
Solute carrier family 22 member 11010017
Solute carrier family 22 member 8014017
Solute carrier family 22 member 707011
Beta-lactamase 0106
Beta-lactamase 0003
Metallo-beta-lactamase VIM-19 0007
Beta-lactamase 0107
Beta-lactamase0003
Beta-lactamase0003
Beta-lactamase0104
Beta-lactamase 0107
Metallo-beta-lactamase VIM-20008
Beta-lactamase 0005
BlaVIM-1 0007
Beta-lactamase 0004
Beta-lactamase 0107
Solute carrier family 22 member 808011
Insulin-degrading enzyme0404
Beta-lactamase 0205
Beta-lactamase 0003
DNA dC->dU-editing enzyme APOBEC-3A isoform a0202
L-ornithine N(5)-monooxygenase0112
Ubiquitin carboxyl-terminal hydrolase isozyme L10202
Receptor-type tyrosine-protein phosphatase epsilon0404
Tyrosine-protein phosphatase non-receptor type 60909
Tryptophan 2,3-dioxygenase0809
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN0101
Heat shock factor protein 10314
Tyrosine-protein phosphatase non-receptor type 11010012
Regulator of G-protein signaling 170314
Ubiquitin carboxyl-terminal hydrolase 150101
Ubiquitin carboxyl-terminal hydrolase isozyme L50101
Chain A, Carbonic anhydrase II0101
Cytochrome c oxidase subunit 10202
Cytochrome c oxidase subunit 20101
Catechol O-methyltransferase0101
Cytochrome c oxidase subunit 20707
Quinolone resistance protein NorA0607
Prostaglandin G/H synthase 10707
Prostaglandin G/H synthase 2014015
Prostaglandin G/H synthase 10101
Cyclooxygenase-2 0202
Beta-lactamase OXA-100002
Beta-lactamase 0004
Beta-lactamase IMP-1 0004
Beta-lactamase 0004
DNA (cytosine-5)-methyltransferase 1 isoform b0101
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 10505
Beta-lactamase OXA-10103
Beta-lactamase 0003
Chain A, STROMELYSIN-10101
Chain A, COLLAGENASE 30101
Tumor necrosis factor receptor superfamily member 1A0101
Stromal cell-derived factor 10101
Sortase A0303
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 0202
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 0101
Aromatic-L-amino-acid decarboxylase0101
Ileal sodium/bile acid cotransporter0709
Bile acid receptor0145
Tyrosine-protein phosphatase YopH0202
Nicotinamide phosphoribosyltransferase0415
Dihydroxyacetone phosphate acyltransferase0002
Methionine--tRNA ligase, mitochondrial0011
calcineurin A1, putative0044
hepatocyte nuclear factor 4-alpha isoform 20303
protein AF-9 isoform a0006
melanocortin receptor 40213
CAAX prenyl protease0002
bcl-2-related protein A10505
hexokinase HKDC10112
DNA repair protein RAD52 homolog isoform a0007
Peroxisomal N(1)-acetyl-spermine/spermidine oxidase0203
Spermine oxidase0202
1,3-beta-D-glucan synthase catalytic subunit 0101
Dihydrofolate reductase 0404
Riboflavin-binding protein0235
Histidine-rich protein PFHRP-II0607
Spike glycoprotein0224
DNA ligase 10101
Calcium-dependent protein kinase 10112
DNA ligase A0101
Phosphoethanolamine N-methyltransferase0202
Cysteine proteinase falcipain 2a 0404
Cysteine proteinase falcipain 2a 0101
MBT domain-containing protein 10202
Lethal(3)malignant brain tumor-like protein 40202
Lethal(3)malignant brain tumor-like protein 30202
Chloroquine resistance transporter0505
Lethal(3)malignant brain tumor-like protein 10202
NADPH oxidase 10505
Snq2p0009
Adenylate cyclase type 1 0303
Major prion protein0112
Cys-loop ligand-gated ion channel0101
Sphingomyelin phosphodiesterase0303
Adenylate cyclase type 30303
Adenylate cyclase type 20314
Adenylate cyclase type 40303
Histamine H1 receptor07614
Pleiotropic ABC efflux transporter of multiple drugs09018
Adenylate cyclase type 80303
Gastrin/cholecystokinin type B receptor0505
Adenylate cyclase type 60303
Adenylyl cyclase 7 0303
Cytochrome P450 1440088
Steroid C26-monooxygenase0088
Cholesterol 24-hydroxylase0224
Phospholipase A20426
G-protein coupled bile acid receptor 10112
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Acetylcholinesterase0022
Chain A, Putative Glycine Betaine-binding Abc Transporter Protein0011
Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN0011
Chain A, Choline-binding protein0011
Sodium- and chloride-dependent creatine transporter 10101
High affinity choline transporter 10101
Chain A, Glycogen phosphorylase, muscle form0101
Chain A, Glycogen phosphorylase, muscle form0101
Cholecystokinin receptor type A111012
Cholecystokinin receptor type A010414
Gastrin/cholecystokinin type B receptor010515
Nuclear receptor corepressor 10505
15-hydroxyprostaglandin dehydrogenase [NAD(+)]0303
Beta-2 adrenergic receptor08111
Beta-1 adrenergic receptor010316
Dipeptidase 10101
Beta-3 adrenergic receptor0617
Integrin beta-60101
Potassium-transporting ATPase alpha chain 10202
Potassium-transporting ATPase subunit beta0202
Histamine H4 receptor0729
Solute carrier family 22 member 40404
Extracellular calcium-sensing receptor0022
shiga toxin 1 variant A subunit3003
shiga toxin 1 B subunit3003
Cell division protein FtsZ0115
DNA gyrase subunit B0202
DNA gyrase subunit A0202
DNA gyrase subunit B0507
DNA gyrase subunit A010015
DNA gyrase subunit B010115
DNA topoisomerase 4 subunit A0202
DNA topoisomerase 4 subunit B0203
DNA topoisomerase 4 subunit A0506
DNA gyrase subunit A0507
Multidrug resistance protein MdtK0033
DNA gyrase subunit B09011
DNA gyrase subunit A010012
Enoyl-[acyl-carrier-protein] reductase [NADH]0509
DNA topoisomerase 4 subunit A0202
DNA topoisomerase 4 subunit B0202
Renin0202
5-hydroxytryptamine receptor 2A0202
Heparanase0134
Sodium-dependent noradrenaline transporter0505
Sodium-dependent serotonin transporter0505
Sodium-dependent dopamine transporter0606
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, Proto-oncogene Tyrosine-protein Kinase Src0202
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase0011
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase0011
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase0011
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase0011
Beta-lactamase0202
3-dehydroquinate dehydratase0011
ATP-citrate synthase 0304
3-dehydroquinate dehydratase0011
Prolyl 4-hydroxylase0606
Alpha-ketoglutarate-dependent dioxygenase FTO0606
N(G),N(G)-dimethylarginine dimethylaminohydrolase 109011
General amino-acid permease GAP10001
Cathepsin L20202
Type IV secretion-like conjugative transfer relaxase protein TraI 0101
Macrophage metalloelastase0606
mitogen-activated protein kinase kinase kinase kinase 2 isoform 10011
mitogen-activated protein kinase kinase kinase 3 isoform 10011
Alpha-1B adrenergic receptor 0033
Alpha-1A adrenergic receptor08311
Alpha-2B adrenergic receptor0507
Alpha-2C adrenergic receptor0507
Alpha-2A adrenergic receptor0507
Alpha-2A adrenergic receptor0202
Nischarin0404
Sigma non-opioid intracellular receptor 10101
Amine oxidase [flavin-containing] A 0607
Amine oxidase [flavin-containing] B0708
Sigma intracellular receptor 20101
beta-2 adrenergic receptor90110
Intermediate conductance calcium-activated potassium channel protein 40202
Heme oxygenase 1 0808
Epoxide hydrolase 10004
Heme oxygenase 20707
C-X-C chemokine receptor type 10303
Malate dehydrogenase, cytoplasmic0808
Transitional endoplasmic reticulum ATPase0202
Mycocyclosin synthase0044
Lanosterol 14-alpha demethylase0055
Nuclear receptor subfamily 1 group I member 3 0404
Sterol 14-alpha demethylase0033
Indoleamine 2,3-dioxygenase 20909
14-alpha sterol demethylase 0034
Cysteinyl leukotriene receptor 1013316
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION0011
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION0011
Chain H, Fab M82G2, Heavy chain0011
Chain L, Fab M82G2, Light chain0011
Chain H, Fab M82g2, Heavy Chain0011
Chain L, Fab M82g2, Light Chain0011
Fatty acid-binding protein, heart0303
Muscarinic acetylcholine receptor M20123
Lysosomal Pro-X carboxypeptidase0202
Cytochrome P450 2D10303
Cytochrome P450 2D260404
Cytochrome P450 2D30404
Kappa-type opioid receptor011317
Cytochrome P450 2D40404
Mas-related G-protein coupled receptor member X20066
Histone acetyltransferase KAT2B0505
Histone acetyltransferase KAT50202
AMP deaminase 30101
Adenosine deaminase 0202
Vesicular acetylcholine transporter0202
Tubulin polymerization-promoting protein0011
Adenylate cyclase type 80011
Relaxin receptor 10011
Nuclear receptor subfamily 1 group I member 20077
B2 bradykinin receptor0606
Dihydrofolate reductase0202
Beta-galactosidase0203
PH domain leucine-rich repeat-containing protein phosphatase 20101
Chymotrypsin-C0404
Sterol 14-alpha demethylase0325
RNA-directed RNA polymerase 0327
Receptor-type tyrosine-protein phosphatase F0606
Receptor-type tyrosine-protein phosphatase alpha0303
Exportin-10303
NAD-dependent histone deacetylase SIR20305
SUMO-10303
Sodium- and chloride-dependent creatine transporter 10101
Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 20202
Sodium-dependent phosphate transport protein 2B0101
Tyrosine-protein kinase ABL10505
HLA class II histocompatibility antigen gamma chain0101
ALK tyrosine kinase receptor0101
Angiopoietin-1 receptor0101
Lysine--tRNA ligase0202
Macrophage-stimulating protein receptor0101
Mixed lineage kinase domain-like protein0011
Echinoderm microtubule-associated protein-like 40101
Aurora kinase A-interacting protein0202
Alkaline phosphatase, germ cell type0101
G protein-coupled receptor GPR350022
G-protein coupled receptor 350011
Toll-like receptor 40202
Tyrosine-protein phosphatase non-receptor type 90101
toll-like receptor 90202
Neuronal proto-oncogene tyrosine-protein kinase Src 0102
Microtubule-associated protein tau08110
Lymphocyte antigen 960022
Protein phosphatase 1A0101
Solute carrier organic anion transporter family member 1A20108
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform0101
Chain A, Homo sapiens cyclin-dependent kinase 20101
Chain C, Cell division protein kinase 20101
Chain C, Cell division protein kinase 20101
Dual specificity protein kinase CLK20202
Dual specificity protein kinase CLK30202
Dual specificity protein kinase CLK40202
Dual specificity tyrosine-phosphorylation-regulated kinase 30303
cGMP-dependent protein kinase 1 0101
Synapsin-10101
Casein kinase I isoform alpha0101
Cyclin-dependent-like kinase 50101
Dual specificity tyrosine-phosphorylation-regulated kinase 1A0101
Cyclin-dependent kinase 200102
Multidrug resistance-associated protein 50102
Interferon regulatory factor 30011
Eukaryotic initiation factor 4A-I0112
Peptidyl-prolyl cis-trans isomerase FKBP1A0628
Peptidyl-prolyl cis-trans isomerase FKBP30101
Peptidyl-prolyl cis-trans isomerase FKBP40101
Peptidyl-prolyl cis-trans isomerase FKBP140101
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 40101
Chain A, Glutamate [NMDA] receptor subunit zeta 10101
Chain A, Glutamate [NMDA] receptor subunit zeta 10101
Chain A, Glutamate [NMDA] receptor subunit zeta 10101
S-adenosylmethionine synthase isoform type-10102
Smoothened homolog0213
Sonic hedgehog protein0203
Sonic hedgehog protein0314
Uridine-cytidine kinase 10101
chaperonin GroEL4004
5-hydroxytryptamine receptor 2C 0303
D(2) dopamine receptor0202
Histone-lysine N-methyltransferase SETD7014014
Glutaminyl-peptide cyclotransferase0505
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]0606
nuclear receptor coactivator 3 isoform a0606
Thymidine kinase 2, mitochondrial0101
Thymidine kinase0101
Probable deoxycytidylate deaminase0002
Cytidine deaminase0307
Enoyl-[acyl-carrier-protein] reductase [NADH] 0404
Deoxynucleoside kinase0101
Cdk-related protein kinase 60101
Protein kinase domain-containing protein0101
Mitogen-activated protein kinase 0101
Proline--tRNA ligase0101
Calcium-dependent protein kinase 40202
Lysine--tRNA ligase 0101
Uridine-cytidine kinase 1 0002
Seminal ribonuclease0202
Beta-galactoside alpha-2,6-sialyltransferase 10101
CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase0101
Orotidine 5'-phosphate decarboxylase 0202
Chain A, Glucose-1-phosphate cytidylyltransferase0101
Chain B, CTP synthase0101
Glucose-1-phosphate cytidylyltransferase0101
neutrophil cytosol factor 10505
Solute carrier family 2, facilitated glucose transporter member 30101
Solute carrier family 2, facilitated glucose transporter member 40202
Deoxycytidine kinase0001
Alpha-tocopherol transfer protein0011
Pirin0303
Isocitrate lyase0202
RAD510303
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 10101
Growth factor receptor-bound protein 20102
Pantothenate synthetase0202
Growth factor receptor-bound protein 2 0101
Aldehyde dehydrogenase, mitochondrial0415
Chain A, Aldehyde Dehydrogenase, Mitochondrial0101
Retinal dehydrogenase 20101
Aldehyde dehydrogenase X, mitochondrial0101
Aldehyde dehydrogenase family 1 member A30101
Interleukin-20022
Chain B, Retinoid X receptor, alpha0011
Casein kinase II subunit alpha0202
Serine/threonine-protein kinase SULU0101
Protein DBF4 homolog A0202
Sodium/glucose cotransporter 10538
Sodium/glucose cotransporter 20538
Sodium/glucose cotransporter 20112
Sodium/myo-inositol cotransporter 20202
Solute carrier family 5 member 40202
Glandular kallikrein0101
Myelin transcription factor 10101
Breakpoint cluster region protein0202
NF-kappa-B essential modulator0101
LANA0007
14-3-3 protein gamma0303
Acetylcholine receptor subunit alpha0314
Acetylcholine receptor subunit beta0314
Acetylcholine receptor subunit gamma0314
Acetylcholine receptor subunit delta0314
Acetylcholine-binding protein0213
Chain A, Odorant binding protein0011
Chain B, Odorant binding protein0011
Lysine-specific demethylase 4A0303
Deoxyhypusine hydroxylase0101
Glucose-6-phosphate 1-dehydrogenase 0101
Solute carrier organic anion transporter family member 1A500011
ATP-binding cassette sub-family C member 110002
Solute carrier organic anion transporter family member 1A10002
Solute carrier organic anion transporter family member 1B20105
Chain A, STEROID DELTA-ISOMERASE0011
Steroid Delta-isomerase0011
AAA family ATPase 0001
Chain A, Dutpase0011
Chain A, Dutpase0011
Chain B, Dutpase0011
Chain A, Dutpase0011
Chain B, Dutpase0011
Sodium-dependent neutral amino acid transporter B(0)AT20202
Alpha-1A adrenergic receptor0448
metallo beta-lactamase0202
metallo-beta-lactamase IMP-10202
glutathione S-transferase, partial0011
BZLF20303
Gamma-aminobutyric acid 0224
Alpha-1-acid glycoprotein 10001
Gamma-aminobutyric acid receptor subunit alpha-106010
Gamma-aminobutyric acid receptor subunit beta-106010
Gamma-aminobutyric acid receptor subunit alpha-20509
Gamma-aminobutyric acid receptor subunit alpha-30509
Gamma-aminobutyric acid receptor subunit alpha-60224
Gamma-aminobutyric acid receptor subunit alpha-40509
Gamma-aminobutyric acid receptor subunit gamma-20509
Gamma-aminobutyric acid receptor subunit gamma-20224
Gamma-aminobutyric acid receptor subunit delta0224
Gamma-aminobutyric acid receptor subunit alpha-20224
Gamma-aminobutyric acid receptor subunit alpha-30224
Gamma-aminobutyric acid receptor subunit gamma-30224
Translocator protein0101
Translocator protein0428
Gamma-aminobutyric acid receptor subunit beta-10224
Gamma-aminobutyric acid receptor subunit alpha-10426
Gamma-aminobutyric acid receptor subunit beta-30224
Gamma-aminobutyric acid receptor subunit alpha-50224
Gamma-aminobutyric acid receptor subunit pi0224
Sphingosine-1-phosphate lyase 10202
Gamma-aminobutyric acid receptor subunit alpha-40224
Gamma-aminobutyric acid receptor subunit theta0224
Gamma-aminobutyric acid receptor subunit gamma-10224
ATP-binding cassette sub-family C member 80415
ATP-sensitive inward rectifier potassium channel 110516
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial0303
Chain A, Cell division protein kinase 90101
Chain A, Cell division protein kinase 20101
Casein kinase II subunit beta0101
Casein kinase II subunit alpha 0101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Chain A, Carbonic anhydrase 20101
Interleukin-80303
UDP-glucuronosyltransferase 1A70206
NAD0101
ATP phosphoribosyltransferase0101
Proprotein convertase subtilisin/kexin type 70202
UDP-glucose 4-epimerase0404
High mobility group protein B10044
2-amino-3-carboxymuconate-6-semialdehyde decarboxylase0202
Chain A, DigA160022
Chain A, DigA160022
Sodium/potassium-transporting ATPase subunit alpha-1 010011
Sodium/potassium-transporting ATPase subunit beta-1010011
Sodium/potassium-transporting ATPase subunit alpha-30708
Sodium/potassium-transporting ATPase subunit beta-20708
Sodium/potassium-transporting ATPase subunit alpha-2010011
Sodium/potassium-transporting ATPase subunit alpha-10303
Potassium-transporting ATPase alpha chain 20102
Sodium/potassium-transporting ATPase subunit beta-30708
Sodium/potassium-transporting ATPase subunit gamma0708
Sodium/potassium-transporting ATPase subunit alpha-40708
Solute carrier organic anion transporter family member 4C10306
Sodium/potassium-transporting ATPase subunit alpha-20202
Sodium/potassium-transporting ATPase subunit alpha-3 0202
Sodium/potassium-transporting ATPase subunit beta-1 0303
Sodium/potassium-transporting ATPase subunit alpha-40303
Solute carrier organic anion transporter family member 4C10002
Solute carrier organic anion transporter family member 1A40001
mu-type opioid receptor isoform MOR-10044
fatty acid synthase0202
5-hydroxytryptamine receptor 2A0033
Dihydrofolate synthase/folylpolyglutamate synthase0101
ELAV-like protein 10303
Chain A, Sex Hormone-Binding Globulin0011
Sex hormone-binding globulin0202
Neuropeptide FF receptor 20002
Cereblon isoform 4010010
Insulin-like growth factor-binding protein 50011
Niemann-Pick C1 disease protein, partial1001
Thromboxane A2 receptor 0327
Prostaglandin F2-alpha receptor0202
Prostaglandin F2-alpha receptor0224
Prostaglandin F2-alpha receptor0011
Solute carrier organic anion transporter family member 2A10202
Prostaglandin E2 receptor EP4 subtype0112
Prostaglandin E2 receptor EP2 subtype0112
Solute carrier family 22 member 70001
Histamine N-methyltransferase0104
Calcium release-activated calcium channel protein 10404
Protein orai-20101
Protein orai-30101
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta0314
3',5'-cyclic-AMP phosphodiesterase 0606
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha0202
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma0202
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta0202
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma0202
Exopolyphosphatase PRUNE10101
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A0606
Phosphodiesterase 0303
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A0708
polypyrimidine tract-binding protein 1 isoform a2002
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase0303
Carbamate kinase0101
C-X-C chemokine receptor type 20202
Gasdermin-D0202
Lysyl oxidase homolog 30101
Lysyl oxidase homolog 40101
Monoglyceride lipase0404
Gasdermin-D0202
Lysyl oxidase homolog 20202
hypothetical protein CAALFM_CR05890CA0004
H3 histone acetyltransferase0004
Kinesin-like protein KIF110303
Nucleotide-binding oligomerization domain-containing protein 20202
Chain A, Synaptobrevin homolog YKT60011
Acetylcholinesterase 010010
Cholinesterase0404
Acetylcholine receptor subunit epsilon0325
Acyl-CoA:cholesterol acyltransferase 0505
Carboxylic ester hydrolase 011011
Bone morphogenetic protein 40101
UDP-galactopyranose mutase0001
N-arachidonyl glycine receptor0112
Monoacylglycerol lipase ABHD60202
N-acetyltransferase Eis0303
Pro-cathepsin H0303
Cathepsin S0202
Liver carboxylesterase0101
Cysteine protease falcipain-30202
Cysteine protease falcipain-30101
3-oxoacyl-[acyl-carrier-protein] synthase 3 0303
Arrestin, beta 10101
hexokinase0303
hexokinase-1 isoform HKI0011
phosphomannomutase 20101
phosphoethanolamine/phosphocholine phosphatase isoform 10202
eukaryotic translation initiation factor 4 gamma 1 isoform 40606
eukaryotic translation initiation factor 4E isoform 10606
Sulfhydryl oxidase 10101
Gamma-butyrobetaine dioxygenase0213
Toxin B0101
Methionine aminopeptidase 20505
Structural capsid protein 0101
Ultraspiracle0808
20-hydroxy-ecdysone receptor 0808
Ecdysone receptor0303
Ecdysone receptor0202
Protein ultraspiracle0101
Ultraspiracle 0101
20-hydroxy-ecdysone receptor 0101
Ultraspiracle protein 0101
20-hydroxy-ecdysone receptor 0101
UDP-glucuronosyltransferase 2B170001
Platelet-activating factor receptor0505
Eyes absent homolog 20202
Substance-P receptor0011
Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta))0101
Serine/threonine-protein kinase ULK30055
Serine/threonine-protein kinase 30044
Chain A, FATTY ACID-BINDING PROTEIN, BRAIN0011
Chain A, Fatty Acid-binding Protein, Brain0011
Chain A, Liver Fatty Acid Binding Protein0011
Chain A, Casein kinase II subunit alpha0101
acetyl-CoA acetyltransferase/HMG-CoA reductase0101
unnamed protein product0202
heat shock 70kDa protein 1A0202
Aldehyde oxidase 10303
dual specificity protein phosphatase 30303
heat shock cognate 71 kDa protein isoform 10202
dual specificity protein phosphatase 60202
heat shock cognate 71 kDa protein isoform 20202
Glutathione S-transferase Mu 10101
Mitogen-activated protein kinase kinase kinase 80505
DNA primase0303
Tyrosine-protein kinase Lyn 0101
Polypeptide N-acetylgalactosaminyltransferase 20639
ELAV-like protein 30404
Tyrosine-protein kinase Fgr0101
Glutathione S-transferase0101
Translin-associated protein X0101
likely tRNA 2'-phosphotransferase0202
voltage-dependent T-type calcium channel subunit alpha-1H isoform a0011
G protein-activated inward rectifier potassium channel 10011
D(2) dopamine receptor isoform long1001
Macrophage-expressed gene 1 protein0202
Serine hydrolase RBBP90101
Chain A, PROTEIN KINASE CK2, ALPHA SUBUNIT0101
Chain A, Casein kinase II, alpha chain0101
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0011
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0011
3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ0303
Protein tyrosine phosphatase type IVA 30303
Accessory gene regulator protein A0101
Genome polyprotein0101
Opioid receptor, delta 1b 0202
Opioid receptor homologue0202
Proenkephalin-B0011
Mu-type opioid receptor0202
UDP-glucuronosyltransferase 2B150002
Histone deacetylase 80718
Histone deacetylase-like amidohydrolase0617
Aldo-keto reductase family 1 member A10505
Aldo-keto reductase family 1 member A10404
Aldo-keto reductase family 1 member B70303
M18 aspartyl aminopeptidase0404
cathepsin L10303
Chain A, Troponin C, slow skeletal and cardiac muscles0011
Chain A, Peptidyl-prolyl cis-trans isomerase NIMA-interacting 10011
Chain A, POLYMERASE PA0101
Chain A, Polymerase Pa0101
Chain A, Polymerase Pa0101
Chain A, Polymerase Pa0101
Chain A, Polymerase Pa0101
Polycomb protein EED0415
NAD kinase0314
Plasminogen activator inhibitor 10303
Phosphoglycerate mutase 10303
3-oxoacyl-[acyl-carrier-protein] reductase 0101
Protein arginine N-methyltransferase 70202
HRAS, partial0001
Voltage-dependent anion-selective channel protein 20011
Cystine/glutamate transporter0404
Serine/threonine-protein kinase B-raf 0303
Motilin receptor0011
low molecular weight phosphotyrosine protein phosphatase isoform c0202
Motilin receptor0112
Chitinase B0101
Low molecular weight phosphotyrosine protein phosphatase0505
Flavin reductase (NADPH)0033
ERAP2 protein0001
M17 leucyl aminopeptidase0101
M1-family alanyl aminopeptidase0101
leucyl-cystinyl aminopeptidase [Mus musculus]0001
Chain A, GLUTATHIONE TRANSFERASE A1-10101
Chain A, Glutathione S-transferase P1-10101
Chain A, Glutathione S-transferase P1-10101
Chain B, Glutathione S-transferase P1-10101
Hematopoietic prostaglandin D synthase0303
Glutathione S-transferase A10101
14 kDa phosphohistidine phosphatase0303
FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE)0003
3-oxo-5-alpha-steroid 4-dehydrogenase 1 0303
Voltage-dependent calcium channel subunit alpha-2/delta-10303
Chain A, Carbonic anhydrase 20101
delta-type opioid receptor0011
5-hydroxytryptamine receptor 5A0011
Sodium/hydrogen exchanger 20101
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)0101
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)0101
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)0101
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)0101
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN)0101
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN)0101
Regulatory protein E20022
DNA topoisomerase 20002
DNA topoisomerase 2-alpha 0001
Chain A, Reverse transcriptase/ribonuclease H0101
Chain B, p51 RT0101
Chain A, Reverse transcriptase/ribonuclease H0101
Chain B, p51 RT0101
Reverse transcriptase 0112
Ubiquitin carboxyl-terminal hydrolase isozyme L30202
Ubiquitin carboxyl-terminal hydrolase isozyme L10202
Luciferin 4-monooxygenase0415
Vesicular glutamate transporter 30202
TGF-beta receptor type-10202
Trypanothione reductase0101
Squalene--hopene cyclase0202
Protein farnesyltransferase subunit beta0102
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha0102
Geranylgeranyl pyrophosphate synthase0203
Chain E, cAMP-dependent protein kinase, alpha-catalytic subunit0202
Chain I, cAMP-dependent protein kinase inhibitor, alpha form0202
Chain B, Rho-associated protein kinase 10202
Chain A, Rho-associated protein kinase 10202
Chain A, Rho-associated protein kinase 10202
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit0202
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit0202
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit0202
Chain I, cAMP-dependent protein kinase inhibitor alpha0202
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit0202
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit0202
Chain I, cAMP-dependent protein kinase inhibitor alpha0202
Chain A, Rho-associated protein kinase 10202
cAMP-dependent protein kinase catalytic subunit alpha isoform Calpha10002
cAMP-dependent protein kinase catalytic subunit alpha 0314
C-C motif chemokine 20202
Cell division control protein 42 homolog0202
Ras-related C3 botulinum toxin substrate 10134
Rho-associated protein kinase 20404
Cathepsin B0202
procathepsin L isoform 1 preproprotein0202
fructose-bisphosphate aldolase0101
Caspase-40505
Caspase-50505
Fatty acid-binding protein, liver0224
Peroxisome proliferator-activated receptor alpha0022
Chloride channel isoform 1 0011
Retinol-binding protein 40033
Prosaposin0011
Na(+)/H(+) exchange regulatory cofactor NHE-RF10101
Sphingosine 1-phosphate receptor 10134
RCG53912, isoform CRA_a 0001
Sphingosine kinase 1 0001
Sphingosine kinase 20506
Sphingosine kinase 10506
Chain B, Cell division protein kinase 60101
Chain A, Nicotinamide phosphoribosyltransferase0011
Chain B, Nicotinamide phosphoribosyltransferase0011
Chain A, Nicotinamide phosphoribosyltransferase0011
Chain B, Nicotinamide phosphoribosyltransferase0011
Chain A, Nicotinamide phosphoribosyltransferase0101
Chain B, Nicotinamide phosphoribosyltransferase0101
Nicotinamide phosphoribosyltransferase0101
twin arginine protein translocation system - TatA protein0003
Lanosterol 14-alpha demethylase0124
Cytochrome P450 11B1, mitochondrial0505
Cytochrome P450 11B2, mitochondrial0606
Lanosterol 14-alpha demethylase0011
Chain A, PROTEIN (TRANSTHYRETIN)0011
Chain B, PROTEIN (TRANSTHYRETIN)0011
Transcription factor SOX-180303
Transcriptional enhancer factor TEF-30224
Potassium channel subfamily K member 180112
Acid-sensing ion channel 50011
Voltage-dependent L-type calcium channel subunit beta-10101
Voltage-dependent calcium channel subunit alpha-2/delta-10101
Voltage-dependent N-type calcium channel subunit alpha-1B0101
Voltage-dependent T-type calcium channel subunit alpha-1I0213
Chain A, Uracil Phosphoribosyltransferase0101
Potassium voltage-gated channel subfamily C member 10101
Gastrin/cholecystokinin type B receptor 0101
Acid-sensing ion channel 30202
Nociceptin receptor0505
Arylacetamide deacetylase0103
Arylacetamide deacetylase0001
Arylacetamide deacetylase0001
Cytochrome P450 1A2 0303
Chain A, Dihydrofolate reductase0011
Multidrug resistance associated protein0206
Chain A, MTA/SAH nucleosidase0101
Chain B, MTA/SAH nucleosidase0101
Chain A, MTA/SAH nucleosidase0101
Chain B, MTA/SAH nucleosidase0101
Chain A, 5'-methylthioadenosine nucleosidase0101
Chain B, 5'-methylthioadenosine nucleosidase0101
Chain A, 5'-methylthioadenosine nucleosidase0101
Chain B, 5'-methylthioadenosine nucleosidase0101
Tubulin polymerization-promoting protein0101
Programmed cell death protein 10303
Beta-tubulin 0303
Programmed cell death 1 ligand 10303
Nuclear receptor subfamily 2 group C member 20203
TGF-beta-activated kinase 1 and MAP3K7-binding protein 10303
Phospholipase A-2-activating protein0707
Menin0112
Lecithin retinol acyltransferase0101
Protein Rev 0022
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha0202
Protein farnesyltransferase subunit beta0202
Geranylgeranyl transferase type-1 subunit beta0404
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha0213
Protein farnesyltransferase subunit beta0213
Fucose-binding lectin PA-IIL0202
CD209 antigen0303
Steroid hormone receptor ERR10404
Methionine aminopeptidase 10101
Holo-[acyl-carrier-protein] synthase0101
Dopamine beta-hydroxylase 0203
Dopamine beta-hydroxylase0101
Chain A, Type Iii Chloramphenicol Acetyltransferase0101
Protein-serine O-palmitoleoyltransferase porcupine0202
P-selectin0202
Lipopolysaccharide heptosyltransferase 10101
PA-I galactophilic lectin0022
Jacalin0011
Protein disulfide-isomerase0202
Chain A, ACETYLCHOLINESTERASE0101
Chain A, Acetylcholinesterase0101
L-selectin0101
E-selectin0101
Ribonuclease HI0202
integrase, partial0707
lens epithelium-derived growth factor p750707
cardiac alpha tropomyosin0202
troponin I, cardiac muscle0202
troponin T, cardiac muscle isoform 30202
troponin C, slow skeletal and cardiac muscles0202
Thioredoxin, mitochondrial0101
Gamma-aminobutyric acid receptor subunit rho-30012
Gamma-aminobutyric acid receptor subunit rho-20023
Sodium- and chloride-dependent GABA transporter 10101
Sodium- and chloride-dependent taurine transporter0202
Sodium- and chloride-dependent betaine transporter0101
4-aminobutyrate aminotransferase, mitochondrial0113
Sterol O-acyltransferase 10011
Platelet glycoprotein VI0135
Zinc finger protein GLI10101
Zinc finger protein GLI20101
7,8-dihydro-8-oxoguanine triphosphatase0707
epidermal growth factor receptor isoform a precursor2204
Heat shock protein HSP 900202
Putative heat shock protein HSP 90-alpha A40202
Heat shock protein 90, putative0011
Cytochrome P450 3A43 0101
Chain A, DEOXYNUCLEOSIDE KINASE0101
Chain A, Estrogen receptor 1 (alpha)0101
Chain A, Transthyretin0011
Chain A, Transthyretin0011
Steroid hormone receptor ERR20101
Ornithine decarboxylase0303
Solute carrier family 2, facilitated glucose transporter member 40101
Cystic fibrosis transmembrane conductance regulator0011
DNA (cytosine-5)-methyltransferase 3-like0202
DNA (cytosine-5)-methyltransferase 3A0404
beta-amyloid peptide, A beta {N-terminal} [human, cerebrospinal fluid, conditioned medium of mixed-brain cell cultures, Peptide Partial, 33 aa]1001
alpha synuclein, partial1001
Glutamate receptor ionotropic, kainate 117211
Glutamate receptor ionotropic, kainate 215310
Glutamate receptor ionotropic, kainate 41507
Glutamate receptor ionotropic, kainate 51507
Phosphatidylcholine:ceramide cholinephosphotransferase 1 0101
Phosphatidylcholine:ceramide cholinephosphotransferase 20101
SUMO-activating enzyme subunit 10303
Histone-lysine N-methyltransferase SUV39H10505
Acetolactate synthase catalytic subunit, mitochondrial0101
Mycothiol S-conjugate amidase0202
E3 ubiquitin-protein ligase RNF310101
RanBP-type and C3HC4-type zinc finger-containing protein 10101
Sharpin0101
Glucagon-like peptide 1 receptor0011
Glucagon-like peptide 1 receptor0336
Glucagon receptor0011
Glucagon receptor0011
Chain A, Phosphomannomutase/phosphoglucomutase0011
Asialoglycoprotein receptor 10112
Chain A, GLUTAMATE RECEPTOR SUBUNIT 20101
Chain A, Glutamate Receptor Subunit 20101
Chain B, Glutamate Receptor Subunit 20101
Chain A, Slr1257 protein0011
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing]0101
Bifunctional aspartokinase/homoserine dehydrogenase 10101
Metabotropic glutamate receptor 10415
Metabotropic glutamate receptor 20112
Metabotropic glutamate receptor 30213
Metabotropic glutamate receptor 40213
Metabotropic glutamate receptor 60112
Metabotropic glutamate receptor 70112
Glutamate receptor ionotropic, kainate 10325
Metabotropic glutamate receptor 80011
Excitatory amino acid transporter 3 0001
Glutamate racemase0001
Metabotropic glutamate receptor 80213
Glutamate carboxypeptidase 20101
Glutamate receptor ionotropic, kainate 20325
Glutamate receptor ionotropic, kainate 30303
Metabotropic glutamate receptor 70113
Metabotropic glutamate receptor 30113
Glutamate receptor ionotropic, kainate 50303
Glutamate racemase0001
Chain A, Glutamine Binding Protein0011
Asc-type amino acid transporter 10202
Glutathione reductase0103
ATP-binding cassette sub-family C member 90202
ATP synthase subunit beta, mitochondrial0101
ATP synthase subunit delta, mitochondrial0101
ATP synthase subunit gamma, mitochondrial0101
ATP synthase subunit epsilon, mitochondrial0101
Cholesteryl ester transfer protein0101
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E0011
Sodium- and chloride-dependent glycine transporter 10202
Large neutral amino acids transporter small subunit 1010011
Sodium- and chloride-dependent glycine transporter 20202
Sodium/bile acid cotransporter0106
Bile salt export pump0003
Solute carrier family 15 member 10001
Solute carrier family 15 member 10001
High mobility group protein B10001
Corticosteroid 11-beta-dehydrogenase isozyme 20112
Estrogen receptor 10505
Malate dehydrogenase, mitochondrial0202
Malate dehydrogenase, cytoplasmic0202
L-lactate dehydrogenase B chain0202
Type 1 InsP3 receptor isoform S2 3003
L-lactate dehydrogenase0202
L-lactate dehydrogenase0202
L-lactate dehydrogenase B chain0202
L-lactate dehydrogenase0202
Inosine-5'-monophosphate dehydrogenase 0101
estrogen receptor beta isoform 10505
Polycomb protein SUZ120404
Histone-lysine N-methyltransferase 2D0101
Protein arginine N-methyltransferase 30303
DNA (cytosine-5)-methyltransferase 3B0101
Histone-lysine N-methyltransferase 2A0606
Histone-binding protein RBBP40202
Histone-binding protein RBBP70202
Histone-lysine N-methyltransferase SETMAR0101
Zinc finger protein AEBP20101
Histone-arginine methyltransferase CARM10202
Histone-lysine N-methyltransferase 2C0101
Histone-lysine N-methyltransferase EZH10303
Histone-lysine N-methyltransferase SUV39H20202
Histone-lysine N-methyltransferase 2B0101
Chain A, Bromodomain-containing protein 40011
ATPase family AAA domain-containing protein 20011
Ricin0303
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase0022
Purine nucleoside phosphorylase 0024
Chain A, Probable hydrogenase nickel incorporation protein hypB0011
Chain B, Probable hydrogenase nickel incorporation protein hypB0011
Chain A, ELONGATION FACTOR TU (EF-TU)0011
Chain A, Elongation Factor G0011
Chain A, ADP-RIBOSYLATION FACTOR-LIKE PROTEIN 30011
Chain A, Eukaryotic peptide chain release factor GTP-binding subunit0011
Chain A, ras-related C3 botulinum toxin substrate 1 isoform Rac1b0022
Chain A, ras-related C3 botulinum toxin substrate 1 isoform Rac1b0022
Chain A, interferon-inducible GTPase0011
Chain A, interferon-inducible GTPase0011
Chain A, Elongation factor 20011
Chain A, Guanine nucleotide-binding protein G(i), alpha-1 subunit0011
Ras-related protein Rab-7a0022
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT50101
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 90404
Chain A, Hypoxanthine Phosphoribosyltransferase0202
Chain A, HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE0202
Chain A, HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE0022
Chain B, HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE0022
Chain A, HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE0022
Chain A, Xanthine phosphoribosyltransferase0011
Histidine triad nucleotide-binding protein 10011
Chain A, Uracil Phosphoribosyltransferase0011
Chain B, Uracil Phosphoribosyltransferase0011
Chain C, Uracil Phosphoribosyltransferase0011
Free fatty acid receptor 10011
Chain E, C-amp-dependent Protein Kinase0101
Chain I, Protein Kinase Inhibitor Peptide0101
Chain E, C-amp-dependent Protein Kinase0101
Chain E, C-amp-dependent Protein Kinase0101
Chain I, Protein Kinase Inhibitor Peptide0101
cAMP-dependent protein kinase type II-alpha regulatory subunit0202
cAMP-dependent protein kinase catalytic subunit beta 0202
cAMP-dependent protein kinase type II-beta regulatory subunit0202
Vitamin D-binding protein0101
HLA class I histocompatibility antigen, A alpha chain 0145
5-hydroxytryptamine receptor 3A0707
5-hydroxytryptamine receptor 2A0101
5-hydroxytryptamine receptor 2A0101
D(2) dopamine receptor0101
D(3) dopamine receptor0101
AP-2 complex subunit sigma0101
5-hydroxytryptamine receptor 2B0101
Calcitonin gene-related peptide type 1 receptor0101
Zinc finger protein 6640101
DNA repair and recombination protein RAD54-like isoform 10003
Chain A, Dual specificity tyrosine-phosphorylation-regulated kinase 1A0101
CDC-like kinase 1, isoform CRA_c0001
dual specificity protein kinase CLK41001
Sodium-dependent dopamine transporter0101
5-hydroxytryptamine receptor 1B0819
Neuromedin-B receptor0101
5-hydroxytryptamine receptor 5A0606
Mitogen-activated protein kinase 10303
Serine/threonine-protein kinase haspin0202
Dual specificity tyrosine-phosphorylation-regulated kinase 40101
Transient receptor potential cation channel subfamily V member 4 0112
Substance-K receptor0246
Chain E, Fibrin beta chain0303
Cyclin-dependent kinase 5, regulatory subunit 1 (p35)0001
CDK50001
Vesicular acetylcholine transporter0101
3-oxo-5-alpha-steroid 4-dehydrogenase 20202
envelope glycoprotein0303
neuropeptide Y receptor type 10011
neuropeptide Y receptor type 20011
small ubiquitin-related modifier 2 isoform b precursor0101
enteropeptidase precursor1001
N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D0202
N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D0101
Chain A, CARBONIC ANHYDRASE II0011
Chain A, Protein (female-specific Histamine Binding Protein 2)0011
Histamine H3 receptor0101
Histamine N-methyltransferase 0202
Equilibrative nucleoside transporter 40001
Histamine H4 receptor0123
Histamine H4 receptor0123
Histamine H4 receptor 0101
Chain A, HISTIDINE-BINDING PROTEIN0011
Histidine-binding periplasmic protein0011
Histidinol dehydrogenase0001
Intestinal-type alkaline phosphatase0606
N-glycosylase/DNA lyase0303
Chain A, Carbonic anhydrase 20202
Chain A, Carbonic anhydrase 20202
Chain A, Carbonic anhydrase 20202
Cyclic GMP-AMP synthase0303
Toll-like receptor 90101
Toll-like receptor 70125
Uracil nucleotide/cysteinyl leukotriene receptor0505
Ribonucleoside-diphosphate reductase large subunit0102
Corticosteroid 11-beta-dehydrogenase isozyme 1 0101
Oleandomycin glycosyltransferase0001
Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial0011
Dopamine beta-hydroxylase0202
Corticotropin-releasing factor receptor 10101
2-5A-dependent ribonuclease0304
Chain A, Purine-nucleoside Phosphorylase0101
Chain C, Xanthine dehydrogenase/oxidase0011
Dehydrogenase/reductase SDR family member 90101
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform 0101
Acetolactate synthase 0101
Mitogen-activated protein kinase kinase kinase 140303
P2X purinoceptor 70325
Transmembrane protease serine 40202
Beta-lactamase 0001
Metallo-beta-lactamase type 20001
Beta-lactamase 0203
Toll-like receptor 80024
Tyrosine-protein kinase JAK2 0011
Disintegrin and metalloproteinase domain-containing protein 100101
Disintegrin and metalloproteinase domain-containing protein 170101
Disintegrin and metalloproteinase domain-containing protein 80101
Disintegrin and metalloproteinase domain-containing protein 90202
Disintegrin and metalloproteinase domain-containing protein 330101
Chain A, Cell Division Protein Kinase 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, Cell Division Protein Kinase 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, CELL DIVISION PROTEIN KINASE 20101
Chain A, Cell Division Protein Kinase 20101
Chain A, PROTEIN (PROTEASE)0101
Chain B, PROTEIN (PROTEASE)0101
Chain A, PROTEIN (PROTEASE)0101
Chain B, PROTEIN (PROTEASE)0101
Chain A, HIV-1 PROTEASE0101
Chain B, HIV-1 PROTEASE0101
Chain A, HIV-II PROTEASE0101
Chain B, HIV-II PROTEASE0101
Chain A, POL polyprotein0011
Chain B, POL polyprotein0011
Chain A, POL polyprotein0011
Chain B, POL polyprotein0011
Chain A, POL polyprotein0011
Chain B, POL polyprotein0011
Chain A, POL polyprotein0011
Chain B, POL polyprotein0011
Chain A, protease RETROPEPSIN0101
Chain B, protease RETROPEPSIN0101
Chain A, protease RETROPEPSIN0101
Chain B, protease RETROPEPSIN0101
Chain A, protease RETROPEPSIN0101
Chain B, protease RETROPEPSIN0101
Chain A, POL polyprotein0202
Chain B, POL polyprotein0202
Chain A, POL polyprotein0202
Chain B, POL polyprotein0202
Chain A, HIV-1 protease0101
Chain B, HIV-1 protease0101
Chain A, Pol polyprotein0101
Chain B, Pol polyprotein0101
Chain A, Pol polyprotein0101
Chain B, Pol polyprotein0101
Chain A, Pol polyprotein0101
Chain B, Pol polyprotein0101
Chain A, Pol polyprotein0101
Chain B, Pol polyprotein0101
Chain A, Hiv-1 Protease0101
Chain B, Hiv-1 Protease0101
Chain A, Hiv-1 Protease0101
Chain B, Hiv-1 Protease0101
Chain A, Hiv-1 Protease0101
Chain B, Hiv-1 Protease0101
Protease 0101
Malate dehydrogenase0606
Kit ligand0101
Trp operon repressor0022
Peptide deformylase 1A, chloroplastic/mitochondrial0101
Peptide deformylase 0101
Chain A, membrane-associated prostaglandin E synthase-20101
Phospholipase A2, major isoenzyme0202
C-X-C chemokine receptor type 30303
Prostaglandin D2 receptor 0202
Chain A, ADENOSINE DEAMINASE0101
Chain A, ADENOSINE DEAMINASE0101
Chain A, hypoxanthine phosphoribosyltransferase0011
Chain A, hypoxanthine phosphoribosyltransferase0011
Chain A, Hypoxanthine-guanine phosphoribosyltransferase0101
Chain B, Pulmonary surfactant-associated protein D0101
Chain A, Pulmonary surfactant-associated protein D0101
Chain A, BETA-SPECTRIN0011
Chain A, Phospholipase C Delta-10011
Chain A, Inositol 1,4,5-trisphosphate receptor type 10011
Inositol-trisphosphate 3-kinase A0101
Inositol 1,4,5-trisphosphate receptor type 1 0022
Inositol 1,4,5-trisphosphate receptor type 20101
Inositol 1,4,5-trisphosphate receptor type 30112
Inositol polyphosphate-5-phosphatase A0101
Inositol 1,4,5-trisphosphate receptor type 10112
Chain A, Acetylcholinesterase0101
Chain A, meta-Cleavage product hydrolase0101
Free fatty acid receptor 30044
Neuronal acetylcholine receptor subunit beta-209111
Neuronal acetylcholine receptor subunit alpha-707512
Formamidopyrimidine-DNA glycosylase0101
Endonuclease III-like protein 10101
Putative FAD-containing monooxygenase MymA0101
Dihydrofolate reductase0202
Endonuclease 8-like 10101
Chain A, beta-galactosidase0101
Chain A, Beta-galactosidase0101
Chain A, Beta-galactosidase0101
Chain A, Beta-galactosidase0101
Chain A, Beta-galactosidase0101
Chain A, Beta-galactosidase0101
Chain A, Beta-galactosidase0101
Chain A, Beta-galactosidase0101
Chain A, Beta-galactosidase0101
Chain A, Beta-galactosidase0101
Chain A, Beta-galactosidase0101
Chain A, Beta-galactosidase0101
Chain A, Beta-galactosidase0101
Chain A, Beta-galactosidase0101
Chain A, Beta-galactosidase0101
Beta-galactosidase0101
Beta-2 adrenergic receptor0011
Beta-3 adrenergic receptor0011
Beta-2 adrenergic receptor0202
Taste receptor type 2 member 380035
Taste receptor type 2 member 390011
Taste receptor type 2 member 400011
Taste receptor type 2 member 410011
Taste receptor type 2 member 430011
Taste receptor type 2 member 310145
Taste receptor type 2 member 450011
Taste receptor type 2 member 460022
Taste receptor type 2 member 300011
Taste receptor type 2 member 190011
Taste receptor type 2 member 200011
Taste receptor type 2 member 500011
Taste receptor type 2 member 600022
Beta-2 adrenergic receptor 0112
Taste receptor type 2 member 420011
Taste receptor type 2 member 140023
Taste receptor type 2 member 130022
Taste receptor type 2 member 90022
Taste receptor type 2 member 80011
Taste receptor type 2 member 70011
Taste receptor type 2 member 50011
Taste receptor type 2 member 40022
Taste receptor type 2 member 30011
Taste receptor type 2 member 10022
Isocitrate lyase 10101
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0101
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase0101
Monoglyceride lipase0101
Monoglyceride lipase0202
Protein E60404
Chain A, Glutamate receptor 20011
Chain A, Glutamate receptor 20011
Chain C, Glutamate receptor 20011
Glutamate receptor ionotropic, kainate 40101
3-oxoacyl-[acyl-carrier-protein] synthase 30101
Gap junction alpha-1 protein0101
Gap junction beta-2 protein0101
Acyl-protein thioesterase 10101
Synaptic vesicular amine transporter0415
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial0202
Epoxide hydrolase 1 0202
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial0202
Camphor 5-monooxygenase0001
Steroid 21-hydroxylase0101
Cholesterol side-chain cleavage enzyme, mitochondrial 0101
Cytochrome P450 2A20101
Cytochrome P450 7A1 0101
Cytochrome P450 4F20101
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial0101
Cytochrome P450 7A10101
Lanosterol 14-alpha demethylase 0202
P2X purinoceptor0101
P2X purinoceptor 70202
p2X7 purinoceptor 0101
Calcium/calmodulin-dependent protein kinase type II subunit beta0101
Calcium/calmodulin-dependent protein kinase type II subunit gamma0101
Calcium/calmodulin-dependent protein kinase type II subunit delta0101
Cysteinyl leukotriene receptor 20426
Leukotriene C4 synthase0202
Leukotriene C4 synthase0001
Prostaglandin E synthase 20101
Splicing factor 3B subunit 30303
Trans-sialidase0102
Chain A, Lectin0011
Chain A, Lectin0011
Chain A, Lectin0011
Chain A, Lectin0011
Chain A, ERYTHRINA CRISTA-GALLI LECTIN0011
Chain A, ERYTHRINA CRISTA-GALLI LECTIN0011
Chain A, cellulase0011
Chain A, cellulase0011
Chain A, Galectin-30011
Chain A, Anti-tumor lectin0101
Galectin-30101
Galectin-90022
Galectin-80022
Beta-galactoside-binding lectin0101
Galectin-10124
Galectin-30112
Galectin-30124
Galectin-70022
Alpha 1,4 galactosyltransferase0001
Capsid protein 0123
WD repeat-containing protein 50404
Cytosolic endo-beta-N-acetylglucosaminidase0303
Chain A, Epidermal growth factor receptor0101
Alpha-1A adrenergic receptor 0101
Ubiquitin-like modifier-activating enzyme 10101
P2X purinoceptor 70101
matrix metalloproteinase 1, partial0011
Dihydroorotate dehydrogenase (quinone), mitochondrial0202
DNA-binding protein Ikaros0027
DNA damage-binding protein 10325
Zinc finger protein Aiolos0022
Nuclear receptor coactivator 40101
Protein delta homolog 10257
Chain A, AMINOPEPTIDASE0202
Chain A, AMINOPEPTIDASE0202
Chain A, Leucine Aminopeptidase0101
Cathepsin B 0101
Plasminogen 0101
Cysteine protease0202
Gonadotropin-releasing hormone receptor0101
Alkaline phosphatase, placental type0101
Alkaline phosphatase, tissue-nonspecific isozyme 0303
Intestinal-type alkaline phosphatase0202
Neurotensin receptor type 20549
SLC16A10 protein0004
Monocarboxylate transporter 100004
CAAX prenyl protease 2 isoform 20001
Protein-serine O-palmitoleoyltransferase porcupine0101
Isocitrate dehydrogenase [NADP] cytoplasmic0213
Potassium voltage-gated channel subfamily D member 20202
inositol monophosphatase 12002
Ephrin type-A receptor 20202
Phosphoribosylglycinamide formyltransferase0101
Trifunctional purine biosynthetic protein adenosine-30303
Potassium channel subfamily K member 90202
Type-1 angiotensin II receptor0213
5-hydroxytryptamine receptor 1A0101
Chain A, Antigen Cd11a (p180)0101
Queuine tRNA-ribosyltransferase0101
histidine kinase 0101
Chemotaxis protein CheA0101
Cytosol aminopeptidase0202
Protein polybromo-10011
DNA topoisomerase 10101
Melatonin receptor type 1C0112
5-hydroxytryptamine receptor 1E0303
Sodium-dependent dopamine transporter0101
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast0101
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast0101
Lysophosphatidic acid receptor 60011
Lysophosphatidic acid receptor 4 0011
Lysophosphatidic acid receptor 10123
Lysophosphatidic acid receptor 40011
Lysophosphatidic acid receptor 50011
Lysophosphatidic acid receptor 20011
Lysophosphatidic acid receptor 30112
Chain A, Retinoic acid receptor RXR-alpha0011
Chain A, Peroxisome proliferator-activated receptor gamma0011
C-C chemokine receptor type 60202
Chain A, Phosphoenolpyruvate carboxykinase0101
D-aspartate oxidase 0101
D-aspartate oxidase0101
Serine racemase0202
Carnitine O-palmitoyltransferase 1, muscle isoform0101
Sphingomyelin phosphodiesterase0101
Alpha-mannosidase 2C10213
Phosphatidylcholine 2-acylhydrolase 0101
Acidic phospholipase A2 beta0101
Phospholipase A20101
Phospholipase A2, membrane associated0202
Acidic phospholipase A2 20202
DNA polymerase kappa0101
C-C chemokine receptor type 50101
C-C chemokine receptor type 50101
Chain A, A disintegrin and metalloproteinase with thrombospondin motifs 50101
Chain A, Catalytic Domain of ADAMTS-50101
Chain A, A disintegrin and metalloproteinase with thrombospondin motifs 50101
Zinc metalloproteinase dpy-310101
Zinc metalloproteinase dpy-310101
ADAM100101
disintegrin and metalloproteinase domain-containing protein 17 isoform 1 preproprotein0101
Matrix metalloproteinase-200101
A disintegrin and metalloproteinase with thrombospondin motifs 40101
Tumor necrosis factor0415
Stromelysin-20101
Matrix metalloproteinase-150101
Matrix metalloproteinase-160101
Matrix metalloproteinase-250101
Matrix metalloproteinase-260101
A disintegrin and metalloproteinase with thrombospondin motifs 50101
Matrix metalloproteinase-240101
Proto-oncogene c-Fos0101
Transcription factor AP-10303
Seed linoleate 9S-lipoxygenase0101
Lipoxygenase 0101
REST corepressor 10101
Calmodulin-domain protein kinase 10101
Acetylcholine receptor subunit alpha0325
Acetylcholine receptor subunit gamma0325
Acetylcholine receptor subunit beta0325
Neuronal acetylcholine receptor subunit beta-40517
Neuronal acetylcholine receptor subunit alpha-30617
Neuronal acetylcholine receptor subunit alpha-408110
Acetylcholine receptor subunit delta0325
Neuronal acetylcholine receptor subunit alpha-20202
bioA0001
Nociceptin receptor0101
Large neutral amino acids transporter small subunit 1 0202
UDP-glucose 6-dehydrogenase0101
UDP-glucose 6-dehydrogenase0101
UDP-glucuronosyltransferase 1A1 0101
Hydroxyacid oxidase 10101
Chain A, Methionyl-tRNA synthetase0011
Chain A, Methionyl-tRNA synthetase0011
Chain A, Aminopeptidase0101
Chain A, Methionine aminopeptidase0101
S-ribosylhomocysteine lyase0101
Adenylate cyclase type 50001
S-adenosylmethionine synthase isoform type-20001
Chain B, DIHYDROFOLATE REDUCTASE0011
Chain B, DIHYDROFOLATE REDUCTASE0011
Chain B, DIHYDROFOLATE REDUCTASE0011
ATP-binding cassette sub-family C member 30103
Bifunctional dihydrofolate reductase-thymidylate synthase0101
Dihydrofolate reductase0101
Thymidylate synthase0202
Folate receptor beta0303
Folate receptor alpha0303
Dihydrofolate reductase0909
Reduced folate transporter0404
Bifunctional dihydrofolate reductase-thymidylate synthase0303
Dihydrofolate reductase 0101
Proton-coupled folate transporter0405
Cytochrome P450 2A130448
SUMO-1-specific protease0101
SUMO1/sentrin specific peptidase 70101
sentrin-specific protease 80101
T cell receptor, partial1001
luteinizing hormone receptor1001
Dihydrolipoyl dehydrogenase, mitochondrial0104
Dihydrolipoyl dehydrogenase 0102
Seed linoleate 9S-lipoxygenase-30101
5-hydroxytryptamine receptor 3B0606
Chain A, Histamine N-methyltransferase0202
Chain A, Histamine N-methyltransferase0202
Chain A, Histamine N-methyltransferase0202
Chain A, Histamine N-methyltransferase0202
Chain A, androgen receptor0011
Chain A, androgen receptor0011
Thioredoxin reductase 0101
Flavodoxin0002
G-protein coupled receptor 0101
Cytochrome P450 1A20101
methionyl-tRNA synthetase, putative0101
Chain A, PROGESTERONE RECEPTOR0101
Glucocorticoid receptor 0101
Tegument protein VP160011
Glucocorticoid receptor0112
Glucocorticoid receptor0101
Multidrug transporter MdfA0202
S-adenosylmethionine decarboxylase proenzyme0102
S-adenosylmethionine decarboxylase proenzyme0101
Chain A, Probable serine/threonine-protein kinase pknB0101
phospholipase A2, group III0202
NEDD8-activating enzyme E1 regulatory subunit0123
NEDD8-activating enzyme E1 catalytic subunit0123
Serine/threonine-protein kinase WNK30101
Putative nucleoside diphosphate kinase0011
Aurora kinase A0606
Targeting protein for Xklp20101
Aurora kinase B0101
Kinesin-like protein KIFC10101
Chain A, HEAT SHOCK PROTEIN 900011
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 10101
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 30101
Chain A, Atp-dependent Molecular Chaperone Hsp820011
Chain A, Atp-dependent Molecular Chaperone Hsp820011
Chain B, Type 2 DNA topoisomerase 6 subunit B0011
Chain A, Virulence sensor histidine kinase phoQ0011
Virulence sensor histidine kinase PhoQ0011
ATP-dependent molecular chaperone HSC820303
Proto-oncogene tyrosine-protein kinase Src 0101
Histidine kinase 0101
Cysteinyl leukotriene receptor 10202
Islet amyloid polypeptide0101
Low molecular weight phosphotyrosine protein phosphatase0101
Solute carrier family 22 member 120101
Solute carrier family 22 member 120303
Nociceptin receptor0101
Mu-type opioid receptor0101
DNA gyrase subunit B0202
Transmembrane domain-containing protein TMIGD30101
Adenosine receptor A30202
5-hydroxytryptamine receptor 1B0101
Chain A, Inosine-5'-Monophosphate Dehydrogenase 20101
Inosine-5'-monophosphate dehydrogenase0102
UDP-glucuronosyltransferase 1A80006
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-10101
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-10101
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-10101
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-10101
Chain A, Pancreatic alpha-amylase0101
Chain A, Pancreatic alpha-amylase0101
Tyrosine-protein kinase transforming protein Fps0101
Solute carrier family 2, facilitated glucose transporter member 20202
Solute carrier family 2, facilitated glucose transporter member 4 0202
DNA primase TraC0101
Aldo-keto reductase family 1 member C210505
Prolyl 4-hydroxylase, beta polypeptide0003
RNA-editing ligase 1, mitochondrial0101
Toll-like receptor 20202
Dynamin-10101
Sialidase A0101
Carboxypeptidase B20202
Prostaglandin E synthase0101
Glycogen synthase kinase-3 beta0101
Presenilin-10314
Presenilin-20314
Gamma-secretase subunit APH-1B0314
Nicastrin0314
Gamma-secretase subunit APH-1A0314
Chain A, SusD homolog0011
Sialidase-40101
Sialidase-10101
Sialidase-30101
Formyl peptide receptor-related sequence 10011
fMet-Leu-Phe receptor0224
N-formyl peptide receptor 20033
FML2_HUMAN 0011
Chain A, Venom Allergen 20011
Elastase0101
Muscarinic acetylcholine receptor 0011
Muscarinic acetylcholine receptor 0101
Glucose-dependent insulinotropic receptor0011
Glucose-dependent insulinotropic receptor0011
N(G),N(G)-dimethylarginine dimethylaminohydrolase 10002
N(G),N(G)-dimethylarginine dimethylaminohydrolase 10001
Adenosine receptor A10202
Adenosine receptor A2a0101
Chain B, Exotoxin A0011
Chain B, Exotoxin A0011
Chain B, Exotoxin A0011
ubiquitin-like modifier-activating enzyme 10101
ubiquitin-conjugating enzyme E2 variant 1 isoform a0101
Complement C1r subcomponent0101
Complement C1s subcomponent0202
DNA polymerase I, thermostable0101
Chain A, Cholix toxin0101
Beta-hexosaminidase subunit alpha0203
Hormone-sensitive lipase0101
Chain A, Hth-type Transcriptional Regulator Ttgr0022
Chain A, Hth-type Transcriptional Regulator Ttgr0022
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
G protein-activated inward rectifier potassium channel 20011
G protein-activated inward rectifier potassium channel 40011
G protein-activated inward rectifier potassium channel 10011
Chain A, ASPARTYLPROTEASE0101
Chain B, ASPARTYLPROTEASE0101
Microsomal glutathione S-transferase 10101
Adenosylhomocysteinase0102
Adenosylhomocysteinase0303
Neuromedin-K receptor0033
Substance-K receptor0303
Substance-K receptor0303
Neuromedin-K receptor0112
Neurotensin receptor type 10011
Neurotensin receptor type 20315
Myelin basic protein0011
Neurotensin receptor type 10417
Neurotensin receptor type 105512
Sortilin0202
Hydroxycarboxylic acid receptor 30011
Nicotinamidase0101
Hydroxycarboxylic acid receptor 20011
Hydroxycarboxylic acid receptor 20112
Chain A, NAD-dependent deacetylase0101
NAD-dependent protein deacetylase HST20505
NAD(+) hydrolase SARM10202
NAD-dependent protein deacetylase sirtuin-60415
NAD-dependent protein deacetylase 0101
Equilibrative nucleoside transporter 10101
Anoctamin-10202
Neuronal acetylcholine receptor subunit alpha-40213
Neuronal acetylcholine receptor subunit alpha-40101
Acetylcholine receptor subunit beta-like 20202
Neuronal acetylcholine receptor subunit alpha-50011
Neuronal acetylcholine receptor subunit alpha-70404
Neuronal acetylcholine receptor subunit beta-30112
Neuronal acetylcholine receptor subunit alpha-60112
Neuronal acetylcholine receptor subunit alpha-50202
Liver carboxylesterase B-10101
Neuronal acetylcholine receptor subunit beta-30202
Neuronal acetylcholine receptor subunit beta-40202
Neuronal acetylcholine receptor subunit alpha-30202
Soluble acetylcholine receptor0101
Neuronal acetylcholine receptor subunit alpha-20202
Neuronal acetylcholine receptor subunit beta-20213
Neuronal acetylcholine receptor subunit alpha-60202
Voltage-dependent L-type calcium channel subunit alpha-1C0101
Voltage-dependent L-type calcium channel subunit alpha-1S0101
Voltage-dependent L-type calcium channel subunit alpha-1D0101
Voltage-dependent L-type calcium channel subunit alpha-1F0101
Chain A, Phospholipase A2 isoform 30011
Voltage-dependent L-type calcium channel subunit beta-40202
Voltage-dependent P/Q-type calcium channel subunit alpha-1A0202
Voltage-dependent calcium channel gamma-3 subunit0202
Voltage-dependent L-type calcium channel subunit beta-30202
Voltage-dependent calcium channel subunit alpha-2/delta-10202
Voltage-dependent calcium channel gamma-7 subunit0202
Voltage-dependent L-type calcium channel subunit beta-10202
Voltage-dependent calcium channel gamma-1 subunit0202
Voltage-dependent L-type calcium channel subunit beta-20202
Voltage-dependent R-type calcium channel subunit alpha-1E0202
Voltage-dependent calcium channel subunit alpha-2/delta-40202
Voltage-dependent calcium channel subunit alpha-2/delta-30202
Voltage-dependent calcium channel gamma-8 subunit0202
Voltage-dependent calcium channel gamma-6 subunit0202
Voltage-dependent calcium channel subunit alpha-2/delta-20202
Voltage-dependent calcium channel gamma-4 subunit0202
Voltage-dependent calcium channel gamma-5 subunit0202
Voltage-dependent calcium channel gamma-2 subunit0202
Platelet-derived growth factor receptor beta010010
Platelet-derived growth factor receptor alpha 0707
Pyruvate-flavodoxin oxidoreductase0101
Sodium/iodide cotransporter0202
Nitric oxide synthase, inducible0202
Nitric oxide synthase, brain0202
Chain A, Glutathione-requiring prostaglandin D synthase0101
PPP5C protein, partial0101
serine/threonine-protein phosphatase PP1-alpha catalytic subunit isoform 30101
Tubulin beta 8B0011
Chain A, Gyrase0011
DNA gyrase subunit B0101
DNA gyrase subunit B0101
Cell division inhibitor SulA0001
DNA topoisomerase 4 subunit B0101
DNA topoisomerase 0101
Microtubule-associated proteins 1A/1B light chain 3B0213
Microtubule-associated proteins 1A/1B light chain 3A0213
Acyl-homoserine lactone acylase PvdQ0101
Chain A, G protein-coupled receptor kinase 60011
M-phase inducer phosphatase 30303
N-lysine methyltransferase KMT5A0213
1-acyl-sn-glycerol-3-phosphate acyltransferase beta0101
Chain A, Poly(adp-ribose) Polymerase0101
Chain A, Poly(adp-ribose) Polymerase0101
Chain A, Poly(adp-ribose) Polymerase0101
E3 ubiquitin-protein ligase Mdm20101
E3 ubiquitin-protein ligase Mdm20101
Peptidyl-prolyl cis-trans isomerase D0101
L-cysteine:1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside ligase0101
Solute carrier family 22 member 190001
STE240001
Protein mono-ADP-ribosyltransferase PARP60202
Neurogenic locus notch homolog protein 10101
Phosphotyrosine protein phosphatase 0202
Hemagglutinin [Cleaved into: Hemagglutinin HA1 chain; Hemagglutinin HA2 chain]0011
Chain A, Adipocyte Lipid-binding Protein0011
Chain A, MUSCLE FATTY ACID BINDING PROTEIN0022
Chain A, MUSCLE FATTY ACID BINDING PROTEIN0022
Chain A, MUSCLE FATTY ACID BINDING PROTEIN0022
putative potassium channel subunit0011
Bifunctional cytochrome P450/NADPH--P450 reductase0011
Bombesin receptor subtype-30011
Interleukin-6 receptor subunit alpha0101
Thyrotropin-releasing hormone receptor0101
Glycine receptor subunit alpha-40101
Leukotriene B4 receptor 10101
Lipoprotein lipase0101
Hepatic triacylglycerol lipase0101
Diacylglycerol lipase-alpha0101
Acyl-protein thioesterase 20101
Endothelial lipase0101
Chain A, ARGINASE 10101
Chain A, Arginase 10101
Chain A, ARGINASE 10101
Chain A, L-ARGININE\\:GLYCINE AMIDINOTRANSFERASE0101
Solute carrier family 2, facilitated glucose transporter member 90224
Chain H, Igg2b-kappa 40-50 Fab (heavy Chain)0101
Chain L, Igg2b-kappa 40-50 Fab (light Chain)0101
Chain A, Na, K-ATPase alpha subunit0011
Kruppel-like factor 50101
Sodium/potassium-transporting ATPase subunit alpha-1 0101
Sodium/potassium-transporting ATPase subunit beta-30101
MecA 0101
Kynurenine 3-monooxygenase0101
Lysine-specific demethylase 5C0202
Prolyl 4-hydroxylase subunit alpha-10202
Peptidyl-prolyl cis-trans isomerase A 0101
Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial0101
Lysine-specific demethylase 5D0101
Lysine-specific demethylase 5B0101
Lysine-specific demethylase 2A0202
Lysine-specific demethylase 3A0101
L-lactate dehydrogenase C chain0101
L-lactate dehydrogenase A chain0101
L-lactate dehydrogenase A chain0101
L-lactate dehydrogenase 0101
Chain A, Bacterial leucyl aminopeptidase0101
Methionine aminopeptidase 10101
Oxytocin receptor0011
Chain B, Cell division protein kinase 60101
Chain B, Cell division protein kinase 60101
Genome polyprotein0101
Chain A, Fatty acid-binding protein, adipocyte0101
Protein Tat0022
NAD-dependent protein deacetylase sirtuin-70202
Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A0101
Serine hydroxymethyltransferase, mitochondrial0303
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A 0202
Xaa-Pro dipeptidase0001
Photosystem I iron-sulfur center 0001
Pyrroline-5-carboxylate reductase 1, mitochondrial0101
Beta-adrenergic receptor kinase 10202
Rhodopsin kinase GRK10101
G protein-coupled receptor kinase 50303
G protein-coupled receptor kinase 50101
Beta-adrenergic receptor kinase 10001
Casein kinase I isoform alpha0101
Glycogen synthase kinase 3 0101
Tyrosine-protein kinase transforming protein Abl0101
Protein kinase C alpha type0202
Fructose-1,6-bisphosphatase 1 0101
Chain A, Protein (fibroblast Growth Factor (fgf) Receptor 1)0101
Chain A, Proto-oncogene tyrosine-protein kinase ABL10101
Chain A, Proto-oncogene tyrosine-protein kinase ABL10101
Chain A, Proto-oncogene tyrosine-protein kinase ABL10101
Chain A, Proto-oncogene tyrosine-protein kinase ABL10101
Chain A, Proto-oncogene tyrosine-protein kinase ABL10101
Dual specificity mitogen-activated protein kinase kinase 2 0101
Dual specificity mitogen-activated protein kinase kinase 1 0101
Chymotrypsin-like elastase family member 10202
Chymotrypsin-like elastase family member 2A0303
Chain A, Thymidylate Synthase0101
Chain A, Thymidylate Synthase0101
Chain A, Thymidylate Synthase0101
Serine hydroxymethyltransferase, cytosolic0112
Thymidylate synthase 0202
Beta-lactamase 10001
Protein S100-B0112
Protein S100-B0011
Amiloride-sensitive amine oxidase [copper-containing]0101
Diamine acetyltransferase 10101
Protein tyrosine phosphatase type IVA 20101
Protein tyrosine phosphatase type IVA 10101
Chain A, CATHEPSIN D0101
Chain B, CATHEPSIN D0101
Chain A, PLASMEPSIN II0101
Chain E, ENDOTHIAPEPSIN0101
Chain E, RHIZOPUSPEPSIN0101
Chain E, ENDOTHIAPEPSIN0101
Chain E, ENDOTHIAPEPSIN0101
Chain E, RHIZOPUSPEPSIN0101
Chain E, RHIZOPUSPEPSIN0101
Candidapepsin-20101
Pepsin A-50101
Gag-Pro polyprotein0101
Cathepsin E0101
Plasmepsin-10101
Plasmepsin-20101
Plasmepsin 4 0101
Aldehyde oxidase 10202
Aldehyde oxidase 10202
Ubiquitin-like modifier-activating enzyme 60101
Ubiquitin-like modifier-activating enzyme ATG70101
Ubiquitin-like modifier-activating enzyme 1 0101
NEDD80101
SUMO-activating enzyme subunit 20101
Macrophage colony-stimulating factor 1 receptor0101
Fatty-acid amide hydrolase 20101
Fibroblast growth factor 10022
Fibroblast growth factor 20112
Chain A, Mitogen-activated protein kinase 140101
Chain A, Mitogen-activated protein kinase 140101
Chain A, Immunoglobulin0011
Chain B, Immunoglobulin0011
Muscarinic acetylcholine receptor M50113
Membrane primary amine oxidase0102
Chain A, TRYPSIN0101
Chain A, TRYPSIN0101
Chain A, TRYPSIN0101
Chain A, TRYPSIN0101
Chain A, TRYPSIN0101
Chain A, TRYPSIN0101
Membrane primary amine oxidase0001
Trace amine-associated receptor 10033
Trace amine-associated receptor 10022
Trace amine-associated receptor 10134
Chain A, Lysozyme0011
Chain A, Lysozyme0011
Chain A, Lysozyme0011
Chain A, Lysozyme0011
Chain A, Ferritin light chain0022
Chain A, Ferritin light chain0022
Chain A, Ferritin light chain0022
Chain A, Ferritin light chain0022
Chain A, Ferritin light chain0022
Chain A, Ferritin light chain0022
Chain A, Ferritin light chain0022
Alpha-1B adrenergic receptor0505
Trace amine-associated receptor 50033
Myeloblastin0101
Sodium/hydrogen exchanger 9B20101
Sodium/glucose cotransporter 1 0101
Proto-oncogene vav0011
Protein kinase C delta type0112
Chain A, phosphoenolpyruvate carboxykinase, cytosolic0101
Chain A, Phosphoenolpyruvate Carboxykinase, Cytosolic0101
Phosphoenolpyruvate carboxykinase, cytosolic [GTP]0101
Chain A, Alkaline Phosphatase0101
Chain A, ALKALINE PHOSPHATASE0101
Fe(3+)-Zn(2+) purple acid phosphatase0101
Chain E, THERMOLYSIN0101
Chain E, Thermolysin0101
Neprilysin0202
Acetylcholinesterase0101
Chain D, PROTEIN (PHOSPHOGLYCERATE MUTASE 1)0101
Chain A, PROTEIN (PHOSPHOGLYCERATE MUTASE 1)0101
Chain A, Beta-arrestin 10011
Chain A, PHOSPHOTIDYLINOSITOL 3 KINASE 59F0101
Chain A, PHOSPHOTIDYLINOSITOL 3 KINASE 59F0101
Chain A, PHOSPHOTIDYLINOSITOL 3 KINASE 59F0101
Chain A, PHOSPHOTIDYLINOSITOL 3 KINASE 59F0101
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial0202
Acyl carrier protein, mitochondrial0202
Peroxiredoxin-10011
4-hydroxyphenylpyruvate dioxygenase0101
CDGSH iron-sulfur domain-containing protein 10202
Peroxisome proliferator-activated receptor gamma0101
Carnitine O-palmitoyltransferase 2, mitochondrial0202
CDGSH iron-sulfur domain-containing protein 20202
Transforming growth factor beta-1 proprotein0101
Mothers against decapentaplegic homolog 3 0101
C-X-C chemokine receptor type 40101
Atypical chemokine receptor 30011
C-X-C chemokine receptor type 40215
dual specificity mitogen-activated protein kinase kinase 12002
RAF proto-oncogene serine/threonine-protein kinase isoform b2002
Chain A, B-Raf proto-oncogene serine/threonine-protein kinase0101
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-10101
Chain A, Basic fibroblast growth factor receptor 10101
Chain A, AKAP9-BRAF fusion protein0101
Dual specificity mitogen-activated protein kinase kinase 40011
Regulatory protein E20011
Regulatory protein E20011
Calcium-activated potassium channel subunit alpha-10101
E3 ubiquitin-protein ligase ZFP910001
Sodium/potassium/calcium exchanger 40112
Sodium/potassium/calcium exchanger 20112
Oxygen-insensitive NAD(P)H nitroreductase0002
Beta-casein0101
Alpha-2A adrenergic receptor0202
3-oxo-5-alpha-steroid 4-dehydrogenase 20202
luciferase0001
Glutamine synthetase0011
Nociceptin receptor0011
Pannexin-10101
Solute carrier organic anion transporter family member 1C10303
Vascular cell adhesion protein 10101
Low molecular weight protein-tyrosine phosphatase A0202
Chain H, ALPHA-THROMBIN0011
Chain A, Transcriptional regulator qacR0011
Chain A, Transcriptional regulator qacR0011
Chain A, TETR FAMILY TRANSCRIPTIONAL REPRESSOR LFRR0011
Major pollen allergen Bet v 1-A0011
Glutamate 5-kinase0001
Nuclear receptor subfamily 2 group E member 10044
Free fatty acid receptor 20011
NADH-cytochrome b5 reductase 3 0101
Thyroid peroxidase0101
tyrosine-protein phosphatase non-receptor type 7 isoform 20404
Chain A, Protocatechuate 3,4-dioxygenase alpha chain0011
Chain B, Protocatechuate 3,4-dioxygenase beta chain0011
Exoribonuclease H 0202
Coproheme decarboxylase0011
Chain A, Protein (ricin)0101
Chain A, Protein (ricin)0101
Interleukin-50101
Interleukin-50101
Interleukin-5 receptor subunit alpha0101
Puromycin-sensitive aminopeptidase0202
Cyclin-dependent kinase 10101
Cdc20101
Chain A, PUTRESCINE-BINDING PROTEIN0011
Chain A, S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA CHAIN0101
Chain B, S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN0101
Chain A, S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA CHAIN0101
Chain B, S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN0101
Chain A, Mitogen-activated protein kinase 100101
Chain A, Mitogen-activated protein kinase 100101
Chain A, Mitogen-activated protein kinase 100101
Trans-sialidase0101
tyrosine-protein phosphatase non-receptor type 22 isoform 10202
Bifunctional dihydrofolate reductase-thymidylate synthase0101
Beta-hexosaminidase subunit beta0101
Dihydrofolate reductase0303
Bifunctional dihydrofolate reductase-thymidylate synthase0101
Bifunctional dihydrofolate reductase-thymidylate synthase0202
Multidrug and toxin extrusion protein 10101
Cytidine deaminase0101
Chain A, dATP pyrophosphohydrolase0101
Chain A, Adenylate cyclase type 50101
Chain B, Adenylate cyclase type 20101
Monocarboxylate transporter 20002
Chain A, APH(2')-Id0101
glucose-6-phosphate dehydrogenase0101
cGMP-dependent 3',5'-cyclic phosphodiesterase0303
N0101
DNA-directed RNA polymerase subunit alpha0101
DNA-directed RNA polymerase subunit omega0101
DNA-directed RNA polymerase subunit beta'0101
DNA-directed RNA polymerase subunit beta0101
Multidrug resistance protein 1a0001
Advanced glycosylation end product-specific receptor0011
Advanced glycosylation end product-specific receptor0011
5-hydroxytryptamine receptor 5A0101
Chitinase0202
Gastric inhibitory polypeptide receptor0101
Chain A, Thymidylate Synthase0101
Chain B, Thymidylate Synthase0101
Chain A, THYMIDYLATE SYNTHASE0101
Chain A, THYMIDYLATE SYNTHASE0101
Vascular endothelial growth factor receptor 30202
Chromaffin granule amine transporter0101
Synaptic vesicular amine transporter0101
Chain A, Bacterial regulatory proteins, tetR family0011
Chain A, Troponin C, slow skeletal and cardiac muscles0011
Chain A, Leukotriene A-4 hydrolase0101
Chain A, Leukotriene A-4 hydrolase0101
Chain A, Leukotriene A-4 hydrolase0101
Chain A, Leukotriene A-4 hydrolase0101
Chain A, Leukotriene A-4 hydrolase0101
Chain A, Leukotriene A-4 hydrolase0101
Chain A, Leukotriene A-4 hydrolase0101
Chain A, Leukotriene A-4 hydrolase0101
Chain A, Leukotriene A-4 hydrolase0101
Chain A, Leukotriene A-4 hydrolase0101
Chain A, Leukotriene A-4 hydrolase0101
Chain A, Leukotriene A-4 hydrolase0101
Chain A, Leukotriene A-4 hydrolase0101
Chain A, Leukotriene A-4 hydrolase0101
Chain A, Leukotriene A-4 hydrolase0101
Chain A, Leukotriene A-4 hydrolase0101
Chain A, Leukotriene A-4 hydrolase0101
N1L 0101
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR0011
Beta-lactoglobulin0011
MSRA protein0101
plectin 10101
Polymerase basic protein 20011
RNA-directed RNA polymerase catalytic subunit0011
Genome polyprotein0011
Chain A, 6,7-Dimethyl-8-ribityllumazine Synthase0011
Chain B, 6,7-Dimethyl-8-ribityllumazine Synthase0011
Chain H, Immunoglobulin Igg1 Heavy chain0011
Chain L, Immunoglobulin Igg1 Lambda Light Chain0011
Chain A, DODECIN0011
Chain A, DODECIN0011
Chain C, DODECIN0011
Chain E, DODECIN0011
DNA-directed RNA polymerase subunit beta0101
NH(3)-dependent NAD(+) synthetase0101
DNA-directed RNA polymerase subunit beta0101
Chain A, HIV-1 PROTEASE0101
Chain B, HIV-1 PROTEASE0101
Chain A, Endothiapepsin0101
Chain A, Endothiapepsin0101
Plasmepsin V 0101
Chain A, Activated Factor Xa Heavy Chain0101
Serine/threonine-protein kinase VRK10101
Lanosterol synthase0101
Prostaglandin G/H synthase 20101
Cytochrome c oxidase subunit 10101
Transporter0101
Sodium-dependent serotonin transporter0101
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B0404
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B0404
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B0404
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B0404
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B0404
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B0404
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D0404
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D0404
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D0404
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D0404
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B0404
Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4B0404
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase0404
Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase0404
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B0101
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D0101
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D0101
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D0101
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D0101
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D0101
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D0101
Phosphodiesterase 0202
Retina-specific copper amine oxidase0101
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B0202
cGMP-specific 3',5'-cyclic phosphodiesterase0202
Thrombin 0011
UDP-galactopyranose mutase0022
UDP-galactopyranose mutase0022
Eukaryotic elongation factor 2 kinase0101
Ubiquitin carboxyl-terminal hydrolase 10202
WD repeat-containing protein 480202
RuvB-like 10202
Neuromedin-U receptor 20011
Spermidine synthase0101
Spermine synthase0101
Spermidine synthase0101
Chain A, ADENINE-N6-DNA-METHYLTRANSFERASE TAQI0011
Chain A, Adenine-n6-dna-methyltransferase Taqi0011
Chain A, Histamine N-Methyltransferase0101
Chain A, Histamine N-Methyltransferase0101
Chain A, Modification Methylase Rsri0011
Chain A, Modification Methylase Rsri0011
Chain A, Ermc' Methyltransferase0101
Chain A, Ermc' Rrna Methyltransferase0101
Chain A, Uroporphyrin-III C-methyltransferase0101
Chain B, ADENINE-N6-DNA-METHYLTRANSFERASE TAQI0011
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase0011
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase0011
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase0011
Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase0011
tRNA (cytosine(38)-C(5))-methyltransferase0112
Adenosylhomocysteinase0001
Histone-lysine N-methyltransferase NSD20202
rRNA adenine N-6-methyltransferase0101
tRNA (guanine-N(1)-)-methyltransferase0011
Histone-lysine N-methyltransferase SETDB10101
Retinoblastoma-binding protein 50101
tRNA (guanine-N(1)-)-methyltransferase0011
N6-adenosine-methyltransferase catalytic subunit0101
Histone-lysine N-methyltransferase KMT5C0101
Protein dpy-30 homolog0101
Histamine N-methyltransferase0001
tRNA (guanine-N(1)-)-methyltransferase0011
N-lysine methyltransferase SMYD20101
DNA (cytosine-5)-methyltransferase 3B0101
Set1/Ash2 histone methyltransferase complex subunit ASH20101
Protein-S-isoprenylcysteine O-methyltransferase0101
Protein-S-isoprenylcysteine O-methyltransferase 0101
Transcription intermediary factor 1-alpha0202
E3 ubiquitin-protein ligase TRIM330202
Chain A, Lysr-type Regulatory Protein0011
Chain A, Lysr-type Regulatory Protein0011
Chain A, Lysr-type Regulatory Protein0011
Chain A, 146aa long hypothetical transcriptional regulator0011
Chain A, Anthranilate phosphoribosyltransferase0101
Chain A, Anthranilate phosphoribosyltransferase0101
Chain A, Anthranilate phosphoribosyltransferase0101
Chain B, Anthranilate phosphoribosyltransferase0101
Chain C, Anthranilate phosphoribosyltransferase0101
Chain A, Anthranilate phosphoribosyltransferase0101
Anthranilate phosphoribosyltransferase0101
Tyrosine-protein phosphatase YopH0101
Ubiquitin-like domain-containing CTD phosphatase 10101
B-cell CLL/lymphoma 9 protein0202
Cadherin-10303
Catenin beta-10617
Transcription factor 7-like 20303
Alanine aminotransferase 10002
Chain A, Hiv-1 Protease0101
Chain B, Hiv-1 Protease0101
Chain A, Protease0011
Chain B, Protease0011
Chain A, Protease0011
Chain B, Protease0011
Chain A, Proto-oncogene tyrosine-protein kinase Src0101
Tau-tubulin kinase 10101
Tau-tubulin kinase 20101
Chain A, Erk20101
Mitogen-activated protein kinase 20101
Mitogen-activated protein kinase 14 0112
Chain A, MAP KINASE P380101
Chain A, PROTEIN (MAP KINASE P38)0101
Chain A, PROTEIN (MAP KINASE P38)0101
Chain A, Protein (map Kinase P38)0101
Chain A, Extracellular Regulated Kinase 20101
Chain A, Extracellular Regulated Kinase 20101
Histone-lysine N-methyltransferase SMYD30101
Lanosterol synthase 0101
Chain A, PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET0101
Chain A, PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET0101
Chain A, PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET0101
vasopressin V1a receptor0011
oxytocin receptor0011
Vascular endothelial growth factor receptor 10303
Vascular endothelial growth factor receptor 20303
1,25-dihydroxyvitamin D-3 receptor 0101
Transcriptional activator protein LuxR0202
Chain A, POL polyprotein0011
Chain B, POL polyprotein0011
Chain A, POL polyprotein0011
Chain B, POL polyprotein0011
Chain A, POL polyprotein0011
Chain B, POL polyprotein0011
Chain A, POL polyprotein0011
Chain B, POL polyprotein0011
Chain A, POL polyprotein0011
Chain B, POL polyprotein0011
Chain A, Shikimate kinase0011
Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase0101
Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase0101
Pyruvate kinase PKLR0101
Neuraminidase0101
Cholecystokinin receptor type A0101
Eukaryotic translation initiation factor 4E0011
Peptidyl-prolyl cis-trans isomerase FKBP1A0101
Peptidyl-prolyl cis-trans isomerase FKBP1B0022
Programmed cell death protein 40112
Corticotropin releasing hormone receptor 20202
Laccase 0101
Chain A, Mitogen-activated protein kinase 140011
Chain A, Mitogen-activated protein kinase 140011
Chain A, Mitogen-activated protein kinase 140011
Chain A, Mitogen-activated protein kinase 140011
Chain A, Mitogen-activated protein kinase 140011
Chain A, Mitogen-activated protein kinase 140011
Chain A, Mitogen-activated protein kinase 140011
RuvB-like 20112
Sulfate anion transporter 10001
C-X-C chemokine receptor type 5 isoform 10101
Endoglycoceramidase II 0001
Sphingosine 1-phosphate receptor 20112
Sphingosine 1-phosphate receptor 40112
Sphingosine 1-phosphate receptor 30112
Sphingosine 1-phosphate receptor 50112
Chain A, Mineralocorticoid receptor0101
Chain A, Mineralocorticoid receptor0101
neurotensin receptor type 10033
Substance-K receptor0101
Orexin receptor type 10001
Cathepsin B0101
Thioredoxin glutathione reductase 0101
Chain A, Serine/threonine-protein kinase Chk10101
Chain A, Serine/threonine-protein kinase Chk10101
Chain A, Serine/threonine-protein kinase Chk10101
Chain E, Camp-dependent Protein Kinase0101
Chain A, Tyrosine-protein kinase ZAP-700101
Chain A, Tyrosine-protein kinase SYK0101
Chain A, Protein kinase C, theta type0101
Chain X, Proto-oncogene tyrosine-protein kinase Fyn0101
Chain A, Serine/threonine-protein kinase TAO20101
Casein kinase II subunit alpha'0101
Cyclin-T20101
Retinoblastoma-associated protein 0101
Cyclin-dependent kinase 1 0101
Acyl-CoA desaturase 10101
Insulin receptor0101
Cyclin-O0101
Hexokinase-40101
Beta-adrenergic receptor kinase 20101
Phosphorylase b kinase regulatory subunit alpha, liver isoform0101
Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform0101
Mitogen-activated protein kinase 1 0101
Casein kinase II subunit beta0101
Epidermal growth factor receptor0101
Mitogen-activated protein kinase kinase kinase 210101
Casein kinase II subunit alpha 0101
Testis-specific serine/threonine-protein kinase 10101
Calcium/calmodulin-dependent protein kinase type 1B0101
Kinase suppressor of Ras 20101
Serine/threonine-protein kinase Nek80101
Casein kinase II subunit alpha'-interacting protein0101
Kinase suppressor of Ras 10101
Protein odd-skipped-related 10101
Phosphorylase b kinase regulatory subunit beta0101
Lymphokine-activated killer T-cell-originated protein kinase0101
Testis-specific serine/threonine-protein kinase 20101
Testis-specific serine/threonine-protein kinase 30101
Testis-specific serine/threonine-protein kinase 60101
Serine/threonine-protein kinase WNK10101
Inactive tyrosine-protein kinase PEAK10101
Serine/threonine-protein kinase Sgk20101
Ribosomal protein S6 kinase beta-20101
Serine/threonine-protein kinase WNK20101
Chain A, Ribosomal protein S6 kinase alpha-10101
Chain X, Tyrosine-protein kinase Lyn0101
Chain A, Dual specificity protein kinase TTK0011
Chain A, Dual specificity protein kinase TTK0011
Zinc finger protein GLI20202
DNA repair and recombination protein RAD54-like0011
Sentrin-specific protease 60101
Sentrin-specific protease 20101
Sentrin-specific protease 10202
Protein-arginine deiminase type-10101
Protein-arginine deiminase type-30101
Protein-arginine deiminase type-20101
Glycine receptor subunit beta0101
Mast/stem cell growth factor receptor Kit0101
Bromodomain-containing protein 90011
Bromodomain-containing protein 70011
Fibroblast growth factor receptor 10202
Chain A, Cell division protein kinase 20101
Chain A, Cell division protein kinase 20101
Chain A, Cell division protein kinase 20101
Chain A, Cell division protein kinase 20101
Substance-P receptor0202
Growth hormone secretagogue receptor type 10011
Chain A, Protein (aspartate Aminotransferase)0011
Chain A, Aspartate Aminotransferase0011
Delta-aminolevulinic acid dehydratase0101
NADP-dependent malic enzyme, mitochondrial0001
Solute carrier family 13 member 30101
Chain A, MALTOPORIN0011
Chain B, MALTOPORIN0011
Protein argonaute-20022
Cytochrome P450 2C180101
Chain A, Glutathione S-transferase0101
Transcription regulator protein BACH10101
Transcription factor MafK 0101
Complement C50011
ATP-dependent 6-phosphofructokinase0101
Ectonucleoside triphosphate diphosphohydrolase 20101
Ectonucleoside triphosphate diphosphohydrolase 10101
Dual specificity protein phosphatase 50101
Ectonucleoside triphosphate diphosphohydrolase 80101
Ectonucleoside triphosphate diphosphohydrolase 3 0101
Chain A, Alpha-mannosidase Ii0101
Chain A, ALPHA-MANNOSIDASE II0101
Chain A, Alpha-mannosidase Ii0101
Lysosomal alpha-mannosidase0101
Mannosyl-oligosaccharide alpha-1,2-mannosidase IA0202
Alpha-mannosidase 20101
Alpha-1,2-mannosidase family protein0101
Putative alpha-1,2-mannosidase0101
Alpha-1,2-mannosidase, putative0101
Putative alpha-1,2-mannosidase0101
Putative alpha-1,2-mannosidase0101
Putative alpha-1,2-mannosidase0101
Putative alpha-1,2-mannosidase0101
Glycoside hydrolase family 920101
Glycoside hydrolase family 920101
Alpha-1,2-mannosidase0101
Putative alpha-1,2-mannosidase0101
Alpha-1,2-mannosidase, putative0101
Putative alpha-1,2-mannosidase0101
Alpha-1,2-mannosidase0101
Alpha-1,2-mannosidase, putative0101
Putative alpha-1,2-mannosidase0101
Putative alpha-1,2-mannosidase0101
Alpha-1,2-mannosidase0101
Putative alpha-1,2-mannosidase0101
Putative alpha-1,2-mannosidase0101
Putative alpha-1,2-mannosidase0101
Putative alpha-1,2-mannosidase0101
Alpha-1,2-mannosidase family protein0101
alpha-1,2-Mannosidase 0101
Chain A, Oxysterols receptor LXR-beta0101
Chain A, Oxysterols receptor LXR-beta0101
Nuclear receptor ROR-alpha0314
Oxysterols receptor LXR-beta0011
Oxysterols receptor LXR-beta0011
Nuclear receptor ROR-beta0213
Chain A, ACETYLCHOLINESTERASE0101
Chain A, liver Carboxylesterase I0101
Gastrotropin0011
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform0202
cGMP-specific 3',5'-cyclic phosphodiesterase0112
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma0101
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha0101
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'0101
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma0101
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta0101
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta0101
Kynurenine 3-monooxygenase0101
Prolyl endopeptidase FAP0101
Chain A, CES1 protein0101
Phospholipase D1 0101
Emopamil-binding protein-like0202
7-dehydrocholesterol reductase0112
Alpha-1D adrenergic receptor0101
Alpha-1B adrenergic receptor0101
Alpha-1A adrenergic receptor0101
Heat-shock protein0101
menin isoform 11001
Chain A, Prostatic Acid Phosphatase0101
Sodium/bile acid cotransporter0001
Ileal sodium/bile acid cotransporter0001
Ileal sodium/bile acid cotransporter0001
Solute carrier organic anion transporter family member0001
Solute carrier organic anion transporter family member 4A10002
Beta-lactamase 0101
Beta-lactamase0101
Metallo-beta-lactamase type 20101
Metallo-beta-lactamase L1 type 30101
Beta-lactamase 0101
Beta-lactamase 0101
Stromal interaction molecule 10101
cGMP-gated cation channel alpha-10011
Tetracycline resistance protein, class B0001
Ras guanyl-releasing protein 30011
Solute carrier family 22 member 40001
Solute carrier family 22 member 30001
Solute carrier family 22 member 40001
Chain A, Multidrug-efflux Transporter 1 Regulator Bmrr0011
Alpha-enolase0101
Chain A, Pyridoxal kinase0101
Chain A, Pyridoxal Kinase0101
Adenosine receptor A10101
Serine palmitoyltransferase 10011
Serine palmitoyltransferase 20101
Chain A, ykoF0011
Chain B, ykoF0011
Chain A, ThiT0011
Thiamine transporter ThiT0011
Transketolase0011
Thiamine-binding periplasmic protein0011
Urease subunit alpha0101
Urease subunit beta 0101
Thymidine kinase 0204
Thymidine kinase0103
Chain A, ANAEROBIC RIBONUCLEOTIDE-TRIPHOSPHATE REDUCTASE LARGE CHAIN0011
Chain A, ANAEROBIC RIBONUCLEOTIDE-TRIPHOSPHATE REDUCTASE LARGE CHAIN0011
Chain A, Deoxynucleoside kinase0101
Chain A, Thymidylate Synthase0011
Thymidine phosphorylase0101
Chain X, Thyroid hormone receptor beta-10022
Chain X, Thyroid hormone receptor beta-10022
Proliferating cell nuclear antigen0202
Malate dehydrogenase, mitochondrial0101
Monocarboxylate transporter 80001
Solute carrier organic anion transporter family member 1C10001
Glutamate dehydrogenase 1, mitochondrial 0101
P2Y purinoceptor 130101
Chain B, Protein farnesyltransferase beta subunit0101
Geranylgeranyl transferase type-1 subunit beta0101
Protein farnesyltransferase alpha subunit0101
CAAX farnesyltransferase subunit beta 0101
Chain A, Carbonic anhydrase 10101
Carbonic anhydrase 20101
jumonji domain containing 2C, partial0001
jumonji domain containing 2A0001
cathepsin S isoform 1 preproprotein0101
Transcription factor 40101
Adenomatous polyposis coli protein0202
Chain A, RIO-type serine/threonine-protein kinase Rio10011
Tyrosine-protein phosphatase non-receptor type 120101
Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with trehalose0101
Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with cellobiose0101
Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with maltose0101
Trehalose-phosphatase0101
Putative nitroreductase0102
Nitroreductase0001
Nitroreductase A0101
Chain A, Nuclear Receptor ROR-beta0101
Chain A, HDLP (HISTONE DEACETYLASE-LIKE PROTEIN)0101
Chain B, HDLP (HISTONE DEACETYLASE-LIKE PROTEIN)0101
Chain A, Histone deacetylase 7a0101
Chain A, Histone deacetylase 7a0101
Histone deacetylase 0202
unnamed protein product0001
Histone deacetylase 10404
Histone deacetylase 30101
Histone deacetylase 20101
Histone deacetylase 10202
Adenosine receptor A10101
Histone deacetylase 0202
Histone deacetylase 40101
Polyamine deacetylase HDAC100101
Histone deacetylase 30202
Histone deacetylase 70101
Histone deacetylase 80101
Histone deacetylase 110101
HD2 type histone deacetylase HDA106 0404
Histone deacetylase 90101
Histone deacetylase 70202
Histone deacetylase 6 0202
Histone deacetylase 40202
Histone deacetylase 60202
Histone deacetylase 50101
Histone deacetylase 0202
NLRP3 protein0101
Epoxide hydrolase B0101
Chain A, enoyl-acyl carrier reductase0101
Chain C, enoyl-acyl carrier reductase0101
Chain A, enoyl-acyl carrier reductase0101
Chain C, enoyl-acyl carrier reductase0101
Chain A, enoyl-acyl carrier reductase0101
Chain C, enoyl-acyl carrier reductase0101
Chain A, Repressor0011
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI0101
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI0101
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI0202
Enoyl-acyl carrier reductase0101
Enoyl-ACP reductase II 0101
Delta0101
Cycloeucalenol cycloisomerase0101
Sterol-8,7-isomerase0101
Dihydrofolate reductase 0101
Dihydrofolate reductase0101
Forkhead box protein M10202
Chain A, CARBONIC ANHYDRASE II0101
5-hydroxytryptamine receptor 4 0001
Chain A, Trp Rna-binding Attenuation Protein0011
Chain K, Trp Rna-binding Attenuation Protein0011
Chain B, tryptophanyl-tRNA synthetase0011
Chain C, Tryptophanyl-tRNA synthetase II0011
Tryprostatin B synthase0001
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase0011
Chain A, Purine nucleoside phosphorylase0101
Chain A, Purine nucleoside phosphorylase DeoD-type0101
guanine nucleotide-binding protein subunit alpha-150112
D(3) dopamine receptor isoform e1001
trace amine-associated receptor 10112
Chain A, CHORISMATE MUTASE0101
Chain A, TYROSYL-tRNA SYNTHETASE0011
Chain A, Bacterial leucyl aminopeptidase0101
Aminopeptidase B0202
M1 family aminopeptidase0202
Cytosol aminopeptidase0202
Aminopeptidase N 0101
Interleukin-1 receptor antagonist protein0101
Cytosol aminopeptidase0202
Aminopeptidase N0202
Leucyl-cystinyl aminopeptidase0101
Bacterial leucyl aminopeptidase0202
Endoplasmic reticulum aminopeptidase 20101
Aminopeptidase B0101
Endoplasmic reticulum aminopeptidase 10101
Spindlin-10101
Chain A, Uracil-DNA Glycosylase0101
CAD protein0001
Chain A, Cytidine Deaminase0101
UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit0202
P2Y purinoceptor 140022
P2Y purinoceptor 60011
Ribonucleoside-diphosphate reductase subunit M2 B0001
Chain A, orotidine 5'-monophosphate decarboxylase0101
Chain B, orotidine 5'-monophosphate decarboxylase0101
Chain A, orotidine 5'-monophosphate decarboxylase0101
Chain A, orotidine monophosphate decarboxylase0101
Chain A, orotidine monophosphate decarboxylase0101
Chain B, orotidine monophosphate decarboxylase0101
Chain B, PyrR bifunctional protein0011
P2Y purinoceptor 40011
N-acetyllactosaminide alpha-1,3-galactosyltransferase0101
P2Y purinoceptor 2 0112
P2Y purinoceptor 20011
Polypeptide N-acetylgalactosaminyltransferase 10101
Polypeptide N-acetylgalactosaminyltransferase 30101
Polypeptide N-acetylgalactosaminyltransferase 100101
Polypeptide N-acetylgalactosaminyltransferase 130101
Polypeptide N-acetylgalactosaminyltransferase 60101
Polypeptide N-acetylgalactosaminyltransferase 140101
Basic phospholipase A2 10101
Hemagglutinin0011
Basic phospholipase A2 PLA-A0101
Acidic phospholipase A2 EC-I0101
Ubiquitin carboxyl-terminal hydrolase 470101
Valacyclovir hydrolase0001
Chain A, Carbonic anhydrase II0101
Chain A, Arginase 10101
Aldo-keto reductase family 1 member A10101
Tripeptidyl-peptidase 20101
D-alanyl-D-alanine dipeptidase0101
Heat shock-related 70 kDa protein 20101
Chain A, Heat shock protein HSP 90-alpha0101
Chain A, Heat shock protein HSP 90-alpha0101
Chain A, Heat shock protein HSP 90-alpha0101
Glycoprotein0101
Sterol 14-alpha-demethylase0011
14-alpha sterol demethylase 0011
14-alpha sterol demethylase 0011
Chain A, Histone deacetylase-like amidohydrolase0101
Chain A, Histone deacetylase-like amidohydrolase0101
Gli10101
protein Wnt-3a precursor0101
Leukotriene A-4 hydrolase0101
Renin0101
Histone deacetylase 0101
REST corepressor 30101
Receptor-interacting serine/threonine-protein kinase 1 0101
Aurora kinase B-A0101
Vitamin K epoxide reductase complex subunit 1-like protein 10101
Vitamin K epoxide reductase complex subunit 10101
Vitamin K epoxide reductase complex subunit 1-like protein 10101
Vitamin K epoxide reductase complex subunit 1 0202
Ras-like protein 20101
Chain A, Tankyrase-20011
Chain A, Tankyrase-10101
Chain A, Tankyrase-10101
Protein Wnt-3a0101
Axin-20011
Lysosomal alpha-glucosidase0101
Chain A, Phosphodiesterase 4D0101
Chain A, cytokinin-specific binding protein0011
Histidine kinase 40011
Histidine kinase 30011
Ectonucleoside triphosphate diphosphohydrolase 10001
Tumor necrosis factor ligand superfamily member 110101
Butyrophilin subfamily 3 member A10012
Farnesyl diphosphate synthase0101
H0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
Chain A, PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT DELTA ISOFORM0101
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]